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The skeleton is an important structural framework for vertebrates that 
consists of bone and cartilage. Generally, the vertebrate skeletal system can 
be categorized into the appendicular, trunk and craniofacial skeletons. Each 
of these have different cellular origins and form through two distinct 
mechanisms: endochondral ossification, in which a cartilaginous template is 
first formed and then replaced by bone; or intramembranous ossification, in 
which cellular precursors are directly differentiated into bone. Some 
skeletal structures, such as the mandible, are unique and form via 
combinations of both processes. Skeletal dysplasias can affect both types 
ossification. Patients with ciliopathies manifest with multiple defects that 
affect most skeletal systems. In addition, two other classes of disease, the 
craniosynostosis syndromes and the chondrodysplasias, have several 
skeletal phenotypes also seen in ciliopathies, such as short limbs and 
craniosynostosis. In this project I focus on a ciliopathic mouse model, Fuzzy, 
in which both endochondral and intramembranous bones are affected. Cilia 
are cellular organelles that have multiple functions from fluid flow to signal 
transduction. They are associated with signalling perturbations in different 
pathways such as Hedgehog and Wnt. Specifically, I investigate molecular 
mechanisms, which cause micrognathia, mandibular hyperossification and 
short long bones. Furthermore, this project aims to compare and contrast 
some overlapping phenotypes between ciliopathies, chondrodysplasias and 
craniosynostosis syndromes, such as vertebral and sternal defects. Results 
obtained indicate that many craniofacial defects in the Fuzzy mutant, 
including micrognathia, mandibular hyperossification and craniosynostosis, 
can be rescued with genetic reduction of Fgf8. Defects affecting other 
skeletal elements are not rescued. These data suggest that loss of Fuzzy 
converges on Fgf8 regulation during craniofacial development, but effects 
on other skeletal systems are probably due to other signalling perturbations, 
notably Hedgehog signalling. 
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Chapter 1 General Introduction 
1.1 The skeleton 
The skeleton consists of bone and cartilage and is the structural framework 
for all vertebrates. Broadly speaking it can be classified into the axial and the 
appendicular skeleton. These portions of the skeleton form through 
different mechanisms and from different cellular origins (Reviewed by 
(Olsen et al., 2000). Generally, ossification can occur in two different 
methods: endochondral ossification, in which a cartilage template is first 
formed and then replaced by bone; and intramembranous ossification, in 
which bone is formed in the absence of cartilage. These two processes are 
described in detail in section 1.3. This project aims to compare the two types 
of ossification in a ciliopathic model: the Fuzzy mutant mouse (Gray et al., 
2009). 
 
The axial skeleton consists of the trunk and craniofacial skeleton. The 
former consists of the vertebrae, ribs and pelvis, whilst the latter gives rise 
to the head and face. The appendicular skeleton gives rise to the long bones 
and the sternum. Embryonically, these different skeletal regions develop 
from different cellular origins. 
1.1.1 Embryonic origins of the skeleton 
In vertebrates, the skeleton is derived from three different embryonic cell 
types. The lateral plate mesoderm gives rise to the appendicular skeleton, 
the paraxial mesoderm gives rise to the trunk skeleton, and the cranial 
neural crest (NC) contributes to most of the craniofacial skeleton (Hall and 
Miyake, 1992, Cohn and Tickle, 1996, Tam and Trainor, 1994). These 
precursors all arise from discrete regions in and around the neural tube on 
the dorsal region of vertebrates (schematized in fig 1.1). Initially, the 
ectoderm is differentiated into the neural plate and a non-neural epithelium. 
As the edges of the neural plate come together and fuse to form the neural 
tube, NC cells are induced (Gallera, 1971, Gilbert, 2006).  
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Once formed, the NC cells delaminate, undergoing an epithelial to 
mesenchymal transition as they leave the neural tube, and migrate to the 
periphery of the embryo (Duband et al., 1995). Subsequently, depending on 
their position along the rostral-caudal axis of the embryo, NC cells 
differentiate into a variety of cell types. The cranial neural crest cells give 
rise to the majority of the facial skeleton. Vagal, sacral and trunk NC are the 
more caudal cells. Trunk NC give rise to structures such as the adrenal gland 
and pigment cells while vagal and sacral NC give rise to the enteric nervous 
system and the parasympathetic ganglia, respectively (Trainor, 2005, 
Murdoch et al., 2012, Simkin et al., 2013, Gilbert, 2006).  
Embryonic origins of the craniofacial skeleton 
Cranial neural crest cells give rise to many craniofacial structures including 
but not limited to craniofacial neurons, teeth, cartilage, bone and connective 
tissue of the head and face.  There are distinct populations of NC cells arising 
from the forebrain, midbrain and hindbrain, which migrate to populate the 
head and face (LaBonne and Bronner-Fraser, 1998, Knecht and Bronner-
Fraser, 2002). Cells from the midbrain, or presumptive posterior 
mesencephalon, populate the first branchial arch (Osumi-Yamashita et al., 
1997). This is schematized in Fig 1.2.   
 
The branchial arches (BA) consist of a series of paired protrusions. They are 
lined up on either side of the midline along the ventral region of the embryo 
(Fig 1.2 shows a lateral view). BAs are formed by NC cells surrounding a 
mesodermal core. Both cell populations give rise to different skeletal 
structures of the head and face. NC cells give rise to the upper and lower jaw, 
and the frontal bone of the calvaria, whilst mesodermal cells give rise to the 
parietal bone of the calvaria and posterior parts of the cranium (Noden, 
1983, Noden, 1988). The majority of craniofacial cartilage and bone is 
derived from BA1. Cranial NC populates this arch by migrating from the first 
and second rhombomeres, the hindbrain and the midbrain. Cells that 
populate BA1 ultimately go on to form craniofacial structures including, but 
not limited to the upper and lower jaws and the palate (Gilbert, 2006). 
Formation of these bones is by both endochondral and intramembranous 





Figure 1.1 Cellular origins of the skeleton 
A) Dorsal tissue is separated into neural and non-neural ectoderm, which 
flank the neural folds. Neural folds specify the neural crest. 
B) Neurulation occurs as the non-neural ectoderm converges to form the 
neural tube.  
C) Neural crest cells arise from the neural folds and the non-neural 
ectoderm forms a continuous epidermis. Paraxial mesoderm is formed 
adjacent to the neural tube and is subsequently specified into sclerotome, 
which gives rise to the vertebra. The lateral plate mesoderm is formed more 
laterally and gives rise to the somatic mesoderm, subsequently giving rise to 














Figure 1.2 Schematic of a lateral view of the mammalian branchial 
arches.  
 
Dorsally the embryo can be segmented into rhombomeres (R1-R7) and the 
midbrain. Streams of neural crest cells originate from these regions and 
migrate into the branchial arches.  Neural crest derived mesenchyme that 




Embryonic origins of the appendicular skeleton 
The appendicular skeleton is derived from the lateral plate mesoderm. This 
consists of two mesodermal sheets, the splanchnic mesoderm and the 
somatic mesoderm, which are specified during neurulation (schematized in 
Fig 1.1 C). The former covers the dorsal endoderm and forms a mesothelium 
that covers visceral organs. The latter covers the ventral ectoderm and gives 
rise to connective tissue of the limb bud and appendicular skeleton. This 
skeletal derivative is thought to form entirely via endochondral ossification. 
 
Embryonic origins of the trunk skeleton 
The trunk skeleton, made up of the vertebra and ribs, is derived from the 
paraxial mesoderm, which flanks the neural tube on the dorsal region of the 
embryo (Schematized in Fig 1.1 C). This mesoderm is ultimately segmented 
into somites, which subsequently give rise to sclerotomal cells (Christ and 
Ordahl, 1995). The sclerotome migrates away from the somites and gives 
rise to different tissue types including the dorsal dermis and skeletal 
muscles as well as the trunk skeleton (Brand-Saberi and Christ, 2000). This 
comprises the vertebra, ribs and pelvis, all of which form through 
endochondral ossification. Development of the spine will be discussed in 
more detail in chapter 6. 
 
Apart from the embryonic origins from which different skeletal elements 
form, the key difference between them is in the method through which they 
ossify. Endochondral ossification is preceded by the formation of a 
cartilaginous template, whilst intramembranous ossification does not. 
1.1.2 Cartilage 
Cartilage is a flexible, avascular connective tissue, consisting of chondrocyte 
cells contained in a rich extracellular matrix (ECM). This tissue is hugely 
important throughout animals ranging from fish to amphibian to mammal, 
and for this reason it is highly evolutionarily conserved (Hall, 2005). The 
ECM in which the chondrocytes sit is composed of different types of 
collagens, most commonly collagen type II (COL2), as well as 
glycosaminoglycans (GAGs), such as proteoglycans, and various other 
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connective tissue fibers, such as elastin (Hall, 2005). Differences in 
cartilaginous composition contribute to different functions and define three 
main types of vertebrate cartilage: hyaline, elastic and fibrocartilage. 
 
Elastic cartilage consists of col2 and many elastic fibers, such as elastin and 
fibronectin. These fibers are densely packed enabling support of structures 
such as the pinna (the external ear.) Fibrocartilage consists mostly of type 1 
collagen fibers (COL1) arranged in parallel groups. In this way, dense COL1 
fibers provide a high degree of tensile strength and provide support during 
fracture healing and in structures such as the vertebral disks (Hall, 2005). 
 
Hyaline cartilage predominantly consists of GAGs and COL2. It is found at 
the articular tips of bones, the tips of ribs as well as the trachea and bronchi 
(Hall, 2005). High COL2 presence accounts for the high tensile strength 
found in this cartilage, and the high GAG content provides resistance to 
pressure. Due to its flexible yet supportive nature, hyaline cartilage acts as a 
template for bone formation during the process of endochondral ossification. 
1.1.3 Bone development 
Bone is extremely dense connective tissue, which has important roles in 
support, protection of internal organ and production bone marrow, which is 
needed for differentiation of lymphocytes and erythrocytes (Zhu et al., 2007, 
Morrison and Scadden, 2014, Hall, 2005). Structurally, it consists mainly of 
mineralized osseous tissue, of which there are two main types; cortical bone 
and cancellous bone. Cortical bone is very dense and typically makes up 
outer-bone mass. They have many small hollow passages running through 
them, called lacunae, which house bone forming cells known as osteocytes, 
and allow transport of ions such as calcium and phosphate (Talmage, 1970, 
Hall, 2005, Enlow, 1962). Cortical bone typically surrounds cancellous bone. 
Cancellous bone is less dense and highly vascular due to the presence of 
spicules of calcified fiber which are called trebeculae, (Odgaard, 1997). 
These fibers have space between them to house bone marrow and allow 
metabolic activity, such as hematopoiesis and calcium ion exchange 
(Morrison and Scadden, 2014, Hall, 2005). 
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On a cellular level, bone is formed from osteoblasts, which mature into 
osteocytes. The former produces a matrix, consisting of unmineralized 
osteoid. Osteoid is a metabolic bone matrix, which predominantly consists of 
type 1 collagen (COL1). Once this matrix forms, osteoblasts can mature into 
osteocytes to form mature bone. Osteocytes synthesize COL1 as well as 
other proteins, such as osteopontin (Hall, 2005). They are ultimately 
permeated with mineralized hydroxyapatite, which is a natural mineral 
consisting of calcium, phosphate and hydroxide (Clarke, 2008). Bone 
formation is a dynamic process in which osseous tissue is constantly being 
formed by osteoblasts and osteocytes as well as reabsorbed by osteoclasts. 
This is needed for maintenance of integrity and bone repair (Hall, 2005). 
 
As mentioned above, bone formation occurs through two key processes: a 
cartilage-dependent process called endochondral ossification, and cartilage-
independent intramembranous ossification. 
Endochondral Ossification 
Endochondral ossification, seen in the majority of skeletal elements in the 
body, is a well-characterised event in which cartilage is deposited and 
undergoes maturation, which is required for subsequent bone formation 
(reviewed by (Olsen et al., 2000). This occurs in a structure known as the 
growth plate and is schematized in Fig 1.7 .  
 
The initial cartilage template is formed from precursor cells, which 
aggregate at the site of cartilage formation, adhere to each other and 
become more tightly packed in a process called cellular condensation. This 
is done under the control of the transcription factor SOX9. In the presence of 
SOX5 and SOX6, SOX9 homodimerizes and directly binds to the first intronic 
enhancer of Col2a. (Lefebvre et al., 1998)(Bernard et al., 2003, Ng et al., 
1997, Bell et al., 1997) The importance of this is seen in Sox9 null mice, in 
which conditional inactivation in the limb bud results in an absence of long 
bone skeleton (Akiyama et al., 2002). 
 
These precursors are then differentiated into a specialized cell type known 
as chondrocytes. They deposit an extracellular matrix rich in collagens: 
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COL2, Collagen 9 and Collagen 11, as well as extracellular matrix 
components such as aggrecans, and GAGs (Hall, 2005, Han and Lefebvre, 
2008). This happens within a structure called the perichondrium, which is a 
layer of connective tissues surrounding the developing cartilage. In the 
growth plate these are referred to as resting chondrocytes. Under signaling 
cues, such as Fgf and Hh signaling (expanded upon in section 1.3), they are 
induced to proliferate in columns running parallel to the orientation of the 
developing skeletal element.  
 
Proliferating chondrocytes then differentiate into pre-hypertrophic and 
hypertrophic chondrocytes. During this process, morphological changes 
occur and cells become enlarged in size. These hypertrophic chondrocytes 
alter their collagen secretion from COL2 to a more ‘mature’ COLX, which is 
specific to hypertrophic chondrocytes (Shen, 2005). It is the formation of 
proliferative and hypertrophic chondrocytes, which is believed to drive 
longitudinal growth of the endochondral skeleton.  
 
Onset of hypertrophy is associated with the transcription factor RUNX2, 
which then upregulates factors necessary for osteoblast differentiation, 
including Osterix (Nakashima et al., 2002). Angiogenesis and vascularization 
of the mature cartilage enables delivery of hematocytes, osteoblasts and 
osteoclasts, which degrade the cartilage and synthesize bone in discrete 
regions known as primary ossification centers. These different stages of 
chondrocyte differentiation and bone deposition take place in a spatially 
organized structure known as the growth plate. Key signaling pathways 
relevant to this project that are involved in endochondral ossification will be 
described in section 1.3. 
Intramembranous ossification 
A variety of craniofacial bones, such as the cranial vault and sutures; as well 
as the lateral part of the clavicles, which are part of the appendicular 
skeleton, form via an alternative strategy without a cartilaginous template. 
This is called intramembranous ossification (Noden, 1992, Garzon-Alvarado 
et al., 2014). During this process, precursor cells, typically mesoderm or 
neural crest derived, undergo condensations similar to those described in 
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endochondral ossification. As in endochondral ossification, RUNX2 activity 
commits these cells to the osteoblast lineage and haploinsufficiency of 
Runx2 results in reduced ossificion of intramembranous bones (Nakashima 
et al., 2002, Komori et al., 1997, Lee et al., 1997).  
1.2 Signaling pathways relevant to this project 
Multiple signaling pathways are involved in development of the skeleton. 
These pathways include Wnt, Hedgehog (Hh), fibroblast growth factor 
signaling (Fgf) and bone-morphogenetic protein (BMP) signaling, to name a 
few. In this section I will describe the Wnt, Hh and FGF signaling, as they are 
particularly relevant to this project.  
1.2.1 Wnt signaling 
Wnt signaling is comprised of multiple intracellular signaling pathways: 
Wnt/b-catenin (or canonical Wnt), planar cell polarity (PCP) and the 
Wnt/calcium pathways. All of these pathways are initiated by binding of an 
extracellular Wnt ligand to the transmembrane Frizzled (Fz) receptor. The 
two most relevant to this thesis are the canonical and PCP pathways. 
 
Wnt ligands are secreted glycoproteins that are heavily modified prior to 
extracellular release. They can signal to the cell from which they were 
synthesized (autocrine signaling) or to neighboring cells (paracrine 
signaling). Post-translational modifications include lipid additions such as 
glycosylation and palmitoylation, which serve multiple roles from targeting 
ligands to different cellular domains and assistance in receptor binding 
(Smolich et al., 1993, Willert et al., 2003, Cong et al., 2004, Tanaka et al., 
2002). Classically it was believed that different Wnts conferred differential 
pathway activation. Recently however, it has been shown that ‘non-
canonical Wnts’ can activate the canonical pathway in certain contexts (He 
et al., 1997, Mikels and Nusse, 2006, Tao et al., 2005). This suggests that 
pathway specification is determined by the cellular context in which ligands 
bind to FZ and its co-receptors. 
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Binding of the Wnts to FZ activates the intracellular protein Dishevelled 
(DVL). It is through this protein that signaling of both canonical and PCP 
pathways are mediated. 
Canonical Wnt signaling 
Canonical Wnt signaling is mediated through β-catenin, which is a 
transcriptional co-activator. On binding of canonical Wnt ligands to FZ, DVL 
inhibits the formation of a β-catenin destruction complex. This complex 
consists of multiple proteins including adenomatosis polyposis coli (APC), 
Axin and glycogen synthase kinase-3 (GSK-3).  
In the absence of canonical Wnt ligand, the destruction complex 
phosphorylates β-catenin, which leads to ubiquitination and targeting of b-
catenin to the proteosome for degradation. On ligand binding, the 
destruction complex is disrupted, leaving β-catenin is free to translocate 
into the nucleus and bind to TCF/LEF1 factors facilitating downstream 
transcription. These transcription factors control functions ranging from 
progenitor cell expansion, cell migration and cell fate decisions (well 
reviewed by (Grigoryan et al., 2008). Canonical Wnt signaling is schematized 
in Fig 1.3. 
Non-canonical Wnt PCP signaling 
PCP signaling does not involve β-catenin. It refers to the coordinated 
orientation of cells and structures along the plane of an epithelial surface. 
The pathway gives polarity to cells, thereby enabling them to perform 
complex and coordinated movements. As such, in mice, PCP is needed for 
cell orientation and migration that drives processes such as neural tube 
closure, and orientation of stereocilia in the cochlea (Montcouquiol et al., 
2003, Wang et al., 2005a, Kibar et al., 2001, Murdoch et al., 2001)  
 
Like the canonical pathway, PCP is dependent on Wnt binding to FZ and 
subsequent signaling via DVL. Outcomes of this pathway stem from a variety 
of different intracellular signaling cascades. For example, the establishment 
of polarity has been best described in Drosophila. Asymmetric localization of 
Dsh (the invertebrate homologue of DVL) and another core PCP 
transmembrane protein, Van Gogh (Vang) distinguishes “proximal” versus 
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“distal” sides of the cell (Figure X). During this process, Vang is localized 
asymmetrically and recruits an accessory protein Prickle (Pk). Pk 
subsequently binds to Dvl and inhibits the formation of local Dsh and Fz 
complexes. In this way, Vang/Pk complexes are activated in different 
cellular regions to one another, thus inducing polarity (schematized in fig 
1.4). Although this has been best described in controlling hair cell 
orientation in Drosophila, loss of core PCP components, such as DVL and 
VANGL2 in mice results in non-uniform cell orientation in the cochlea and a 
loss of PCP dependent digit extension (Wang et al., 2005a, Gao et al., 2011). 
With regards to cell motility, PCP signaling induces a cascade resulting in 
actin rearrangement. In this situation, FZ activation of DVL initiates a 
signaling cascade of the Rho GTPase family, such as RhoA, Cdc42 and Rac, 











Figure 1.3 Schematic of canonical wnt signaling 
 
The Wnt ligand binds to the transmembrane Frizzled (Fz) receptor. 
Subsequently, Dischevelled (Dvl) inhibits a β-catenin destruction complex, 
enabling β-catenin mediated transcription of TVC and LEF1  target genes. 
In the anbsence of the Wnt ligand, Dvl does not inhibit the destruction 
complex. Accordingly β-catenin is targeted for proteosomal degradation and 










Figure 1.4 Schematic of non-canonical Wnt PCP signaling 
 
Differential accumulation of Frizzled (Fz)  and Dishevelled (Dvl) on the 
‘dorsal’ side of the cell, compared to Van-Gogh (Vang) and Prickle (Pk) on 
the ‘proximal’ side, induces polarity. This is established by feedback 
signaling from Vang/Pk to Fz/Dvl in the ‘proximal’ region. 
Fz and Dvl can also influence the actin cytoskeleton by signaling through the 







1.2.2 Hedgehog signaling 
Hedgehog (Hh) signaling is a key developmental pathway during 
embryogenesis. Like Wnt signaling, its main function is in transduction of 
extracellular signals into intracellular responses. This is done via Hh ligand 
binding to the extracellular Patched (PTC) receptor. Subsequent 
downstream events are mediated by Gli transcription factors. 
 
In mammals there are three Hh ligands: Desert Hedgehog (DHH), Indian 
Hedgehog (IHH) and Sonic Hedgehog (SHH). The former is important for 
spermatogenesis whilst the latter two are more involved throughout 
development (Clark et al., 2000). Like the Wnts, Hh ligands are proteins that 
undergo multiple post-translational lipidation modifications prior to 
secretion (Pepinsky et al., 1998, Chamoun et al., 2001). Lipid modification, 
as well as oligomerisations is reported to contribute to long range signaling, 
whilst membrane tethering influences short range events (Vyas et al., 2008, 
Zeng et al., 2001, Gallet et al., 2006, Pathi et al., 2001). As such HHs are 
known to travel short and relatively long distances to bind to PTC. As such 
they have been seen to 300μm in vertebrate limb buds (Briscoe and 
Therond, 2013).  
 
Structurally all three ligands are similar and can all bind to and activate Ptc 
and its co-receptors (Kavran et al., 2010). In addition, the amino terminal of 
HHs is sufficient to induce downstream signaling events (Porter et al., 1996, 
Bumcrot et al., 1995, Lee et al., 1994) Comparative analysis, in cell and organ 
culture, has been carried out to determine whether there are differences 
between each ligand to mediate downstream events. This, revealed that in 
most contexts, such as limb bud explant manipulation of digit patterning, 
and Hh regulation of hypertrophy, there is differential potency between 
them such that SHH>IHH>DHH (Pathi et al., 2001). In neural plate explants, 
however, they were equipotent in inducing Islet-1, which is typically induced 
by Shh during neurogenesis. PTC exists in two homologues with PTC1 
thought to be the major receptor during embryogenesis (Adolphe et al., 
2014). In the absence of Hh ligands, PTC inhibits transmembrane protein 
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smoothened (SMO). Hh binding to PTC stops this inhibition and allows SMO 
to mediate downstream Hh events (Wang et al., 2009). 
 
Gli proteins mediate transcriptional responses to Hh signaling. In mammals, 
there are three different Gli proteins which all have similar DNA binding 
properties. They all contain a C-terminal activation domain whilst only Gli2 
and Gli3 contain an N-terminal repressor domain (Pan and Wang, 2007, 
Briscoe and Therond, 2013). When at full length, Gli2 and Gli3 can be 
processed into either activators or repressors however Gli2 mostly provides 
activator activity whilst Gli3 usually provides repressor activity (Matise et 
al., 1998, Litingtung et al., 2002, Pan and Wang, 2007). Gli1 has not been 
shown to have essential roles in mammals, but excessive Gli1 activity is 
associated with tumorigenicity (Park et al., 2000, Clement et al., 2007, Stecca 
et al., 2007). 
 
In general terms, in the absence of the Hh ligand, PTC inhibits activity of 
SMO. This enables full length Gli2 and Gli3 to be phosphorylated by protein 
kinase A (PKA), Casein kinase I (CKI) and GSK3β. Phosphorylation causes 
proteolytic cleavage of full length Glis into their repressor forms (Liu et al., 
2005b, Tuson et al., 2011, Sillibourne et al., 2002, Barzi et al., 2010). 
Conversely, binding of Hh ligands to PTC relieves inhibition of SMO. Active 
SMO enables Glis to avoid post-translational processing and in this way they 
are maintained in their long-form activator forms. Therefore, as a result of 
Hh ligand binding, there is an increase in the amount of Gli activator (GliA) 
compared to Gli repressor (GliR). This is schematized in Fig 1.5.  
 
Adding further complexity to the Hh signaling pathway, different Glis act 
individually or in combination to regulate tissue specific processes (Ruiz i 
Altaba, 1999, Pan and Wang, 2007). Hence, proper Hh signal transduction is 
dependent on the ratios of Gli activators to Gli repressors and different 
target genes respond differentially to these ratios. For example, in mouse 
neural tube formation, ventral neuronal differentiation is dependent on 
inhibition of Gli repressors whilst in floor plate induction; Gli2 activators are 
crucial (Matise et al., 1998, Ruiz i Altaba, 1999). In recent years, proper Hh 
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signaling has been seen to be dependent on proper formation of the cilia. 









Figure 1.5 Basic schematic of Hedgehog signaling 
 
On binding of the Hedgehog (Hh) ligand, Patched (Ptc) no longer inhibits 
Smoothened (Smo). Smo inhibits multiple phosphorylation proteins, which 
enables full length Gli to act as a transcriptional activator (GliA). 
In the absence of the Hh ligand, Ptc inhibits Smo. As a result, 
phosphorylation proteins target full length Gli for proteosomal degradation 
into its repressor form (GliR). 
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1.2.3 FGF signaling 
FGF signaling is an important mechanism through which a variety of 
biological processes are controlled. These range from early developmental 
programs of the embryo, regulation of cellular behaviors such as cell 
survival, proliferation and differentiation; and control of tissue behavior 
such as patterning, morphogenesis and organogenesis (Niswander et al., 
1993, Bellusci et al., 1997, Peters et al., 1993). As a result of the diverse roles 
of FGF signaling, it is no surprise that aberrant FGF signaling has been 
associated with a plethora of human diseases ranging from deafness to 
skeletal malformations (Mohammadi et al., 2005). 
 
The diverse roles of FGF signaling have evolved through the presence of a 
large number of FGF ligands, coupled with multiple forms of FGF Receptors 
(FGFRs) and co-receptors, which are expressed in a tissue specific context. 
In mammals, there are 18 secreted FGF glycoprotein ligands numbered FGF 
1-10 and FGF 16-23. FGFs 11-14 are intracellular proteins that function in a 
receptor-independent manner. FGFs 15, -19, -21 and -23 circulate in the 
blood stream to exert their functions in a hormone-like manner; whilst FGFs 
1-10, 16-18, -20 and -22 act as local growth factors (Goldfarb, 2005, Itoh and 
Ornitz, 2008). All FGFs have a homologous central region flanked by highly 
divergent amino and carboxy termini (Goetz et al., 2010, Kalinina et al., 
2009).,The different activities of the ligands can be partially attributed to 
these varying regions (Mohammadi et al., 2005). In addition, alternative 
splicing, as seen in FGF8 in the brain, and FGF10, in part confers ligand-
receptor specificity (Olsen et al., 2006, Yeh et al., 2003). 
 
Ligands act through transmembrane FGFRs, of which there are 5. 
Structurally, the FGFR1-4 are similar and consist of an extracellular 
immunoglobulin (Ig)-like domain, a transmembrane domain and an 
intracellular tyrosine kinase domain. FGFR5 lacks the tyrosine kinase 
domain. The extracellular portions of FGFRs consist of 3 Ig-like motifs (IgI-
IgIII). It is the IgII and IgIII regions that are essential for ligand binding. 
Extracellular portions of FGFRs also have an ‘acid box’, which is a serine-
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threonine rich domain that sits in the linker region between IgI and IgII, and 
is thought to be important for auto-inhibition.  
 
During signal transduction, ligands must bind specifically to FGFRs. 
Receptor diversity is established by exon skipping, which removes the acid 
box, and alternative splicing in the IgIII domain. Through these mechanisms, 
FGFR1-4 are diversified into 7 main FGFRs as a means to generate different 
ligand affinity (Beenken and Mohammadi, 2009). Receptor diversity is tissue 
specific, for example with regards to FGFR2, the –b isoforms are typically 
expressed in epithelia, whilst –c isoforms are usually expressed in 
mesenchyme (Orr-Urtreger et al., 1993).  
 
A functioning ligand-receptor interaction consists of ligand binding to IgII 
and –III and associated heperan sulphate proteoglycans. This leads to 
dimerization of the receptors and is essential for signal transduction to 
occur (Schlessinger et al., 2000). Receptor dimerization causes a change in 
conformation of the FGFRs. This subsequently activates the intracellular 
tyrosine kinase domains to trans-phosphorylate each other. Consequently 
there is recruitment of adapter proteins and activation of different 
intracellular signaling cascades. Three key pathways regulate cell 
proliferation, survival and motility. In each case, a variety of accessory 
proteins are required to bind to the FGFR in order to mediate these 
responses. 
 
FGFR substrate 2 (FRS2), son of sevenless (SOS), growth factor-receptor 
bound 2 (GRB2), Phospholipase Cγ (PLCγ) and GRB2-associated binding 
protein 1 (GAB1) are key accessory proteins. FRS2, GRB2 and SOS initiate a 
MAPK cascade. This primarily promotes genes required for cell 
proliferation; however, it can also lead to cell differentiation and migration. 
On the other hand, FRS2, GRB2 and GAB1 stimulate AKT kinase to inhibit 
apoptotic factors, thus promoting cell survival. Thirdly, PLCγ initiates a 
complex cascade involving diacyglycerol (DAG) and protein kinase C (PKC), 
which stimulates the expression of proteins needed for cell motility. These 
three pathways are schematized in fig 1.6. In more tissue specific contexts, 
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several other pathways can be activated including signal transducer and 
activator of transcription (STAT), p38 MAPK, Jun N-terminal kinase (JNK) 
and ribosomal protein S6 kinase 2 (RSK2) (see reviews by (Turner and 
Grose, 2010, Goetz and Mohammadi, 2013)). 
 
In a developmental context, one important downstream FGF signaling 
cascade is the MAPK/ERK pathway, which has been shown to stimulate 
cellular proliferation (Ho and Dowdy, 2002). Interestingly, in different 
cellular contexts, MAPK signaling can result in cell cycle arrest and 
differentiation (Laprise et al., 2002, Pumiglia and Decker, 1997). This shows 
the importance of tissue specificity for different FGF signaling roles. In 
addition, signaling can be modulated by negative feedback. A good example 
of this is the Sprouty (SPRY) proteins. These proteins form hetero- and 
homo- oligomers, through their C-terminal domains, and are thought to 
compete with binding of adaptor proteins such as GRB2 and FRS2. In doing 
so, SPRYs can inhibit and modulate downstream FGF signaling (Casci et al., 
1999, Ozaki et al., 2005). 
 
To summarize, FGF signaling can lead to many different outcomes in 
different biological contexts. This complexity is generated by tissue specific 
expression of ligands and receptors, differing binding affinities between 
ligands and receptors and a vast array of downstream signaling pathways 








Figure 1.6 Key downstream pathways of FGF signaling 
Receptor dimerization and signaling through the accessory proteins 
substrate 2 (FRS2), growth factor-receptor bound 2 (GRB2) and son of 
sevenless (SOS), initiate a MAPK signaling cascade to regulate cell 
proliferation 
Signaling through the accessory proteins FRS2, GRB2 and GRB2-associated 
binding protein 1 (GAB1) initiates an AKT cascade needed to promote cell 
survival. 
Signaling via FRS2 can also initiate a diacyglycerol (DAG) and protein kinase 





1.3 Hh, Wnt and Fgf in skeletal development 
The signaling pathways described above have specific and well-defined 
roles in both endochondral and intramembranous ossification. Key signaling 
events discussed are schematized in Fig 1.7. 
1.3.1 Signaling during endochondral ossification: 
Pre-chondrogenic condensations 
Prior to differentiation into chondrocytes, precursor cells undergo 
epithelial-mesenchymal transitions, which drive cellular condensations 
(Hall and Miyake, 2000). Condensed cells are densely packed as a result of 
upregulation of cell surface molecules, such as tenascin and heperan 
sulphate and adhesion molecules, such as N-CAM and N-cadherin. This 
enables cells to adhere to one another as a means of initiating condensations 
and establishing the condensation boundaries (Hall and Miyake, 2000). TGF-
β and BMP receptors are expressed in pre-chondrogenic condensing 
mesenchyme but not differentiated chondrocytes themselves, implicating 
them in the formation of an inductive environment (Hall and Miyake, 2000).  
 
One important transcription factor, SOX9, is expressed by condensing cells. 
It acts to initiate chondrogenesis in the place of ossification. SOX9 has roles 
in inhibiting RUNX2 activity via direct binding, and hence inactivation, as 
well as transcriptional repression and targeting for lysosomal degradation 
(Zhou et al., 2006, Yamashita et al., 2009, Cheng and Genever, 2010). This is 
one way in which cells are restricted from differentiating into osteoblasts. In 
addition to this, SOX9 is thought to make a physical complex with β-catenin. 
As a result of this, both proteins are inactivated, thus canonical Wnt 
signaling is thought to regulate condensations (Akiyama et al., 2004). The 
prediction is that as a result of the SOX9 and β-catenin interactions, as well 
as SOX9 and RUNX2 interactions, condensing cells are restricted to the 
endochondral pathway (Akiyama et al., 2004). The importance of this is seen 
in Sox9 null mice, in which conditional inactivation in the limb bud results in 
an absence of long bone skeleton (Akiyama et al., 2002). 
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Chondrogenic Differentiation 
Col2a1 expression induced by SOX9 is the hallmark of endochondral 
cartilage and Col2a1 is required for proper chondrogenic development. As 
such, mice lacking functional regions of the gene have severely stunted 
cartilage development (Zhou et al., 1995). Given the important role of SOX9 
in controlling Col2a1 expression, and the role of β-catenin in regulating Sox9 
expression, it is suggested that canonical Wnt signaling controls 
chondrogenic onset in the growth plate (Akiyama et al., 2004, Bell et al., 
1997).  
Chondrogenic proliferation and hypertrophy 
 
Proliferating chondrocytes express the same markers as resting 
chondrocytes (Leung et al., 2011). The characteristic columnar 
arrangements of proliferative chondrocytes are thought to be oriented by 
PCP signaling and in the absence of Prickle, columnar organization is lost 
(Yang et al., 2013). Sox9 expression in proliferative chondrocytes is required 
to inhibit Runx2 expression and activity in pre-hypertrophic chondrocytes. 
In this way it is believed to regulate transition from proliferation to pre-
hypertrophy (Dy et al., 2012, Zhou et al., 2006).  
 
FGF signaling is a key pathway in regulating the numbers of both 
proliferative and pre-hypertrophic chondrocytes in the developing growth 
plate. Fgfr3 expression in proliferating chondrocytes inhibits both 
proliferation and hypertrophic onset (Murakami et al., 2004, Peters et al., 
1993, Delezoide et al., 1998).  Although multiple FGF ligands, including FGF7, 
-8, -17 and -18 have all been detected in the perichondrium of developing 
limbs, FGF18 is thought to be the key ligand that signals via the FGFR3 in 
this context (Mason et al., 1994, Xu et al., 1999, Liu et al., 2002, Ohbayashi et 
al., 2002). In keeping with the important role of FGFR3, mouse knockout and 
gain-of-function mutants have dwarfism and enlarged long bones 




Ihh signaling is another main pathway through which pre-hypertrophic and 
hypertrophic onset is regulated. This is expanded upon in chapter 4 but 
briefly, Ihh is secreted from hypertrophic chondrocytes and works in a 
feedback loop with parathyroid hormone-related protein (PTHrP) in order 
to regulate the numbers of chondrocytes committed to hypertrophy. Ihh 
expression in hypertrophic chondrocytes also stimulates blood vessel 
invasion, needed for osteoblast migration and differentiation as well as 
apoptosis of the zone of hypertrophy as new bone is being formed (Colnot et 
al., 2005). The importance of Ihh for chondrocyte maturation is best seen in 
Ihh null mutants, which have severe dysplasia of all skeletal elements. This 
is associated with a loss of COLX expression and absence of chondrocyte 
hypertrophy in the growth plate of the humerus at multiple embryonic ages 
(St-Jacques et al., 1999) 
 
In humans, a common set of disorders called chondrodysplasias result in 
short endochondral. The most common is achondroplasia, also known as 
dwarfism. In these patients, chondrocyte maturation is perturbed during 
elongation of the long bones. This is due to gain of function mutations in 
Fgfr3, as is seen in FGFR3 mouse models. Additional skeletal abnormalities, 
including premature calvarial suture closure (craniosynostosis), can also be 





Figure 1.7 Pathways controlling endochondral and 
intramembranous ossification 
Both processes are initiated by cellular condensations, which express 
adhesion molecules such as N-CAM and N Cahdherin. This is in part under 
the control of TGF and BMP4. 
Endochondral ossification is associated with high Sox9 expression coupled 
with low Wnt and Runx2. Precursors are then differentiated into resting 
chondrocytes, which abundantly express COL2. Resting chondrocytes 
proliferate in columnar orientations prior to pre- hypertrophic and 
hypertrophic differentiation. Hypertrophic chondrocytes abundantly 
express COL10. Chondrocyte maturation is under the control of two key 
pathways. Signaling through FGFR3  and via and Ihh-PTHrP negative 
feedback loop (described in the text). Hypertrophic chondrocytes are 
subsequently replaced by bone under the control of Runx2. 
Intramembranous ossification is associated with low Sox9 expression and 
high Wnt and Runx2. Cellular precursors proliferate and differentiate into 
the osteoblasts. Osteoblast maturation into osteocytes is under the control 




1.3.2 Signaling during intramembranous ossification 
 
In pre-osteogenic condensations, contrary to chondrocyte differentiation, 
high levels of β-catenin degrades SOX9, which in turn allows Runx2 
expression (Akiyama et al., 2004, Zhou et al., 2006). This commits tissues to 
an osteogenic fate. In this way, Wnt signaling acts as a switch favoring 
intramembranous bone development over cartilage formation (Day et al., 
2005, Akiyama et al., 2004).  
 
Intramembranous ossification has been best described in the developing 
calvaria. Pre-osteogenic cells condense and directly differentiate into 
osteoblasts. This differentiation is dependent on maintenance of canonical 
Wnt signaling and as such it was shown that enhanced signaling resulted in 
excessive calvarial ossification in mice (Day et al., 2005). Initially, the 
calvaria grow as separate bones, with intervening joins known as calvarial 
sutures. The sutures are themselves sites of intramembranous bone 
formation (Opperman, 2000). 
 
In humans, premature closure of the sutures results in craniosynostosis 
(expanded upon in chapter 3). Given the clinical significance of this, 
ossification at these sites has been very well characterised and multiple 
defects have been attributed to aberrant FGFR signaling. Signaling through 
FGFRs stimulates all levels of osteoblast maturation during 
intramembranous bone formation. Specifically, enhanced osteoblast 
differentiation, proliferation and maturation has been attributed to 
activating mutations in three of the FGFRs . Signaling via FGFR1 and FGFR2, 
however, are the must culpable (Muenke and Schell, 1995, Park et al., 1995, 
Webster and Donoghue, 1996).  
 
FGFR1 is expressed in the calvarial mesenchyme and mature osteoblasts, 
whilst FGFR2 is expressed in differentiating osteoblasts (Hughes, 1997, 
Britto et al., 1998, Delezoide et al., 1998). Gain of function mutations in these 
receptors causes hyperactivation. These mutations in are typically dominant 
missense, in-frame insertions, or deletions resulting in constitutive receptor 
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activation, ligand independent dimerization, or receptor activation from 
inappropriate ligands (Wilkie, 1997, Britto et al., 2001, Wilkie and Morriss-
Kay, 2001). For example, several mutation in FGFR1 and -2 cause synostosis 
via constitutive activation of FGFRs. These mutations stabilize disulphide 
bonds within the receptor, causing ligand independent dimerization(Neilson 
and Friesel, 1995, Wilkie et al., 1995, Galvin et al., 1996, Robertson et al., 
1998).  
1.4 The cilium 
Abnormal formation or function of cilia results in a heterogeneous group of 
disorders known as ciliopathies (Veland et al., 2009). Recently, these have 
been associated with a variety of phenotypes ranging from cystic kidneys to 
obesity and mental retardation (Yoder, 2007, Han et al., 2014). 
Developmental defects are incredibly common and include defective 
skeletal development (expanded on in chapter 3) and organogenesis (well 
reviewed by (Goetz and Anderson, 2010). Cilia are finger-like, microtubule-
based organelles, which project from the cell surface on almost every cell 
type of the human body. Structurally they are composed of a basal body, 
which anchors the cilium to the cell membrane; and a microtubule based 
body known as the axoneme.  
 
There are two classes of cilia: motile or immotile. Motile cilia beat in 
coordinated waves, are present in large numbers, and have roles in fluid 
flow and clearance. For example, the cilia lining the trachea remove mucus 
from the airways while the cilia found in the fallopian tube are important in 
movement of the ovum (Engstrom, 1951, Halbert et al., 1976). Immotile cilia, 
also called primary cilia, are typically found singularly on the cell surface of 
most vertebrate cells and have very important roles in sensing the 
environment and in signal transduction. Microtubule organization within 
the axoneme differs between motile and primary cilia. Both have nine pairs 
of microtubules that project down the length of the axoneme, positioned 
around the circumference of the cilia. In addition, motile cilia have an 
additional pair positioned in the center (Pazour et al., 2005).  
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1.4.1 Ciliary Transport 
Proper formation of cilia is dependent on intracellular transport of proteins. 
This transport machinery is required to move structural axonemal 
components, membrane proteins and signaling molecules throughout the 
cilium. Within the cilium, the transport machinery consists of intraflagellar 
transport proteins A and B (IFT-A/B) and their associated IFT machinery. 
Kinesin-2 motor complexes consist of two kinesin-2 family proteins (KIF), 
KIF3A and KIF3B, which drive trains of IFT-B up the axenome (anterograde 
transport); whilst dynein motor complexes drive trains of IFT-A back down 
(Pedersen and Rosenbaum, 2008, Pigino et al., 2009). Because the transport 
machinery is critical for maintenance of the cilium, loss of proper 
ciliogenesis or transport of cargo has very severe consequences.  
1.4.2 Signaling pathways influenced by the primary cilium 
The primary cilium is critically important in vertebrate signal transduction. 
During development, Gli processing during Hh signal transduction appears 
to be dependent on an intact cilium (Tukachinsky et al., 2010). In addition, it 
has been suggested to act as a ‘switch’ to modulate between canonical and 
non-canonical wnt signaling (Zhang et al., 2011). 
Gli processing 
As described above in section 1.2.2, the ratios of GliAs to GliRs modulates 
the output of Hh signaling. In vertebrates, this processing has been shown to 
be dependent on the cilium. In the absence of the Hh ligand, Glis are 
associated with a Hh signaling complex consisting of Suppressor of fused 
(SUFU), Costal 2 and Fused. This complex delivers Gli proteins to a kinase 
complex, consisting of  multiple proteins including protein kinase A (PKA), 
Casein kinase I (CKI) and GSK3β. This protein complex is believed to 
associate with the base of the cilium (Sillibourne et al., 2002, Fumoto et al., 
2006, Barzi et al., 2010). Subsequently, phosphorylation is necessary to 
promote ubiquitination, which targets Glis for cleavage into their repressor 
forms (Jiang, 2006). Conversely, in the presence of the Hh ligand, SMO 
activation results in transport of Gli2, Gli3 and SUFU to the tip of the cilium 
(Wen et al., 2010, Kim et al., 2009, Chen et al., 2009). This is coupled with 
the dissociation of full length Glis with SUFU (Tukachinsky et al., 2010). This 
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translocation through the cilium is thought to allow them to avoid post-
transcriptional processing (Tukachinsky et al., 2010, Humke et al., 2010). 
Therefore, in the absence of a functioning cilium, full length Gli can not be 
processed into its activator or repressor forms  (reviewed by (Briscoe and 
Therond, 2013). 
Wnt and non-canonical Wnt Signaling 
The cilium is suggested to modulate both the canonical and non-canonical 
PCP signaling pathways. During PCP signaling, Dvl must localize to the basal 
body for signal transduction (Gao and Chen, 2010). In ciliated MEFs, 
immunostaining reveals that  DVL localizes with the basal body. Conversely, 
in unciliated MEFS, it did not. This was associated with a loss of PCP 
dependent processes such as a loss of cell polarization and significantly 
reduced cell movement (Zilber et al., 2013).  
 
On the other hand, the authors also showed in un-ciliated MEFs, there was 
hyperactivation of the canonical wnt pathway. There was greater canonical 
signal output in response to Wnt ligand, seen with a TopFlash reporter assay. 
Furthermore, un-ciliated MEFs had a high concentration of β-catenin in cell 
nuclei, whilst in ciliated MEFs, it was restricted to the cytoplasm. (Zilber et 
al., 2013). This led the authors to speculate that in the absence of the cilium 
there is more DVL available to contribute to the canonical pathway (Zilber et 
al., 2013, Zhang et al., 2011). Together, this data suggests that the cilium as 
the ability to modulate both PCP and canonical wnt signaling in certain 
contexts. This raises the intriguing question of whether it could also act as a 
‘cellular switch’ between the two pathways. 
1.4.3 Ciliopathies 
Given the important cellular and signaling functions of the primary cilium, 
ciliary dysfunction has been associated with a range of human phenotypes. 
These heterogeneous disorders are classified as ciliopathies (Veland et al., 
2009). In recent times, these have been associated with a variety of 
phenotypes ranging from cystic kidneys to obesity and mental retardation 
(Yoder, 2007, Han et al., 2014).  
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Ciliopathic mouse models are generated by knocking out structural and 
transport proteins required for ciliary formation and function. These mouse 
models have been shown to have defects in Hh signaling. This is seen well in 
IFT mutants. Kif3a null embryos have a severe reduction in Ptc1 expression, 
at e9.5. This is associated with spinal cord patterning defects similar to 
those seen in Gli3 null mutants (Persson et al., 2002, Huangfu et al., 2003). In 
addition IFT88 mutants display polydactyly attributed to misexpression of 
downstream Shh targets in the developing limb bud, which is also seen in 
Gli3 mutants, as well as neural tube patterning defects (Liu et al., 2005a, 
Babbs et al., 2008)  
 
Loss of proteins required in the basal body such as Meckel syndrome type-1 
(MKS1) and oro-facial digital syndrome type 1 (OFD1) is also associated 
with Hh defects. OFD1 mutants have reduced Shh, Ptc1 and Gli1 expression 
in the neural tube. They also have polydactyly, which they speculate is from 
abnormal Gli3 processing (Ferrante et al., 2006). Mks1 null embryos have 
similar phenotypes. In mouse mutants, Hh dependent neural tube 
patterning is abnormal and Mks1 was shown to act downstream of Ptc1, 
suggesting Gli processing is abnormal (Weatherbee et al., 2009). Polydactyly 
is observed in both mutants. Although increased expression of Shh, Ptc1 and 
Gli1 was not detected in developing limb buds, downstream targets of Gli 
repression were reduced. This implies that defective Gli3 processing is 
driving polydactyly (Ferrante et al., 2006). 
 
Ciliopathic mouse models have also shown defects in PCP signaling. Bardet-
Biedl Syndrome (BBS) genes code for a variety of proteins, which localize to 
basal bodies and contribute to axonemal trafficking (Su et al., 2014, Ansley 
et al., 2003, Tobin and Beales, 2007). In mouse, loss of several of these genes 
resulted in PCP defects such as loss of cellular orientation in the cochlea and 
abnormal neural tube closure resulting in exencephaly (Ross et al., 2005).  
 
The most striking phenotypes observed in ciliopathies are skeletal 
malformations such as truncations of the axial skeleton and craniofacial 
defects including craniosynostosis and a small lower jaw, which overlap 
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with those seen in achondroplasia and craniosynostosis syndromes (These 
are compared and described in chapter 7).  
 
Skeletal phenotypes in ciliopathic mouse models are striking. Mks1 mutants 
have a high arching palate, abnormal fusions between the ribs and the 
sternum as well as shortened and bowed hind limbs. In addition, reduced 
ossification of the calvaria is seen (Weatherbee et al., 2009). Ofd1 mutants 
have a bifid and hyperossified sternum, as well as short limbs, 
craniosynostosis and a high arching palate (Ferrante et al., 2006).  
 
Several of these phenotypes, such as craniosynostosis and short limbs are 
observed in chondrodysplasia and craniosynostosis syndromes. Chapter 3 
aims to compare and contrast some of the underlying causes driving these 
phenotypes. This will be done using the Fuzzy mutant, which is a ciliopathic 
mouse model that has a variety of skeletal defects. 
1.5 Fuzzy 
In this project I will use the Fuzzy mutant, which is a ciliopathic mouse 
model. This mutant has a variety of signaling and skeletal defects, which are 
discussed in this section 1.5.3. For this reason it is a good model in which to 
study defective skeletogenesis in ciliopathies 
 
My gene of interest in the project is Fuzzy. This gene was first identified in 
Drosophila, in which it was shown to regulate wing hair cell polarity and the 
numbers of hair cells (Collier and Gubb, 1997). The former observation 
suggests a role in planar cell polarity (PCP) signaling, which has historically 
been important for regulation of cellular orientation and polarity, whilst the 
later was attributed to a role in maintenance of cytoskeletal integrity which 
influences numbers of hair cells formed (Collier and Gubb, 1997, Tian et al., 
2009). Since then, cellular roles have been further characterised and the Fuz 
protein is shown to have important roles in ciliogenesis. The Fuzzy gene is 
evolutionarily conserved and has been identified in a variety of organisms 
including Xenopus, mouse and human. 
 43 
1.5.1 Fuzzy expression 
In vertebrates, Fuzzy expression is detected in dorsal tissue and in key 
regions important for craniofacial development. In situ hybridization shows 
that Fuzzy mRNA is detected in the developing mouse embryo at e8.5 in the 
dorsal tissue surrounding the neural tube and the brain (Seo et al., 2011). At 
later stages, Zhang et al., using a LacZ knock-in allele as a reporter, show X-
gal staining in dorsal tissue surrounding the neural tube. Later, at e11.5, 
expression is more concentrated in the brain, spinal cord and eyes but also 
weakly expressed in the heart and limbs. Staining then spreads more 
ventrally into craniofacial structures by e12.5 and can be seen in the oral 
epithelium and mesenchyme, as well as Meckel’s cartilage. By e14.5 it is 
widely detected in many craniofacial tissues including the oral epithelium, 
mesenchyme, palate, tongue, Meckel’s cartilage and the perichondrium. In 
addition, expression analysis in cell lines, by way of quantitative polymerase 
chain reaction (QPCR), also reveal an abundance in LS-8 (oral epithelial 
cells), MEFs, human embryonic kidney cells and human chondrocytes with 
weak expression in mouse dental mesenchyme cells (Zhang et al., 2011). 
1.5.2 Cellular roles of FUZ 
Studies in Xenopus and mouse have shed light on important cellular 
functions of the FUZ protein. Generally it appears to have roles in cellular 
trafficking. As a result of this, vesicular trafficking and secretion, as well as 
ciliogenesis are affected on manipulation of Fuzzy. 
 
In order to determine the Fuz protein structure and function, Gray et al 
carried out a yeast-two-hybrid screen (Gray et al., 2009). Results from this 
analysis suggested an interaction with open reading frame 89 on human 
chromosome 1. Subsequent BLAST analysis predicted this to encode a 
GTPase similar to vesicle targeting Rab proteins, which was re-named as 
RSG1. Co-immunoprecipitation studies then confirmed an association with 
between Fuz and RSG1 (Gray et al., 2009). Further studies revealed that 
RSG1 is associated with the cilia basal bodies and necessary for ciliogenesis 
(Brooks and Wallingford, 2013, Gray et al., 2009) 
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Homology modeling by Gray et al revealed that the C-terminus of the 
Xenopus Fuz protein adopts a quaternary structure of 5 beta-sheets flanked 
by 5 alpha-helices reminiscent of a longin domain, which is also seen in a 
variety of membrane trafficking and membrane fusion proteins such as 
membrane-fusing SNARE proteins (Gray et al., 2009, Pryor et al., 2008, Rossi 
et al., 2004). 
Roles in secretion and trafficking 
Consistent with homology modeling showing the FUZ longin domain, 
morpholino-oligonucleotide (MO) treated Xenopus cells revealed abnormal 
exocytotic and trafficking behavior. Scanning electron microscopy on 
Xenopus goblet cells (mucus secreting cells), revealed a reduction in open 
exocytotic vesicles associated with reduction mucous granule secretion. 
This is consistent with a loss of vesicular membrane fusion (Gray et al., 
2009). To confirm this, immunostaining for Intelectin2, which is a 
component of secreted mucus, was carried out in MO-treated embryos. In 
control samples, Intelectin2 was observed at and above the apical cell 
surface. In contrast, MO-treated cells, Intelectin2 accumulated below the 
apical cell surface only (Gray et al., 2009). In addition to this, Gray et al 
showed that interestingly, in Fuzzy morphants, vesicles could still fuse to 
one another. Together this data suggests that FUZ is needed for a subset of 
membrane fusions, and hence vesicular secretions in Xenopus. 
 
More generally, FUZ has been associated with trafficking in the cytoplasm. In 
mouse embryonic fibroblasts (MEFs), FUZ localized with a small GTPase 
known as Rab8, which is essential for vesicular transport (Zilber et al., 2013, 
Nachury et al., 2007, Linder et al., 2007). Subsequently, Zilber et al showed 
that DVL, which is trafficked to the cilium in certain contexts, was absent 
from the basal body in Fuzzy mutant MEFs (Park et al., 2008, Mahuzier et al., 
2012, Zilber et al., 2013).  
Role in ciliogenesis 
FUZ is now known to be a key regulator of ciliogenesis. Several imaging 
studies have reported loss or shortening of primary and motile cilia in fuzzy 
morpholino treated Xenopus embryos (Park et al., 2006, Gray et al., 2009). In 
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addition, on loss of Fuzzy, absence and shortening of cilia in mouse embryos 
has been documented in the notochord and limb buds at e11.5; the 
mandibular mesenchyme and Meckel’s cartilage at e14.5; and dermal cells at 
e15.5 (Zhang et al., 2011, Gray et al., 2009, Heydeck et al., 2009, Pigino et al., 
2009, Dai et al., 2011). These defects in ciliogenesis have been attributed to 
its role as a trafficking molecule. Rab8 (mentioned above) is not only 
important in vesicular trafficking but specifically trafficking of structural 
components to the ciliary axoneme (Nachury et al., 2007). Consistent with 
the association of FUZ and Rab8, overexpression of Fuzzy results in 
enhanced cilia length (Zilber et al., 2013). 
 
Defective trafficking to the cilium gives FUZ important roles for transport of 
cargo on the axoneme. Brooks and Wallingford showed that in the absence 
of Fuzzy, anterograde transport within the cilia is defective, with no 
localization of IFT-A trains to the basal body or trafficking on the ciliary 
axoneme. Conversely, IFT-B trains were localized to the basal body. This 
unidirectional transport allows initial building of the cilium but over time 
creates a ‘traffic-jam effect’. (Brooks and Wallingford, 2012, Gray et al., 
2009). In keeping with this, it was shown in Xenopus, that Fuzzy knockdown 
causes a loss of calponin homology and microtubule-associated protein 
(CLAMP) localization to the ciliary tip (Brooks and Wallingford, 2012, Gray 
et al., 2009). CLAMP is involved in the building of microtubules and is 
associated with the ciliary axoneme. As such transport on the axoneme is 
compromised. Together this data reveals that FUZ is needed for cilial 
integrity and functionality. 
1.5.3 Signaling perturbations and phenotypes in the Fuzzy mutant. 
Given the important roles of the cilium for different signaling pathways, it is 
no surprise that signaling perturbations have been associated with dramatic 
phenotypes in Fuzzy mutants. The proposed role of FUZ with regards to 
these pathways are schematized in Fig 1.8. 
Hh signaling 
Proper Hh signal transduction is dependent on proper transport of Gli 
proteins on the ciliary axoneme. Given the role of FUZ in ciliogenesis, it is no 
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surprise that the Fuzzy mutant has been associated with abnormal HH 
signaling.  
 
Previously we have shown that there is abnormal Gli processing in Fuzzy 
mutant heads at e9.0. Knock out of Fuzzy significantly increased levels of 
long form Gli proteins on loss of Fuzzy, indicative of a lack of Gli processing 
(Tabler et al., 2013). Consistent with this, we noted reduced expression of 
Hh signaling targets Ptc1 and Gli. Loss of Gli processing was also observed 
by Heydeck et al, who showed that there was a huge increase in the amount 
of long form to repressor form Gli in Fuzzy mutant whole embryos and limb 
buds at e10.5 (Heydeck et al., 2009). In addition, at e14.5, in Fuzzy mutant 
mandibles, a reduction in downstream Hh gene expression such as Shh, Gli1, 
and Ptch1 mRNA and protein was detected (Zhang et al., 2011). 
 
Phenotypes associated with Hh signaling are observed in multiple 
developmental systems of the Fuzzy mutant. Defective limb and neural tube 
patterning, as well as abnormal skeletal development have all been 
observed. 
 
The Fuzzy mutant has polydactyly. During the establishment of digit identity, 
a gradient of Gli3 is established to limit the number of digits formed 
(expanded upon in chapter 4). As such it was shown by Heydeck et al, that 
downstream targets of this gradient were all increased in Fuzzy mutant limb 
buds at e10.5. As a result of this, polydactyly in the Fuzzy mutant was 
attributed to abnormal Gli processing (Heydeck et al., 2009). In keeping with 
this suggestion, Gli3 mutants also have polydactyly (Babbs et al., 2008). 
 
Abnormal patterning of the spinal cord in the Fuzzy mutant has also been 
attributed to defective Hh signaling. Shh signaling is known to dictate 
dorsal-ventral patterning of the neural tube. In order to do this Shh is 
expressed in the floor plate, which is the most ventral structure of the spinal 
cord, and a gradient of expression is established with lower SHH in the more 
dorsal tissue. The strength of the signal specifies ventral cells into 
molecularly distinct domains by turning on different genes. In this way Shh 
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is important for neural tube patterning (well reviewed in (Sasai et al., 2014). 
Heydeck et al showed, with immunostaining, that there was a loss of SHH 
protein in the floor plate, as well as severely reduced expression of targets 
of the gradient, such as Foxa2 and Nkx2.2 (Heydeck et al., 2009, Heydeck 







Figure 1.8 Schematic showing proposed cellular functions of FUZ 
A) Signaling roles of FUZ in a normal cell. Three key pathways are thought to 
be influenced by FUZ activity.  
(i) FUZ is needed for ciliary assembly. The cilium is needed for processing 
the long from Gli into a repressor (Gli3R). This causes repression of 
downstream target genes. 
(ii) In non-canonical Wnt signaling, FUZ targets DVL the cilium. Cilia bound 
DVL is important in transducing PCP signals needed for cell polarity and 
actin dynamics. 
(iii) During Canonical Wnt signaling, DVL is needed to repress the β-catenin 
destruction complex. This enables β-catenin to activate downstream 
transcription events. 
B) In the absence of FUZ, cilia formation and trafficking is abnormal. This 
has knock on effects on signaling pathways described above. 
(i) On Hh ligand binding, full length Gli3 is not processed, this results in less 
Gli3 repressor, 
(ii) FUZ mediated localization of DVL to the cilium is inhibited causing a loss 
of PCP function. 
(iii) Loss of DVL targeting the cilium results in a greater pool of cytoplasmic 
DVL. This is thought to increase β-catenin stability and thus enhance the 






Canonical and PCP Wnt signaling 
The link between PCP signaling and ciliogenesis is an intriguing one. In 
recent years, it has been suggested that DVL trafficking to the cilium is 
essential for proper ciliary polarity (Park et al., 2008). As such, it has been 
suggested that ciliogenesis may be in part regulated by PCP signaling 
(Wallingford, 2006). It has also been suggested that there are perturbations 
in both non-canonical Wnt PCP and canonical Wnt signaling. Consistent with 
the role of Fuz in membrane trafficking seen in Xenopus and in tissue culture, 
vesicular trafficking of DVL from the cytoplasm to the cilium is disrupted on 
loss of Fuzzy (Zilber et al., 2013). This is associated with an increase in 
cytoplasmic DVL and hyperactivity in response to Wnt ligand (Zilber et al., 
2013). In addition, an upregulation of β-catenin and related target genes is 
seen in Fuzzy mutant mandibles at e14.5. As a result, Fuz is suggested to 
alter the balance between non-canonical and canonical wnt signaling (Zhang 
et al., 2011). Contrary to this, analysis of the skin of Fuzzy mutants revealed 
no changes in levels of Lef1, suggesting that this may be a tissue specific 
effect (Dai et al., 2011).  
 
The Fuzzy mutant has many phenotypes associated with defective PCP 
signaling. Loss of the Fuzzy gene in Drosophila resulted in a loss of hair cell 
and compound eye cell orientation (Collier and Gubb, 1997). PCP dependent 
convergence and extension movements are also defective in the mouse 
embryos. An open neural tube, occasionally associated with exencephaly is 
typically observed, as well as a kinked tail and heart development with a 
single outflow tract. These phenotypes are attributed to varying degrees of 
PCP driven convergent extension defects (Wallingford, 2006, Guyot et al., 
2011, Etheridge et al., 2008). In addition the role of Fuzzy in epidermal and 
dermal cells was shown via a lack of hair follicle differentiation in mouse, 
associated with abnormal PCP signaling (Dai et al., 2011).  
 
A subset of phenotypes in the Fuzzy mutant have also been attributed to 
enhanced canonical Wnt signaling . It was suggested by Zhang et al, that 
increased proliferation in mouse MC at e14.5 was responsible for cartilage 
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bifurcation in the Fuzzy mutant (Zhang et al., 2011). This is highly debatable 
and is the topic of chapter 4. 
Fgf Signaling 
Recently we discovered aberrant FGF gene expression in the Fuzzy mutant. 
Typically at e9.0 Fgf8 is expressed at the mid-hindbrain (MHB) boundary, 
frontonasal process and on lateral sides on the BA1 epithelium (See Fig 1.9). 
We showed that in Fuzzy mutants, the regions of Fgf8 expression were 
expanded in all of these regions and this was associated with increased 
expression of downstream markers erm1 and Pea3. Loss of Fuz in mouse 
mutants leads to maxillary hyperplasia and a high arching palate. We found 
that this phenotype was rescued on reduction of Fgf8 expression in the 
Fuzzy mutant, suggesting that FGF increases were directly linked to the 
craniofacial phenotype. Fig 1.9 shows BA1 expansion of Fgf8 expression. 
 
In addition, we saw aberrant NC migration into BA1 as well as increased 
numbers of NC in the maxillary portion of BA1 at e9.5. As such we have 
proposed a model in which loss of Gli3 repressor allows Fgf8 expansion in 
the regions described. Subsequently, NC migration into the maxillary 






Figure 1.9 Taken from (Tabler et al., 2013) Lateral views of Fgf8 
expression  
(A and B) Lateral views of Fgf8 expression in e9.0 embryos. Fgf8 is 
expressed in the midhindbrain boundary (MHB), frontonasal prominence 
(FNP), and the BA1 epithelium. In mutants, the region of Fgf8 expression is 
expanded, indicated arrowheads. 
(A’ and B’)  Magnified lateral view of BA1. Brackets indicated Fgf8 
expression.  
(C and D) Lateral view of BA1 in control and mutant embryos at e10.5. 
Arrowheads indicate increased region of Fgf8 expression.  
(E and F) Frontal view of Fgf8 expression in e10.5 embryos. Note 







The most striking phenotypes in the Fuzzy mutant are in the skeleton. The 
mutant has been shown to have defects in almost all skeletal systems 
ranging from craniofacial elements such as calvarial synostosis and 
micrognathia, as well as short long bones, polydactyly, sternal ossification 
and neural tube closure defects (Gray et al., 2009, Tabler et al., 2013, Zhang 
et al., 2011, Zilber et al., 2013). These phenotypes have mostly been 
attributed to lack of cilia mediated Hh signaling. However, as described 
above, loss of cilia has consequences on a variety of signaling pathways. This 
project will look in depth at some of these phenotypes and attempt to 
determine molecular causes of these defects. 
1.6 Project aims 
Generally this project aims to further characterise skeletal malformations in 
the fuzzy mutant and investigate which signaling perturbations could be 
driving these malformations. In more detail, chapter aims are as follows: 
 
 Chapter 3: Abnormal development of the long bones: In this chapter I 
document the phenotype seen in the long bones of Fuzzy mutants and 
attribute abnormal development to delayed chondrocyte 
hypertrophy. 
 
 Chapter 4: Micrognathia in the Fuzzy mutant. In this chapter I 
demonstrate that several key steps in mandibular outgrowth that can 
lead to micrognathia. Notably abnormal NC distribution in the 
presumptive mandible coupled with abnormal medio-lateral 
patterning during early embryogenesis affects the position of the 
prechondrogenic condensations of Meckel’s cartilage, resulting in 
premature fusion. 
 
 Chapter 5: Hyperossification of the mandible. In this chapter I 
characterise abnormal bone deposition in the Fuzzy mutant, which 
has not been previously observed. I determine that genetic reduction 
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of Fgf8 in the mutant rescues the phenotype implying defects in early 
embryogenesis, which contribute to abnormal ossification. 
 
 Chapter 6 Characterization of skeletal malformations of the sternum, 
vertebra and calvaria: By comparing phenotypes observed in 
craniosynostosis syndromes, chondrodysplasias and ciliopathies, I 
will try to establish whether overlapping phenotypes reveal 




Chapter 2 Material and Methods 
2.1 Animals 
Work using genetically modified animals was conducted in accordance with 
the UK Animals (Scientific Procedures) act of 1986 and King’s College 
London Research Ethics Committee. Work was carried out under project 
license (PPL) 70/6607 and 70/7441, with personal license number 
70/22485. 
2.1.1 Mouse strains 
Mouse lines were maintained on a mixed genetic background and 
maintained as heterozygotes. Matings were set up by introducing male and 
female mice in the evening. Vaginal plug checks were carried out on 
subsequent mornings; embryonic day 0.5 (e0.5) was defined from noon on 
the day of plug detection. At appropriate ages, pregnant mothers were 
sacrificed by cervical dislocation and the uterus was dissected out into ice-
cold phosphate buffered saline (PBS). Embryos were removed from yolk 
sacs whilst under a stereo-microscope (Leica Mz95) 
2.1.1.1 Fuzzy mutant mice 
Fuzzy mutant mice were generated as described by Gray et al (2009). A 
gene-trapping vector was inserted into the second exon of the Fuzzy gene 
(found on chromosome 7) in embryonic stem cells. It is predicted that this 
disrupts the transcription of the gene. Transcripts were selected by 
antibiotic resistance since the vector containing the gene trap contained a 
splice acceptor and neomycin resistant cassette (NEO). This enabled splicing 
to retain the NEO cassette. Vectors were microinjected into the blastocyst of 
C57BL/6 mice. This resulted in heterozygous FuzGt(neo) males and females, 
which were intercrossed to produce homozygous fuzzy mutants. 
Throughout the thesis they are denoted as Fuzzy-/-. 
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2.1.1.3 Col2::LacZ reporter mice 
A reporter mouse in which the col2 promoter driving expression of the lacZ 
reporter gene was used to visualize col2 expression (Zhou et al., 1995).  
 
2.1.1.3 Reduction of FGF8  
Fgf8L/+ mice have reduced Fgf8 expression due to insertion of a lacZ cassette 
into the coding region of the Fgf8 allele (Ilagan et al., 2006). These mice 
were intercrossed with heterozygous Fuzzy mice to generate compound 
Fuzzy+/-; Fgf8L/- males, which were subsequently mates with Fuzzy+/- females. 
2.1.2 Genotyping and genomic visualization 
2.1.2.1 DNA preparation 
Embryo tail tissue was used for DNA extraction. Tissue samples were 
digested at 55°C overnight in 250μl lysis buffer (50mM Tris pH8.0; 50mM 
EDTA; 50mM NaCL; 0.5% SDS) and 7.5μl of 20mg/ml proteinase K. DNA was 
precipitated using 5M NaCL and isolated using isopropanol. Resulting DNA 
was re-suspended in 500μl 0.1xTE. 
2.1.2.2 DNA amplification 
Standard polymerase chain reaction protocols were used to selectively 
amplify genomic DNA. The following reaction was used per sample. 
 
Water: 5.55μl 




Taq polymerase: 0.1μl 




The following PCR primers were used: 
 




Wildtype Forward AGTAGAGGCTCGGAGCCTTTA 
295bp 
Wildtype Reverse TCACCTAAGCCAGGAACCACT 
Mutant Forward AGTAGAGGCTCGGAGCCTTTA 
220bp 
Mutant Reverse ATAAACCCTCTTGCAGTTGCA 
LacZ 
Generic Forward TTTACAACGTCGTGACTG 
700bp 
Generic Reverse TGATTTGTGTAGTCGGTT 
 
2.1.2.3 Agarose gel electrophoresis 
Gels were made consisting of 2% agarose in 1x Tris-acetate buffer (TAE), 
which was also used as the running buffer during electrophoresis. DNA 
ladders of 1000bp were used to determine sample fragment sizes. 
Electrophoresis was carried out at 120V in a gel electrophoresis tank (alpha-
laboratories) and gels were imaged using an ultraviolet transilluminator 
(BioDock-ItTM Imaging system). 
2.2 Histology 
2.2.1 Tissue processing 
Dissected embryos were fixed in 4% paraformaldehyde (PFA) in PBS 
overnight at 4°C. Embryos were then washed in PBS then underwent a 
graded series of ethanol dehydrations (25%, 50%, 70%, 95%) for half a day 
in each concentration. Ethanol was then replaced by histoclear and washed 
twice at room temperature followed by an hour incubation in 1:1 paraffin to 
histoclear mixture. Samples were then incubated at 60°C in paraffin for a 
minimum of 4 hours with a minimum of 4 solution changes. Samples were 
then embedded at appropriate orientations and stored at 4°C ready for 
sectioning. 
2.2.2 Sectioning 
Wax embedded samples were sectioned at 7μms on a microtome and 
disposable blades (Leica). Sections were either mounted continuously or 
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sequentially over several slides on superfrost plus slides (Thermo Scientific) 
using RNAse free water. Slides were dried on a heating block (Raymond A 
Lamb Hotplate) over night at 37°C and then stored at room temperature 
until further use. 
2.2.3 Pico-Sirius red and Alcian Blue trichrome staining 
Paraffin was removed from slides via 2x 10-minute incubations in histoclear 
and then re-hydrated through decreasing ethanol concentrations for 2 mins 
per concentration (100%; 90%; 70; and 50%). Slides were then washed in 
de-ionised water (dH2O) and stained with Alcian Blue 8GX solution for 10 
minutes (1% in 3% acetic acid, pH2.5; Fluka), which stains for 
glycosaminoglycans and mucopolysaccharides. Slides were then washed in 
running water for 10 mins and incubated in Ehlrich’s Haematoxylin 
(Solmedia) for 2 mins to stain for cell nuclei and cytoplasm. Slides were 
again rinsed in dH2O and then exposed to 2.5% phosphomolybdic acid for 
10 mins prior to further dH2O rinsing. Subsequently sections were 
incubated in Sirius Red solution (0.5% in saturated picric acid; Direct Red 
80), to stain for bone, for one hour. Finally slides were rinsed twice in 0.5% 
acetic acid and de-hydrated over a graded series of ethanol. 3x 3-minute 
xylene washes were performed prior to mounting in DPX (Solmedia) 
 
2.2.4 Imaging 
Stained slides were imaged with a brightfield microscope (Zeiss AxioScop 2 
Plus) with an attached camera (Zeiss AxioCam HRc). Axiovision software 
was used for photograph acquisition. 
 
2.2.5 Cell counting 
For each sample, cell counts were taken over 3 successive sections and 
averaged. A minimum of 3 samples were analyzed for each genotype. 
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2.3 Whole Mount Embryo Staining 
2.3.1 X-gal Staining 
Embryos were dissected from pregnant mothers and fixed in ice cold 
4%PFA for 30mins. Samples were then washed in solution A (500ml 1x PBS 
with 1ml 1M MgCl2) for 5 minutes followed by 15 minutes (both at room 
temperature). Samples were then incubated in solution B for 5 mins at room 
temp (50ml PBS with 500μl 10% deoxycholic acid, 1ml 10% Igepal and 50μl 
1M MgCl2). Finally samples were left in staining solution consisting of 
solution B with 5mM K3Fe(CN)6, 5mM K4Fe(CN)6 and 1mg/ml X-Gal at room 
temperature. Samples were checked regularly to ensure no over staining 
occurred. Once staining was finished, samples were then imaged (Section 
2.3.5) or fixed for several days for optical projection tomography (OPT). 
2.3.2 Optical projection tomography 
After X-gal staining and fixation, embryos were thoroughly washed in PBS 
and suspended in 1% agarose in a petri dish. Once the agarose was set, 
excess agarose was trimmed away. The mount was washed with methanol 
and then the agarose block was attached with superglue. Once attached the 
agarose is further trimmed to ensure that the edges are flush with the 
mount. Sample and mount are then dehydrated and washed in methanol 
until no water is remaining in the agarose block and then washed a further 
time. Methanol is then replaced with 2 benzyl benzoate:1 benzyl alcohol 
(BBBA) and stored at room temperature away from light until the specimen 
is transparent. At this point the specimen is ready for imaging which took 
place in the OPT Scanner 3001 (Bioptonics). 3D image reconstruction was 
done using NRecon software (Bioptonics) and then the Bioptonics viewer 
(Bioptonics) was used for 3D image manipulation. 
 
2.3.3 Cartilage Staining 
Embryos younger then e15.5 were dissected into ice cold PBS and fixed in 
Bouins fixative (70% picric acid; 25% formaldehyde (37%) and 5% acetic 
acid) for 2 hours. Samples were then washed 6-8 times over 24 hours in 
70% ethanol with 1% ammonium hydroxide until embryos are white. 
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Samples were then washed twice in 5% acetic acid for 1 hour each and then 
stained in 0.05% alcian blue 8XG (Fluka) in 5% acetic acid overnight. Post-
staining, samples were washed in 100% methanol twice for an hour each 
and the cleared in BBBA until tissue was transparent. 
 
2.3.4 Alizarin Red staining 
Embryos older then E14.5, in which we wanted bone visualized as well as 
cartilage were dissected from pregnant mothers and skin and was dissected 
away. Samples were then fixed overnight in 95% ethanol at room 
temperature and then incubated with alcian blue staining solution for up to 
48 hours. Post-fixation was carried out in 95% ethanol overnight at room 
temperature and then specimens were cleared in 2% potassium hydroxide 
(KOH) until slightly translucent. At this point, extraneous tissues are further 
removed and samples were incubated in alizarin red staining solution  for 
24-48 hours. After staining, samples are cleared in 1% KOH with 20% 




Whole mount imaging was carried out using a stereoscope (Nikon 
SMZ1500) and photographs were taken with an attached camera (Nikon 
digital sight DS-Fi1). 
 
2.4 RNA in situ hybridisation 
All work with RNA was carried out in RNAse free conditions using 
autoclaved solutions and glassware. 
2.4.1 DNA transformation into competent cells 
Bacterial work was done with aseptic technique. DH5α competent cells 
(Invitrogen), stored at -80°C, were thawed on ice. 30μl of competent cells 
were mixed with approximately 1 μg/μl of stock plasmid. This mixture was 
incubated on ice for 20 mins and then heat shocked at 42°C for 30 seconds. 
Cells were then placed on ice again for 2 mins and then added to lysogeny 
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broth (LB) media to make a total volume of 500μl. This solution was 
incubated at 37°C for 30 mins. After this incubation, 100μl of cells were 
plated onto LB media with 100mg/ml ampicillin to select for resistant 
colonies. Cultures were grown over night and placed at 4°C until ready for 
amplification. 
2.4.2 DNA amplification 
Single colonies for amplification were isolated and transferred to either 
15ml falcon tubes containing 5ml LB media; or 1l conical flasks containing 
100ml LB media, both with 100mg/ml ampicillin. The former were used for 
mini preps and the latter for midi preps. Solutions were incubated overnight 
shaking at 225 rotations per minute (RPM) at 37°C. The next day plasmids 
were isolated from cultures using either the Qiaprep®Spin MiniprepKit or 
MidiprepKit, according to manufacturers instructions. Resultant DNA was 
quantified using a NanoDrop Lite Spectrophotometer (Thermo Scientific) 
and stored at -20°C.  
 
2.4.3 Plasmid linearization 
Plasmids were linearized using restriction enzymes with sites closest to the 
5’ end of the insert of interest (shown in table below). This was done in 
100μl reactions as follows: 2μl restriction enzyme (as specified in table 
below), 20μg plasmid DNA, 1μl bovine serum albumin (BSA), 10μl 10x 
reaction buffer and water up to 100μl. Reactions happened at 37°C 
overnight. The next morning, samples were treated with 1μl of 20mg/ml 
proteinase K, 5μl of 10% SDS and water to make the total reaction volume 
200μl. This was incubated at 55°C for 15 mins and then cleaned by adding 
200μl phenol:chloroform, spinning at 13000 RPM on a table top centrifuge 
and then removing the top aqueous layer (approximately 180μl) into a clean 
eppendorf. DNA was then precipitated by adding 20μl of 3M sodium acetate 
and 200μl isopropanol. Samples were spun and supernatants were removed 
and cleaned with 70% ethanol before being re-suspended in 20μl RNAse 
free water. RNA was then quantified, again using the NanoDrop Lite 

















mSox9 EcoR1 Ampicillin pBSIISK 525bp T3 
(Healy et 
al., 1999) 
mIhh BamH1 Ampicillin pBSIISK 1.8kbp T7 
(St-Jacques 
et al., 1999) 
mRunx2 EcoR1 Ampicillin pCMV5 1000bp T7 
(Xiao et al., 
2005) 
mBarx1 EcoR1 Ampicillin pBSIISK 951bp T7 
(Cobourne 
et al., 2004) 
 
2.4.4 Digoxigenin labeled RNA probe synthesis 
Probe synthesis reactions were carried out in total volumes of 50μl. Each 
reaction contained 3μl polymerase (as appropriate for each probe – see 
table above), 2μl of 40μg/μl RNAse inhibitor; 5μl Digoxigenin labeled NTPs, 
1μg DNA template, 10μl of 5x reaction buffer, 5μl of 100mM DTT and water 
to make reaction volume 50μl. The reaction was incubated at for 2 hours at 
37°C and then treated with 1μl DNAse1 for 20 mins at 37°C. The probe was 
then precipitated by adding 25μl of 8M lithium chloride and incubating at -
20°C for 1-2 hours. Samples were spun at 13000 RPM on a tabletop 
centrifuge, the supernatant was removed and the sample washed in 70% 
ethanol before being resupsended in 55μl RNAse free water. Probe was then 
quantified with the Nanodrop (Thermo Scientific) and stored at -80°C. 
 
2.4.5 Digoxigenin labeled in situ hybridization on paraffin sections. 
In situ hybridisation with digoxigenin labeled probes was used to visualize 
gene expression. Paraffin was removed from slides by washing three times 
in xylene for 10 mins each. Slides were then re-hydrated through a series of 
ethanol concentrations, twice for 2mins each (100%, 95%, 70%) and then 
washed in RNAse free water twice and post-fixed in 4% PFA for 10mins. PFA 
was removed by washing twice in PBS for 5mins each and then samples 
were incubated with 4μg/ml proteinase K for 8mins. After a 5 minute PBS 
wash, slides were fixed again in 4% PFA followed by another PBS wash. Next, 
acetylation was carried to remove electric charge on the slides in order to 
reduce background staining. This was done using 50ml H2O, with 625μl 
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triethanolamine (TEA), 130μl of 37% hydrochloric acid (HCL) and 125μl 
acetic anhydride. Slides were incubated for 10mins and then washed 3 times 
in PBS for 5mins each. Slides were again dehydrated through 70% and 95% 
ethanol and air-dried. During these dehydration steps 1μg of probe was 
added to 1ml of hybridisation solution. 100ml hybridization solution 
consists of the following:  
 
Formamide 50ml 
50% Dextran sulphate 20ml 
50x Denhardt’s solution 2ml 
10mg/ml Yeast tRNA 2.5ml 
5M NaCl 6ml 
1M Tris-HCL pH8 2ml 
0.5M EDTA 1ml 
1M Sodium phosphate 1ml 
20% Sarcosyl 5ml 
Water 10.5ml 
 
300μl of probe/hybridization solution was added to each slide and slides 
were subsequently covered with RNAse free coverslips and incubated at 
65°C overnight in a humid chamber. Finally, 20X saline sodium citrate (SSC), 
pH7 in 1litre of water was prepared ready for use the next day. 20X SSC 
consists of 175.3g sodium chloride and 88.2g sodium acetate dissolved in 
water. 
 
The next day, coverslips were removed in 5X SSC and washed in a high 
stringency wash, consisting of 50% formamide and 2X SSC, twice for 30mins 
at 65°C. Slides were then washed 3 times for 15mins each in RNAse buffer. 
This consists of 0.5M NaCl, 10mM Tris-HCL and 5mM EDTA pH8 made up in 
water. After the third wash, slides were incubated in RNAse buffer treated 
with 20mg/ml RNAse A (Invitrogen) for 30mins at 37°C. After this, again 
samples were washed in fresh RNAse buffer without RNAse A. High 
stringency washes are then repeated twice followed by washes in 2X SSC 
and then 0.1X SSC at 37°C for 15mins each. Then specimens were washed in 
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PBS Tween (PBTw), consisting of PBS and 0.1% Tween-20 for 15mins at 
room temperature. Finally slides were blocked for 1 hour in PBTw with 10% 
goat serum (GS) before incubating with alkaline phosphatase-coupled anti 
digoxigenin antibody (Boerhringer Mannheim), diluted at 1:5000 in PBTw 
with 1% GS, overnight at 4°C. 
 
In order to visualize RNA expression, on the next day, slides are washed 4 
times for 15mins in PBTw at room temperature. Then wash twice for 
10mins each in NTMT buffer. 100ml NTMT buffer consists of the following: 
 
5M NaCl 2ml 
1ml Tris-HCL pH9.5 10ml 




Prior to addition of NTMT buffer add 0.5mg/ml levamisole in order to 
reduce background staining. After NTMT washes incubate slides in BM-
purple AP substrate (Roche) with 0.5mg/ml levamisole and incubate in the 
dark at room temperature. Check slides every hour to ensure that over-
staining does not occur. Once staining has finished, was slides in PBS twice 
for 5mins each and then counterstain in 0.005% fast red (Polyscientific) for 
5mins. Finally dehydrate slides through 70%, 95% and 100% ethanol 
sequentially, incubate in xylene three times for 3mins each and then 





Chapter 3 Endochondral ossification in the Fuzzy mutant 
3.1 Introduction 
It has been previously observed that the Fuzzy mutant has short limbs and 
polydactyly (Tabler et al., 2013, Gray et al., 2009, Park et al., 2006). 
Individuals who have with a short stature as a result of reduced bone 
growth are described as having dwarfism. One of the most obvious 
phenotypes of dwarfism is delayed or reduced growth of the long bones 
resulting in short limbs relative to the trunk skeleton. Although in most 
cases of dwarfism, achondroplasia (enhanced FGFR signaling) is credited 
with being the causative factor, other signaling pathways have multiple 
roles in different aspects of limb development (Bellus et al., 1995, Elejalde 
and de Elejalde, 1985, Foldynova-Trantirkova et al., 2012). Both Hh and FGF 
signaling are essential for key steps of limb bud outgrowth, patterning and 
subsequent long bone elongation. 
 
A series of epithelial-mesenchymal interactions regulates outgrowth of the 
limb. Fgf10 expression in the mesenchyme initiates the budding of the limb 
mesenchyme, by stimulating cell survival and proliferation, and is believed 
to be responsible for inducing the apical ectodermal ridge (AER) (Ohuchi et 
al., 1997, Xu et al., 1998, Yonei-Tamura et al., 1999). This is an ectodermal 
thickening at the most distal tip of the limb bud, which overlies the 
mesenchyme.  
 
The AER is a key signaling center, which controls outgrowth of the limb bud. 
Removal of this region corresponds to varying degrees of truncation of the 
distal limb skeleton in chick (Saunders, 1948). Addition of FGF proteins to 
the limb bud can substitute for loss of the AER (Niswander et al., 1993, Vogel 
et al., 1996). Whilst both Fgf4 and Fgf8 are expressed in the AER, Fgf8 is the 
earliest detected in this region and is the key signal, whilst FGF4 can 
compensate in its absence to a certain degree (Crossley and Martin, 1995, 
Boulet et al., 2004). Recently it was shown that expression of these FGFs are 
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under the control of Tbx5, in the forelimb, and Tbx4, in the hind limb (Duboc 
and Logan, 2011). 
 
Proximal and distal zones of the developing limb are established through a 
counteracting retinoid acid gradient, emerging from the proximal limb bud, 
which works against the FGF gradient from the AER. Thus it is believed that 
exposing limb bud mesenchyme to FGF8 commits them to a distal fate, 
whilst exposure to retinoic acid commits to a more proximal fate (Mercader 
et al., 2000, Niederreither et al., 2002, Niswander et al., 1993, Yashiro et al., 
2004).  
 
As well as initial limb bud expansion and proximal-distal outgrowth, 
polarity is tightly regulated to ensure the correct number of digits is formed. 
This is controlled from a signaling center called the zone of polarizing 
activity (ZPA). The ZPA is a key organizer of anterior-posterior patterning, 
located in the posterior limb bud mesenchyme. A gradient of Gli3 repressor 
expression from the anterior (high expression) to the posterior (low 
expression) limb bud is responsible for ensuring the correct spatial 
expression of genes driving more anterior versus more posterior digit 
identity, including Pax9 and 5’ Hoxd genes respectively (Wang et al., 2000, 
McGlinn et al., 2005, te Welscher et al., 2002b).  
 
This Gli3 gradient is first set up through reciprocal antagonism between 
Gli3R, in anterior tissue, and dHAND, which is expressed in the more 
posterior limb bud (te Welscher et al., 2002a). In this way, dHAND 
subsequently activates Shh in the ZPA, which reduces Gli3 cleavage in the 
more posterior tissues, thus establishing a gradient of Gli3 from anterior to 
posterior (te Welscher et al., 2002b). Loss of Shh results in a single digit, 
whilst dual inactivation of Shh and Gli3 results in polydactyly (te Welscher et 
al., 2002b). This implies that in the distal part of the developing limb bud, 
Shh acts to counteract effects of the Gli3-R in the developing limb to 
establish the number of digits formed (Litingtung et al., 2002).  
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Signaling from the AER and ZPA must occur at similar times to ensure 
correct patterning of the developing limb bud as it grows out. This is done 
via a positive feedback loop in which the Shh expressed in the ZPA signals to 
the distal mesenchyme. This activates Fgf4 in the AER, which goes on to 
further stimulate Shh expression via gremlin mediated BMP4 antagonism in 
the ZPA (te Welscher et al., 2002b, Zuniga and Zeller, 1999). 
 
Once the anterior-posterior and proximal-distal identities of the developing 
limb have been established, long bone formation occurs via endochondral 
ossification (described in the chapter 1). Elongation of the individual 
elements is driven by cartilage maturation in the center of the cartilaginous 
growth plate. A schematic showing the key roles of Hh and FGF in long bone 
formation is shown in fig 1.6. 
As chondrocytes undergo hypertrophy they enlarge, as such, in mature 
chondrocytes, increases of cellular fluid volume by up to twenty times have 
been detected (Goldring et al., 2006). These cellular changes drive limb 
elongation (Goldring et al., 2006). Two key signaling pathways: Hh and Fgf 
control onset of cartilage hypertrophy. Ihh is the main ligand which is 
expressed in pre-hypertrophic and hypertrophic chondrocytes; its 
expression signifies and encourages hypertrophic maturation (St-Jacques et 
al., 1999). Ihh expression stimulates the expression of parathyroid related 
hormone protein (PTHrP), which in turn feeds back to inhibit Ihh expression. 
Via this feedback loop, the amount of hypertrophic chondrocyte 
differentiation is regulated and dictates the amount of longitudinal 
elongation (Chung et al., 2001). Interestingly, it was later discovered that 
Ihh activation of PTHrP is via inhibition of Gli3 mediated PTHrP repression 
(Koziel et al., 2005). Consistent with the importance of Ihh in long bone 
growth, Ihh null mice have severe shortening of the long bones, associated 
with a loss of proliferation and  hypertrophy (St-Jacques et al., 1999). 
 
FGF signaling is the other key regulator of cartilage maturation. Fgf9, -8, -17, 
and -18 have all been detected in long bone chondrocytes (Mason et al., 
1994, Xu et al., 1999, Ohbayashi et al., 2002). loss of FGF18 and -9 results in 
chondrogenic and osteogenic defects, such as a larger region of proliferative 
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and hypertrophic chondrocytes, and as such are thought to be the main 
FGFR3 ligands in this context (Liu et al., 2002, Ohbayashi et al., 2002, Hung 
et al., 2007). Signaling through the FGFR3 acts to regulate long bone 
elongation by limiting chondrocyte proliferation and hypertrophy (See 
Chapter 1). As such, animal models with gain of Fgfr3 mutations, have 
severely stunted long bone growth (Chen et al., 1999, Wang et al., 1999). 
Consistent with this, missense gain of function mutations of FGFR3 have 
been identified as causative in chondrodysplasia syndromes in humans 
(Bellus et al., 1995, Elejalde and de Elejalde, 1985).  
 
Interestingly, short limbs are occasionally observed in humans with certain 
ciliopathies such as Sensenbrenner and Ellis-Van Crevald syndromes, as 
well as mouse models of these same ciliopathies (Sensenbrenner et al., 1975, 
Pacheco et al., 2012). Therefore, short long bones are an example of an 
overlapping phenotype observed in both chondrodysplasia and ciliopathies. 
The former is attributed to gain of FGFR3 signaling whilst the mechanism 
driving the phenotype in ciliopathies and the Fuzzy mutant has not been 
explored in great detail. This chapter aims to fully characterise the onset of 
this phenotype in Fuzzy mutant mice, and to establish whether it is as a 




3.2.1 Cartilaginous elements of Fuzzy mutant limbs are shorter than in 
wildtype controls from e13.5 
 
Since it has been previously documented that the limbs of Fuz mutants are 
shorter then wildtype controls, I wanted to first characterise the defect in 
limb elongation. The maturation of resting chondrocytes into hypertrophic 
chondrocytes is believed to control the longitudinal elongation of the long 
bones (Goldring et al., 2006, St-Jacques et al., 1999). I carried out Alcian blue 
staining at e13.5, which is the age of hypertrophic onset in the limbs. 
Staining of wildtype and mutant forelimbs reveals that at this age, all of the 
cartilaginous elements of the mutants appear shorter (Fig 3.1 A and B). 
Quantification of the length of the radius (r) and humerus (h) reveal that 
both elements are significantly shorter in mutant embryos (Fig 3.1 C; 
p=0.0443 and p=0.0004 respectively; n=4). Polydactyly is also observed in 
the mutant forelimbs, which possess 8 digits as opposed to the normal 5 in 
the wildtype. 
3.2.2 At e14.5, Fuzzy mutant limbs do not have obvious regions of 
chondrocyte hypertrophy  
 
In wild-type embryo limbs, by e14.5, different stages of chondrocyte 
maturation within the growth plate are readily observable (Fig 3.2 A). Alcian 
blue staining in the wildtype limbs reveals regions with less Alcian blue 
colour retention, which correspond to chondrocyte hypertrophy (Fig 3.2 B, 
red arrowhead). All cartilaginous elements in the mutant forelimbs appear 
shorter then those in wildtype littermates and quantification of the radius 






Figure 3.1 e13.5 Fuzzy mutants have polydactyly and shorter 
cartilaginous elements of the forelimbs. 
(A and B) Alcian blue stained forelimbs of mutant and littermate control 
embryos at e13.5. The humerus (h) and radius (r) in the mutant (B) are 
shorter then the control (A). Polydactyly is observed in the limb of the 
mutant (8 digits compared to 5). Scale bar is 1mm. 
(C) Quantification of the radius and humerus lengths between Fuzzy 
mutants and littermate controls. Both cartilaginous elements are shorter on 







Figure 3.2 e14.5 Fuzzy mutants have shorter limbs and polydactyly.  
(A and B) Alcian blue stained forelimbs of wildtype (A) and Fuzzy mutant 
(B) embryos at e14.5. Wildtype limbs have regions of hypertrophy 
(arrowheads) in the humerus (h) and radius (r), as well as 5 clear digits 
(numbered 1-5). Fuzzy mutants have shortened cartilaginous elements of 
the humerus and radius and polydactyly is also observed (B, numbered 1-8). 
Scale bar is 1mm. 
(C) Quantification of the radius and the humerus lengths as shown in (A). 






3.2.3 Fuzzy mutant limbs have delayed chondrocyte maturation 
Since chondrogenic hypertrophy is believed to drive longitudinal elongation 
I carried out trichrome staining on sagittal sections of wildtype and mutant 
radii at multiple stages. This enabled me to visualize the growth plate of the 
developing limbs (Fig 3.3). In wildtype limbs, by e14.5, a clear region of 
hypertrophic (hc), proliferative (pc) and resting chondrocytes (rc) can be 
observed (Fig 3.3 A). One day later at e15.5, the regions of hypertrophy and 
proliferation are clearly enlarged and bone collar formation is taking place 
surrounding the central region of hypertrophy (Fig 3.3 C, black asterisk). By 
e16.5, there is a clear boundary between the proliferative and hypertrophic 
chondrocytes and the region of bone deposition (Fig 3.3 E). In Fuzzy 
mutants, histology at e14.5 and e15.5 reveals that the chondrocytes of the 
radii have not yet progressed past the resting phase (Fig 3.3 B & D). It is not 
until e16.5 that we begin to see regions of stacked proliferating 
chondrocytes and hypertrophic chondrocytes suggesting a delay in 
hypertrophic onset (Fig 3.3 F). 
3.2.4 Fuzzy mutant limbs have a loss of Ihh expression in developing 
long bones 
During chondrocyte differentiation, the transcription factor sox9 is 
expressed in resting chondrocytes while Ihh, a key regulator of chondrocyte 
terminal differentiation, is expressed in hypertrophic chondrocytes (St-
Jacques et al., 1999). Since we observed a delay in hypertrophic onset we 
decided to examine the expression of both Sox9 and Ihh (Fig 3.4). At e14.5 
trichrome staining of transverse sections through the radius revealed three 
different stages of chondrocyte progression as seen in fig 3.3 A. Sox9 
expression in the wild-type is restricted to the resting chondrocytes (Fig 3.4 
C), and Ihh expression is restricted to the hypertrophic chondrocytes (Fig 
3.4 E). In comparison, in the mutant limb, Sox9 expression appears to be 
expressed throughout the cartilaginous rod (Fig 3.4 D) and Ihh expression is 
massively diminished (Fig 3.4 F). This suggests that a loss of Ihh expression 





Figure 3.3 Delayed onset of hypertrophic chondrocytes in Fuzzy 
mutant limbs. 
Trichrome staining showing cartilage in blue and bone in red in sagittal 
sections of radii, cartilage in blue. (A and B) E14.5 embryos. Wildtype 
embryos (A) have defined regions of resting (rc), proliferative (pc) and 
hypertrophic (hc) chondrocytes. The mutant radius (B) appears to only have 
resting chondrocytes. 
(C and D) E15.5 embryos. In controls (C), the region of hypertrophy has 
expanded and is surrounded by the onset of bone formation (asterisk). 
Mutant forelimbs (D) only consist of resting chondrocytes at this stage. 
(E and F) E16.5. Control samples (E) have a defined region of bone 
formation (bc) adjacent to the zone of hypertrophy. In mutant samples (F), 
chondrocytes have just acquired a hypertrophic morphology. Vertical black 








Figure 3.4 E14.5 Fuzzy mutants have diminished Ihh expression in 
radii 
(A and B) Trichrome stained sagittal sections of radii, cartilage in blue. Fuzzy 
mutants (B) and littermate controls (A) at e14.5. ‘hc’ denotes region of 
hypertrophic chondrocytes and ‘rc’ represents region of resting 
chondrocytes. These are duplicates of Fig 3.3 A-B, for reference. 
(C and D) mRNA in situ hybridisation for Sox9 expression. Sox9 expression is 
restricted to resting chondrocytes of wildtype radii (C). In mutant radii (D), 
Sox9 is expressed throughout the cartilage. 
(E and F) mRNA in situ hybridisation for Ihh expression. In wildtype limbs 
(E) Ihh is expressed in the region of hypertrophic chondrocytes. In mutants 







3.2.5 Fuzzy mutant limbs have smaller regions of ossification 
Since, during normal development, the cells in the region of hypertrophy are 
degraded and replaced by bone, and the Fuzzy mutant has delayed onset of 
hypertrophy, we would expect less ossification in mutants. To examine this 
we carried out Alizarin red staining for osteogenic calcification (Fig 3.5). At 
e18.5, in the wildtype forelimb, ossification of the humerus (h), radius (r), 
and ulna (u) is evident (Fig 3.5). Ossification of the phalanges is also under 
way (Fig 3.5 A, green arrowheads). In contrast, in the Fuzzy mutant limb, 
although some ossification is observed, regions of ossification are shorter in 
the mutant limbs and ossification of the phalanges has not yet begun (Fig 3.5 
B). This observation is consistent with a delay in chondrocyte maturation. 
3.2.6 Genetic reduction of Fgf8 does not rescue the limb phenotype of 
the Fuzzy mutant. 
We have previously shown that genetic reduction of Fgf8 gene expression in 
the Fuzzy mutant rescues the phenotype of maxillary hyperplasia (Tabler et 
al., 2013). In addition, FGF signaling is the other key regulator of 
chondrocyte hypertrophy, with Fgf8 having previously been detected in 
chondrocytes (Xu et al., 1999). This led us to ask whether genetic reduction 
of Fgf8 rescues the short limb phenotype observed in our mutant. We tested 
this by genetically reducing the levels of Fgf8 in our Fuzzy mutants using a 
null allele of Fgf8 (Fgf8LacZ/+).  (Fig 3.6). In the wild-type embryo at e14.5, as 
has been described above, clear regions of chondrocyte maturation are 
observed (Fig 3.6 A; black arrowheads); whilst in the mutant, limbs are 
shorter and growth plate regions are less well defined (Fig 3.6 B; black 
arrowheads). Genetic reduction of FGF8 does not rescue either the short 
limb phenotype or polydactyly (Fig 3.6 C). Panel 3.6 D shows a control 
sample, which is heterozygous for both Fuzzy and Fgf8. The limb is 
comparable to that of the wild type, which suggests that a reduced level of 












Figure 3.5 Fuzzy mutants have shorter regions of ossification 
 
(A and B) Alizarin red staining for bone in forelimbs at e18.5. All skeletal 
elements of the long bone (humerus, radius and ulna; h, r and u 
respectively) can be seen in the wildtype sample (A). In addition, 
ossification of the phalanges is under way (green arrowheads; Fig 3.5 A).  In 
the mutant (B), the ossified region of all skeletal elements is shorter and no 








Figure 3.6 Reduction of Fgf8 gene expression does not rescue the short limb phenotype in the Fuzzy mutant.  
Alcian blue staining of forelimbs at e14.5. 
(A) Wildtype forelimbs have clear regions of chondrocyte hypertrophy (black arrowheads) and 5 digits. (B) Loss of Fuzzy results in short 
limbs with less obvious regions of chondrocyte hypertrophy (black arrowheads) and polydactyly. (C) Reduction of Fgf8 in the Fuzzy mutant 
does not rescue the short limb phenotype. Black arrowheads indicate less obvious regions of hypertrophy when compared with the wildtype. 
Embryos have polydactyly. (D) Control sample heterozygous for both Fuzzy and Fgf8 has is normal and identical to wild type (A). Limbs are 





3.2.7 Hypertrophic onset is also delayed in the basioccipitol bone  
The developing limb bones are good models for endochondral ossification. 
In order to assess whether delayed chondrocyte maturation is likely to play 
a role in the developmental defects in other endochondral elements, I 
carried out histological staining on the basioccipitol bone of the cranial base 
between e13.5 and e16.5 (Fig 3.7). As was described in the developing 
radius, at e13.5 resting chondrocytes can be observed, these have 
progressed to hypertrophic chondrocytes at e14.5, and by e16.5 they are 
being replaced with newly forming bone (Fig 3.7 A, C, E). In the Fuzzy 
mutant however, resting chondrocytes are seen to persist from e13.5 to 
e14.5 (Fig 3.7 B and D). Strikingly, by e16.5, no bone deposition has taken 
place and chondrocytes are just beginning to undergo hypertrophy onset 
(Fig 3.7 F). This delay in hypertrophic onset is very similar to that seen in 
the long bone (Fig 3.3), suggesting a comparable mechanism driving lack of 






Figure 3.7 The basioccipitol bone of the Fuzzy mutant has delayed 
hypertrophic onset.  
Frontal sections, trichrome staining, cartilage in blue. 
(A and B) Basioccipitol of wildtype and mutant littermates at e13.5. At this 
age, resting chondrocytes (rc) are seen in both wildtype (A) and mutant (B) 
samples. 
(C and D) By e14.5, chondrocytes in the wildtype (C) are becoming 
hypertrophic (hc), whereas the mutant chondrocytes (D) appear to be in the 
resting state. 
(E and F)  At e16.5, a clear bone collar (bc) is visible in the wildtype sample 
(E) with ossification, seen in red, surrounding the hypertrophic 






Analysis carried out on the long bones of fuzzy mutants suggest that a loss of 
elongation is due to delayed chondrocyte maturation which also results in 
less ossification of the limb. My data suggests that a loss of Ihh expression 
may be driving this phenotype. As described above, Ihh expression is 
regulated by a negative feedback loop with PTHrP. The Gli3 repressor, 
which we previously showed to be up-regulated in the Fuzzy mutant, 
mediates this feedback loop (Tabler et al., 2013); see figure 5.8). The 
repressor acts to inhibit PTHrP expression during chondrocyte maturation 
(Koziel et al., 2005); hence loss of Gli3 repressor in the Fuzzy mutant, would 
result in a derepression of PTHrP and a subsequent inhibition of Ihh 
expression.  
 
It is likely that in our Fuzzy mutant, the absence of the cilium means that 
binding of the Ihh ligand cannot regulate Gli3 repressor activity; this has 
previously been shown to delay chondrocyte maturation through both 
PTHrP dependent and independent mechanisms (Koziel et al., 2005). This 
model is supported by the observation that Gli3 mutants have shortened 
long bones (Panman et al., 2005, Mo et al., 1997, Hui and Joyner, 1993, 
Johnson, 1967). Given the nature of Hh signaling, it could be suggested that 
reduced Ihh expression would result in increased formation of the Gli3 
repressor (See Fig 3.8). However, in the absence of Gli processing in the 
Fuzzy mutant we would expect that we have no formation of the Gli3 
repressor irrespective of Hh ligand binding. For this reason Ihh mutants 
have severely shortened long bones associated with a loss of PTHrP 
expression (St-Jacques et al., 1999); while, enhanced signaling through the 
PTHrP receptor also results in a delay of chondrocyte hypertrophy (Karp et 







Figure 3.8 Predicted model for delayed onset of hypertrophy in 
Fuzzy mutant long bones. 
 
A) In the wildtype situation, Ihh is expressed by, and stimulates the 
differentiation of hypertrophic chondrocytes. Hypertrophic cells express Ihh, 
which restricts the amount of Gli3 repressor. The Gli3 repressor is necessary 
for inhibition of PTHrP, which limits Ihh expression. In this way, the level of 
IHH and hence the number of hypertrophic chondrocytes is regulated.  
B) In the Fuzzy mutant, we believe that a loss of the Gli3 repressor reduces 
the amount of PTHrP repression. Increased levels of PTHrP cause Ihh 






Interestingly, I observed shortening of the basioccipitol cartilage element via 
a delay in hypertrophy. It has been reported that loss of Gli3 causes reduced 
ossification in this element, which is in keeping with our observation of 
reduced hypertrophy (Bose et al., 2002); interestingly, in the basosphenoid, 
reduction in Gli2 causes a more severe shortening (Mo et al., 1997). This 
may be an example of tissue specific differences between relative 
contributions of Gli2 and Gli3 in skeletal development and could reflect the 
different origins of the limb, derived from the lateral plate mesoderm, and 
the basosphenoid bone, which derives from cephalic mesoderm. Along these 
same lines, mouse mutants lacking Gli2 have also been reported to have 
slight defects in long bone elongation and Gli2 has been shown to have roles 
in regulating chondrocyte hypertrophy (Mo et al., 1997, Joeng and Long, 
2009). Although we have only showed altered processing of Gli3 in the 
Fuzzy mutant, this role for Gli2 in long bone development suggests that our 
mutant may also have defective Gli2 processing.   
 
Another important aspect of limb development, as described in the 
introduction above, is the importance of Gli3 repression in patterning the 
digits. Mouse mutants for Gli3, as well as having short limbs, have 
polysyndactyly (Johnson, 1967, Hui and Joyner, 1993). In digit patterning, 
Shh signaling is required to restrict the levels of Gli3, which controls the 
number of fingers formed. For this reason, Shh mutants have only one digit 
and Gli3 mutants have multiple (Chiang et al., 2001). Polydactyly observed 
in the Fuzzy mutant is also most likely due to the loss of the Gli3 repressor 
(Heydeck et al., 2009). Previous reports on the IFT88 hypomorph mutant, 
another ciliopathy mouse model, have reported polydactyly to be due to 
abnormal limb bud patterning as a result of to abnormal Gli3 regulation (Liu 
et al., 2005a). This study also reported lower levels of Gli1 and Ptc1 in their 
mutants, which we have also previously demonstrated in the Fuzzy mutant 
(Tabler et al., 2013).  
 
Together, this data suggests that in the case of the shortened limbs of Fuzzy 
mutants, the main signaling defect is the regulation of Gli3R. It is important 
to remember, however, that in all of the developmental stages described in 
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this chapter, FGF signaling has significant contributions. This is a 
particularly important consideration since we have shown enhanced FGF8 
signaling in the Fuzzy mutant (Tabler et al., 2013). 
 
FGF signaling has multiple roles in chondrocyte maturation and specific 
roles with regards to regulation of chondrocyte hypertrophy. In mice, 
enhanced FGF signaling, specifically via hyper-activation of FGFR3 has been 
shown to result in a long bone phenotype which is very similar to that 
observed in the Fuzzy mutant, whereas diminished signaling through FGFR3 
causes excessive long bone growth (Brodie and Deng, 2003). Fgfr3 
expression has been detected in proliferative and hypertrophic 
chondrocytes in the growth plate and mutations in this gene have been 
shown to be the most common cause of chondrodysplasia syndromes in 
humans (Peters et al., 1993, Delezoide et al., 1998, Rousseau et al., 1994, 
Shiang et al., 1994, Tavormina et al., 1995). These phenotypes have been re-
created with activating mutations of FGFR3 in mice as well as constitutive 
activation of downstream FGF signaling components such as MEK1 (Li et al., 
1999, Segev et al., 2000, Murakami et al., 2004). This is evidence to suggest 
that abnormal FGF signaling may contribute to the phenotypes we observe.  
 
Due to this, and because FGF8 does in some contexts signal via binding to 
FGFR3, and also because reducing levels of FGF8 in the Fuzzy mutant 
rescues a hyperplastic maxilla (Tabler et al., 2013). We analyzed the limb 
phenotype in a Fuzzy-/-;Fgf8L/+ and Onset of hypertrophy was not restored. 
Even though Fgf8 has been detected in rib chondrocytes at e14.5 and e15.5, 
it is not known to have roles in long bone elongation. In fact, loss of FGF18 
results in a short long bone phenotype consistent with the suggestion that 
FGF18 is the key ligand that signals via FGFR3 to regulate chondrocyte 
hypertrophy (Ohbayashi et al., 2002). No evidence to date suggests that one 
would expect altered expression of Fgf18 in the Fuzzy mutant however this 
does not mean that the possibility can be ruled out. For this reason, further 
analysis of mutant limbs with manipulation of other FGF ligands, 
particularly FGF18, would be a logical next experiment in order to assess 
whether a loss in FGF signaling contributes to the phenotype observed. 
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Furthermore, these experiments would help determine whether there are 
any commonalities between the short limb phenotype observed in 
ciliopathies and chondrodysplasias; this is particularly important since 
FGFR3 signaling has been reported to inhibit Ihh expression in the growth 
plate (Naski et al., 1998, Chen et al., 2001). 
 
With regards to patterning of the mutant limb bud, Fgf8 is expressed in the 
AER and is said to be important for determining the homeotic identity of the 
skeletal elements in the developing limb. This works via a gradient of FGF 
expressed across the longitudinal plane of the limb with the cells exposed 
for longer adopting a more distal fate (Niswander et al., 1993). Previous 
experiments reveal that a loss of Fgf8 expression in the mesenchyme causes 
a slight loss of ossification, whilst reduction in early limb ectoderm reduces 
proximal-distal limb bud growth, mainly by inhibiting growth of the most 
proximal limb element (the stylopod) development resulting in a short limb 
(Lewandoski et al., 2000). Since we do not see a homeotic transformation in 
the limb, and our Fuzzy-/-;FGF8L/+ compound mutants show no rescue of any 
limb phenotypes, combined with the fact that we observe no defects in the 
initial outgrowth of the limb bud, it is unlikely that enhanced FGF8 signaling 
contributes to the defects we have characterised.  
 
In conclusion, it appears that the defective long bone elongation and digit 
patterning in the Fuzzy mutant are likely as a result of loss of regulation of 
the Gli3R and altered FGF signaling from the AER probably does not 
contribute to any of these phenotypes. It is likely that altered FGF signaling 
also does not contribute to lack of long bone elongation however analysis of 
expression of key FGFs required for limb bud growth or further compound 
mutants should be generated to confirm this. If indeed a loss of Gli3R were 
driving the Fuzzy long bone phenotype, then my data would suggest that 
there are different underlying causes to the phenotype in chondrodysplasias 




Chapter 4 Micrognathia in the Fuzzy mutant 
4.1 Introduction 
Micrognathia, or small jaw, has an incidence of about 1:1000 births (Copel et 
al., 2012). In patients, the small jaw can cause misplacement of the tongue, 
which then obstructs palatal closure (Copel et al., 2012). In the most severe 
instances of micrognathia, an infant’s feeding and breathing can be 
restricted. Later in life, the teeth may be misaligned due to space restrictions 
and agenesis of the condyle has also been reported (Gangopadhyay et al., 
2012, Lam et al., 2014, Storm et al., 2005). Micrognathia is present in 
ciliopathies such as Meckel Gruber syndrome, Sensenbrenner syndrome, 
orofaciodigital syndrome and Bardet-Biedl syndrome (Brugmann et al., 
2010, Bacino et al., 2012, Biswas et al., 2009, Beales et al., 1999). In addition, 
micrognathia is also associated with non-ciliopathic diseases such as Marfan 
syndrome, Treacher Collins syndrome and Pierre Robin Sequence (Ornek et 
al., 2012, Martelli-Junior et al., 2009, Buntinx et al., 1991, Summers et al., 
2014). Interestingly it is also reported in rare chondrodysplasias such as 
Larsen-Like syndrome, kyphomelic dysplasia and thoracopelvic dysplasia 
(Orhan et al., 2008, Toledo et al., 1999, Hsieh et al., 1999, Dinno et al., 1976).  
 
To date, etiology and physical mechanisms causing micrognathia during 
embryogenesis are unclear. Understanding how this phenotype arises is not 
only important from a clinical perspective but will also shed light on 
mechanisms of mandible growth and elongation, which are not fully 
understood. This chapter aims to identify underlying causes of micrognathia 
observed in the Fuzzy mutant, which act as a ciliopathic mouse model.  
 
Micrognathia observed as a small Meckel’s cartilage (MC), associated with 
ectopic rostral spikes of cartilage has previously been documented in the 
Fuzzy mutant (Zhang et al., 2011). However mechanisms driving this defect 
are not clear-cut. Perturbations in Hh and Wnt signaling have been observed 
in Fuzzy mutants (Zhang et al., 2011). At e14.5, in the mandible there were 
reduced levels of Shh, Ptc1 and Gli1 in the mesenchyme, as well as less PTC1 
in MC (Zhang et al., 2011). Additionally, increased levels of β-catenin and 
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LEF1 in the oral epithelium were noted, as well as increased expression of a 
Wnt-responsive luciferase (Topflash) in the oral mesenchyme (Zhang et al., 
2011). As such increased proliferation seen in Meckel’s cartilage was 
attributed to enhanced canonical wnt output (Zhang et al., 2011) 
 
Meckel’s cartilage is the initial skeletal support in the mandible. In the 
mouse, at approximately e8, CNC cells migrate laterally from the neural tube 
to populate the first branchial arch (BA1) (Kuo and Erickson, 2010). The 
mandibular and maxillary compartments are subsequently specified within 
BA1. Cells aggregate in two locations on either side of the midline of the 
presumptive mandible forming prechondrogenic condensation (Hall and 
Miyake, 1992).  These differentiate into chondrocytes, which produce 
cartilage in bilateral rods running proximo-dorsally. At approximately e13.5, 
MC contains a mixed population of non-CNC cells and CNC cells (Chai et al., 
2000). By e13.5 MC has adopted the characteristic ‘V’ shape, since the rods 
fuse at their distal tips forming the rostral process. The most proximal 
regions go on to form middle ear components such as the malleus and incus 
(Bhaskar et al., 1953, Frommer and Margolies, 1971). The cartilage then 
continues to elongate proximo-distally. Mechanisms driving elongation are 
largely unknown. However, FGFR3 dependent proliferation and levels of 
chondrocyte turnover are thought to be important (Havens et al., 2008, 
Ramaesh and Bard, 2003).  
 
By e15.5, enlarged IHH and COLX secreting hypertrophic cells, similar to 
those observed in endochondral bones, can be observed in the distal half of 
MC in vivo and in cell culture (Shimo et al., 2004, Chung et al., 1995, Ishizeki 
et al., 1996, Yang et al., 2012). These cells appear to undergo autophagy at 
around e16.5 but are not replaced with ossified bone in a typical 
endochondral manner, and hence their contribution or role in mandible 
development is not truly known (Yang et al., 2012). As such there is a 




Immature chondrocytes of the limbs express Rank-ligand (RANKL) and 
osteopontin (OPN), which are markers of bone onset, whereas MC 
chondrocytes do not (Sakakura et al., 2005). In addition, during chondrocyte 
hypertrophy in endochondral elements, the chondrocytes become heavily 
vascularized; a process which is not seen in hypertrophic-like cells of MC 
(Ishizeki et al., 1999, Shimada et al., 2003). Conversely, during hypertrophy, 
MC chondrocytes express RANKL, OPN and apoptotic markers, all of which 
are expressed in endochondral chondrocytes. As such, it has been suggested 
that some regions of MC give way to bone (Ishizeki et al., 1999, Trichilis and 
Wroblewski, 1997, Cheung et al., 2003). Interestingly, in tissue culture, 
chondrocytes were shown to differentiate into osteocytes (Ishizeki et al., 
1996).  
 
Instead, it is thought that bone formation takes place within a membranous 
sheath surrounding Meckel’s cartilage. This persistent cartilaginous support, 
with the presence of hypertrophic-like cells and membranous deposition of 
bone, makes the ossification of the mandible a unique example of 
intramembranous ossification (This is expanded upon in chapter 6).  
 
Mechanisms driving initial outgrowth of the mandible are not very well 
understood. Removal of the BA1 epithelium results in reduced mandibular 
outgrowth suggesting a role for epithelial to mesenchymal signals in BA1 
(Richman and Tickle, 1989, Mina et al., 1994). Regional gene expression of 
Msx and Bmp genes in the mandibular arch contributes to zones of 
proliferation and medial cells appear to contribute more then their lateral 
neighbors during outgrowth of the mandibular arch in chick (Mina et al., 
1994, McGonnell et al., 1998, Barlow and Francis-West, 1997). It is not 
known for sure if MC growth drives the elongation of the mandible however 
mice with Sox9 null neural crest cells have a complete absence of Meckel’s 
cartilage and severe micrognathia, suggesting that growth, at least in part, 
requires MC (Mori-Akiyama et al., 2003).  
 
As described previously, cilia have important signaling roles and we have 
seen aberrant Hh and FGF signaling in our Fuzzy mutant (Tabler et al., 2013). 
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Abnormal Hh and FGF8 signaling are both associated with craniofacial 
malformations. Loss of Shh during embryogenesis results in a complete loss 
of craniofacial structures, while temporal reduction of Hedgehog signaling at 
later stages results in midline defects ranging from holoprosencephaly to 
cyclopia (Brugmann et al., 2010, Nanni et al., 1999, Babbs et al., 2008, Hu 
and Helms, 1999).  Cobourne et al showed, in mandibular explant cultures, 
that Shh activity has essential roles in tooth bud formation (Cobourne et al., 
2001). More specific to the mandibular growth, treatment of mandibular 
explant cultures with cyclopamine, a small molecule inhibitor of Hh 
signaling, leads to an inhibition of chondrogenic differentiation of Meckel’s 
cartilage (Melnick et al., 2005). The Gli proteins themselves have also been 
shown to have redundant roles in mandibular development, since loss of 
Gli2 causes a truncation of the proximal mandible with a loss of incisors 
whilst loss of Gli3 alone does not appear to have any obvious mandibular 
phenotype. Compound mutants, however, have a severely shortened 
mandible (Veistinen et al., 2012, Mo et al., 1997). 
 
Interestingly, SHH and FGF signaling are shown to work together to control 
patterning of BA1 in chick (Haworth et al., 2007). Shh is expressed in the 
more ventral endoderm, whilst Fgf8 is expressed adjacent to this in the 
more dorsal ectoderm prior to BA specification in chick, (Haworth et al., 
2007), In addition, Fgf8 and -9, and FGFR1 and -2 are expressed in the 
mouse mandibular epithelium at e10.5 (Bachler and Neubuser, 2001). 
Furthermore, loss of Shh results in NC and mesenchymal cell death resulting 
in a smaller head in chick embryos as well as smaller BAs in mouse embryos 
(Ahlgren and Bronner-Fraser, 1999, Moore-Scott and Manley, 2005, 
Yamagishi et al., 2006). More over, in Shh null mice, a smaller BA1 was 
associated with a loss of epithelial Fgf8 expression in BA1 at e9.5 (Yamagishi 
et al., 2006). This data suggests Fgf8-Shh interactions are important for 
initial BA outgrowth. 
 
FGF8 has been shown to act as a NC survival factor and and has been shown 
to increase NC cell migration and proliferation within the developing face. In 
the developing maxilla, an increased domain of Fgf8 expression in the 
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epithelium is associated with aberrant NC migration, whilst reduced 
expression in the developing mandibles is associated with extensive 
mesenchymal apoptosis in mice, as well as increased NC cell migration and 
proliferation within the mandible of the duck (Tabler et al., 2013, Abu-Issa 
et al., 2002, Trumpp et al., 1999). Further highlighting the importance of Fgf 
signaling in mandibular outgrowth and chondrogenesis, overexpression of 
Fgf8 alters the polarity of MC condensation leading to ectopic and bifurcated 
Meckel’s cartilage, while expression of dominant-negative FGFR3 results in a 
truncated and asymmetric mandible (Haworth et al., 2007, Havens et al., 
2008). Taken together this data suggests that FGF8 is important for normal 
NC survival and migration during mandibular outgrowth and in addition, it 
has important roles in patterning the mandibular arch. 
 
Another important role for Fgf8 signaling is to specify different regions of 
tooth formation and establish medio-lateral spacing within the mandibular 
process. FGF8 is expressed in the lateral mandibular epithelium, whilst 
medially in this same epithelium, bone morphogenic protein-4 (BMP4), a 
member of the transforming growth factor beta superfamily, is expressed 
(Tucker et al., 1999). It is thought that the adjacent positioning of FGF8 and 
BMP4 regulate medio-lateral patterning within the mandibular primordia 
(Tucker et al., 1998, Bei and Maas, 1998). During this process, mesenchymal 
homeobox genes are expressed in strict temporo-spatial patterns. In molar 
forming regions, FGF8 drives BARX homeobox1 (Barx1) expression whilst in 
the medial incisor forming mesenchyme, BMP4 induces MSH homeobox 1 
and 2 (Msx-1 and -2) expression, which induces incisor formation (Barlow et 
al., 1999, Tucker et al., 1998, Cobourne and Sharpe, 2003).  
 
We have previously shown defective Gli3 processing in the Fuz-/- embryos at 
e9.0, In addition, we note an expansion of Fgf8 expression in the mid-hind 
brain boundary. Together, this leads to an increase in NC cell numbers. Later, 
during facial development, Fuz mutants also have an expansion of Fgf8 
expression in the BA1 epithelium (Tabler et al., 2013). Ordinarily, Fgf8 is 
expressed in a stripe on lateral regions of the BA1 epithelium (see chapter 1; 
Fig 1.9). The best-characterised role of Fgf8 in this context is in governing 
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mediolateral patterning of the mandible and positioning sites of tooth 
formation (Tucker et al., 1999, Tucker and Sharpe, 2004). Thus, we 
considered two possibilities: first, that ciliopathic mutations had altered 
medio-lateral patterning and constriction in BA1 due to increased neural 
crest cell numbers; and second, that the Fgf8 increase might contribute to 
shape changes in the lower jaw. Our data shows that genetic reduction of the 
levels of Fgf8 rescues micrognathia of the Fuzzy mutant. Altogether, our data 
documents several important stages in mandible formation and suggests a 
























4.2.1 The Fuzzy mutant has micrognathia which manifests as early as e10.5 
We had previously observed that during development of the first branchial 
arch, Fuzzy mutant mice displayed a dramatically enlarged maxillary 
process, which subsequently led to development of a high arching palate 
(Tabler et al., 2013). It has also previously been observed that Fuzzy 
mutants had micrognathia (Fig 4.1 A & B, and (Gray et al., 2009). This raised 
the possibility that the enlargement of the maxillary domain came at the 
expense of the mandibular portion of BA1. Indeed, examining E10.5 mouse 
embryos, we noted that compared to littermate controls, the Fuz mutants 
were narrower in the mediolateral axis (Fig 4.1 C-D) and shorter in the 
dorsal-ventral axis (Fig 4.1 C’-D’).  
4.2.2 There is increased cell density and a larger region of Sox9 expression 
on loss of Fuzzy  
The size and density of prechondrogenic condensations are known to be 
important factors regulating the dimensions of the developing cartilage 
(Hall, 1992). We had previously shown an increase in neural crest cells in 
Fuzzy mutants (Tabler et al., 2013). But, as the mutant mandibular process 
appears smaller at e10.5, we asked whether cell packing was changed. To do 
this, we assessed the proximity of nuclei in the mandibular processes of 
e11.5 wildtype and mutant embryos. In mutant mandibular processes, cells 
appear closer together then in wildtype controls (Fig 4.2 A & B). As a result 
of this I counted cell nuclei in a fixed area of 0.2mm2 and found that cell 
density is significantly increased in Fuzzy mutants compared to controls (Fig 
4.2 C; p=0.0042; n=3). This suggests an increase in condensing mesenchyme 
signifying the onset of chondrogenesis. Consistent with this, when we 
examined mRNA expression of Sox9, which marks prechondrogenic 
condensations, we found that expression was expanded toward the midline 
in mutants (Fig 4.2 D & E). Taken together these data suggest that during 
early mandibular development, there is increased cell packing associated 
with an abnormal region of prechondrogenic condensations, specifically 








Figure 4.1 Fuzzy mutants exhibit micrognathia 
(A and B) Ventral views of alizarin red stained heads at e18.5. The 
mandibular bone (MB) is demarcated between black arrowheads. The jaw of 
the Fuzzy mutant (B) is clearly shorter then that of the wildtype littermate 
(A). 
(C and D) Frontal views of e10.5 embryos. Mandibular processes (Md) of 
BA1 are outlined in dashed yellow lines. The mutant mandible (D) is 
narrower and smaller then that of the wildtype (C). 
(C’ and D’) Sagittal views of the mandibular process of BA1, outlined in 
dashed yellow lines. The mandible of the mutant (D’) is smaller than 







Figure 4.2 Fuzzy mutant mandibles have increased cell density at 
e11.5 
(A and B) Frontal sections of the mandibular processes of mutant and 
control embryos. Nuclei are stained with Hoescht in cyan. Scale bar is 
0.1mm. 
(A’ and B’) Higher magnification of (A and B). An individual cell is 
highlighted in pink and its immediate neighbours are highlighted in yellow. 
Cells in mutant mandibles (B’) are closer together then control samples (A’). 
Scale bar is 0.1mm. 
(C) Quantification of the number of cells in an area of 0.2mm2 in e11.5 
mandibles. Mutants have a higher cell density (p=0.0042; n=3). 
(D and E) mRNA in situ hybridization showing Sox9 expression in mandibles 
of e12.5 embryos. (D) In control mandibles, Sox9 expression corresponds to 
bilateral condensations of Meckel’s cartilage. (E) In mutants, Sox9 
expression occupies a larger area and is more spread towards the midline. 
Scale bar is 1mm. 
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4.2.3 Bilateral rods of MC are closer together by e11.5 and MC has 
prematurely fused by e12.5 in the Fuzzy mutant 
Because of the expansion of Sox9, we decided to examine expression of Col2, 
which marks the cartilage precursors. To do this, we used a transgenic 
mouse carrying a β-galactosidase reporter under the control of the collagen 
II promoter (Col2::lacZ) (Zhou et al., 1995). When intercrossed with the Fuz 
mutants we observed that, at e11.5, the width of the mandibular process in 
mutants is significantly narrower then that of control littermates (p=0.013; 
n=4; Fig 5.3 A- C). Moreover, when we measure between the newly forming 
bilateral rods of Meckel’s cartilage, we found that the distance at both the 
most distal and most proximal ends of MC were significantly narrower 
(Figure 4.2 C; distal: p=0.024 and proximal: p=0.017; n=4).  
  
Because the mutant mandible is abnormally narrow, we considered the 
possibility that the bilateral rods of Meckel’s cartilage might meet 
prematurely at the rostral process. To investigate this we again used 
Col2::lacZ reporter animals to mark the cartilaginous rods, this time using 
optical projection tomography (OPT) to visualize them in three dimensions. 
We see that at e12.5, Meckel’s cartilage of the wildtype animals has not yet 
fully fused at the rostral process (Fig 4.3 E and E’). Strikingly, in the mutant 
littermates, the cartilage appears to be prematurely fused (Fig 4.3 F and F’).   
 
Quantification of the total proximo-distal length of the mandible between 
e12.5 to e16.5, reveal that at e12.5, there is no difference in length between 
wildtype and mutant mandibles. At e13.5 there is a trend of a shorter 
mandible in Fuzzy mutants and this difference in significant at e14.5 





Figure 4.3 Fuzzy mutants have premature fusion of Meckel’s 
cartilage at the rostral process 
(A and B) Col2 expression in control and mutant mandibles at e11.5 seen 
with col2::lacZ reporter staining. Overall width of mandible (Md) as well as 
the most dorsal (d) and proximal (p) regions of col2 expression appear 
closer together in the mutant (B) when compared to control (A) mandibles. 
(C) Quantification of most dorsal, most proximal, and overall mandibular 
width in mutant and control embryos. All dimensions measured in the 
mutant are narrower then in control embryos (p<0.05; n=4). (D) Growth 
curve of the proximo-distal length of mandibles from e12.5 to e16.5. There 
is no real difference in length at e12.5 however by e13.5, mutant mandibles 
show a trend of being shorter.  This difference is significant at e14.5 
(p=0.0034; n=6) and e16.5 (p=0.0014; n=3). (E and F)  Optical projection 
tomography of ventral views of col2 expression, which represent Meckel’s 
cartilage. In control and mutant embryos most dorsal and proximal regions 
are indicated. (E) In control embryos the most dorsal region of Meckel’s 
cartilage has not yet fused (open arrowhead). (F) In mutant embryos 
Meckel’s cartilage has already fused in the midline (white arrowhead). (E’ 
and F’) Frontal views of col2 expression in control and mutant embryos. (E’) 
In control samples col2 expression has not yet fused in the midline (open 
arrowhead). (F’) In mutant samples, bilateral rods of Meckel’s cartilage have 
prematurely fused at the most dorsal region (white arrowhead).  
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4.2.4 MC at the rostral process between e13.0 and e13.5 
Since we saw premature fusion of MC at e12.5, we set out to document the 
consequences at later stages. At e13.0, in the wildtype, the rostral process 
had not yet fully fused. In the mutant, the rostral process appeared to be 
fused (red arrowhead; Fig 4.4 A & B). Half a day later, at e13.5, optical 
project tomographic (OPT) analysis of col2::lacZ reporter mice revealed 
wildtype MC developing into a characteristic ‘V’ shape, whereas the mutant 
cartilage appeared shorter and a prominent spike of cartilage could be seen 
protruding from the rostral process (red arrowhead) and the cartilage 
appears to be thicker towards the midline (green arrowheads) (Fig 4.4 C 
&D). These prominent rostral protrusions can also be seen in sagittal and 
frontal views (red arrowheads; Fig 4.4 E &F; Fig 4.4 G&H). Quantification of 
MC length (l) and distance between the bilateral rods of MC (d) at e13.5 
reveal a slight trend that both parameters are shorter in the Fuzzy mutant 
however this difference is not significant (parameters measured are 
depicted in fig 4. 4 A). Taken together, these observations suggest a 
premature impact of MC causes the bilateral rods of cartilage to grow into 
one another at the rostral process causing an anterior thickening of the 





Figure 4.4 Meckel’s cartilage of the Fuzzy mutant is malformed 
between e13.0 and e13.5. 
(A and B) Dorsal view of Alcian blue stained Meckel’s cartilage at e13.0. The 
most anterior portion of Meckel’s cartilage is more fused in the mutant (red 
arrowhead, B), when compared to the control (A). Distance between the 
rods of MC (d) and the proximo-dorsal length of MC (l) represent distances 
measured in (I). (C and D) Dorsal view of 3D reconstructions of Col2 
expression in Meckel’s cartilage at e13.5. The wildtype MC (C) has a 
characteristic ’V’ shape. The anterior of mutant Meckel’s cartilage (D) is 
thickened towards the midline (green arrowheads) and the rostral process 
appears more pointed (red arrowhead). 
(E and F) Sagittal views of Col2 expression at e13.5. The rostral process in 
the mutant (F) appears to have two prominent spikes protruding from the 
end (red arrowheads), which are not present in the wild type (E). 
(G and H) Frontal view of col2 expression at e 13.5. Prominent spikes of the 
rostral process in the mutant (H) are highlighted with red arrowheads. 
(I) Quantitation of the length (l) and distance between the two rods of 
Meckel’s cartilage (d) as shown in (A). Mutant embryos show a trend of  a 
shorter and narrower cartilage at e13.5 (n=4). Scale bar is 1mm. 
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4.2.5 MC is shorter and narrower at e14.5 
Our observations above led us to consider the possibility that premature 
fusion of MC prevents elongation at later stages, thus constraining distal 
outgrowth of the mandible. Alcian blue staining of MC reveals the 
characteristic V shape in the wildtype, whilst the mutant cartilage appears 
shorter and a thickening of cartilage towards the midline is observed (Fig 
4.5 A and B). 3D imaging of col2::lacZ reporter expression of MC at e14.5, 
similar to that seen at e13.5, shows a V shaped MC, which lies in one plane in 
the wildtype (Fig 4.5 C, E and G). In the Fuzzy mutant, as was seen at e13.5, 
there are two spiked protrusions of cartilage extending above and below the 
rostral process (Fig 4.5 D, F and H). Quantification of the proximodistal 
length and distance between the rods of MC (l and d shown in Fig 4.5 A), 
reveal that both parameters are significantly shorter in the Fuzzy mutant 
(p=0.0034 and p=0.0381 respectively; n=6; Fig 4.4 I). These observations 
follow on from the trend seen at e13.5, suggesting that premature fusion as 
early as e12.5 causes significant loss of elongation at later stages. 
4.2.6 Barx1 expression has a lateral to medial shift in the Fuzzy mutant 
mandible which is restored on reduction of Fgf8 
 
We have previously shown that Fuzzy mutants have an expansion of Fgf8 
expression in the BA1 epithelium (Tabler et al., 2013). In BA1, Fgf8 
expression is thought to influence outgrowth of the maxillary and 
mandibular processes (Fish. 2014). Our previous data suggested that the 
maxillary phenotype could largely be attributed to an increase in cell 
numbers populating the dorsal component of BA1. However, the mandibular 
process did not show a similar expansion, and instead, was smaller. 
Therefore, I considered the possibility that FGF8 could contribute to the 
narrowing of the mandibular process. We tested this by looking at Fuzzy-/-
;Fgf8L/+ compound mutants. I looked at expression of Barx1 at e12.5, which 
is typically expressed in the lateral mandibular process, with no medial 
expression (Figure 545 A, (Tissier-Seta et al., 1995).  In Fuzzy mutants, 
Barx1 expression is clearly shifted toward the midline (Fig 4.6 B, black 
arrow). Interestingly, heterozygous loss of Fgf8 was sufficient to restore 
normal medio-lateral placement of Barx1 in the Fuzzy mutant mandible 







Figure 4.5 Meckel’s cartilage of mutants is significantly shorter and 
there is a narrower distance between rods of cartilage at e14.5 
(A and B) Alcian blue stained Meckel’s cartilage at e14.5. Wild type cartilage 
is seen as a characteristic ‘V’ shape (A), whilst the mutant appears to have 
roughly the same shape but is visibly shorter (B). Green arrowhead in B 
shows a thickening towards the anterior portion of Meckel’s cartilage. 
Arrows in (A) represent the dimensions quantified in (I).  
(C and D) Stills from OPT reconstructions of Col2 expression visualized by 
means of a col2::lacZ reporter gene in Fuzzy mutant and littermate controls 
at e14.5. Wildtype cartilage (C) is a characteristic ‘V’ shape. In the Mutant 
(D), MC length appears visibly shorter. Green arrowheads show anterior 
thickening of Meckel’s cartilage and red arrowhead  shows anterior 
protrusions of Meckel’s cartilage at the rostral process.  
(E and F) Sagittal images of OPT reconstructions. Wildtype cartilage (E) sits 
in one plane, whilst mutant cartilage is noticeably shorter and has two 
spikes protruding from the rostral tip (red arrowheads). 
(G and H) Frontal views of OPT reconstructions. In mutant MC (H), a spike of 
cartilage can be seen protruding above the plane of MC whilst wildtype MC 
does not protrude from its plane (G). 
(I) Quantification of the length (l) and distance between the two rods of 
Meckel’s cartilage (d) in Fuzzy mutants and control animals. Loss of Fuzzy 
results in a significantly shorter Meckel’s cartilage (p=0.0034) with a 
narrower distance between the two cartilaginous rods (p=0.0381; n=6). 










Figure 4.6 Medio-lateral spread of Barx1 in the Fuzzy mutant is 
restored on reduction of Fgf8 
(A-C) Reference slides showing haematoxylin and eosin stained frontal 
sections taken through the molar tooth bud of embryos at e12.5.  
(D-F) Barx1 expression in serial sections shown in (A-C). In the wildtype (D), 
Barx1 expression is restricted to the lateral regions of the developing 
mandible and there is no expression in the tongue (asterisk). In the Fuzzy 
mutant (E), Barx1 expression seems to be shifted towards the midline of the 
mandible (black arrow). The tongue is hypoplastic. On genetic reduction of 
Fgf8 in the Fuzzy mutant (F), the lateral to medial shift of Barx1 is rescued 





4.2.7 Genetic reduction of Fgf8 in the Fuzzy mutant rescues the phenotype 
of MC 
Since genetic reduction of Fgf8 rescued the early mediolateral shift in 
expression of Barx1, I looked at MC at e14.5, again using alcian blue to mark 
the cartilage in compound mutants. As I showed previously, wild-type 
Meckel’s cartilages have a characteristic ‘V’ shape while loss of fuzzy causes 
a shortening and narrowing of MC. (Fig 4.7 A and B). Fig 4.7 D shows that 
genetic reduction of Fgf8 in the Fuzzy mutant rescues the phenotype of MC. 
The littermate control for this sample is a Fuzzy heterozygous embryo, 
which has no phenotype (Fig 4.7C). Quantification of the length (E), and the 
distance between bilateral rods of MC (F), reveal that whilst the differences 
between wildtype and Fuzzy-/- embryos are significantly different (p=0.0027 
and p=0.0169 respectively; n>3), reduction of Fgf8 partially restores these 
parameters (Fig 4.7 E and F). This observation combined with observations 
from early embryos suggests that abnormal mediolateral patterning, 
probably as a result of FGF8, influences MC positioning causing premature 




Figure 4.7 Reduction of Fgf8 rescues the Meckel’s cartilage 
phenotype of Fuzzy mutants 
(A-D) Ventral views of Alcian blue stained Meckel’s cartilage (MC) at e14.5. 
In control embryos (A), Meckel’s cartilage can be seen as 2 bilateral rods, 
which are fused at the most rostral region. (B) Mutant Meckel’s cartilage is 
noticeably shorter and is narrower between the rods of cartilage. (D) 
Reduction of Fgf8 restores the shape of Meckel’s cartilage. (C) is a littermate 
control for (D), revealing that heterozygous loss of both Fuzzy and Fgf8 has 
no effect of Meckel’s cartilage. (E) Quantification of the length of Meckel’s 
cartilage.  The length in Fuzzy mutants is shorter then control cartilages 
(p=0.0027; n=3). The length of compound mutant cartilages was not 
significantly different to control or mutant embryos. (H) Quantification of 
the width between bilateral rods of Meckel’s cartilage. Measurements were 
taken at the most proximal region. Mutant width is significantly shorter then 
those of control samples (p=0.0169; n=3). Compound mutants reveal 
distances that are not significantly different to control samples. Scale bar is 
1mm.  
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4.2.8 Hypertrophic chondrocytes and incisors are not seen in the mandible 
at e16.5 in Fuzzy-/- and Fuzzy-/-;Fgf8L/+ mutants 
During embryogenesis, Meckel’s cartilage plays an important role in the 
placement and patterning of the mandibular skeleton. The jaw must 
continue growing even after Meckel’s cartilage fuses at the rostral process. 
Previous reports suggest that late in gestation enlarged hypertrophic-like 
chondrocytes can be observed within Meckel’s cartilage, which then 
presages chondrocyte degradation after birth (Bhaskar et al., 1953, 
Frommer and Margolies, 1971, Harada and Ishizeki, 1998) These cells 
appear to be induced by the developing incisors (Yang et al., 2012, Sakakura 
et al., 2005, Sakakura et al., 2007). This change in chondrocyte shape may 
contribute to further outgrowth of the mandible. In long bones, 
hypertrophic chondrocytes depend on Ihh signaling; Thus, we examined 
e16.5 mandibles to see if analogous events occur in Meckel’s cartilage. As 
predicted, we noted enlarged chondrocytes in wildtype animals (Fig 4.8 A-
A’). These were not found in mutants (Figure 4.8 B-B’), suggesting that lack 
of hypertrophy could also contribute to the micrognathia seen in the Fuzzy 
mutant.  
 
The onset of chondrocyte hypertrophy s in MC is associated with the onset 
of incisor development (Yang et al., 2012). Frontal sections of wildtype and 
mutant mice at e16.5 reveal that the incisors, which can be clearly seen in 
the wildtype are not present in the mutant (Fig 4.8 C and D). Furthermore 
hypertrophic-like chondrocytes are clearly visible within Meckel’s cartilage, 
whilst in the mutant only a few cells appear to be slightly enlarged (black 
arrowhead). Surprisingly, hypertrophic chondrocytes and the incisors are 
the only mandibular structures that are not rescued in Fuz-/-; Fgf8L/+ 




Figure 4.8 Fuzzy mutants lack of enlarged hypertrophic-like 
chondrocytes 
(A-B) Trichrome staining of transverse sections of e16.5 embryos. Cartilage 
is stained in blue; mandibular bone is stained in red. Black boxes represent 
high magnification in A’ and B’. 
(A’ and B’) Higher magnifications of control and mutant Meckel’s cartilage. 
Control sections (A’) show enlarged hypertrophic-like chondrocytes (black 
arrowhead). Mutant sections do not have hypertrophic chondrocytes (open 
arrowhead). 
(C-E) Trichrome staining of frontal sections of e16.5 embryos. Control 
sections (A) show hypertrophic chondrocytes, which have begun degrading. 
Two developing incisors (I) can be seen flanking MC. Fuzzy mutant cartilage 
(D), is mostly in the resting phase (open arrowhead) and has not yet begun 
to degrade. Discrete regions of MC are just beginning to undergo 
hypertrophy (black arrowhead). No incisors are present. In compound 
mutants (E), none of MC is yet undergoing hypertrophy (open arrowhead), 





4.2.9 Ihh is not expressed in Fuzzy mutant MC 
I previously showed that in the mutant long bones, a loss of Ihh expression 
causes delayed elongation (Chapter 3). In addition, from e15.5, Ihh is 
expressed in hypertrophic-like chondrocytes in MC (Shimo et al., 2004). 
Therefore, because I see a loss of chondrocyte hypertrophy in mutant MC, I 
wanted to determine whether there is a disruption in a similar growth-plate 
like region in MC. To do this I looked at both sox9 expression, which is 
expressed in immature chondrocytes, and Ihh expression, which is 
expressed in mature chondrocytes. In transverse sections of wildtype 
cartilage at e16.5, H & E staining reveals a region of enlarged hypertrophic–
like chondrocytes adjacent to resting chondrocytes (Fig 5.9 A). In the mutant, 
only resting chondrocytes can be seen (Fig 5.8 B). In the wild-type, Sox9 
appears to be restricted to resting chondrocytes while Ihh expression is 
restricted to hypertrophic chondrocytes (Fig 5.9 C and E). In the mutant, 
however, Sox9 is expressed throughout the cartilage and there is a clear 
absence of Ihh expression (Fig 4.9 D and F). This absence of chondrocyte 






Figure 4.9 Meckel’s cartilage of Fuzzy mutants does not undergo 
chondrocyte maturation 
(A and B) Transverse views of MC from e16.5 embryos stained with 
haematoxylin and eosin. MC is outlined in dashed yellow line. (A) In the wild 
type cartilage chondrocytes within MC can be seen in both resting (RC) and 
hypertrophic (HC) states. (B) In the Fuzzy mutants, chondrocytes have not 
progressed to hypertrophy and they all appear to be in the resting state.  
(C and D) Serial sections of (A and B) showing Sox9 mRNA expression. In the 
wildtype (C), Sox9 is restricted to the resting chondrocytes whilst in the 
mutant (D), Sox9 is expressed throughout MC. 
(E and F) Serial sections of (A and B) showing Ihh mRNA expression. In the 
wildtype embryos (E), Ihh expression is associated with hypertrophic 





Although micrognathia is fairly common, little is known about the etiology 
of this congenital anomaly. Micrognathia can be associated with ciliopathies; 
thus, we have turned to a ciliopathic mouse model to further our 
understanding of this phenotype. In particular, we consider a number of key 
steps during mandibular outgrowth: initial patterning of the first branchial 
arch, condensation of the mesenchyme destined to become Meckel’s 
cartilage, fusion of Meckel’s cartilage at the rostral process, and finally, 
hypertrophy of the chondrocytes. Our findings suggest that all of these steps 
in development can contribute to micrognathia, and that ciliopathic 
micrognathia may be due in part to aberrant FGF signaling (Summarized in 
Fig 4.10). 
  
The majority of mesenchyme in the mandibular prominence is populated by 
cranial neural crest cells, which migrate from the posterior mesencephalon 
and the rostral hindbrain. As these cells are distributed within BA1, 
signaling cues, such as FGF, Hh and BMP, act to correctly position of 
developing facial structures in both the medio-lateral and anterior-posterior 
axes of the mandibular prominence (Barlow and Francis-West, 1997, Tucker 
et al., 1999, Ferguson et al., 2000, Abzhanov and Tabin, 2004). In Fuzzy 
mutants, the narrow mandible, combined with enhanced Fgf8 expression 
toward the midline, leads to mispositioning of the mesenchymal 
condensations (Figure 4.2 A and B and Fig 4.10 A and B). Additional changes 
include increased local cell packing (Fig 4.2 A –C and Fig 4.10 C and D). My 
data suggests that these two factors combined leads to ectopic Sox9 
expression towards the midline (Fig 4.2 D and E and 4.10 E and F). This is 
consistent with observations that the Fuzzy mutant has increased 
proliferation and Sox9 expression in MC at e14.5 (Zhang et al., 2011). As it 
has been suggested that increased cell density can result from neural crest 
migration into BA1, we propose that cellular changes in the Fuz mutants are 
in part due to the altered neural crest migration previously observed in the 
Fuz mutant mice (Smith and Schneider, 1998, Tabler et al., 2013). 
Interestingly, it was seen in duck and quail that pre-migratory NC cell 
numbers moving into the mandibular prominence have roles in regulating 
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mandible length, however on reduction of these cells, post-migratory NC can 
compensate (Fish et al., 2014). This is in keeping with our suggestion that 
perturbations occur in several key steps (summarized in Fig 4.10), and not 
simply one developmental defect that causes the overall micrognathic 
phenotype.  
 
As the correct positioning of condensations is established, Meckel’s cartilage 
forms bilaterally, elongating and fusing at the rostral process. Using the 
Fuzzy mutant, we can observe the physical consequences of a narrow 
mandible. In the mutant, the rods of Meckel’s cartilage are positioned closer 
together then in the wildtype. As a result, they meet at the rostral tip at least 
one day earlier than their littermate controls (Fig 4.3 E-F’; Fig 4.10 E-H). 
Subsequently, the mutant cartilage fails to elongate appropriately, leading to 
a shorter, thicker Meckel’s cartilage (Fig 5.4D, 5.5D). Frequently, this 
cartilage is also misshapen and twisted (Fig 5.7B) with two “spikes” 
emerging from the rostral tip (Fig 5.4F, 5.5F). Thus, it would appear that in 
the mutant, each cartilage rod continues to grow, but does so while 
constrained. 
 
Many of the processes which contribute to micrognathia in the Fuzzy mutant 
have been shown to be influenced by FGF signaling. As described in the 
introduction, FGF signaling, particularly FGF8 have important roles in 
mandibular arch outgrowth and polarity. In cranial neural crest cells, 
conditional loss of FGF results in an increase in apoptosis and subsequent 
loss of BA1 derived skeletal elements (Trumpp et al., 1999). Conversely, FGF 
signaling from the frontonasal process stimulates neural crest cell 
proliferation (Szabo-Rogers et al., 2008). Subsequent polarity of the first 
branchial arch is also FGF8-dependent (Crump et al., 2004, Tucker et al., 





Figure 4.10 Proposed model for ciliopathic micrognathia in Fuzzy 
mutant mice 
(A and B) Mandibular process of e10.5 embryos. (A) In normal situations, 
Fgf8 expression (schematized in purple) is expressed on either side of the 
midline. In Fuzzy mutants, (B) Fgf8 expression is expanded medially and the 
mandibular process is narrower.(C and D) represent cell packing in the 
mandibular process. (C) In wildtype situations, cells must be appropriately 
distributed. (D) In the mutant, there is increased cell density. 
(E and F) represent the mandibular process at e11.5. (E) In wildtype 
embryos, bilateral rods of Meckel’s cartilage are formed and Barx1 
expression is restricted to lateral regions. (F) In the mutant,  the mandibular 
process is narrower then that of the wildtype and rods of cartilage are 
formed closer together. In addition, Barx1 expression is also shifted to more 
medial regions representing a lateral to medial shift of tissue.  
(G and H) show mandibles at e12.5. (G) In wild type embryos, rods of 
Meckel’s cartilage are extended but have not yet fused in the midline. (H) In 
mutants the mandible is narrower then wild type mandibles and rods of 
Meckel’s cartilage have prematurely fused at the rostral process. 
(I and J) depict Meckel’s cartilage at e16.5 (I) In wildtype embryos, a region 
of enlarged hypertrophic like chondrocytes are present and further 
contribute to mandibular elongation. (J) In mutants, enlarged chondrocytes 
cannot be seen. 
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Consistent with the widespread roles of FGF during sequential stages of jaw 
development, we found that heterozygous loss of Fgf8 was sufficient to 
rescue the MC phenotype and restore medio-lateral patterning. Interestingly, 
Tbx1 mutants, which have a loss of both FGF8 and FGF10, have mild 
micrognathia (Jerome and Papaioannou, 2001, Vitelli et al., 2002). It was 
subsequently shown that these changes are probably as a result of abnormal 
mesodermal medio-lateral patterning in BA1 at e10.5 (Aggarwal et al., 2010). 
In contrast to our Fuzzy mutant, FGF8 expression was shifted from medial 
positions to lateral positions, as were other medial markers (Aggarwal et al., 
2010). This is particularly interesting since the Fuzzy mutant and tbx1 
mutant have similar mandibular phenotypes which appear to arise from 
opposing changes in FGF8 expression (although that of the Fuzzy mutant is 
significantly more severe). Such an observation is hard to explain, especially 
since no real explanation as to how Tbx1 loss causes micrognathia has been 
provided, however this further highlights the importance of proper 
mediolateral patterning and FGF8 in proper jaw formation. Our 
observations are backed up by those seen in compound Prx1 and Prx2 
mutants in the chick which have a truncated mandible accompanied by 
lateral-medial shifts of FGF8, Barx1 and other laterally expressed genes such 
as Dlx5 (Balic et al., 2009).  
 
It should be noted, however, that in addition to these processes described, 
additional mechanisms, such as apoptosis, might contribute to micrognathia. 
Micrognathia seen in conditional Fgf8 knockouts was suggested to be in the 
absence of changes in proliferation of apoptosis (Aggarwal et al., 2010). 
Conversely, micrognathia seen by Balic et al was suggested to be from 
enhanced apoptosis from e10.5, causing loss of tissue in the medial 
mandibular prominence (Balic et al., 2009). Apoptosis linked to 
micrognathia has also been documented on loss of the Obfc2b gene, a DNA 
binding protein important for genomic stability. Loss of this gene is thought 
to cause micrognathia from increased apoptosis in skeletal tissue at e12.5 
(Feldhahn et al., 2012).  In support of this, FGF8 has been heavily implicated 
as a NC survival factor  and along these same lines, loss of Fgf8 was shown to 
result in a hypoplastic BA1 as a result of increased NC apoptosis (Abu-Issa et 
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al., 2002, Trumpp et al., 1999). Dose dependent effects of FGF8 may explain 
these differences in roles of Fgf8 with regards to apoptosis, during NC 
survival. Apoptotic pathways are activated on both loss of, and increased, 
Fgf8 expression (Storm et al., 2003). This reveals the strict requirements 
and complicated role for FGF8 during early craniofacial development and 
may explain similarities in the Fuzzy mutant phenotype and loss of function 
Fgf8 mutants. In support of this, electroporation of Fgf2 into quail NC, 
reveals dose dependent responses with high doses inducing chondrogenesis 
and low doses causing upregulation of chondrogenic markers in the absence 
of actual differentiation (Petiot et al., 2002). These observations suggest that 
it would be a good idea to look at markers for apoptosis in the mandible of 
the Fuzzy mutant to establish whether this contributes the small 
mandibular prominence of BA1 that we see at e10.5 (Fig 4.1).  
 
Additional signaling pathways may interplay with mechanisms described 
above. For example, mouse mutants for different Tgfβ subtypes have MC 
malformations. loss of Tgfβ1, which is known to be important in cartilage 
and bone formation, causes abnormal shaping of the rostral process, whilst 
loss of TGFβ3 results in a smaller MC, thought to be due to reduced 
chondrocyte col2 synthesis. This can be rescued with exogenous TGFb3 
application and is (Chai, 1994). Although it is a tentative link, given the 
complexity and multiple signaling pathway interactions that occur during 
mandibular development, convergence of Fgf8 misregulation on other 
signaling interactions cannot be ruled out. 
 
Once Meckel’s cartilage has assumed it’s characteristic inverted ‘V’ shape, it 
continues to elongate, suggesting additional mechanisms drive growth after 
rostral process fusion. In endochondral bone growth, chondrocyte 
enlargement drives further elongation. Shimo and colleagues have observed 
similar hypertrophic cells in Meckel’s cartilage, but their function has been 
unclear (Shimo et al., 2004). These hypertrophic cells are associated with 
the onset of incisor development (Yang et al., 2012); indeed, Fuz mutants 
lack incisors and the accompanying hypertrophic chondrocytes (Figure 4.8 
D)(Tabler et al., 2013, Zhang et al., 2011).  
 112 
 
It is worth noting that the hypertrophic chondrocytes in Meckel’s cartilage 
were not rescued in the compound mutants (Fig 6). The reasons for this are 
unclear. Whilst some groups have stated that the incisors are responsible for 
initiating chondrocyte maturation and subsequent degradation within 
Meckel’s cartilage, others have stated that processes driving typical 
endochondral ossification, such as Ihh, PTHrP and colX expression are 
important (Shimo et al., 2004, Yang et al., 2012, Yamazaki et al., 1997). Since 
we see a loss of Ihh expression in developing mutant MC, (Fig 4.9 F) coupled 
with a lack of incisors (Fig 4.8 D), it is possible that a combination of the two 
is responsible for loss of chondrocyte maturation. I would postulate that the 
loss of Ihh expression is probably due to defective Gli3 processing which 
inhibits chondrocyte maturation, as described in the limbs (chapter 3); and 
subsequent to this, the lack of incisor development inhibits the degradation 
of these cartilages. This is supported by observations that reduction of FGF8 
in the Fuzzy mutant does not rescue loss of hypertrophy in the developing 
long bones (Chapter 3, Fig 3.6) and developing incisors stimulate osteoclast 
differentiation (Wise et al., 2000, Kitahara et al., 2002). However, since 
mechanisms of chondrocyte maturation may be different between MC and 
endochondral elements, further work must be done to verify whether loss of 
MC hypertrophy is as a result of loss of incisors, or via the Ihh-PThRP 
feedback loop, or via both. It would be interesting to study this further by 
observing MC maturation in animal models lacking incisors but which have 
properly functioning cilia. Interestingly, Gli3 mutant mice also lack incisors  
(Mo et al., 1997). It is therefore possible that in our mutant, defective Gli3 
processing could be driving both the lack of incisors and chondrocyte 
hypertrophy. Furthermore, the fact that Gli2 mutants have a more severe 
mandibular truncation then Gli3 mutants suggests that Gli2 processing may 
also be defective in the Fuzzy mutant (Mo et al., 1997). Further work 
examining relative levels of Gli proteins and activator:repressor ratios 
within the mandible will help to establish if this is the case. Another 
interesting way to determine this would be comparative analysis of 
Fuzzy;Gli2 and Fuzzy;Gli3 compound mutants. 
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It is clear that growth of the mandible is complex, multistep process. Our 
analysis suggests that ciliopathic micrognathia arises in large part from 
aberrant FGF8 signaling during patterning of the first branchial arch. 
Furthermore, FGF signaling likely plays several additional roles in 
mandibular development, during the initiation and shaping of the 
chondrogenic condensations. Subsequently, several stages of mandibular 
development can go wrong resulting in micrognathia  (summarized in fig 
4.10).  
 
As one final consideration, it was also mentioned that loss of Fuzzy was 
reported to cause increased canonical Wnt signaling and an increase in Sox9 
expression in the Fuzzy mutant (Zhang et al., 2011). The authors also 
suggested that these signaling changes cause the micrognathic phenotype. 
However, current consensus in the field is that low Wnt signaling is required 
to maintain Sox9 expression so the observations made appear counter 
intuitive. In order to address this, more analysis into Wnt signaling in the 
mutant should be carried out. For example, it would be important to 
establish specifically when we see an increase in signaling. One possibility 
could be that increased in canonical Wnt activity seen at e14.5 could 
correspond to enhanced bone formation in the mandible (discussed further 
in chapter 6), since it is thought that Wnt signaling is a switch between 
cartilage and bone formation (Day et al., 2005). Thus, to further explore if 
Wnt signaling contributes to the micrognathic phenotype, further 
quantification of Wnt responsive markers, as well as regions of expression 
should be carried out at earlier and later time points. This is especially 
important since e14.5 is quite a dynamic time for MC development in terms 
of ossification, which is just starting is some regions. Furthermore, at e14.5 
MC should already have formed its characteristic shape. I would suggest that 
analysis at earlier time points, such as that carried out in this chapter. 
Therefore, I would suggest that analysis carried out in this chapter is more 
definitive then that carried out by Zhang et al., and is more beneficial for 
establishing mechanisms driving the phenotype since it enables us to 
visualize what is happening during elongation as opposed to once it is 
already defective. 
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Our studies allow us to distinguish between the FGF dependent aspects of 
micrognathia (early patterning) versus FGF-independent events 
(chondrocyte maturation); and characterise key steps for proper mandible 
development that have not been described previously. Interesting further 
work would be to assess whether FGFs or Glis are integrating with other 
signaling pathways, such as TGFβ, in the etiology of micrognathia. 
Deciphering these interactions will be necessary for a full understanding of 




Chapter 5 Hyperossification of the mandible 
5.1 Introduction 
The skeletal element of the lower jaw is the mandibular bone. Functionally, 
it provides housing for the developing teeth and forms the 
temporomandibular joint, which is the articulation between the lower jaw 
and the cranium. In this way, abnormal ossification of the lower jaw could 
have serious consequences by affecting basic functions such as mastication 
and speech. 
 
In humans, disorders in mandibular bone development are rare, with the 
majority causing cysts within the jaw or discontinuation of the bone. For 
example, haplo-insufficiency of patched causes odontogenic cysts on the 
mandible; whilst patients with magnesium deficiency are reported with 
increased levels of jaw osteoclastogenesis (Unden et al., 1996, Belluci et al., 
2013). Although clinically hyperossification of the lower jaw is rarely 
described, syngnathia, which is fusion of the upper and lower jaw with 
unknown causes, is a rare anomaly that can occur as part of maxillofacial 
syndromes or on its own (Inman et al., 2013, Turksen et al., 2012). 
 
Developmentally, mandibular skeletogenesis is a unique process which has 
aspects of both intramembranous and endochondral ossification. 
Development begins from NC derived mesenchyme, first seen at 
approximately e13.5, located laterally to the developing Meckel’s cartilage 
(Ramaesh and Bard, 2003). It is generally thought that during normal bone 
formation, high Wnt signaling is required to switch between chondrogenic 
and osteogenic differentiation (Day et al., 2005). Consistent with this Wnt 
signaling has been shown to stimulate mandibular ossification (Leucht et al., 
2008). During ossification, the proximal and distal bone fronts elongate and 
at the same time, the superior and inferior edges grow towards the midline 
to form an osseous membrane, which encapsulates Meckel’s cartilage 
(Ramaesh and Bard, 2003). In a typical intramembranous manner, the cells 
at the periphery of the membrane proliferate much more then those in the 
mesenchyme causing bone formation to occur within the membranous 
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sheath (Tomo et al., 1997, Ramaesh and Bard, 2003). It has been suggested 
that MC plays a role in mandibular ossification but that role remains elusive. 
It was shown that the endothilin-converting-enzyme-1 knockout mouse 
lacks MC and the mandibular bone, whilst conditional Sox9 mutants have 
complete absence of MC but a relatively normal mandibular bone, albeit 
severely micrognathic (Yanagisawa et al., 1998, Mori-Akiyama et al., 2003). 
This not only suggests that Meckel’s cartilage has roles in elongating the jaw 
and creating space in which ossification can occur, but also implies that the 
mandibular bone formation is not entirely dependent on Meckel’s cartilage 
formation.  
 
To date, several differences between endochondral ossification and 
ossification of Meckel’s cartilage have been documented. From around e15.5, 
chondrocytes of Meckel’s cartilage undergo hypertrophic maturation, 
followed by autophagy, similar to that seen during endochondral 
ossification (Yang et al., 2012, Shimo et al., 2004, Roach et al., 2004). 
Similarly, hypertrophic cells of MC are shown to express the same 
successive markers of chondrocyte maturation seen in endochondral 
ossification, including Col2 in resting chondrocytes and Ihh and ColX in 
hypertrophic chondrocytes (Shimo et al., 2004). Unlike in endochondral 
ossification, however, hypertrophic chondrocytes of Meckel’s cartilage are 
not vascularized and infiltrated with osteocytes; it is simply degraded by 
early post-natal stages (Bhaskar et al., 1953). In mature chondrocytes of 
mouse MC, high levels of Rank-Ligand (RANKL) and osteoprotogenin (OPG) 
immunoreactivity is detected in MC. These proteins are not detected during 
these developmental stages in the hind limbs (Sakakura et al., 2005). 
Typically during bone development, RANKL will bind to the RANK receptor 
to stimulate osteoclastogenesis; to limit this process the ‘decoy’ receptor, 
OPG is synthesized, reducing osteoclastogenesis (Baud'huin et al., 2007). 
OPG secretion could therefore be a possible mechanism by which 
degradation of MC is limited to post-bone formation.  
 
One other interesting aspect of mandibular ossification is the presence of a 
secondary cartilage called the mandibular symphisis.  Secondary cartilages 
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are fibro-cartilaginous joints, which can undergo endochondral ossification 
and are typically associated with membranous bones (Trevisan and Scapino, 
1976, Kjaer, 1975). In the mandible, the symphysis at the most distal region 
of the jaw exists between the two mandibular bones; in this way, there is a 
lack of ossification surrounding the rostral process (Trevisan and Scapino, 
1976). In mice, it has been shown in compound Ihh and Gli3 mutants, that 
formation of the symphisis is dependent on Ihh-Gli3 signaling, as occurs in 
the long bone growth plate. Specifically the Gli3 repressor was shown to 
inhibit chondrocyte maturation and proliferation at the distal tip (Sugito et 
al., 2011). 
 
This chapter aims to characterise hyperossification observed in the 
mandible of the Fuzzy mutant. This phenotype of the lower jaw is rarely 




5.2.1 The mandibular bone is hyperossified and intertwined with Meckel’s 
cartilage 
Loss of Fuzzy has already been shown to cause a shortening of endochondral 
derived skeletal elements (See chapter 3). In Fig 5.1 A and B (Chapter 5), as 
well as the mandible of the Fuzzy mutant being shorter then the control, the 
bone of the mandible also appears to be thicker. Therefore, in order to 
characterise this malformation, I carried out trichrome staining on 
transverse and frontal sections of wildtype and mutant heads at e18.5. In 
transverse sections of wild-type animals, the mandibular bone (MB) is 
formed and ossification is taking place within a sheath of ossified tissue (Fig 
5.1 A). The rostral process is the only region of Meckel’s cartilage to not 
have bone formation around it. Conversely, in the Fuzzy mutant, the 
mandibular bone appears to be much thicker with a loss of organization 
between the mandibular bone and Meckel’s cartilage (Fig 5.1 B, yellow 
arrowhead). In addition there is clear ossification covering the rostral 
process. Frontal views of the wildtype reveal that Meckel’s cartilage can be 
seen as a discreet rod running through the inside of the mandibular bone 
(Fig 5.1 C, black arrowhead), whilst in the mutant, MC can again be seen 
tangled with the bone (Fig 5.1 D, yellow arrowheads). In addition, the 
mandibular bone in the mutant appears to be larger in the rostrocaudal axis 







Figure 5.1 The mandible of the Fuzzy mutant is hyperossified and 
organization of Meckel’s cartilage and the mandible bone is disrupted.  
Trichrome stained sections of wildtype and mutant mandibles at e18.5. 
Cartilage is stained in blue and bone is stained in red. In the wildtype section 
(A and B) Transverse sections.  (A) The two tubes of mandibular bone can 
be clearly seen independent of Meckel’s cartilage. The rostral process (rp) 
can be seen at the most anterior tip.  (B) In the mutant mandible bone is 
thicker and Meckel’s cartilage can be seen encroaching into the bone (yellow 
arrowheads) 
(C and D) Sagittal sections. (C) In the wildtype embryo, there is a clearly 
defined boundary between Meckel’s cartilage and the surrounding 
mandibular bone (black arrowhead). (D) In the mutant, the boundary 
between cartilage and bone is less well defined (yellow arrowheads) and the 





5.2.2 Runx2 expression is expanded in the Fuzzy mutant at e12.5 and e14.5 
Runx2 is one of the key transcription factors that regulates bone formation 
by committing precursor cells to osteogenic differentiation. In normal 
situations, Runx2 is expressed in pre-cartilaginous mesenchymal 
condensations of the mandible from as early as e10.5. By e12.5, this 
expression is suggested to be regulating osteoblast differentiation markers 
such as osterix (Shibata et al., 2004, Stricker et al., 2002). At e13.5, bone 
formation of the mandible has just started to commence (Ramaesh and Bard, 
2003). For these reasons I decided to compare Runx2 expression at e12.5 
and e14.5. In frontal sections of wild-type embryos at e12.5, Runx2 
expression can be seen faintly in the mandibular mesenchyme (Fig 5.2 A). In 
the Fuzzy mutant, Runx2 expression appears to be expanded in the 
rostrocaudal axis with ectopic expression in the tongue (Fig 5.2 B, green 
arrowhead). Two days later, at e14.5, in wildtype transverse sections, runx2 
is expressed around Meckel’s cartilage and the incisors (Fig 5.2 C). 
Conversely, in the mutant, incisors are absent and Runx2 is expressed 
throughout the mesenchyme (Fig 5.2 D). This data suggests that the Fuzzy 
mutant has more widespread Runx2 expression then wildtype embryos. 
5.2.3 Calcium deposition in the mandible appears closer to the midline in 
mutants 
In order to visualize new bone formation in the mandible, calcein labeling 
was carried out. Calcein chemically binds to calcified tissue and can be 
visualized under green fluorescence. Pregnant females were injected twice, 
at e14.5 and e16.5, and sacrificed at e17.5. Calcium accumulation was 
assessed with fluorescent microscopy. Fig 5.3 A and B show ventral views of 
wild type and mutant heads. Fig 5.3  shows a fluorescent image of a wild-
type sample in which calcium accumulation surrounds the two branches 
mandibular bone (yellow arrowheads). In the Fuzzy mutant, calcium 
accumulation is not restricted to each mandibular bone and appears to be 
more spread towards the midline, implying a shift in bone position (Fig 5.3 







Figure 5.2 Fuzzy mutants have larger domains of Runx2 expression 
(A and B) Frontal sections of Fuzzy mutant and wildtype control embryos at 
e12.5 showing mRNA in situ hybridisation for Runx2 expression. (A) In the 
control, Runx2 is expressed in distinct domains in the developing mandible 
and is absent from the tongue (t). (B) Runx2 appears to be more abundantly 
expressed in the mutant mandible. Ectopic expression can also be seen in 
the mutant tongue (green arrowheads). 
(C and D) Transverse sections of Fuzzy mutants and littermate controls at 
e14.5.  (C) In the control embryo, Runx2 expression can be seen surrounding 
Meckel’s cartilage (MC) and is absent in the incisors (i). In the mutant, Runx2 
appears to be more abundantly expressed, especially in the  region of absent 







Figure 5.3 Calcein accumulation across the midline of Fuzzy mutants 
at e17.5 
(A and B) Brightfield images of ventral views of wildtype and mutant heads. 
(C and D) Green fluorescence shows positive calcein labeling reflecting 
calcium deposition. (C) In the wildtype, calcein deposition occurs bilaterally 
in the mandibular bone (yellow arrowheads). (D) In mutants, calcein 






5.2.4 Bone mineralization is seen in a larger region and is spread across the 
midline in the mutant mandible 
In order to better visualize deposition in the mutant, calcein labeled 
embryos were sectioned. Dapi counterstained frontal sections of wildtype 
and mutant heads taken at the level of the molar tooth bud at e17.5 (Fig 5.4 
A and B). Visualization of green fluorescence and hence calcium 
accumulation in these same sections are shown in Fig 6.4 C and D. GFP and 
Dapi merged images are shown in Fig 5.4 E and F. In the wildtype, Calceine 
accumulation is clearly seen on the lateral flanks of Meckel’s cartilage (Fig 
5.4 E). In the mutant however, the region of calcium accumulation 
surrounding Meckel’s cartilage is noticeably larger (red asterisk) and there 
is ectopic ossification towards the midline (Fig 5.4 F; red arrowhead). Note 
that in this mutant sample, bilateral rods of Meckel’s cartilage have clearly 
prematurely fused (Fig 5.4 F; yellow arrowhead; also note, premature MC 
fusion is discussed in chapter 4). 
 
In order to further characterise the hyperossification of the mandible, we 
also carried out von Kossa staining for bone mineralization at e16.5. 
Transverse sections were taken at the level of the molar tooth bud. Fig 5.5 A 
and B show whole heads of wildtype and mutant embryos whilst A’ and B’ 
show magnified images of the mandibles. In the wildtype, positive Von 
Kossa staining (seen in black) surrounds Meckel’s cartilage within a sheath 
but mineralization within this region is not complete (Fig 5.5 A and A’). 
Conversely, in the Fuzzy mutant, there is a lot more mineralization 
throughout the mandible and there is hyperossification across the midline 
(Fig 5.5 B and B’, green arrowheads). 
 
Taken together, calcein labeling and von Kossa staining reveals 
hyperossification of the mandible surrounding MC as well as a spread of 






Figure 5.4 Excess calcium deposition in Fuzzy mutants at e17.5. 
Calcein labelling shows calcium accumulation. 
(A and B) Dapi stained frontal sections through the mandible of e17.5 
mutant and littermate controls. Molar tooth buds are marked by ‘m’.  
(C and D) Calcein visualization in green channel shows hyperossification 
across the midline of Fuzzy mutants (D) compared to two discreet regions of 
mandibular ossification in the wildtype (C). 
(E and F) Merged Dapi and GFP channels. In the wildtype (E), calcein 
accumulated in discreet regions surrounding Meckel’s cartilage (MC). In the 
mutant (F), enlarged regions of calcein accumulation (red asterisks) are 
seen around each bar of Meckel’s cartilage and towards the midline (red 












Figure 5.5 The Fuzzy mutant has increased mineralization across the 
midline of the mandible 
Von Kossa staining marks bone in black. Eosin counterstain. 
(A and B) Wild type and mutant littermates at e17.5. 
(C and D) Enlarged images of regions highlighted in (A) and (B). (C) In the 
control embryo, mineralization is seen surrounding the two rods of Meckel’s 
cartilage (MC). (D) In the mutant, mineralization is seen extending all the 




5.2.6 Reduction of Fgf8 in the Fuzzy mutant rescues mandibular 
hyperossification 
Since Fgf8 has been shown to have roles in the regulation of Runx2, and 
reduction of Fgf8 in the Fuzzy mutant rescues the phenotype of Meckel’s 
cartilage, I wanted to see how reducing the levels of Fgf8 affected the 
ossification phenotype in the mandible. As expected, in the wildtype, the 
Alizarin red stained mandible bone can be seen as two bilateral rods that are 
separated at the rostral process (Fig 5.6 A). In the Fuzzy mutant, as well as 
being shorter, the mandible appears thicker in the medio-lateral axis and is 
clearly ossified at the rostral process (Fig 5.6 b). In Fuzzy-/-;FGF8L/+ embryos, 
the length of the mandible is mostly restored (explained in chapter 5) and 
the medio-lateral width of each mandibular ossification does not appear to 
be as thick. In addition, ectopic ossification around the rostral process 
appears to be rescued (Fig 5.6 C). Compound mutants were also sectioned 
frontally at e16.5 and underwent tri-chrome staining. In the wildtype 
samples, as described previously, Alizarin red staining for mature bone can 
be seen in a sheath surrounding Meckel’s cartilage with bone formation not 
fully occupying this region (Fig 5.6 D). In the Fuzzy mutant, the regions of 
alizarin red staining is much larger and there is more positive staining 
within the osseous sheath. Note fusion of bilateral rods of Meckel’s cartilage 
as described in chapter 5. As predicted, reducing Fgf8 gene expression in the 
mutant appears to rescue the hyperossification of the mandible. Fuzzy 
Compound mutant mandibles appear to be more similar to wildtype 
embryos with positive staining seen in a well defined sheath surrounding 
Meckel’s cartilage, when compared to Fuzzy mutants, which have thicker 








Figure 5.6 Mandibular hyperossification is rescued on reduction of 
Fgf8 gene expression in the Fuzzy mutant 
(A-C) Alizarin red staining marks bone in red. Ventral views mandibles at 
e16.5. One half of each mandible is outlined in a yellow dashed line. (A) In 
the control sample (A), the mandible can be seen as two bilateral rods of 
bone. (B) In the Fuzzy mutant, as previously described, the mandible is 
shorter. The bone is be thicker medio-laterally and the distal tips of each 
mandible bone are fused at the rostral process (green arrowhead). (C) In 
compound mutants, the ossification appears to be similar to the wild type. 
Although the bone is not as regularly shaped as in the wild type, the extent 
of mandibular thickening is mild. 
(D-F) Trichrome stained sections show cartilages in blue and bone in red. 
Bone is outlined with yellow dotted lines. Frontal sections of E16.5 mouse 
mandibles, are taken at the level of the molars. The region of mandibular 
bone formation is outlined with a dashed yellow line. (D) In the control 
sample, the mandibular bone surroundS Meckel’s cartilage. (E) In the Fuzzy 
mutant sample, the bone appears to be larger in the medio-lateral axis and 
does not encase Meckel’s cartilage, which has prematurely fused. (F) 
Reduction of Fgf8 gene expression in the mutant restores the appearance of 






Results in this chapter reveal that the Fuzzy mutant has hyperossification of 
the mandible, which is spread towards the midline. This is an interesting 
phenotype since it is rarely described clinically. Our data indicates that prior 
to initiation of mandibular ossification at early developmental stages, there 
is an increased region of Runx2 expression in mutants (Fig 6.2). Since Runx2 
is one of the key transcription factors committing mesenchymal stem cells 
to the osteoblast lineage, it is not surprising that this would lead to 
enhanced bone formation (Komori and Kishimoto, 1998, Komori, 2002). The 
outstanding question is how this upregulation of Runx2 occurs. 
 
The regulation of Runx2 is complex and occurs on many levels. 
Transcriptional control is under the regulation of a variety of signaling 
molecules ranging from FGFs, specifically FGF2, to Retinoic acid and TGF-β 
signaling (Komori, 2005, Niger et al., 2013, Park et al., 2010). Adding 
complication to the issue of Runx2 regulation, it has been shown to both 
positively and negatively regulate its own promoter (Drissi et al., 2000, Ducy 
et al., 1997); subsequently, post translational modifications, such as 
phosphorylation, further regulate activity (Selvamurugan et al., 2000).  
 
Since in Fuzzy mutant, we see changes in Runx2 expression from as early as 
e12.5, it is reasonable to postulate that early signaling changes are 
responsible. Hand2, typically associated with regulation of mandibular 
homeotic identity, is expressed in the medial epithelium of the developing 
mandible from as early as e10.5 and is shown to be important for 
craniofacial development, including the developing mandible and palate 
(Yanagisawa et al., 2003, Balic et al., 2009, Funato et al., 2009). From e13.5, 
Hand2 and Runx2 have been shown to co-localize and Hand2 can inhibit 
Runx2 binding to DNA, and hence regulate its activity (Funato et al., 2009).  
In chapter 4, I showed that Fuzzy mutants have a lateral to medial shift of 
Barx1 expression implying either a loss of midline or change in tissue 
identity within the presumptive mandible. Along these lines, it can be 
proposed that early on we have a smaller domain of medial tissue, in which 
Hand2 is normally expressed. It is therefore possible that loss of medial 
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tissue between e10.5 and e12.5 (since this is when we first see defects in the 
1st branchial arch and changes in medio-lateral tissue markers, see chapter 
5) can result in loss of Runx2 regulation by Hand2 and more osteoblastic 
commitment in the mandible. Giving weight to this hypothesis is the fact 
that loss of Hand2 also results in cleft palate, micrognathia, and alobar 
tongue (which is something also observed in the Fuzzy mutant, data not 
shown). Hand2 mutants also show mandibular hyperossification across the 
midline associated with increased regions of Runx2 expression (Barron et al., 
2011, Xiong et al., 2009, Funato et al., 2009, Liu et al., 2009). If this is the 
case, then, similar to micrognathia described, hyperossification of the 
mandible is as a result of early changes in Fgf8 gene expression. In keeping 
with this, reduction of Fgf8 in the fuzzy mutant appears to rescue most of the 
mandibular ossification phenotype. In order to determine if this is true it 
would be very interesting to look further at expression of medial and 
laterally expressed genes, including Hand2, in the mandible throughout 
development of the Fuzzy mutant.  
 
While Runx2 expression may be indirectly affected by mediolateral 
patterning changes in the Fuzzy mutant, is it also possible that FGF8 plays a 
more direct role in controlling Runx2 expression. FGF8 has been shown to 
induce mouse myoblast cells to differentiate into osteoblasts and RUNX2 is 
known to be needed for intramembranous ossification (Omoteyama and 
Takagi, 2009, Komori et al., 1997, Lee et al., 1997, Mundlos et al., 1997). 
Furthermore, in tissue culture FGF8 has the ability to bind to all the FGFRs 
with highest affinity to FGFR3 (Zhang et al., 2006). Although there are no 
published reports of FGFR3 signaling affecting the mandibular bone, FGFR3 
hyperactivation has been associated with synostosis (Singh et al., 2014, 
Georgoulis et al., 2011). In addition, signaling through FGFR1 and -2 are 
known to be needed to promote osteoblast differentiation and maturation 
during craniosynostosis (Muenke and Schell, 1995, Park et al., 1995). It 
should therefore be considered that abarrent FGF signaling may directly 
causes upregulation of Runx2 expression in the mutant mandible.  
The lack of incisors in the Fuzzy mutant could also be a contributing factor 
to mandibular hyperossification. Fig 5.2 D shows Runx2 expression in the 
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region where the incisors would normally be present. One possibility is that 
the tooth provides an inhibitory signal, and in its absence Runx2 expression 
can expand. That said, rat mutants that lack incisors do not have mandibular 
hyperossification (Bhaskar et al., 1953).  
 
Alternatively, Wnt signaling may play a role. It has been shown that 
application of Wnt10b, which activates canonical Wnt signaling, enhances 
osteoblast differentiation and leads to more mandibular bone at the expense 
of the incisors (Bennett et al., 2007). Since some reports state that canonical 
wnt signaling is enhanced in the Fuzzy mutant mandible at e14.5, it is 
possible that this contributes to the excessive ossification and loss of incisor 
we observe in the mutant (Zhang et al., 2011). Consistent with a possible 
role for Wnt driving this phenotype, a high bone density associated with an 
abnormally wide and deep mandible was observed in two related human 
patients, and attributed to gain of function mutations in LRP5, which is 
generally thought to induce wnt signaling (Boyden et al., 2002). 
Contribution of aberrant Wnt signaling can be tested in two ways. First, we 
could assess relative expression levels of Wnt target genes such as Lef1 and 
TCF, by qPCR. Second, reducing the levels of Wnt signaling using a 
conditional deletion of β-catenin in NC cells (Wnt1::cre; β-cateninfl/+; Fuz-/-), 
may restore normal mandibular development. Subsequent phenotypic 
analysis would determine which aspects of mandibular hyperossification, if 
any, are influenced by aberrant Wnt signaling. 
 
Another consideration for our phenotype is that enhanced bone formation 
towards the midline may be secondary to the smaller and narrower MC. This 
possibility is particularly interesting when one considers that the MC 
phenotype is rescued in compound mutants and the ossification phenotype 
is for the most part rescued. This is possible, however no reports have 
shown that MC is needed to regulate levels of mandibular ossification. In fact, 
in Sox9 mouse mutants, which do not develop MC, the jaw is hypoplastic 
however ossification of the jaw is not spread towards the midline (Mori-
Akiyama et al., 2003).  
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Thus far our mouse model has phenocopied many defects that are observed 
in mouse models and human patients of ciliopathies (described in chapters 
3-5). It is therefore quite surprising that mandibular hyperossification of 
this nature has so rarely been described. Our data reveals that this 
ossification defect may be as a result of changes in early gene expression, 
which manifest in both the Meckel’s cartilage phenotype described in 
chapter 5 and subsequent hyperossification. With this in mind, it is possible 
that the reason this phenotype has not been previously described is for two 
reasons. Firstly, the extent of hyperossification in the Fuzzy mutant is 
variable, so it is possible that in humans, those with more severe ciliopathies 
do not survive birth in which case mandibular hyperossification may not be 
assessed or may not even be developmentally complete depending on the 
stage at which the embryo dies. A good example of this is Meckel-Gruber 
syndrome, which has a 100% mortality rate (Alexiev et al., 2006). Secondly, 
many human patients of ciliopathies may not have been assessed for 
mandibular hyperossification. Therefore, this could provide new diagnostic 




Chapter 6 Additional skeletal phenotypes in the Fuzzy 
mutant 
6.1 Introduction 
6.1.1 Skeletal defects in ciliopathies 
Ciliopathies are a broad class of disorders, which result from defects in 
proper cilia formation. Some ciliopathies are rare syndromic anomalies, 
which exhibit a range of skeletal defects. Patients may have limb phenotypes 
such as polydactyly, as is the case with Bardet-Biedl Syndrome, or defects in 
the endochondral bones, such as short limbs, short ribs and vertebral 
stenosis, as seen in Sensenbrenner and Ellis-van Creveld syndromes (David 
et al., 1999, Beales et al., 1999, Sensenbrenner et al., 1975, Young, 1989, 
Smith and Hand, 1958). In addition, some ciliopathies exhibit craniofacial 
malformations ranging from general changes in shape of the skull, seen in 
Bardet-Biedl syndrome and orofaciodigital  (OFD) syndrome, to exencephaly, 
seen in Meckel-Gruber syndrome, and craniosynostosis, which has been 
reported in Sensenbrenner syndrome (Waters and Beales, 2011, Khalifa et 
al., 2012, Lin et al., 2013). Most skeletal ciliopathies are also reported to be 
associated with a cleft or high arching palate: the former seen in Meckel-
Gruber and Joubert syndromes, the latter seen in Sensenbrenner, Bardet-
Biedl and OFD syndromes (Myageri et al., 2013, Parelkar et al., 2013, Singh 
et al., 2011, Young, 1989, Beales et al., 1997, Shawky et al., 2013). Given the 
dependence of Hh signaling on proper functioning cilia, most of these 
phenotypes are attributed to changes in primary cilia-dependent 
transduction of Hedgehog signals. However the wide range of skeletal 
elements affected suggests a variety of signaling defects (Haycraft and Serra, 
2008). Many phenotypically similar skeletal defects are observed in two 
other classes of skeletal disorders: the chondrodysplasias and the 
craniosynostosis syndromes. 
6.1.2 FGF-related syndromes 
Chondrodysplasia syndromes are characterised by truncation of the 
appendicular skeleton. These diseases arise from gain of function mutations 
of FGFR3 which typically acts to limit terminal differentiation of 
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chondrocytes, regulating long bone elongation, and hence growth (Cohen, 
1998). As such, mouse mutants with enhanced FGFR3 signaling have 
shortening of most endochondral elements (Iwata et al., 2000). In humans, 
most mutations driving chondrodysplasias result in ligand-independent 
constitutive activation of FGF signaling and elevated tyrosine kinase activity. 
This may occur via aberrant FGFR dimerization or aberrant tyrosine kinase 
activity of the receptor (Naski et al., 1998, Neilson and Friesel, 1996, 
Webster and Donoghue, 1996). Examples of these disorders include 
achondroplasia, commonly referred to as dwarfism, hypochondroplasia and 
thanatophoric dysplasia (listed in order of severity).  
 
In humans, the most striking phenotype is short long bones relative to the 
trunk skeleton, which is seen in all the chondrodysplasias. In addition, short 
ribs are also commonly seen in thanatophoric dysplasia and achondroplasia, 
whilst vertebral defects such as dysplastic vertebral bodies and vertebral 
fusions have been reported in chondrodysplasia punctata (Rimoin et al., 
1970, Elejalde and de Elejalde, 1985, Khanna et al., 2001, Mason et al., 1994). 
The cranium, which consists of both endochondral and intramembranous 
bones, also exhibits craniofacial malformations. Skull shape changes are 
common due to reduced growth of the cranial base and craniosynostosis is 
frequently seen (Georgoulis et al., 2011, Cohen et al., 1985). 
 
Craniosynostosis syndromes include disorders such as Apert syndrome, 
Pfeiffer syndrome and Crouzon syndrome. They are principally 
characterised by premature fusion of the cranial sutures associated with 
increased osteoblast maturation (De Pollack et al., 1996, Lomri et al., 1998). 
As described in chapter 1, signaling through FGFR1 and -2 stimulates 
osteoblastic differentiation and maturation, particularly during 
intramembranous bone formation. Hence, hyperactivation stimulates 
excessive bone formation. Clinically a ‘dome shape’ skull, as a result of 
craniosynostosis, and a high arching palate, are most commonly observed 
(Rynearson, 2000, Moore et al., 1995a). Malformations in the trunk skeleton 
have also been described with fusions of the cervical vertebra observed in 
Apert, Pfeiffer and Crouzon syndromes and short limbs and polydactyly 
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reported in Apert syndrome (Hemmer et al., 1987, Anderson et al., 1997, 
Cohen and Kreiborg, 1993). 
 
It is clear that there is a great deal of phenotypic overlap between these 
skeletal syndromes (summarized in Yannakoudakis & Liu, 2014). Moreover, 
the Fuzzy mutant, which is a mouse model for ciliopathies, exhibits all of the 
phenotypes described. These similarities could suggest signals converging 
on deregulated FGF signaling in all of these syndromes. However, ciliopathy 
mouse phenotypes have commonly been attributed to abnormal Hh 
signaling while the role of aberrant FGF signaling is rarely explored. This 
chapter will document certain skeletal malformations of the Fuzzy mutant 
and compare them to those observed in FGF syndromes. In this way new 
light can be shed on underlying molecular changes driving defective 
skeletogenesis and enable us to establish whether individual phenotypes in 
these complex syndromes converge on similar genetic pathways. This 
chapter will mainly discuss phenotypes of the vertebra and the sternum as 
well as craniosynostosis. Phenotypes in the long bones and the mandible 
will be discussed in subsequent chapters. 
6.1.3 Calvarial development 
In mammals, the calvaria of the skull vault consists of paired frontal bones, 
paired parietal bones and the interparietal bone, which form from 
intramembranous ossification. The frontal bones are NC derived whilst the 
parietal bones are mesoderm derived. The interparietal bones consist of 
mixed NC and mesodermal cell populations (Morriss-Kay, 2001). Once these 
cells undergo intramembranous ossification, the bone fronts between them 
must fuse at the calvarial sutures.  
 
Several signaling pathways have been implicated in the development of the 
calvarial bones and their sutures. FGF signaling is particularly important. 
FGF18 and -20 are expressed in the developing calvaria. Fgf18 null mice 
have reduced calvarial ossification associated with a delayed onset of 
osteopontin and lower levels of proliferation in osteogenic cells. This 
suggests that FGF18 is important for proliferation and differentiation during 
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osteogenesis (Ohbayashi et al., 2002).  The importance of FGFR1 and -2 in 
ossification of the suture are described above. 
6.1.4 Sternal development 
The sternum is classified as part of the appendicular skeleton given its 
mesenchymal origins in the lateral somatopleuric mesoderm (Chen, 1952, 
Scheuer and Black, 2004). Development initiates from two sternal primordia 
consisting of mesenchymal rods of condensations in the ventro-lateral body 
wall of the embryo (Chen, 1952). During development, these primordia 
elongate cranio-caudally to form sternal bars. From e12, these pre-
cartilaginous bars migrate medially towards each other (Chen, 1952). By 
e14.5, the sternal bars begin to fuse in a cranial to caudal direction and 
cartilaginous regions in each bar can be seen and fusion is complete by 
e15.5 (Chen, 1952, Kaufman and Bard, 1999). These go on to chondrify 
across the midline and ultimately form one single rostral-caudal 
cartilaginous rod (Kaufman and Bard, 1999). Once chondrogenesis is 
complete, the sternal body, also known as the mesosternum, is segmented 
into sternebrae, which undergo endochondral ossification, at approximately 
e17.5. This happens from individual ossification centers running down the 
length of the manubrium (Chen, 1952, van der Merwe et al., 2013). The most 
caudal portion of the sternum (the xiphoid process) and fusions between 
sternebrae only ossify postnatally (Scheuer and Black, 2004). This is 











Figure 6.1 Schematic of sternal development 
A) The sternum is originally made from two mesenchymal sternal rods 
which move towards the midline from around e12. 
B) Sternal bars begin to fuse in a cranial-caudal direction from 
approximately e14.5. 
C) Chondrogenesis across the midline forms a single cartilaginous sternum. 
D) Subsequent ossification arises from individual ossification centres down 




6.1.5 Vertebral development 
The vertebral column, also known as the spine, can be anatomically 
subdivided into different regions: the cervical, the thoracic and the lumbar 
vertebra (listed rostral-caudal). Embryonically, it arises from two rods of 
paraxial mesoderm on either side of the neural tube which is segmented 
into somites arranged rostro-caudally. These somites go on to 
compartmentalize into sclerotome, syndetome, myotome and 
dermomyotome, which form the vertebra and ribs, tendons, skeletal muscle 
and dermis respectively (Tam and Trainor, 1994). Figure 6.2 A shows the 
outcome of somatic compartmentalization. During this process, the cells 
destined to become sclerotome, which ultimately form the vertebrae, 
undergo epithelial to mesenchymal transitions (Dockter and Ordahl, 1998). 
Shh signaling from the notochord and floor plate dictates dorso-ventral 
patterning, progenitor identity and spatial organization via a graded signal 
(Jeong and McMahon, 2005). All three Gli proteins are expressed in the early 
somites but this expression diverges when looking at discrete 
developmental regions. Gli2 is expressed in the sclerotome whilst Gli3 is 
expressed throughout the sclerotome and in the dermomyotome. It has been 
suggested that both Gli2 and Gli3 are required for Pax1 and Pax9 (early 
sclerotomal markers) induction, which stimulates sox9 expression, and they 
display functional redundancy (Buttitta et al., 2003).  In addition to 
sclerotome induction by Shh, FGF8 signaling from newly formed myotome 
goes on to specify a subset of the sclerotome into syndetome (Brent and 
Tabin, 2004, Gilbert, 2006).   
 
Once the somites have been patterned, individual vertebra, which consist of 
a centrum (more ventral and develops next to the notochord) and a neural 
arch (more dorsal, develops adjacent to the spinal cord), form and together 
make up an individual vertebra,, which when aligned form the vertebral 
column (Hall, 2005). Each vertebra forms via endochondral ossification. 
Cartilaginous templates replace the mesenchyme of the primordial vertebra 
(schematized in Fig 6.2 B). It was shown that in the thoracic vertebrae, the 
centrum forms from two chondrogenic centers, which eventually fuse in the 
midline; this is followed by establishment of chondrogenic centers in the 
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neural arch, which go on to fuse with each other. This creates a cartilaginous 
vertebra surrounding a neural canal, in which the spinal cord will eventually 
sit. Once the cartilaginous template of the vertebra has been established, 
endochondral ossification occurs from different ossification centers 
(schematized in fig 6.2 B). In humans, different vertebral regions have 
different ossification centers. In the thoracic vertebrae, there is 1 primary 
ossification center in the centrum and two on either side in the neural arch. 
The 2nd cervical vertebrae has 5 primary ossification centers: the same 
three seen in the thoracic vertebrae and two additional centers just anterior 
to the centrum; whilst the first cervical vertebrae has 3 primary ossification 
centers, 1 in the anterior arch and 2 in the posterior arch. Secondary 
ossification centers form after puberty (Rosse and Gaddum-Rosee, 1997, 
Butler et al., 2012, Jinkins, 2000). A mature thoracic vertebra is schematized 






Figure 6.2 Schematic of vertebral chondrogenesis 
A). Initially, the somite must me compartmentalized into different layers. 
The dermomyotome, myotome, syndetome and sclerotome. The sclerotome 
goes on to form the vertebra. 
B) the cartilaginous precursors of a single vertebra has different ossification 
centers depending on its location in the body. This image depicts a thoracic 
vertebra with three ossification centers. Two in the future neural arch and 
one in the future centrum. 
C) Ossification from these centers eventually forms continuous bone of the 




6.2.1 Fuzzy mutants have coronal synostosis which cannot be rescued on 
reduction of Fgf8 
We previously showed that genetic reduction of Fgf8 can rescue a high 
arching palate observed in the Fuzzy mutant. In addition, Fgf8 is expressed 
in the developing calvaria. We therefore wanted to see whether reducing 
Fgf8 can rescue craniosynostosis previously documented in the mutant. 
Using Alizarin red staining to mark the mineralized bone, we examined the 
coronal sutures or wildtype, Fuzzy/- and Fuzzy-/-;Fgf8L/+ embryos at e16.5 
(Fig 6.3). In the wild-type samples, a clear boundary between the developing 
frontal (f) and parietal (p) bones can be seen on either side of the coronal 
suture mesenchyme (Fig 6.3 A; black arrow). In Fuzzy mutant embryos, 
craniosynostosis can be observed and there is clear ossification between the 
frontal and parietal bone (Fig 6.3 B. yellow arrow). On genetic reduction of 
Fgf8 in the Fuzzy mutant, craniosynostosis appears to be ameliorated. A 
clear boundary between frontal and parietal bones can be seen flanking un-
ossified tissue (Fig 6.3 C; black arrow). There are, however, small patches in 
which ossification has encroached into the suture (Fig 6.3 C; yellow 
arrowhead). This suggests that although aberrant Fgf8 expression may be 
responsible for the synostosis observed, other mechanisms may contribute 










Figure 6.3 Craniosynostosis is observed in the Fuzzy mutant and is ameliorated on reduction of Fgf8 
Bone is stained with Alizarin red. 
A) Wildtype control embryo at e16.5. A clear suture with absence of ossification can be observed between the frontal (f) and parietal (p) bones 
(black arrows). 
B) In the Fuzzy mutant at e16.5, the frontal and parietal bones have prematurely fused (black arrowhead denotes where the suture should be). 
C) On genetic reduction of Fgf8 in the Fuzzy mutant, the synostosis appears to be ameliorated as suture has not fused between the frontal and 






6.2.1 Fuzzy mutants have vertebral stenosis and fusion of cervical vertebra 
In order to characterise abnormal skeletal development of the vertebra, I 
looked at the developing cartilage and bone. Two different developmental 
times were chosen to try to determine the source of the phenotype. 
Cartilaginous precursors of the vertebra were visualized in e13.5 embryos 
by means of col2::lacZ reporter gene activity (Zhou et al., 1995). In the wild-
type embryos, well-formed vertebral bodies can be seen regularly spaced 
down the length of the thoracic spinal cord (Fig 6.4 A; red arrowhead). In 
mutant embryos, chondrogenesis of the vertebral bodies appears to be 
absent (Fig 6.4 B, red asterisk), or if initiated appears to lack fusion of the 
two chondrogenic sites of the centrum (open red arrowhead).  
 
By e18.5, in wildtype embryos, ossification of the vertebral bodies in the 
thoracic vertebra can be seen clearly under way down the length of the 
vertebra (Fig 6.4 C, yellow arrowhead). In the cervical vertebra, bone from 
the 2 primary ossification centers of the vertebral arch appears regularly 
spaced on either side of the midline (Fig 6.4 C, black arrowheads). In the 
mutant embryos, ossification of the centrum is clearly absent (Fig 6.4 D, 
yellow asterisk) and there is clear fusion of the cervical vertebra (CV). Taken 
together, these data suggest that underlying cartilage abnormalities may be 





Figure 6.4 Chondrogenesis and ossification of the vertebra in the 
Fuzzy mutant is abnormal 
(A and B) Dorsal images of vertebral columns of wildtype and mutant 
embryos at e13.5 showing cartilage visualized with a Col2::lacZ reporter 
gene. (A) In the wild type, chondrogenesis of the vertebral bodies is normal 
and has fused in the midline (red arrowhead).  (B) In the mutant, cartilage 
appears to be either absent (red asterisk), or has failed to fuse in the midline 
(hollow red arrowhead). 
(C and D) Dorsal images of alizarin red stained bone in vertebral columns of 
wildtype and Fuzzy mutant embryos at e18.5. (C) In the wildtype, 
ossification of the vertebral arch of the cervical vertebra appears normally 
sized and regularly spaced apart (black arrowheads). Ossification of the 
vertebral bodies is well under way (yellow arrowhead). (D) In the mutant, 
there is obvious fusion of the cervical vertebra (CV) while ossification of the 
vertebral bodies is absent (yellow asterisk). 
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6.2.3 Reduction of Fgf8 in the Fuzzy mutant does not rescue the cartilage 
phenotype of the vertebral column 
Since we previously showed elevated levels of FGF8 signaling driving a 
maxillary phenotype in the Fuzzy mutant, and since FGFR3, one of the 
receptors for FGF8, is expressed in the developing spine, we decided to see 
whether an increase in FGF has roles in the vertebral phenotype of the Fuzzy 
mutant (Peters et al, 1993)(Tabler et al., 2013, Peters et al., 1993). Fig 6.5 
shows alcian blue stained vertebral columns from e14.5 embryos. In the 
wildtype specimen, fusion of the centrum in the midline appears normal in 
both the cervical vertebra (Fig 6.5 A; asterisk) and the thoracic vertebra 
(black arrowhead). In the Fuzzy-/- specimen, the centra of the cervical 
vertebrae and the thoracic vertebrae are not fused at the midline (Fig 6.5 B; 
black asterisk). Reduction of Fgf8 gene dose in the Fuzzy mutant does not 
rescue the vertebral phenotype. Lack of fusion in the cervical and thoracic 
vertebrae is very obvious  (black asterisk and arrowhead respectively; Fig 
6.5 C). As an additional control, panel (Fig 6.5 D) shows a heterozygous Fgf8 
animal, which appears normal. 
6.2.4 Fuzzy mutants have a cleft sternum with excess ossification 
In order to characterise defective sternal development in the Fuzzy mutant, 
cartilage and bone were visualized at two different stages. The cartilaginous 
development of the sternum was visualized with Alcian blue staining at 
e15.5, whilst ossification was visualized with Alizarin red staining at e18.5. 
At e15.5 (Fig 6.6 A), the frontal views of the wild type sternum reveal fusion 
of the sternal bars. Seven pairs of ribs can be seen attached to the sternal 
bars. In the Fuzzy mutant littermate, the sternal bars have failed to fuse in 
the midline and the sternum is clearly cleft (Fig 6.6 B, black arrow). Later 
observations, at e18.5, reveal that in the wildtype sample individual 
ossification centers in the sternebrae can be seen (Fig 6.6 C). In the mutant 
at this age, the sternum is still clearly cleft (black arrow) but the sternebrae 






Figure 6.5 Reduction of Fgf8 does not rescue the vertebral 
phenotype 
Ventral views of alcian blue stained cartilage of vertebral columns from 
e14.5 embryos. Cervical vertebrae (CV); thoracic vertebrae (TV). 
(A) Wild type animal. Normal fusion of the centrum can be seen in the 
midline of both the cervical (asterisk) and thoracic (arrowhead) vertebrae. 
(B) The Fuzzy mutant vertebra has incomplete fusion of the centrum of both 
the cervical (asterisk) and thoracic (arrowhead) vertebrae. (A) and (B) are 
littermates. 
(C) Reduction of Fgf8 does not rescue the mutant phenotype. Incomplete 
fusion of the centrum is still visible in the cervical and thoracic vertebrae 
(asterisk and arrowheads respectively).  
(D) Heterozygous Fgf8 animals have vertebra that are indistinguishable 








Figure 6.6 The sternum of Fuzzy mutants is bifid and hyperossified 
(A and B) Frontal images of alcian blue stained cartilage in mutant and 
littermate control sterna. (A) In the control sample, the sternum has already 
fused and appears as a single cartilaginous rod. (B) In mutants, the sternum 
is shorter and bifid. Black arrow shows the sternal cleft. 
(C and D) Frontal views of alizarin red stained bone in mutant and 
littermate control sternums. (C) In the wildtype, discrete regions of 
ossification can be seen. (D) In the mutant, the sternum is shorter and bifid 





6.2.5 Reduction of Fgf8 gene expression in the Fuzzy mutant does not rescue 
the sternal phenotype. 
In order to assess the effect of reducing Fgf8 gene expression on the sternal 
phenotype, we carried out Alcian blue staining on compound embryos at 
e14.5. At this stage, in the wildtype, the two sternal rods are just about to 
fuse (Fig 6.7 A). In the Fuzzy-/- mutant, the sternal bars have not come 
together (Fig 6.7 B, black arrow) and they appear shorter (Fig 6.7 B). This 
phenotype appears similar on reduction of Fgf8, in that the sternal bars still 
appear shorter and there is a clear lack of fusion in the midline (Fig 6.7 C, 






Figure 6.7 Genetic reduction of Fgf8 does not rescue the 
cartilaginous sternal phenotype in the Fuzzy mutant 
E14.5 animals, cartilage is stained with alcian blue. 
A) Frontal view of wild type sternum shows sternal bars are fusing in the 
midline. 
B) In the Fuzzy mutant, the sternal bars are shorter and have not yet met in 
the midline. Black arrow shows clefting. (A) and (B) are littermates. 
C) Likewise on reduction of Fgf8, sternal bars have not yet met in the 
midline. 
D) As an additional control, Fuzzy and Fgf8 double heterozygotes are similar 
to the wild type control, as sternal bars are just meeting at the midline. Scale 










Coronal craniosynostosis is observed in the Fuzzy mutant and the 
craniosynostosis syndromes. In the craniosynostosis syndromes, the 
majority of Apert syndrome cases are due to mutations in FGFR2 (Wilkie et 
al., 1995), whereas mutations of Pfeiffer and Crouzon syndromes are more 
varied but still result from FGFR hyperactivation (Muenke et al., 1994, Schell 
et al., 1995). Craniosynostosis can arise from activating mutations in all 
three of the main FGFRs (Ibrahimi et al., 2004). Mutations in FGFR1 and 2 
have been most recognized as causing craniosynostosis; as such, in Apert 
syndrome, FGFR2 mutations are seen to cause enhanced osteoblast 
differentiation either in the absence of an FGF ligand or by increasing 
affinity to the FGF ligand (Lomri et al., 1998, Lemonnier et al., 2000). 
Similarly gain of FGFR2 function in Crouzon syndrome has been shown to 
increase osteoblast proliferation (Galvin et al., 1996). Interestingly, some 
Apert and Crouzon patients have been reported to have lower levels of 
FGFR2 expression as a result of either negative feedback, or FGF ligand-
receptor induced receptor internalization (Bresnick and Schendel, 1995, 
Bresnick and Schendel, 1998, Estival et al., 1996). In keeping with the key 
role of RUNX2 for osteoblast differentiation, FGFR1 mutations in mouse 
have been shown to cause upregulation of osteoblastic markers such as 
Runx2 and osteocalcin in association with synostosis (Zhou et al., 2000). 
 
Craniosynostosis is also seen in the chondrodysplasias but the reasons why 
have not been well characterised. As described above, FGFR3 is the main 
culprit in these disorders, limiting hypertrophy during endochondral 
ossification resulting in reduced bone mass (Su et al., 2010a). Although the 
calvaria do not form via this mechanism, it may be possible that signaling 
through this receptor has a stimulatory effect on osteoblasts in the calvarial 
sutures. In keeping with this idea, patients with Muenke syndrome, which 
have gain of FGFR3 mutations, have craniosynostosis (Singh et al., 2014, 
Georgoulis et al., 2011). Since the only intramembranous bones in which 
FGFR3 is expressed are the calvaria, this could represent an example in 
which FGFRs exert tissue specific functions (Rice et al., 2000). All of this 
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evidence together shows that enhanced FGFR activity acts to stimulate 
osteoblastic activity at the calvarial sutures resulting in craniosynostosis 
seen in both chondrodysplasias and craniosynostosis syndromes.  
 
Given that Runx2 is a key regulator of bone formation, it is no surprise that 
early onset is associated with craniosynostosis (Maeno et al., 2011).  As 
described in chapter 1, FGFR signaling is an important regulator of 
intramembranous bone formation at various stages of osteoblast 
differentiation and proliferation. Constitutively active FGFR1 causes 
craniosynostosis associated with an increase in runx2, and constitutively 
active FGFR2 activity also stimulates Runx2 expression (Zhou et al., 2000, 
Suh et al., 2014). Furthermore, in tissue culture experiments, it was shown 
that exogenous application of FGF4 results in increased transcriptional 
activity of RUNX2, proposed to be via the inositol polyphosphate and PKC 
cascade. (Niger et al., 2013, Grillo et al., 2014). Interestingly, exogenous 
FGF8 treatment of bone cells also upregulates Runx2 expression, apparently 
also via activation of the PKC pathway (Kim et al., 2003, Kim et al., 1998). 
Thus it seems that multiple FGF-FGFR ligand combinations act to stimulate 
osteoblast maturation via Runx2.  
 
Ciliopathies such as Sensenbrenner syndrome and cranioectodermal 
dysplasia can manifest with craniosynostosis but the mechanisms behind 
this have not been explored (Levin et al., 1977). Analysis in the Fuzzy 
mutant suggests that synostosis is at least in part due to aberrant Fgf8 
expression. Both Fgf8 and Gli3 are expressed in the calvarial sutures at e15.5 
(Xu et al., 1999). Loss of Gli3 is shown to cause synostosis by upregulating 
Runx2 and subsequent osteogenic differentiation (Tanimoto et al., 2012, 
Veistinen et al., 2012, Rice et al., 2010). By way of speculation, it is possible 
that loss of the Gli3 repressor could be accompanied by an increase in Fgf8 
expression, as we saw in BA1. Subsequent increases in Fgf8 could be driving 
Runx2 upregulation. This hypothesis is supported by my observations that 
genetic reduction of FGF8 in the Fuzzy mutant appears to ameliorate the 
observed craniosynostosis (Fig 3.1C; (Xu et al., 1999). Thus, this suggests 
that aberrant FGF8 expression may contribute to the phenotype in the Fuzzy 
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mutants and ciliopathy patients. This does not however explain why 
synostosis is not fully rescued.  
 
One interesting possibility to explain this could be that in the sutures, the 
Gli3 repressor may be regulating other FGFs. Craniosynostosis in Gli3 
mutants can be due to enhanced ERK-MAP kinase signaling downstream of 
FGF2, ultimately causing runx2 upregulation (Park et al., 2010, Niger et al., 
2013). It is therefore feasible that in our mutant, aberrant Gli3 processing 
may also converge on misregulation of FGF2. If this were the case we would 
expect a more complete rescue in compound mutants in which FGF2 and 
FGF8 have been reduced. Along these same lines, it could be speculated that 
Gli3 could regulate other FGFs, which are important in processes of 
intramembranous ossification, such as FGF4, but have not previously been 
thought to be regulated by Glis (Kim et al., 1998). Along these same lines, 
FGF 2 , -4 and -9 are all found in the sutural mesenchyme (Britto et al., 2001, 
Kim et al., 1998, Rice et al., 2000). This could be tested by comparing the 
expression of the different Fgfs between wild type and Fuzzy mutants. 
Furthermore, one could analyze Fuzzy compound mutants in which other 
FGFs have been genetically reduced. 
 
As a final thought, another explanation behind the incomplete rescue in our 
Fuzzy-/-; FGF8L/+ compound mutants could be due to the involvement of 
other signaling pathways. The BMP signaling pathway has been known to 
stimulate ossification. This has been seen by ectopic bone formation on 
application of recombinant BMPs in vivo and in vitro (Wang et al., 1990, 
Myllyla et al., 2014). Interestingly, it was shown that Gli3 mutants, which 
have craniosynostosis, lose Gli3 repression of BMP signaling (Tanimoto et al., 
2012). It should therefore not be ruled out that improper Gli3 regulation of 
the BMP signaling pathway could contribute to craniosynostosis observed in 
our mutant mice.  
 
In summary, craniosynostosis has been associated with upregulation of 
Runx2 through both FGF dependent and FGF independent means, as 
described above. The presence of sutural mesenchyme in the Fuzzy-/-;Fgf8L/+ 
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compound mutants suggest that in part excessive FGF8 signaling is driving 
our phenotype. More work must be done to determine additional causes 
contributing to lack of complete rescue such as Gli regulation of other FGFs 
or other signaling pathways such as BMP. These observations have 
interesting implications when comparing craniosynostosis syndromes and 
craniosynostosis observed in chondrodysplasias and ciliopathies. Typically 
in the craniosynostosis syndromes, enhanced osteoblast differentiation and 
proliferation via excessive FGFR1 and FGFR2 signaling has been attributed 
to craniosynostosis; whilst synostosis seen in chondrodysplasia is probably 
due to enhanced signaling through the FGFR3. My observations suggest that 
similar craniosynostotic phenotypes observed between FGF syndromes and 
ciliopathies may arise through different mechanisms.  
6.3.2 Defective vertebral development 
Vertebral chondrogenic phenotype 
My data reveals an interesting vertebral phenotype in the Fuzzy mutant. In 
both the cervical and thoracic vertebra, it appears that cartilage formation 
occurs, however chondrogenesis appears defective in the midline in that 
there is a lack of fusion of the vertebral bodies (Fig 6.4). With regards to 
ossification, the cervical vertebra appears fused whereas there is a loss of 
ossified vertebral bodies in the midline of the thoracic vertebra. 
 
Glis have important roles in early patterning of the developing vertebrae, 
and compound Gli mutant analysis reveals the need for both the Gli3 
repressor and Gli2 activator in sox9 induction during chondrogenesis of the 
sclerotome (Buttitta et al., 2003). Interestingly, cartilage preparations in Gli3 
mutant mice reveal similar vertebral phenotypes to those seen in the Fuzzy 
mutant, with loss of cartilage formation towards the midline (Mo et al., 
1997). Compound mutants in which both Gli2 and Gli3 are knocked out have 
exacerbated phenotypes and it has been suggested that in some vertebral 
regions, in the absence of the Gli3 repressor, Gli2 is functionally redundant 
and can acting as a repressor. Likewise in the absence of the Gli2 activator, 
Gli3 can compensate (Buttitta et al., 2003, Mo et al., 1997). Moreover, both 
chondrogenic and myogenic markers (Pax1 and Myf5 respectively) are 
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mixed in the mesenchyme of Gli2 and Gli3 mutants which suggest a loss of 
organization of cell types; an observation also seen in Smo-/-;Gli3-/- 
compound embryos (Wijgerde et al., 2002, Buttitta et al., 2003). Since these 
cells are organized in response to Shh, it has been suggested that the Gli2-/-
;Gli3-/- compound mutants cannot respond to Hh signaling and thus 
represent a default state independent of Hh activity (Buttitta et al., 2003). 
This is also what we would expect in the Fuzzy mutant given the need for the 
cilium to process Gli proteins in response to Hh ligand.  
 
It is reported that Glis induce sox9 via regulation of Pax1 gene expression. 
Consistent with this, Pax1 mutants have similar chondrogenic defects in 
their vertebral columns (Wallin et al., 1994, Murtaugh et al., 1999, Buttitta et 
al., 2003). Moreover, given that the severity of the Fuzzy mutant phenotype 
is worse then that seen in Gli2 or Gli3 mutant, and the proposed redundancy 
between Gli2 and Gli3 activity, I propose that not only is Gli3 processing 
defective, but also Gli2 function, which has not been previously described in 
the Fuzzy mutant.  
 
Another interesting point is the role of FGF8 signaling from the myotome. In 
this instance, Shh from the notochord induces Fgf8 expression in the 
myotome. Subsequently, this goes on to specify a subset of sclerotome to 
differentiate into tendon forming syndetome. Syndetome is formed at the 
expense of cartilage forming sclerotome (Brent et al., 2003, Brent and Tabin, 
2004). Since we have seen both an upregulation of Fgf8 expression and a 
loss of ability for the Shh ligand to regulate Glis in the Fuzzy mutant, it could 
be proposed that loss of midline cartilage formation may be due to enhanced 
syndetome formation at the expense of sclerotome. This, however, is 
unlikely since genetic reduction of FGF8 in the Fuzzy mutant does not rescue 
the vertebral phenotype, and there has been no evidence for Gli regulation 
of FGF8 expression in the developing somites. In order to test this I would 
look for increased presence of syndetome markers such as scleraxis. 
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Vertebral ossification phenotype 
Defective ossification seems to affect the vertebral body in the thoracic 
vertebra and the neural arches in the cervical vertebrae. These two defects 
appear in Gli2 and Gli3 knock out mice (Mo et al., 1997). Gli2 mutant mice 
have very few vertebral bodies whilst the cervical neural arches appear 
normal and unfused. Conversely, Gli3 mutants have only slightly smaller 
vertebral bodies then wild type. Interestingly they display cervical vertebral 
anomalies in that 1st and 2nd neural arches are fused and the rest are 
malformed (Mo et al., 1997). These differences can be explained given the 
different expression domains of the Glis in the developing embryo. Gli2 is 
expressed in medial sclerotome cells adjacent to the expression of pax1, 
which is an important signal to specify centrum development. Gli3, however, 
is expressed in the more lateral regions adjacent to Pax9, which is important 
for neural arch development (Goulding et al., 1994). The lack of vertebral 
bodies in the Gli2 mutants resembles the phenotype of the Pax1 knockout 
mouse and the cervical fusions observed in Gli3 mutants resembles that 
seen in Pax9 mutants (Peters et al., 1999, Wallin et al., 1994). Since knock 
out of each Gli alone causes relatively mild phenotypes compared to that of 
the double knock out, it reveals functional redundancy between the two.  
These observations suggest that the ossification phenotype could be 
secondary to the loss of chondrogenesis resulting from misregulation of Pax 
genes as explained above. 
 
It should also be considered that as well as ossification effects being 
secondary to cartilaginous defects, there may be a loss cartilage maturation, 
which contributes to the phenotype. This is plausible given that Gli proteins 
have been implicated in controlling cartilage maturation and the spine 
forms through endochondral ossification (Miao et al., 2004). During 
vertebral development, Gli2 is expressed more in the medial sclerotome 
while Gli3 is expressed more laterally. This would explain why Gli2 mutants 
have more obvious ossification defects in the vertebral bodies compared to 
the neural arches, which are malformed on loss of Gli3 (Mo et al., 1997). To 
assess whether cartilage maturation as well as chondrogenic induction is 
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defective in Fuzzy mutants, analysis for key markers for different stages of 
cartilage maturation should be carried out. 
 
We, and others, have previously reported that Fuzzy mutants have defective 
neural tube closure (Gray et al., 2009, Tabler et al., 2013). Moreover, 
occasionally fatal human ciliopathies such as Meckel-Gruber syndrome are 
seen with neural tube anomalies, and mouse models lacking ciliary 
components, such as IFT proteins have abnormal neural tube closure 
(Huangfu and Anderson, 2005, Van Allen et al., 1993). It could be postulated 
that this lack of closure is inhibiting chondrogenic fusion of the vertebral 
bodies in the midline. Previously it has been suggested that cilia, and hence 
FUZ, are required for proper PCP signaling (see chapter 1). As well as this, in 
Xenopus, PCP-dependent convergent extension is required for proper neural 
tube closure (Wallingford and Harland, 2002). This evidence could imply 
that defective ciliogenesis in the Fuzzy mutant inhibits neural tube closure 
by altering PCP signaling. One could therefore suggest that defective 
vertebral development is secondary to defective neural tube closure. 
However,  DVL mutants, which have open neural tubes and mild defects in 
somite segmentation, have ossified vertebral bodies that are disorganized in 
their spacing (Hamblet et al., 2002). This is in contrast to the lack of 
vertebral bodies in the Fuzzy mutants, which suggests that our phenotype is 
more complicated than abnormal PCP signaling during neural tube closure. 
 
Surprisingly, many craniosynostosis patients have progressive cervical 
spine fusions. Two thirds exhibit fusions of the C5-C6 segment and C2-C3 
fusions have also been reported in Saethre-Chotzen and Pfeiffer syndrome 
(Hemmer et al., 1987, Moore et al., 1995b, Moore et al., 1995a, Anderson et 
al., 1997).  Again, this would implicate FGF signaling in the onset of vertebral 
fusions. 
 
Chondrodysplasias generally have no reports of spinal ossification defects 
however spinal stenosis has been reported in rhizomelic chondrodysplasia 
punctata patients (Khanna et al., 2001). Furthermore, mouse models with 
enhanced FGFR3 signaling have premature fusions between ossification 
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centers of the vertebra but no fusions of individual vertebrae as is seen in 
the Fuzzy mutant (Matsushita et al., 2009). This is interesting since typically, 
activating FGFR3 mutations result in reduced bone mass of endochondral 
elements (Su et al., 2010a). However this has been put down to the 
importance of FGFR3 signaling in controlling bony fusions between various 
synchondroses (Su et al., 2010a, Matsushita et al., 2009). Molecular causes of 
these vertebral anomalies are unknown but it is reasonable to speculate that 
they arise from abnormal FGFR signaling. Therefore, if these defects have 
any similarities to those in the Fuzzy mutant vertebra, it would suggest a 
novel link between cilia, Gli proteins and FGF regulation.  
Vertebral phenotype summary 
In summary, my observations suggest a correlation between defective Gli 
processing in the developing vertebra and abnormal vertebral development 
in the Fuzzy mutant. Since chondrogenesis of the vertebra appears to have at 
least partially occurred, it can be suggested that initial chondrogenic 
induction is not defective, however it is still not clear which endochondral 
stages are being affected. In addition, it has been suggested that Gli2 and 
Gli3 play differential roles in cervical versus thoracic vertebral ossification. 
Since we see defects in both subsets of vertebrae, it is possible that we are 
also getting defective Gli2 processing in our mutant, which we have not 
previously shown. This is highly plausible given the roles of proper 
ciliogenesis in Gli2 processing as well as Gli3 processing. If these 
observations are correct then it would imply that vertebral phenotypes 
observed are independent of abnormal FGF or PCP signaling or defective 
neural tube closure. 
6.3.3 Abnormal sternal development 
In humans, failure of sternal bar fusion causes congenital sternal clefts. 
These are rare birth defects that are reported to be more common in 
females then males, with an incomplete cleft being more common then a 
complete cleft (Acastello et al., 2003). This birth defect is usually isolated; 
however, sternal clefts have occasionally been observed in association with 
other congenital anomalies such as ventral hernias, absent pericardium and 
cervicofacial hemangioma to name a few (Acastello et al., 2003, Bernhardt et 
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al., 1968, Cantrell et al., 1958, Aytac and Saylam, 1976, Ishikawa et al., 2002). 
To date no genetic, teratogenic or nutritional cause driving this phenotype 
has been identified. 
 
Abnormal sternal development in the Fuzzy mutant manifests as a bifid 
sternum with hyperossification. Mouse mutants with defective ephrin 
signaling (ephrinB1-EphB) show occasional lack of sternal bar fusion with 
occasional fusion of ossification centers, but none as severe as in the Fuzzy 
mutant(Compagni et al., 2003). This is possibly because ephrin signaling has 
been implicated in many aspects of tissue movements in both skeletal and 
non- skeletal tissues as well as being expressed at sites of tissue fusion 
(Poliakov et al., 2004). Thus defective signaling could inhibit proper sternal 
bar movement or fusion in the midline (Compagni et al., 2003, 
Dimidschstein et al., 2013). 
 
Along the same line, a cleft sternum, with small sternal rods, has been 
observed in mice with enhanced Shh signaling, which typically results in 
reduced levels of Gli3 repressor and increased levels of Gli2 activator 
(Tavella et al., 2004). This suggests a role for Glis in elongation and fusion of 
the sternal rods in the midline. In keeping with this, loss of GSK3β, which is 
required for Gli3 processing, also results in a cleft sternum (Liu et al., 2007). 
Interestingly, both these mouse mutants also have a loss of sternal 
ossification centers, which is in contrast to the hyper-ossification observed 
in the fuzzy mutant.  
 
Although the Gli3 mutant mouse sternal phenotype is very similar to that of 
the Fuzzy mutant: the sternum is bifid with extensive ossification covering 
the length of each unfused sternal bar. Interestingly in Gli2 mutants, there is 
no failure of sternal bar fusion but compound Gli2 and Gli3 mutants have 
both a bifid sternum and sternal hyperossification (Mo et al., 1997). 
Furthermore, conditional mouse mutants lacking Kif3a in the dermis and 
lateral plate mesoderm also have a bifid sternum with fused ossification 
centers (the former being more severe then the later) (Kolpakova-Hart et al., 
2007). The reasons between these discrepancies in ossification phenotypes 
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are unknown. However, in the absence of proper sternal bar fusion in the 
midline, two ossification centers may form on either side of the midline, 
causing excessive ossification (Scheuer and Black, 2004).  
 
Shh mutants have reduced ossification, whilst Gli3 mutants have 
hyperossification. Since Shh activity causes reduction of the Gli3 repressor, 
one could speculate that Shh activity stimulates ossification and in response, 
Gli3 is needed to regulate this process. Indeed, Shh ligand binding has been 
shown to stimulate osteogenesis in tissue culture experiments and in mouse 
fibroblasts transfected with Shh cDNA (Iwamoto et al., 1999, Kinto et al., 
1997). 
 
Interestingly, other observations in mice suggest that the phenotype of 
hyperossification could also be due to disregulation of FGF signaling. Gain of 
FGFR1 expression in mouse models leads to small fusions between 
ossification centers in normal ‘fused’ sternum; whilst gain of FGFR2 
mutations have a delay in sternal bar fusion followed by more pronounced 
fusions of ossification centers (Hajihosseini et al., 2004, Hajihosseini et al., 
2001). A mouse model of Apert syndrome with gain-of-function FGFR2 also 
has fusions of ossification centers (Wang et al., 2005b). Furthermore, mouse 
models for achondroplasia are also reported to have sternebral fusion, as do 
mice in which FGFR3 has been fused to the intracellular domain of FGFR1 
(Wang et al., 2001). It is believed that this phenotype arises from a lack of 
FGFR regulation of joint segmentation resulting in hyperossification down 
the length of the sternum. This link between defective FGF signaling and 
sternal ossification has been observed in humans with Noonan syndrome, 
which is caused by a mutation in SH2 domain-containing protein tyrosine 
phosphatase (SHP-2), which a key regulator of the FGF-Ras-MAPK pathway 
(Hoeffel et al., 1981, Tartaglia et al., 2002). 
 
Although there is no rescue or amelioration of the cartilaginous phenotype 
in Fuzzy-/-;Fgf8L/+ compound embryos, there are ossification similarities 
between Gli mutant mice, and aberrant FGF signaling described above. This 
raises an intriguing question of whether Gli processing may converge on 
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FGF signaling as is described in the maxilla of the fuzzy mutant. To 
determine this properly the link between Gli protein function and 
transcriptional regulation of other Fgfs in the sternum must be further 
assessed. 
6.3.4 Final remarks 
It would appear that all of the skeletal phenotypes described in this chapter 
arise from either abnormal FGF or Hh signaling, or a combination of both. 
The Fuzzy mutant has provided us with a model system in which, in some 
instances at least, defective Gli processing results in excessive FGF signaling. 
To date we have only shown this relationship with regards to FGF8 
regulation during early brain development stages. But, time permitting, it 
would be interesting to examine FGF expression in the axial skeleton in the 
absence of Gli proteins.  
 
A greater understanding of molecular mechanisms driving different 
phenotypes across the spectrum of disorders described will enable better 
classification of diseases. In turn, this will undoubtedly provide the 
opportunity for improved therapy as well as better understanding of 
different phenotypes to expect and classify. For example, Der Kaloustian and 
colleagues in 2001 describe a human patient with a variety of skeletal 
defects including micrognathia, a short neck, which could be caused by 
cervical vertebra fusions, widely spaced nipples, which could be caused 
from a cleft sternum, and polydactyly (Der Kaloustian et al., 2001). The 
authors of this paper suggest that this is a new syndrome yet to be described. 
Given what I have described above, I would speculate that this patient has 
classical hallmarks of a skeletal ciliopathy; furthermore, in the future, 
ciliopathy patients could be screened for defects in multiple skeletal 




Chapter 7  Final Discussion 
7.1 Summary Of Observations 
Observations made in this project have shed interesting light on how 
development of a variety of skeletal structures is affected in the ciliopathic 
Fuzzy mutant mouse. These observations are summarized as follows. 
 Craniosynostosis in the Fuzzy mutant can be partially rescued by 
genetic reduction of Fgf8. This phenotype probably arises from loss 
of Gli processing causing and an upregulation of runx2. My data 
suggests different molecular causes driving craniosynostosis in FGF-
related syndromes and ciliopathies. 
 Vertebral chondrogenic defects in the Fuzzy mutant may be 
secondary to abnormal neural tube closure. Different ossification 
defects are observed between cervical and thoracic vertebra with the 
former showing vertebral fusions and the latter manifesting with lack 
of ossification centers. These differences may reflect novel defects in 
Gli2 processing in the Fuzzy mutant and the relative importance for 
Gli2 in development of thoracic vertebrae versus more importance 
for Gli3 in development of cervical vertebrae. 
 Abnormal sternal bar fusion in the mutant may be due to a loss of 
planar cell polarity as well as defective Gli regulation of FGF 
signaling. Subsequent hyperossification probably occurs as a result 
sternal clefting. 
 Abnormal elongation of endochondral elements is probably due to a 
loss of Gli3 repressor activity causing delayed onset of chondrocyte 
hypertrophic maturation. 
 Analysis of micrognathia in the Fuzzy mutant reveals several key 
steps which have not previously been described in the context of 
mandibular elongation, including the importance of proper medio-
lateral patterning; proper cell packing and chondrogenic 
condensation positioning in the presumptive mandible. Medio-lateral 
patterning, at least, is dependent on proper Fgf8 expression. Finally, 
we suggest the importance of chondrocyte hypertrophy for 
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elongation from approximately e15.5, which is independent of 
abnormal FGF8 expression. 
 The mandible is hyperossified in the Fuzzy mutant; a phenotype 
which has not been previously described in ciliopathies. This appears 
to be due to an early expansion in runx2 expression and can be 
largely rescued on genetic reduction of FGF8. 
7.2  Variability in the phenotypes of the Fuzzy mutant 
The Fuzzy mutant provides us with a great model organism in which to 
study ciliopathies and downstream signaling pathways that are 
dysfunctional as a result of loss of cilia formation and function. The 
developmental defects in Fuzzy mutant are widespread but do not 
encompass all phenotypes observed in ciliopathies: in particular, defects in 
the motile cilia are not seen. For example, situs inversus is a disease in which 
symmetry of internal organs within the body is reversed. This is typically 
associated with defects in motile cilia and is established as early as nodal 
establishment during gastrulation (El Zein et al., 2003, Nonaka et al., 1998). 
This defect may not be observed in Fuzzy because we do not know whether 
or not Fuzzy is expressed at such early stages since the earliest expression 
analysis only covers e8.5-e9.5 (Seo et al., 2011). Interestingly ciliopathy 
patients and mouse models display varied severity in the phenotypes that 
arise. This probably reflects differences in the roles of affected proteins in 
ciliogenesis and axonemal transport. In addition to this, some cilial 
components are only expressed in tissue specific contexts. For example the 
polycystin 1 receptor is only found on the cilia of the kidney (Peters et al., 
1996). As such, mutations in this gene result in polycystic kidneys but no 
defects in internal patterning (Karcher et al., 2005). With this logic, it could 
be suggested that FUZ has roles in formation of only a subset of cilia. In 
keeping with this suggestion, it has been seen that there is tissue specific 
functional roles for cilia since there is significant variability in cilial stability 
in different tissues, and in fact between organisms, although there is 
structural conservation, there is diversity in the over all ciliary proteome. It 
has been suggested that in addition to the core structural units of the cilium, 
there may be organism specific and tissue specific structural adaptations 
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(Ostrowski et al., 2002, Pazour et al., 2005, Smith et al., 2005). In order to 
assess how these factors may influence variability when comparing our 
phenotype with other ciliopathies, better characterization of Fuzzy gene 
expression in a variety of different tissue and in a stage series dependent 
manner would be beneficial. 
 
As a general observation, one could suggest that apart from the limbs, the 
majority of phenotypes affected are NC derived structures. This is not 
surprising since Fuzzy expression at e9.5 is in the neural axis, which is the 
site of NC formation. The argument against this is that defective 
endochondral elements are not neural crest derived. Although Fuzzy 
expression has not yet been visualized in long bones, we would suggest that 
Fuz must be expressed in pre-hypertrophic chondrocytes. This bears further 
analysis.  
 
There is also variability of phenotypes within the Fuzzy mutant itself. 
Defects in endochondral ossification appear to be consistent. However, the 
craniofacial malformations are more variable in their severity. Craniofacial 
development is an extremely complex process under the regulation of many 
signaling molecules. Proper formation of craniofacial structures is essential 
for vertebrate life and as such, there are many reports of functional 
redundancy between signaling molecules; for example FGF4, -8 and -9 are 
known to demonstrate functional redundancy during tooth development 
(Kettunen and Thesleff, 1998). With this in mind it is very possible that 
other proteins can compensate to varying degrees in the absence of the 
Fuzzy protein. A good example of this is Inturned (INTU), which was also 
first described as a PCP effector in Drosophila, and is structurally 
homologous to FUZ (Collier and Gubb, 1997, Park et al., 1996). In Xenopus, 
Intu is expressed in the same regions as Fuzzy and its loss also causes 
similar defects in neural tube closure, loss of ciliogenesis and PCP signaling 
(Park et al., 2006). Similarly, in the mouse, loss of inturned phenocopies loss 
of Fuzzy and can compensate in its absence during neural tube convergent 
extension but not patterning (Heydeck and Liu, 2011). This idea is given 
more strength when one considers that in the Fuzzy mutant, quantitation of 
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cilia reveals that they are not entirely absent and some remaining cilia are 
shortened. This implies that there may still by be some residual ciliary 
function in Fuzzy mutants (Zhang et al., 2011).  
7.3 Implications for Glis in development 
Gli2 and Gli3 can be processed into both repressor and activator forms 
although Gli3 conversion to a repressor, and Gli2 conversion to an activator 
are the most common modifications during Hh signaling. Different Gli 
activators and repressors work in tissue specific contexts to differentially 
control downstream target gene transcription. For example, the Gli3 
repressor has been shown to regulate FGF gene expression in patterning of 
the dorsal telencephalon, in which it restricts expression of FGF -3, -15, -17 
and -18, whilst in the developing limb bud it controls FGF4 (te Welscher et 
al., 2002b, Rash and Grove, 2007). Adding further complexity to Gli activity, 
in some contexts such as Gli regulation of Runx2 expression, the total 
balance of Gli3 repressor and Gli2 activator ultimately controls the overall 
transcriptional output (Shimoyama et al., 2007, Ohba et al., 2008, Komori, 
2011).  
 
Observations made throughout this project provide examples of differential 
Gli regulation of different tissues. For example, I and others suggest, in the 
developing spine, that Gli3 may have more important roles in regulating 
cervical vertebral development whilst Gli2 may have more important roles 
in regulating thoracic vertebral development (Chapter 3 and (Mo et al., 
1997)). Tissue specificity of FGF regulation of Gli3 is also apparent when 
comparing the mandible and the limbs of Fuzzy-/-;Fgf8L/+ compound mutants. 
The fact that we have rescue of the Meckel’s cartilage but no differences in 
the limbs, even though FGF8 is very important in the development of both of 
these structures suggests that Gli misregulation only converges on aberrant 
Fgf8 regulation in a tissue specific context. 
 
One interesting question that arises from this observation is why we don’t 
see micrognathia in Gli3 mutant mice (Mo et al., 1997).  This is especially 
interesting since patients with Greig cephalopolysndactyly syndrome 
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(GCPS), which is known to be due to a loss of function mutations in Gli3, do 
not have micrognathia (Debeer et al., 2007, Vortkamp et al., 1991). Gli3 
mouse mutants have several phenotypes in common with the Fuzzy mutant 
including exencephaly, cleft palate, polydactyly and short long bones 
(Johnson, 1967). Gli3 heterozygotes alone have no obvious mandibular 
phenotypes however compound homozygous Gli2 and heterozygous Gli3 
mutants have a truncated mandible. This probably reflects a shift in the 
overall activating and repressive balance of Gli2 and Gli3 transcription 
factors in the Fuzzy mutant suggesting that a fine balance of the two must 
exist in the developing mandible for proper formation. If this is true this 
suggests a previously undescribed role for Gli2 in mandibular development.  
7.4  Regulation of FGFs 
Our previous data has attributed loss of Gli3 repressor formation to 
upregulation of FGF8 (Tabler et al., 2013). The Gli3 repressor has previously 
been shown to control FGF8 expression in the first branchial arch and 
indeed loss of Gli3 from e9.5 through to e10.5 results in increased domains 
of FGF8 expression (Aoto et al., 2002).  
 
The important role for FGF8 in early mandibular patterning has been well 
documented in chapters 1 and 5.  In keeping with these important roles, I 
have attributed micrognathia in the Fuzzy mutant to enhanced FGF8 
expression driving abnormal medio-lateral patterning. It has been shown in 
mouse models with knock out of the Gli3 repressor, that craniosynostosis 
observed is a result of upregulation of FGF2, which inhibits runx2 (Rice et al., 
2010).  This suggests that a subset of the phenotypes we observe may be 
due to Gli misregulation of general Fgf expression. That said, I would suggest 
that, since many phenotypes can be rescued by genetic reduction of Fgf8, 
this is the main ligand regulated by Gli3 in developmental contexts studied 
in this project. Conversely, craniosynostosis and hyperossification of the 
mandible were partially rescued. This could have several causes. Firstly, 
because the level of FGF8 reduction in Fuzzy-/-;Fgf8L/+ compound mutants 
may not be enough to alleviate FGF8 over-expression in these tissues; and 
secondly, due to misregulation of other FGFs regulating Runx2 in these 
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tissues. In order to assess whether other Fgfs are indeed misregulated in the 
Fuzzy mutant, mutants specific for different FGFs, such as Fgf2, can be 
crossed with the Fuzzy mutant and exacerbation of amelioration of 
phenotypes can be assessed.  
 
Further justifying these experiments is that fact that preliminary 
observations of the mutant trachea see a loss of cartilaginous rings. It has 
been suggested that Shh signaling activates FGF10 expression and FGF10 
acts as an activator-dependent inhibitor of Shh in order to control periodic 
patterning of the cartilage rings (Sala et al., 2011). In this way, one could 
imagine a scenario in which abnormal Gli processing in the Fuzzy mutant 
disrupts the Shh-FGF10 interaction causing loss of cartilage ring formation. 
This scenario is speculation and more work into understanding the nature 
of Shh mediated Fgf10 regulation must be carried out in order to fully 
understand how and if this signaling interaction is perturbed in the Fuzzy 
mutant. 
7.5 Wnt signaling defects in the Fuzzy mutant 
Throughout this project, I have attributed many skeletal phenotypes to 
abnormal Gli processing and subsequent misregulation of FGF transcription. 
Previous reports on the Fuzzy mutant have also focused on its role in PCP 
signaling. This is logical given the subset of phenotypes which can be 
attributed to malfunction of this pathway, such as an abnormal outflow 
track of the heart, defective neural tube closure in mice, as well as loss of 
convergent extension seen in Xenopus (Gray et al., 2009, Wallingford and 
Harland, 2002). It is therefore possible that defective PCP signaling may be 
contributing to some of the phenotypes observed.  
 
A case can also be made for PCP involvement in the mandibular 
malformations. We previously showed that maxillary hyperplasia is due to 
aberrant NCC migration into the maxillary portion of BA1 (Tabler et al., 
2013). My observations on defective MC development show that abnormal 
medio-lateral patterning and increased cell density contribute to 
micrognathia by inducing precocious and out of place Meckel’s cartilage 
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condensations, (Chapter 5). This does not address the role of abnormal NC 
migration into the mandibular portion of BA1 which should be considered 
since we showed by fluorescent activated cell sorting (FACS) analysis that 
there are increased numbers of NCCs in the Fuzzy mutant (Tabler et al., 
2013).  
 
Zebrafish embryos lacking PCP components lose chondrocyte convergent 
extension during cartilage outgrowth. In addition, these mutants have 
defects in secretion from chondrocytes, resulting in misshapen craniofacial 
elements (LeClair et al., 2009). Furthermore, in Xenopus, convergent 
extension is suggested to play a role in growth of Meckel’s cartilage; and in 
addition to this, frizzled mutants have a slightly shorter mandible, 
suggesting that PCP plays a role in jaw extension but not an overriding one 
(Park et al., 2006, Kamel et al., 2013). With this in mind, it is possible to 
imagine a scenario in the fuzzy mutant in which defective PCP signaling or 
convergent extension dependent tissue movements contribute to the 
craniofacial phenotypes.  
 
Earlier in development, PCP signaling is also involved in proper NC cell 
movement (Mayor and Theveneau, 2014). Hence, in our mutant, abnormal 
PCP could contribute to abnormal NC migration seen in Tabler et al. This 
situation seems plausible given previous observations that craniofacial 
abnormalities in Bardet Biedl Syndrome have been partly attributed to 
abnormal NC migration (Tobin et al., 2008). On the other hand, this 
abnormal NC migration could also arise from enhanced FGF8 chemo-
attraction from the BA1 epithelium, as FGF8 has previously been suggested 
to play this role in cranial NC and cardiac NC cells (Kubota and Ito, 2000, 
Sato et al., 2011).  
 
During abnormal development of the sternum in the Fuzzy mutant, we see a 
loss of fusion of the sternal bars. A similar phenotype is observed in mouse 
mutants lacking Dachsous 1 (a core PCP component) and it is suggested that 
this is a direct result of defective convergent extension (Mao et al., 2011). 
Similarly, these authors observe defects in vertebral formation, attributed to 
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defective convergent extension however this appears to be speculation. 
During development of the sternum, cartilaginous structures must move 
towards each other and fuse (Chapter 7). Guided tissue movements of this 
nature, such as neural tube closure and axon guidance, are well 
characterised to occur via PCP driven convergent extension (Ybot-Gonzalez 
et al., 2007, Wang and Nathans, 2007). Along these same lines, PCP signaling 
is suggested to control the organization of proliferating chondrocytes into 
their characteristic columns and as such, loss of Frizzled results in altered 
shape of the long bones in chick (Yang et al., 2013). Given the cellular role of 
Fuz and its purported roles in localization of PCP components to the cilia, it 
can be suggested that defective PCP signaling contributes to a subset of the 
phenotypes observed. Further understanding how PCP signaling is altered 
during the development of these structures can ultimately enable us to 
establish a developmental hierarchy to determine which pathways are more 
important in the development of different tissues and organs.  
 
Canonical Wnt signaling is also reported to be enhanced on loss of Fuzzy in 
vivo and in vitro (Zilber et al., 2013, Zhang et al., 2011). As a result of this, it 
has been suggested that Fuz mediates canonical Wnt signaling. Since this 
pathway regulates Sox9 expression, one may expect excessive cartilage 
formation in the Fuzzy mutant. Although this doesn’t seem to be the case, 
the fact that the Fuzzy promoter itself has 11 binding sites for Wnt 
responsive elements and can physically bind to endogenous β-catenin in 
tissue culture, supports this theory (Zhang et al., 2011). 
 
There are several possible explanations for this. Firstly, potential canonical 
Wnt hyperactivation may be below a threshold needed exert downstream 
effects.  Secondly, the effects from other signaling changes (notably Fgf and 
Hh) may be so critical that effects from Wnt changes may not be as obvious. 
Thirdly, as discussed above, Fuz may have tissue specific roles. Consistent 
with this, loss of Fuzzy resulted in no increases in Wnt target genes in the 
dermal cells of mouse embryos (Dai et al., 2011). One other interesting 
thought is that FUZ may use b-catenin as a means of regulating its own 
expression. Since increased levels of b-catenin have been detected, its 
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possible that this could be going directly to the Fuzzy promoter creating a 
feedback loop to maintain Fuzzy expression (Zhang et al., 2011)  
 
7.6 Endochondral versus intramembranous ossification 
My observations in the long bones and basosphenoid of the cranial base 
suggest that shortening of these elements in the mutant is as a result of loss 
of Gli3 mediated Ihh expression (Chapter 4). Since elongation of all 
endochondral elements is mediated via this feedback loop it is not 
unreasonable to suggest that all of these structures are probably affected in 
the same way. One outstanding question with regards to defective 
endochondral ossification in the Fuzzy mutant is whether defective FGF 
signaling also contributes to the phenotype, given that signaling through 
FGFR3 is also important for regulation of chondrocyte hypertrophy and 
FGF8 is known to bind to this receptor in certain contexts (Jacques et al., 
2007, Wilkie et al., 2002). This doesn’t seem likely since none of the 
endochondral defects are rescued in Fuzzy-/-;Fgf8L/+ compound mutants. 
That said, the main FGF ligand that binds to FGFR3 during hypertrophic 
regulation are believed to be FGF18 and -9 and it cannot be ruled out that 
abnormal Gli processing may result in misregulation of these FGF ligands.  
 
Taken together, these observations suggest that in our Fuzzy mutant, and 
therefore, potentially in ciliopathies, shortened endochondral skeletal 
elements are attributed to the role of Gli3 in the Ihh-PTHrP feedback loop. 
Hyperossification of intramembranous ossification can be attributed 
convergence of Gli transcription factors on FGF, particularly FGF8, signaling. 
This consideration is particularly interesting when looking at a mouse 
model in which the Kif3a transport complex is conditionally knocked out in 
cartilage only. This mutant has very similar endochondral defects to the 
Fuzzy mutant, such as shortened long bones and cranial base 
malformations associated with a loss of hypertrophic maturation and 
excess ossification of intramembranous elements  (Koyama ’07). 
Interestingly ciliopathy patients and mouse models display varied severity 
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and variability of which phenotypes arise. This probably reflects 
differential importance of affected proteins in ciliogenesis.   
 
Intramembranous skeletal elements in the Fuzzy mutants all appear quite 
similar in their defects. Craniosynostosis is observed and both the maxilla 
and the mandible appear to be hyperossified (Tabler et al., 2013) & chapter 
5). The fact that genetic reduction of Fgf8 in Fuzzy ameliorates all of these 
defects suggests that aberrant FGF8 regulation is key to driving this. I 
showed in chapter 5 that mandibular hyperossification is associated with 
increased Runx2 expression and Runx2 overexpression has previously been 
associated with craniosynostosis. These observations suggest that abnormal 
Runx2 activation could be driving these phenotypes. Indeed, in Gli3 mutants, 
craniosynostosis associated with Runx2 upregulation is also observed (Rice 
et al., 2010). 
 
The key outstanding question, however, is whether excessive FGFR 
activation contributes to these phenotypes, especially given the important 
roles of FGFR1 and -2 in various stages of osteoblast maturation during 
intramembranous ossification and Runx2 regulation (Discussed in chapter 1, 
section 1.3.2). 
7.7 FGF syndromes versus ciliopathies and other syndromic diseases 
Skeletal phenotypes observed in the Fuzzy mutant are observed in many 
different diseases and as part of several seemingly unrelated syndromes. As 
I have described previously, there is particular overlap between the 
craniosynostosis syndromes, chondrodysplasias and ciliopathies. 
Comparing phenotypes observed in these disorders will aid in establishing 
similarities between molecular causes driving these phenotypes as a means 
of greater understanding phenotypic overlap. For example, I suggest in 
chapter 4 that short long bones seen in ciliopathies are probably due to loss 
of Gli3 repression in the Ihh-PTHrP feedback loop whilst the molecular 
causes of short limbs in achondroplasias are known to be as a result of 
FGFR3 hyperactivation.  
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Finally, analyzing the phenotype of the Fuzzy mutant in detail may provide 
us with novel phenotypic criteria with which to assess ciliopathies and to 
better understand these syndromes. A good example of this is seen in 
chapter 6 in which I characterise mandibular hyperossification in the Fuzzy 
mutant, which has not previously been described in ciliopathy patients.  
 
Overall, comparative analysis of different overlapping phenotypes will 
provide better molecular understanding of syndromic diseases. Comparing 
animal models with patient case studies, as shown in Table 1, is a powerful 
way to determine these links. In addition, this type of analysis can provide 
us with improved criteria for diagnostics of diseases, which arise from 







Table 1 Taken from Yannakoudakis and Liu, 2013 
Table shows skeletal phenotypes seen in FGF related syndromes and 










Chapter 8 References 
 
 
ABU-ISSA, R., SMYTH, G., SMOAK, I., YAMAMURA, K. & MEYERS, E. N. 2002. 
Fgf8 is required for pharyngeal arch and cardiovascular development 
in the mouse. Development, 129, 4613-25. 
ABZHANOV, A. & TABIN, C. J. 2004. Shh and Fgf8 act synergistically to drive 
cartilage outgrowth during cranial development. Dev Biol, 273, 134-
48. 
ACASTELLO, E., MAJLUF, R., GARRIDO, P., BARBOSA, L. M. & PEREDO, A. 
2003. Sternal cleft: a surgical opportunity. J Pediatr Surg, 38, 178-83. 
ADOLPHE, C., NIEUWENHUIS, E., VILLANI, R., LI, Z. J., KAUR, P., HUI, C. C. & 
WAINWRIGHT, B. J. 2014. Patched 1 and patched 2 redundancy has a 
key role in regulating epidermal differentiation. J Invest Dermatol, 
134, 1981-90. 
AGGARWAL, V. S., CARPENTER, C., FREYER, L., LIAO, J., PETTI, M. & 
MORROW, B. E. 2010. Mesodermal Tbx1 is required for patterning 
the proximal mandible in mice. Dev Biol, 344, 669-81. 
AHLGREN, S. C. & BRONNER-FRASER, M. 1999. Inhibition of sonic hedgehog 
signaling in vivo results in craniofacial neural crest cell death. Curr 
Biol, 9, 1304-14. 
AKIYAMA, H., CHABOISSIER, M. C., MARTIN, J. F., SCHEDL, A. & DE 
CROMBRUGGHE, B. 2002. The transcription factor Sox9 has essential 
roles in successive steps of the chondrocyte differentiation pathway 
and is required for expression of Sox5 and Sox6. Genes Dev, 16, 2813-
28. 
AKIYAMA, H., LYONS, J. P., MORI-AKIYAMA, Y., YANG, X., ZHANG, R., ZHANG, 
Z., DENG, J. M., TAKETO, M. M., NAKAMURA, T., BEHRINGER, R. R., 
MCCREA, P. D. & DE CROMBRUGGHE, B. 2004. Interactions between 
Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev, 
18, 1072-87. 
ALEXIEV, B. A., LIN, X., SUN, C. C. & BRENNER, D. S. 2006. Meckel-Gruber 
syndrome: pathologic manifestations, minimal diagnostic criteria, 
and differential diagnosis. Arch Pathol Lab Med, 130, 1236-8. 
ANDERSON, P. J., HALL, C., EVANS, R. D., HARKNESS, W. J., HAYWARD, R. D. & 
JONES, B. M. 1997. The cervical spine in Crouzon syndrome. Spine 
(Phila Pa 1976), 22, 402-5. 
ANSLEY, S. J., BADANO, J. L., BLACQUE, O. E., HILL, J., HOSKINS, B. E., LEITCH, 
C. C., KIM, J. C., ROSS, A. J., EICHERS, E. R., TESLOVICH, T. M., MAH, A. 
K., JOHNSEN, R. C., CAVENDER, J. C., LEWIS, R. A., LEROUX, M. R., 
BEALES, P. L. & KATSANIS, N. 2003. Basal body dysfunction is a likely 
cause of pleiotropic Bardet-Biedl syndrome. Nature, 425, 628-33. 
AOTO, K., NISHIMURA, T., ETO, K. & MOTOYAMA, J. 2002. Mouse GLI3 
regulates Fgf8 expression and apoptosis in the developing neural 
tube, face, and limb bud. Dev Biol, 251, 320-32. 
AYTAC, A. & SAYLAM, A. 1976. Successful surgical repair of congenital total 
cleft sternum with partial ectopia cordis. Thorax, 31, 466-9. 
BABBS, C., FURNISS, D., MORRISS-KAY, G. M. & WILKIE, A. O. 2008. 
Polydactyly in the mouse mutant Doublefoot involves altered Gli3 
 173 
processing and is caused by a large deletion in cis to Indian hedgehog. 
Mech Dev, 125, 517-26. 
BACHLER, M. & NEUBUSER, A. 2001. Expression of members of the Fgf 
family and their receptors during midfacial development. Mech Dev, 
100, 313-6. 
BACINO, C. A., DHAR, S. U., BRUNETTI-PIERRI, N., LEE, B. & BONNEN, P. E. 
2012. WDR35 mutation in siblings with Sensenbrenner syndrome: a 
ciliopathy with variable phenotype. Am J Med Genet A, 158A, 2917-24. 
BALIC, A., ADAMS, D. & MINA, M. 2009. Prx1 and Prx2 cooperatively regulate 
the morphogenesis of the medial region of the mandibular process. 
Dev Dyn, 238, 2599-613. 
BARLOW, A. J., BOGARDI, J. P., LADHER, R. & FRANCIS-WEST, P. H. 1999. 
Expression of chick Barx-1 and its differential regulation by FGF-8 
and BMP signaling in the maxillary primordia. Dev Dyn, 214, 291-302. 
BARLOW, A. J. & FRANCIS-WEST, P. H. 1997. Ectopic application of 
recombinant BMP-2 and BMP-4 can change patterning of developing 
chick facial primordia. Development, 124, 391-8. 
BARRON, F., WOODS, C., KUHN, K., BISHOP, J., HOWARD, M. J. & CLOUTHIER, 
D. E. 2011. Downregulation of Dlx5 and Dlx6 expression by Hand2 is 
essential for initiation of tongue morphogenesis. Development, 138, 
2249-59. 
BARZI, M., BERENGUER, J., MENENDEZ, A., ALVAREZ-RODRIGUEZ, R. & 
PONS, S. 2010. Sonic-hedgehog-mediated proliferation requires the 
localization of PKA to the cilium base. J Cell Sci, 123, 62-9. 
BAUD'HUIN, M., DUPLOMB, L., RUIZ VELASCO, C., FORTUN, Y., HEYMANN, D. 
& PADRINES, M. 2007. Key roles of the OPG-RANK-RANKL system in 
bone oncology. Expert Rev Anticancer Ther, 7, 221-32. 
BEALES, P. L., ELCIOGLU, N., WOOLF, A. S., PARKER, D. & FLINTER, F. A. 
1999. New criteria for improved diagnosis of Bardet-Biedl syndrome: 
results of a population survey. J Med Genet, 36, 437-46. 
BEALES, P. L., WARNER, A. M., HITMAN, G. A., THAKKER, R. & FLINTER, F. A. 
1997. Bardet-Biedl syndrome: a molecular and phenotypic study of 
18 families. J Med Genet, 34, 92-8. 
BEENKEN, A. & MOHAMMADI, M. 2009. The FGF family: biology, 
pathophysiology and therapy. Nat Rev Drug Discov, 8, 235-53. 
BEI, M. & MAAS, R. 1998. FGFs and BMP4 induce both Msx1-independent 
and Msx1-dependent signaling pathways in early tooth development. 
Development, 125, 4325-33. 
BELL, D. M., LEUNG, K. K., WHEATLEY, S. C., NG, L. J., ZHOU, S., LING, K. W., 
SHAM, M. H., KOOPMAN, P., TAM, P. P. & CHEAH, K. S. 1997. SOX9 
directly regulates the type-II collagen gene. Nat Genet, 16, 174-8. 
BELLUCI, M. M., SCHOENMAKER, T., ROSSA-JUNIOR, C., ORRICO, S. R., DE 
VRIES, T. J. & EVERTS, V. 2013. Magnesium deficiency results in an 
increased formation of osteoclasts. J Nutr Biochem, 24, 1488-98. 
BELLUS, G. A., MCINTOSH, I., SMITH, E. A., AYLSWORTH, A. S., KAITILA, I., 
HORTON, W. A., GREENHAW, G. A., HECHT, J. T. & FRANCOMANO, C. A. 
1995. A recurrent mutation in the tyrosine kinase domain of 
fibroblast growth factor receptor 3 causes hypochondroplasia. Nat 
Genet, 10, 357-9. 
 174 
BELLUSCI, S., GRINDLEY, J., EMOTO, H., ITOH, N. & HOGAN, B. L. 1997. 
Fibroblast growth factor 10 (FGF10) and branching morphogenesis 
in the embryonic mouse lung. Development, 124, 4867-78. 
BENNETT, C. N., OUYANG, H., MA, Y. L., ZENG, Q., GERIN, I., SOUSA, K. M., 
LANE, T. F., KRISHNAN, V., HANKENSON, K. D. & MACDOUGALD, O. A. 
2007. Wnt10b increases postnatal bone formation by enhancing 
osteoblast differentiation. J Bone Miner Res, 22, 1924-32. 
BERNARD, P., TANG, P., LIU, S., DEWING, P., HARLEY, V. R. & VILAIN, E. 2003. 
Dimerization of SOX9 is required for chondrogenesis, but not for sex 
determination. Hum Mol Genet, 12, 1755-65. 
BERNHARDT, L. C., MEYER, T. & YOUNG, W. P. 1968. Bifid sternum. Case 
report and surgical management. J Thorac Cardiovasc Surg, 55, 758-
60. 
BHASKAR, S. N., WEINMANN, J. P. & SCHOUR, I. 1953. Role of Meckel's 
cartilage in the development and growth of the rat mandible. J Dent 
Res, 32, 398-410. 
BISWAS, A., GHOSH, J. K., SINHA, M. K., BASU, K. & CHATTERJEE, S. 2009. 
Mohr-Claussen syndrome or oro-facial-digital syndrome (OFDS) 
type-II. J Pak Med Assoc, 59, 484-6. 
BOSE, J., GROTEWOLD, L. & RUTHER, U. 2002. Pallister-Hall syndrome 
phenotype in mice mutant for Gli3. Hum Mol Genet, 11, 1129-35. 
BOULET, A. M., MOON, A. M., ARENKIEL, B. R. & CAPECCHI, M. R. 2004. The 
roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth. Dev Biol, 
273, 361-72. 
BOYDEN, L. M., MAO, J., BELSKY, J., MITZNER, L., FARHI, A., MITNICK, M. A., 
WU, D., INSOGNA, K. & LIFTON, R. P. 2002. High bone density due to a 
mutation in LDL-receptor-related protein 5. N Engl J Med, 346, 1513-
21. 
BRAND-SABERI, B. & CHRIST, B. 2000. Evolution and development of 
distinct cell lineages derived from somites. Curr Top Dev Biol, 48, 1-
42. 
BRENT, A. E., SCHWEITZER, R. & TABIN, C. J. 2003. A somitic compartment 
of tendon progenitors. Cell, 113, 235-48. 
BRENT, A. E. & TABIN, C. J. 2004. FGF acts directly on the somitic tendon 
progenitors through the Ets transcription factors Pea3 and Erm to 
regulate scleraxis expression. Development, 131, 3885-96. 
BRESNICK, S. & SCHENDEL, S. 1995. Crouzon's disease correlates with low 
fibroblastic growth factor receptor activity in stenosed cranial 
sutures. J Craniofac Surg, 6, 245-8. 
BRESNICK, S. & SCHENDEL, S. 1998. Apert's syndrome correlates with low 
fibroblast growth factor receptor activity in stenosed cranial sutures. 
J Craniofac Surg, 9, 92-5. 
BRISCOE, J. & THEROND, P. P. 2013. The mechanisms of Hedgehog signalling 
and its roles in development and disease. Nat Rev Mol Cell Biol, 14, 
416-29. 
BRITTO, J. A., CHAN, J. C., EVANS, R. D., HAYWARD, R. D., THOROGOOD, P. & 
JONES, B. M. 1998. Fibroblast growth factor receptors are expressed 
in craniosynostotic sutures. Plast Reconstr Surg, 101, 540-3. 
BRITTO, J. A., EVANS, R. D., HAYWARD, R. D. & JONES, B. M. 2001. From 
genotype to phenotype: the differential expression of FGF, FGFR, and 
TGFbeta genes characterizes human cranioskeletal development and 
 175 
reflects clinical presentation in FGFR syndromes. Plast Reconstr Surg, 
108, 2026-39; discussion 2040-6. 
BRODIE, S. G. & DENG, C. X. 2003. Mouse models orthologous to FGFR3-
related skeletal dysplasias. Pediatr Pathol Mol Med, 22, 87-103. 
BROOKS, E. R. & WALLINGFORD, J. B. 2012. Control of vertebrate 
intraflagellar transport by the planar cell polarity effector Fuz. J Cell 
Biol, 198, 37-45. 
BROOKS, E. R. & WALLINGFORD, J. B. 2013. The Small GTPase Rsg1 is 
important for the cytoplasmic localization and axonemal dynamics of 
intraflagellar transport proteins. Cilia, 2, 13. 
BRUGMANN, S. A., CORDERO, D. R. & HELMS, J. A. 2010. Craniofacial 
ciliopathies: A new classification for craniofacial disorders. Am J Med 
Genet A, 152A, 2995-3006. 
BUMCROT, D. A., TAKADA, R. & MCMAHON, A. P. 1995. Proteolytic 
processing yields two secreted forms of sonic hedgehog. Mol Cell Biol, 
15, 2294-303. 
BUNTINX, I. M., WILLEMS, P. J., SPITAELS, S. E., VAN REEMPST, P. J., DE 
PAEPE, A. M. & DUMON, J. E. 1991. Neonatal Marfan syndrome with 
congenital arachnodactyly, flexion contractures, and severe cardiac 
valve insufficiency. J Med Genet, 28, 267-73. 
BUTLER, P., MITCHEL, A. & HEALY, J. C. 2012. Applied Radilogical Anatomy, 
Cmbridge, University Press. 
BUTTITTA, L., MO, R., HUI, C. C. & FAN, C. M. 2003. Interplays of Gli2 and Gli3 
and their requirement in mediating Shh-dependent sclerotome 
induction. Development, 130, 6233-43. 
CANTRELL, J. R., HALLER, J. A. & RAVITCH, M. M. 1958. A syndrome of 
congenital defects involving the abdominal wall, sternum, diaphragm, 
pericardium, and heart. Surg Gynecol Obstet, 107, 602-14. 
CASCI, T., VINOS, J. & FREEMAN, M. 1999. Sprouty, an intracellular inhibitor 
of Ras signaling. Cell, 96, 655-65. 
CHAI, Y., JIANG, X., ITO, Y., BRINGAS, P., JR., HAN, J., ROWITCH, D. H., 
SORIANO, P., MCMAHON, A. P. & SUCOV, H. M. 2000. Fate of the 
mammalian cranial neural crest during tooth and mandibular 
morphogenesis. Development, 127, 1671-9. 
CHAMOUN, Z., MANN, R. K., NELLEN, D., VON KESSLER, D. P., BELLOTTO, M., 
BEACHY, P. A. & BASLER, K. 2001. Skinny hedgehog, an 
acyltransferase required for palmitoylation and activity of the 
hedgehog signal. Science, 293, 2080-4. 
CHEN, J. M. 1952. Studies on the morphogenesis of the mouse sternum. II. 
Experiments on the origin of the sternum and its capacity for self-
differentiation in vitro. J Anat, 86, 387-401. 
CHEN, L., ADAR, R., YANG, X., MONSONEGO, E. O., LI, C., HAUSCHKA, P. V., 
YAYON, A. & DENG, C. X. 1999. Gly369Cys mutation in mouse FGFR3 
causes achondroplasia by affecting both chondrogenesis and 
osteogenesis. J Clin Invest, 104, 1517-25. 
CHEN, L., LI, C., QIAO, W., XU, X. & DENG, C. 2001. A Ser(365)-->Cys mutation 
of fibroblast growth factor receptor 3 in mouse downregulates 
Ihh/PTHrP signals and causes severe achondroplasia. Hum Mol Genet, 
10, 457-65. 
CHEN, M. H., WILSON, C. W., LI, Y. J., LAW, K. K., LU, C. S., GACAYAN, R., 
ZHANG, X., HUI, C. C. & CHUANG, P. T. 2009. Cilium-independent 
 176 
regulation of Gli protein function by Sufu in Hedgehog signaling is 
evolutionarily conserved. Genes Dev, 23, 1910-28. 
CHENG, A. & GENEVER, P. G. 2010. SOX9 determines RUNX2 transactivity by 
directing intracellular degradation. J Bone Miner Res, 25, 2680-9. 
CHEUNG, J. O., GRANT, M. E., JONES, C. J., HOYLAND, J. A., FREEMONT, A. J. & 
HILLARBY, M. C. 2003. Apoptosis of terminal hypertrophic 
chondrocytes in an in vitro model of endochondral ossification. J 
Pathol, 201, 496-503. 
CHIANG, C., LITINGTUNG, Y., HARRIS, M. P., SIMANDL, B. K., LI, Y., BEACHY, P. 
A. & FALLON, J. F. 2001. Manifestation of the limb prepattern: limb 
development in the absence of sonic hedgehog function. Dev Biol, 236, 
421-35. 
CHRIST, B. & ORDAHL, C. P. 1995. Early stages of chick somite development. 
Anat Embryol (Berl), 191, 381-96. 
CHUNG, K. S., PARK, H. H., TING, K., TAKITA, H., APTE, S. S., KUBOKI, Y. & 
NISHIMURA, I. 1995. Modulated expression of type X collagen in 
Meckel's cartilage with different developmental fates. Dev Biol, 170, 
387-96. 
CHUNG, U. I., SCHIPANI, E., MCMAHON, A. P. & KRONENBERG, H. M. 2001. 
Indian hedgehog couples chondrogenesis to osteogenesis in 
endochondral bone development. J Clin Invest, 107, 295-304. 
CLARK, A. M., GARLAND, K. K. & RUSSELL, L. D. 2000. Desert hedgehog 
(Dhh) gene is required in the mouse testis for formation of adult-type 
Leydig cells and normal development of peritubular cells and 
seminiferous tubules. Biol Reprod, 63, 1825-38. 
CLARKE, B. 2008. Normal bone anatomy and physiology. Clin J Am Soc 
Nephrol, 3 Suppl 3, S131-9. 
CLEMENT, V., SANCHEZ, P., DE TRIBOLET, N., RADOVANOVIC, I. & RUIZ I 
ALTABA, A. 2007. HEDGEHOG-GLI1 signaling regulates human 
glioma growth, cancer stem cell self-renewal, and tumorigenicity. 
Curr Biol, 17, 165-72. 
COBOURNE, M. T., HARDCASTLE, Z. & SHARPE, P. T. 2001. Sonic hedgehog 
regulates epithelial proliferation and cell survival in the developing 
tooth germ. J Dent Res, 80, 1974-9. 
COBOURNE, M. T., MILETICH, I. & SHARPE, P. T. 2004. Restriction of sonic 
hedgehog signalling during early tooth development. Development, 
131, 2875-85. 
COBOURNE, M. T. & SHARPE, P. T. 2003. Tooth and jaw: molecular 
mechanisms of patterning in the first branchial arch. Arch Oral Biol, 
48, 1-14. 
COHEN, M. M., JR. 1998. Achondroplasia, hypochondroplasia and 
thanatophoric dysplasia: clinically related skeletal dysplasias that are 
also related at the molecular level. Int J Oral Maxillofac Surg, 27, 451-
5. 
COHEN, M. M., JR. & KREIBORG, S. 1993. Skeletal abnormalities in the Apert 
syndrome. Am J Med Genet, 47, 624-32. 
COHEN, M. M., JR., WALKER, G. F. & PHILLIPS, C. 1985. A morphometric 
analysis of the craniofacial configuration in achondroplasia. J 
Craniofac Genet Dev Biol Suppl, 1, 139-65. 
COHN, M. J. & TICKLE, C. 1996. Limbs: a model for pattern formation within 
the vertebrate body plan. Trends Genet, 12, 253-7. 
 177 
COLLIER, S. & GUBB, D. 1997. Drosophila tissue polarity requires the cell-
autonomous activity of the fuzzy gene, which encodes a novel 
transmembrane protein. Development, 124, 4029-37. 
COLNOT, C., DE LA FUENTE, L., HUANG, S., HU, D., LU, C., ST-JACQUES, B. & 
HELMS, J. A. 2005. Indian hedgehog synchronizes skeletal 
angiogenesis and perichondrial maturation with cartilage 
development. Development, 132, 1057-67. 
COMPAGNI, A., LOGAN, M., KLEIN, R. & ADAMS, R. H. 2003. Control of 
skeletal patterning by ephrinB1-EphB interactions. Dev Cell, 5, 217-
30. 
CONG, F., SCHWEIZER, L. & VARMUS, H. 2004. Wnt signals across the plasma 
membrane to activate the beta-catenin pathway by forming 
oligomers containing its receptors, Frizzled and LRP. Development, 
131, 5103-15. 
COPEL, J. A., D'ALTON, M. E., GRATACOS, E., PLATT, L. D., TUTSCHEK, B., 
FELTOVICH, H. & ODIBO, A. O. 2012. Obstetric Imaging, San Diego, 
Elsevier. 
CROSSLEY, P. H. & MARTIN, G. R. 1995. The mouse Fgf8 gene encodes a 
family of polypeptides and is expressed in regions that direct 
outgrowth and patterning in the developing embryo. Development, 
121, 439-51. 
CRUMP, J. G., MAVES, L., LAWSON, N. D., WEINSTEIN, B. M. & KIMMEL, C. B. 
2004. An essential role for Fgfs in endodermal pouch formation 
influences later craniofacial skeletal patterning. Development, 131, 
5703-16. 
DAI, D., ZHU, H., WLODARCZYK, B., ZHANG, L., LI, L., LI, A. G., FINNELL, R. H., 
ROOP, D. R. & CHEN, J. 2011. Fuz controls the morphogenesis and 
differentiation of hair follicles through the formation of primary cilia. 
J Invest Dermatol, 131, 302-10. 
DAVID, A., BITOUN, P., LACOMBE, D., LAMBERT, J. C., NIVELON, A., 
VIGNERON, J. & VERLOES, A. 1999. Hydrometrocolpos and 
polydactyly: a common neonatal presentation of Bardet-Biedl and 
McKusick-Kaufman syndromes. J Med Genet, 36, 599-603. 
DAY, T. F., GUO, X., GARRETT-BEAL, L. & YANG, Y. 2005. Wnt/beta-catenin 
signaling in mesenchymal progenitors controls osteoblast and 
chondrocyte differentiation during vertebrate skeletogenesis. Dev 
Cell, 8, 739-50. 
DE POLLACK, C., RENIER, D., HOTT, M. & MARIE, P. J. 1996. Increased bone 
formation and osteoblastic cell phenotype in premature cranial 
suture ossification (craniosynostosis). J Bone Miner Res, 11, 401-7. 
DEBEER, P., DEVRIENDT, K., DE SMET, L., DERAVEL, T., GONZALEZ-
MENESES, A., GRZESCHIK, K. H. & FRYNS, J. P. 2007. The spectrum of 
hand and foot malformations in patients with Greig 
cephalopolysyndactyly. J Child Orthop, 1, 143-50. 
DELEZOIDE, A. L., BENOIST-LASSELIN, C., LEGEAI-MALLET, L., LE MERRER, 
M., MUNNICH, A., VEKEMANS, M. & BONAVENTURE, J. 1998. Spatio-
temporal expression of FGFR 1, 2 and 3 genes during human embryo-
fetal ossification. Mech Dev, 77, 19-30. 
DER KALOUSTIAN, V. M., PELLETIER, M., COSTA, T., BLACKSTON, D. R. & 
OUDJHANE, K. 2001. A new syndrome with craniofacial and skeletal 
dysmorphisms and developmental delay. Clin Dysmorphol, 10, 87-93. 
 178 
DIMIDSCHSTEIN, J., PASSANTE, L., DUFOUR, A., VAN DEN AMEELE, J., TIBERI, 
L., HRECHDAKIAN, T., ADAMS, R., KLEIN, R., LIE, D. C., JOSSIN, Y. & 
VANDERHAEGHEN, P. 2013. Ephrin-B1 controls the columnar 
distribution of cortical pyramidal neurons by restricting their 
tangential migration. Neuron, 79, 1123-35. 
DINNO, N., SHEARER, L. & WEISSKOPF, B. 1976. Chondrodysplastic 
dwarfism, cleft palate and micrognathia in a neonate, a new 
syndrome? European Journal of Pediatrics, 123, 39-42. 
DOCKTER, J. L. & ORDAHL, C. P. 1998. Determination of sclerotome to the 
cartilage fate. Development, 125, 2113-24. 
DRISSI, H., LUC, Q., SHAKOORI, R., CHUVA DE SOUSA LOPES, S., CHOI, J. Y., 
TERRY, A., HU, M., JONES, S., NEIL, J. C., LIAN, J. B., STEIN, J. L., VAN 
WIJNEN, A. J. & STEIN, G. S. 2000. Transcriptional autoregulation of 
the bone related CBFA1/RUNX2 gene. J Cell Physiol, 184, 341-50. 
DUBAND, J. L., MONIER, F., DELANNET, M. & NEWGREEN, D. 1995. 
Epithelium-mesenchyme transition during neural crest development. 
Acta Anat (Basel), 154, 63-78. 
DUBOC, V. & LOGAN, M. P. 2011. Regulation of limb bud initiation and limb-
type morphology. Dev Dyn, 240, 1017-27. 
DUCY, P., ZHANG, R., GEOFFROY, V., RIDALL, A. L. & KARSENTY, G. 1997. 
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. 
Cell, 89, 747-54. 
DY, P., WANG, W., BHATTARAM, P., WANG, Q., WANG, L., BALLOCK, R. T. & 
LEFEBVRE, V. 2012. Sox9 directs hypertrophic maturation and blocks 
osteoblast differentiation of growth plate chondrocytes. Dev Cell, 22, 
597-609. 
EL ZEIN, L., OMRAN, H. & BOUVAGNET, P. 2003. Lateralization defects and 
ciliary dyskinesia: lessons from algae. Trends Genet, 19, 162-7. 
ELEJALDE, B. R. & DE ELEJALDE, M. M. 1985. Thanatophoric dysplasia: fetal 
manifestations and prenatal diagnosis. Am J Med Genet, 22, 669-83. 
ENGSTROM, H. 1951. The structure of tracheal cilia. Acta Otolaryngol, 39, 
364-6. 
ENLOW, D. H. 1962. Functions of the Haversian system. Am J Anat, 110, 269-
305. 
ESTIVAL, A., MONZAT, V., MIQUEL, K., GAUBERT, F., HOLLANDE, E., KORC, M., 
VAYSSE, N. & CLEMENTE, F. 1996. Differential regulation of 
fibroblast growth factor (FGF) receptor-1 mRNA and protein by two 
molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability. J 
Biol Chem, 271, 5663-70. 
ETHERIDGE, S. L., RAY, S., LI, S., HAMBLET, N. S., LIJAM, N., TSANG, M., 
GREER, J., KARDOS, N., WANG, J., SUSSMAN, D. J., CHEN, P. & 
WYNSHAW-BORIS, A. 2008. Murine dishevelled 3 functions in 
redundant pathways with dishevelled 1 and 2 in normal cardiac 
outflow tract, cochlea, and neural tube development. PLoS Genet, 4, 
e1000259. 
FELDHAHN, N., FERRETTI, E., ROBBIANI, D. F., CALLEN, E., DEROUBAIX, S., 
SELLERI, L., NUSSENZWEIG, A. & NUSSENZWEIG, M. C. 2012. The 
hSSB1 orthologue Obfc2b is essential for skeletogenesis but 
dispensable for the DNA damage response in vivo. EMBO J, 31, 4045-
56. 
 179 
FERGUSON, C. A., TUCKER, A. S. & SHARPE, P. T. 2000. Temporospatial cell 
interactions regulating mandibular and maxillary arch patterning. 
Development, 127, 403-12. 
FERRANTE, M. I., ZULLO, A., BARRA, A., BIMONTE, S., MESSADDEQ, N., 
STUDER, M., DOLLE, P. & FRANCO, B. 2006. Oral-facial-digital type I 
protein is required for primary cilia formation and left-right axis 
specification. Nat Genet, 38, 112-7. 
FISH, J. L., SKLAR, R. S., WORONOWICZ, K. C. & SCHNEIDER, R. A. 2014. 
Multiple developmental mechanisms regulate species-specific jaw 
size. Development, 141, 674-84. 
FOLDYNOVA-TRANTIRKOVA, S., WILCOX, W. R. & KREJCI, P. 2012. Sixteen 
years and counting: the current understanding of fibroblast growth 
factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat, 
33, 29-41. 
FROMMER, J. & MARGOLIES, M. R. 1971. Contribution of Meckel's cartilage 
to ossification of the mandible in mice. J Dent Res, 50, 1260-7. 
FUMOTO, K., HOOGENRAAD, C. C. & KIKUCHI, A. 2006. GSK-3beta-regulated 
interaction of BICD with dynein is involved in microtubule anchorage 
at centrosome. EMBO J, 25, 5670-82. 
FUNATO, N., CHAPMAN, S. L., MCKEE, M. D., FUNATO, H., MORRIS, J. A., 
SHELTON, J. M., RICHARDSON, J. A. & YANAGISAWA, H. 2009. Hand2 
controls osteoblast differentiation in the branchial arch by inhibiting 
DNA binding of Runx2. Development, 136, 615-25. 
GALLERA, J. 1971. Primary induction in birds. Adv Morphog, 9, 149-80. 
GALLET, A., RUEL, L., STACCINI-LAVENANT, L. & THEROND, P. P. 2006. 
Cholesterol modification is necessary for controlled planar long-
range activity of Hedgehog in Drosophila epithelia. Development, 133, 
407-18. 
GALVIN, B. D., HART, K. C., MEYER, A. N., WEBSTER, M. K. & DONOGHUE, D. J. 
1996. Constitutive receptor activation by Crouzon syndrome 
mutations in fibroblast growth factor receptor (FGFR)2 and 
FGFR2/Neu chimeras. Proc Natl Acad Sci U S A, 93, 7894-9. 
GANGOPADHYAY, N., MENDONCA, D. A. & WOO, A. S. 2012. Pierre robin 
sequence. Semin Plast Surg, 26, 76-82. 
GAO, B., SONG, H., BISHOP, K., ELLIOT, G., GARRETT, L., ENGLISH, M. A., 
ANDRE, P., ROBINSON, J., SOOD, R., MINAMI, Y., ECONOMIDES, A. N. & 
YANG, Y. 2011. Wnt signaling gradients establish planar cell polarity 
by inducing Vangl2 phosphorylation through Ror2. Dev Cell, 20, 163-
76. 
GAO, C. & CHEN, Y. G. 2010. Dishevelled: The hub of Wnt signaling. Cell 
Signal, 22, 717-27. 
GARZON-ALVARADO, D. A., GUTIERREZ, M. L. & CALIXTO, L. F. 2014. A 
computational model of clavicle bone formation: a mechano-
biochemical hypothesis. Bone, 61, 132-7. 
GEORGOULIS, G., ALEXIOU, G. & PRODROMOU, N. 2011. Achondroplasia with 
synostosis of multiple sutures. Am J Med Genet A, 155A, 1969-71. 
GILBERT, S. F. 2006. Developmental Biology, Massachusets USA, Sinaur 
Associates Inc. 
GOETZ, R. & MOHAMMADI, M. 2013. Exploring mechanisms of FGF 
signalling through the lens of structural biology. Nat Rev Mol Cell Biol, 
14, 166-80. 
 180 
GOETZ, R., NAKADA, Y., HU, M. C., KUROSU, H., WANG, L., NAKATANI, T., SHI, 
M., ELISEENKOVA, A. V., RAZZAQUE, M. S., MOE, O. W., KURO-O, M. & 
MOHAMMADI, M. 2010. Isolated C-terminal tail of FGF23 alleviates 
hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex 
formation. Proc Natl Acad Sci U S A, 107, 407-12. 
GOETZ, S. C. & ANDERSON, K. V. 2010. The primary cilium: a signalling 
centre during vertebrate development. Nat Rev Genet, 11, 331-44. 
GOLDFARB, M. 2005. Fibroblast growth factor homologous factors: 
evolution, structure, and function. Cytokine Growth Factor Rev, 16, 
215-20. 
GOLDRING, M. B., TSUCHIMOCHI, K. & IJIRI, K. 2006. The control of 
chondrogenesis. J Cell Biochem, 97, 33-44. 
GOULDING, M., LUMSDEN, A. & PAQUETTE, A. J. 1994. Regulation of Pax-3 
expression in the dermomyotome and its role in muscle development. 
Development, 120, 957-71. 
GRAY, R. S., ABITUA, P. B., WLODARCZYK, B. J., SZABO-ROGERS, H. L., 
BLANCHARD, O., LEE, I., WEISS, G. S., LIU, K. J., MARCOTTE, E. M., 
WALLINGFORD, J. B. & FINNELL, R. H. 2009. The planar cell polarity 
effector Fuz is essential for targeted membrane trafficking, 
ciliogenesis and mouse embryonic development. Nat Cell Biol, 11, 
1225-32. 
GRIGORYAN, T., WEND, P., KLAUS, A. & BIRCHMEIER, W. 2008. Deciphering 
the function of canonical Wnt signals in development and disease: 
conditional loss- and gain-of-function mutations of beta-catenin in 
mice. Genes Dev, 22, 2308-41. 
GRILLO, L., GRECO, D., PETTINATO, R., AVOLA, E., POTENZA, N., CASTIGLIA, 
L., SPALLETTA, A., AMATA, S., DI BENEDETTO, D., LUCIANO, D., 
ROMANO, C. & FICHERA, M. 2014. Increased FGF3 and FGF4 gene 
dosage is a risk factor for craniosynostosis. Gene, 534, 435-9. 
GUYOT, M. C., BOSOI, C. M., KHARFALLAH, F., REYNOLDS, A., DRAPEAU, P., 
JUSTICE, M., GROS, P. & KIBAR, Z. 2011. A novel hypomorphic 
Looptail allele at the planar cell polarity Vangl2 gene. Dev Dyn, 240, 
839-49. 
HAJIHOSSEINI, M. K., LALIOTI, M. D., ARTHAUD, S., BURGAR, H. R., BROWN, J. 
M., TWIGG, S. R., WILKIE, A. O. & HEATH, J. K. 2004. Skeletal 
development is regulated by fibroblast growth factor receptor 1 
signalling dynamics. Development, 131, 325-35. 
HAJIHOSSEINI, M. K., WILSON, S., DE MOERLOOZE, L. & DICKSON, C. 2001. A 
splicing switch and gain-of-function mutation in FgfR2-IIIc 
hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. Proc 
Natl Acad Sci U S A, 98, 3855-60. 
HALBERT, S. A., TAM, P. Y., ADAMS, R. J. & BLANDAU, R. J. 1976. An analysis 
of the mechanisms of egg transport in the ampulla of the rabbit 
oviduct. Gynecol Invest, 7, 306-20. 
HALL, B. K. 2005. Bones and Cartilage, San Diego, Elsevier. 
HALL, B. K. & MIYAKE, T. 1992. The membranous skeleton: the role of cell 
condensations in vertebrate skeletogenesis. Anat Embryol (Berl), 186, 
107-24. 
HALL, B. K. & MIYAKE, T. 2000. All for one and one for all: condensations 
and the initiation of skeletal development. Bioessays, 22, 138-47. 
 181 
HAMBLET, N. S., LIJAM, N., RUIZ-LOZANO, P., WANG, J., YANG, Y., LUO, Z., 
MEI, L., CHIEN, K. R., SUSSMAN, D. J. & WYNSHAW-BORIS, A. 2002. 
Dishevelled 2 is essential for cardiac outflow tract development, 
somite segmentation and neural tube closure. Development, 129, 
5827-38. 
HAN, Y. & LEFEBVRE, V. 2008. L-Sox5 and Sox6 drive expression of the 
aggrecan gene in cartilage by securing binding of Sox9 to a far-
upstream enhancer. Mol Cell Biol, 28, 4999-5013. 
HAN, Y. M., KANG, G. M., BYUN, K., KO, H. W., KIM, J., SHIN, M. S., KIM, H. K., 
GIL, S. Y., YU, J. H., LEE, B. & KIM, M. S. 2014. Leptin-promoted cilia 
assembly is critical for normal energy balance. J Clin Invest, 124, 
2193-7. 
HARADA, Y. & ISHIZEKI, K. 1998. Evidence for transformation of 
chondrocytes and site-specific resorption during the degradation of 
Meckel's cartilage. Anat Embryol (Berl), 197, 439-50. 
HAVENS, B. A., VELONIS, D., KRONENBERG, M. S., LICHTLER, A. C., OLIVER, B. 
& MINA, M. 2008. Roles of FGFR3 during morphogenesis of Meckel's 
cartilage and mandibular bones. Dev Biol, 316, 336-49. 
HAWORTH, K. E., WILSON, J. M., GREVELLEC, A., COBOURNE, M. T., HEALY, C., 
HELMS, J. A., SHARPE, P. T. & TUCKER, A. S. 2007. Sonic hedgehog in 
the pharyngeal endoderm controls arch pattern via regulation of Fgf8 
in head ectoderm. Dev Biol, 303, 244-58. 
HAYCRAFT, C. J. & SERRA, R. 2008. Cilia involvement in patterning and 
maintenance of the skeleton. Curr Top Dev Biol, 85, 303-32. 
HE, X., SAINT-JEANNET, J. P., WANG, Y., NATHANS, J., DAWID, I. & VARMUS, 
H. 1997. A member of the Frizzled protein family mediating axis 
induction by Wnt-5A. Science, 275, 1652-4. 
HEALY, C., UWANOGHO, D. & SHARPE, P. T. 1999. Regulation and role of 
Sox9 in cartilage formation. Dev Dyn, 215, 69-78. 
HEMMER, K. M., MCALISTER, W. H. & MARSH, J. L. 1987. Cervical spine 
anomalies in the craniosynostosis syndromes. Cleft Palate J, 24, 328-
33. 
HEYDECK, W. & LIU, A. 2011. PCP effector proteins inturned and fuzzy play 
nonredundant roles in the patterning but not convergent extension 
of mammalian neural tube. Dev Dyn, 240, 1938-48. 
HEYDECK, W., ZENG, H. & LIU, A. 2009. Planar cell polarity effector gene 
Fuzzy regulates cilia formation and Hedgehog signal transduction in 
mouse. Dev Dyn, 238, 3035-42. 
HO, A. & DOWDY, S. F. 2002. Regulation of G(1) cell-cycle progression by 
oncogenes and tumor suppressor genes. Curr Opin Genet Dev, 12, 47-
52. 
HOEFFEL, J. C., PERNOT, C. & JUNCKER, P. 1981. Radiologic patterns of the 
sternum in Noonan's syndrome with congenital heart defect. Am J Dis 
Child, 135, 1044-6. 
HSIEH, Y. Y., CHANG, C. C., TSAI, H. D., YANG, T. C., LEE, C. C. & TSAI, C. H. 
1999. The prenatal diagnosis of Pierre-Robin sequence. Prenat Diagn, 
19, 567-9. 
HU, D. & HELMS, J. A. 1999. The role of sonic hedgehog in normal and 
abnormal craniofacial morphogenesis. Development, 126, 4873-84. 
HUANGFU, D. & ANDERSON, K. V. 2005. Cilia and Hedgehog responsiveness 
in the mouse. Proc Natl Acad Sci U S A, 102, 11325-30. 
 182 
HUANGFU, D., LIU, A., RAKEMAN, A. S., MURCIA, N. S., NISWANDER, L. & 
ANDERSON, K. V. 2003. Hedgehog signalling in the mouse requires 
intraflagellar transport proteins. Nature, 426, 83-7. 
HUGHES, S. E. 1997. Differential expression of the fibroblast growth factor 
receptor (FGFR) multigene family in normal human adult tissues. J 
Histochem Cytochem, 45, 1005-19. 
HUI, C. C. & JOYNER, A. L. 1993. A mouse model of greig 
cephalopolysyndactyly syndrome: the extra-toesJ mutation contains 
an intragenic deletion of the Gli3 gene. Nat Genet, 3, 241-6. 
HUMKE, E. W., DORN, K. V., MILENKOVIC, L., SCOTT, M. P. & ROHATGI, R. 
2010. The output of Hedgehog signaling is controlled by the dynamic 
association between Suppressor of Fused and the Gli proteins. Genes 
Dev, 24, 670-82. 
HUNG, I. H., YU, K., LAVINE, K. J. & ORNITZ, D. M. 2007. FGF9 regulates early 
hypertrophic chondrocyte differentiation and skeletal 
vascularization in the developing stylopod. Dev Biol, 307, 300-13. 
IBRAHIMI, O. A., ZHANG, F., ELISEENKOVA, A. V., LINHARDT, R. J. & 
MOHAMMADI, M. 2004. Proline to arginine mutations in FGF 
receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis 
syndromes through enhancement of FGF binding affinity. Hum Mol 
Genet, 13, 69-78. 
ILAGAN, R., ABU-ISSA, R., BROWN, D., YANG, Y. P., JIAO, K., SCHWARTZ, R. J., 
KLINGENSMITH, J. & MEYERS, E. N. 2006. Fgf8 is required for 
anterior heart field development. Development, 133, 2435-45. 
INMAN, K. E., PURCELL, P., KUME, T. & TRAINOR, P. A. 2013. Interaction 
between Foxc1 and Fgf8 during mammalian jaw patterning and in 
the pathogenesis of syngnathia. PLoS Genet, 9, e1003949. 
ISHIKAWA, N., HIRANUMA, C., SATO, H., UENO, Y., SEKI, M. & YAMAMOTO, M. 
2002. Congenital sternal cleft with patent ductus arteriosus: report of 
a case. Surg Today, 32, 66-8. 
ISHIZEKI, K., SAITO, H., SHINAGAWA, T., FUJIWARA, N. & NAWA, T. 1999. 
Histochemical and immunohistochemical analysis of the mechanism 
of calcification of Meckel's cartilage during mandible development in 
rodents. J Anat, 194 ( Pt 2), 265-77. 
ISHIZEKI, K., TAKIGAWA, M., NAWA, T. & SUZUKI, F. 1996. Mouse Meckel's 
cartilage chondrocytes evoke bone-like matrix and further transform 
into osteocyte-like cells in culture. Anat Rec, 245, 25-35. 
ITOH, N. & ORNITZ, D. M. 2008. Functional evolutionary history of the 
mouse Fgf gene family. Dev Dyn, 237, 18-27. 
IWAMOTO, M., ENOMOTO-IWAMOTO, M. & KURISU, K. 1999. Actions of 
hedgehog proteins on skeletal cells. Crit Rev Oral Biol Med, 10, 477-86. 
IWATA, T., CHEN, L., LI, C., OVCHINNIKOV, D. A., BEHRINGER, R. R., 
FRANCOMANO, C. A. & DENG, C. X. 2000. A neonatal lethal mutation 
in FGFR3 uncouples proliferation and differentiation of growth plate 
chondrocytes in embryos. Hum Mol Genet, 9, 1603-13. 
JACQUES, B. E., MONTCOUQUIOL, M. E., LAYMAN, E. M., LEWANDOSKI, M. & 
KELLEY, M. W. 2007. Fgf8 induces pillar cell fate and regulates 
cellular patterning in the mammalian cochlea. Development, 134, 
3021-9. 
JEONG, J. & MCMAHON, A. P. 2005. Growth and pattern of the mammalian 
neural tube are governed by partially overlapping feedback activities 
 183 
of the hedgehog antagonists patched 1 and Hhip1. Development, 132, 
143-54. 
JEROME, L. A. & PAPAIOANNOU, V. E. 2001. DiGeorge syndrome phenotype 
in mice mutant for the T-box gene, Tbx1. Nat Genet, 27, 286-91. 
JIANG, J. 2006. Regulation of Hh/Gli signaling by dual ubiquitin pathways. 
Cell Cycle, 5, 2457-63. 
JINKINS, J. R. 2000. Atlas of Neuroradiologic Embryology, Lippincott, 
Williams & Wilkins. 
JOENG, K. S. & LONG, F. 2009. The Gli2 transcriptional activator is a crucial 
effector for Ihh signaling in osteoblast development and cartilage 
vascularization. Development, 136, 4177-85. 
JOHNSON, D. R. 1967. Extra-toes: anew mutant gene causing multiple 
abnormalities in the mouse. J Embryol Exp Morphol, 17, 543-81. 
KALININA, J., BYRON, S. A., MAKARENKOVA, H. P., OLSEN, S. K., 
ELISEENKOVA, A. V., LAROCHELLE, W. J., DHANABAL, M., BLAIS, S., 
ORNITZ, D. M., DAY, L. A., NEUBERT, T. A., POLLOCK, P. M. & 
MOHAMMADI, M. 2009. Homodimerization controls the fibroblast 
growth factor 9 subfamily's receptor binding and heparan sulfate-
dependent diffusion in the extracellular matrix. Mol Cell Biol, 29, 
4663-78. 
KAMEL, G., HOYOS, T., ROCHARD, L., DOUGHERTY, M., KONG, Y., TSE, W., 
SHUBINETS, V., GRIMALDI, M. & LIAO, E. C. 2013. Requirement for 
frzb and fzd7a in cranial neural crest convergence and extension 
mechanisms during zebrafish palate and jaw morphogenesis. 
Developmental Biology, 381, 423-433. 
KARCHER, C., FISCHER, A., SCHWEICKERT, A., BITZER, E., HORIE, S., 
WITZGALL, R. & BLUM, M. 2005. Lack of a laterality phenotype in 
Pkd1 knock-out embryos correlates with absence of polycystin-1 in 
nodal cilia. Differentiation, 73, 425-32. 
KARP, S. J., SCHIPANI, E., ST-JACQUES, B., HUNZELMAN, J., KRONENBERG, H. 
& MCMAHON, A. P. 2000. Indian hedgehog coordinates endochondral 
bone growth and morphogenesis via parathyroid hormone related-
protein-dependent and -independent pathways. Development, 127, 
543-8. 
KAUFMAN, M. H. & BARD, J. B. 1999. The anatomical basis of mouse 
development, Texas, Gulf professional publishing. 
KAVRAN, J. M., WARD, M. D., OLADOSU, O. O., MULEPATI, S. & LEAHY, D. J. 
2010. All mammalian Hedgehog proteins interact with cell adhesion 
molecule, down-regulated by oncogenes (CDO) and brother of CDO 
(BOC) in a conserved manner. J Biol Chem, 285, 24584-90. 
KETTUNEN, P. & THESLEFF, I. 1998. Expression and function of FGFs-4, -8, 
and -9 suggest functional redundancy and repetitive use as epithelial 
signals during tooth morphogenesis. Dev Dyn, 211, 256-68. 
KHALIFA, O., RAHBEENI, Z., ALHASHMI, N. & ALMANE, K. 2012. Oral-facial-
digital syndrome type 1: unique radiological findings. Clin 
Dysmorphol, 21, 77-9. 
KHANNA, A. J., BRAVERMAN, N. E., VALLE, D. & SPONSELLER, P. D. 2001. 
Cervical stenosis secondary to rhizomelic chondrodysplasia punctata. 
Am J Med Genet, 99, 63-6. 
KIBAR, Z., VOGAN, K. J., GROULX, N., JUSTICE, M. J., UNDERHILL, D. A. & GROS, 
P. 2001. Ltap, a mammalian homolog of Drosophila Strabismus/Van 
 184 
Gogh, is altered in the mouse neural tube mutant Loop-tail. Nat Genet, 
28, 251-5. 
KIM, H. J., KIM, J. H., BAE, S. C., CHOI, J. Y., KIM, H. J. & RYOO, H. M. 2003. The 
protein kinase C pathway plays a central role in the fibroblast growth 
factor-stimulated expression and transactivation activity of Runx2. J 
Biol Chem, 278, 319-26. 
KIM, H. J., RICE, D. P., KETTUNEN, P. J. & THESLEFF, I. 1998. FGF-, BMP- and 
Shh-mediated signalling pathways in the regulation of cranial suture 
morphogenesis and calvarial bone development. Development, 125, 
1241-51. 
KIM, J., KATO, M. & BEACHY, P. A. 2009. Gli2 trafficking links Hedgehog-
dependent activation of Smoothened in the primary cilium to 
transcriptional activation in the nucleus. Proc Natl Acad Sci U S A, 106, 
21666-71. 
KINTO, N., IWAMOTO, M., ENOMOTO-IWAMOTO, M., NOJI, S., OHUCHI, H., 
YOSHIOKA, H., KATAOKA, H., WADA, Y., YUHAO, G., TAKAHASHI, H. E., 
YOSHIKI, S. & YAMAGUCHI, A. 1997. Fibroblasts expressing Sonic 
hedgehog induce osteoblast differentiation and ectopic bone 
formation. FEBS Lett, 404, 319-23. 
KITAHARA, Y., SUDA, N., KURODA, T., BECK, F., HAMMOND, V. E. & TAKANO, 
Y. 2002. Disturbed tooth development in parathyroid hormone-
related protein (PTHrP)-gene knockout mice. Bone, 30, 48-56. 
KJAER, I. 1975. Histochemical investigations on the symphysis menti in the 
human fetus related to fetal skeletal maturation in the hand and foot. 
Acta Anat (Basel), 93, 606-33. 
KNECHT, A. K. & BRONNER-FRASER, M. 2002. Induction of the neural crest: 
a multigene process. Nat Rev Genet, 3, 453-61. 
KOLPAKOVA-HART, E., JINNIN, M., HOU, B., FUKAI, N. & OLSEN, B. R. 2007. 
Kinesin-2 controls development and patterning of the vertebrate 
skeleton by Hedgehog- and Gli3-dependent mechanisms. Dev Biol, 
309, 273-84. 
KOMORI, T. 2002. Runx2, a multifunctional transcription factor in skeletal 
development. J Cell Biochem, 87, 1-8. 
KOMORI, T. 2005. Regulation of skeletal development by the Runx family of 
transcription factors. J Cell Biochem, 95, 445-53. 
KOMORI, T. 2011. Signaling networks in RUNX2-dependent bone 
development. J Cell Biochem, 112, 750-5. 
KOMORI, T. & KISHIMOTO, T. 1998. Cbfa1 in bone development. Curr Opin 
Genet Dev, 8, 494-9. 
KOMORI, T., YAGI, H., NOMURA, S., YAMAGUCHI, A., SASAKI, K., DEGUCHI, K., 
SHIMIZU, Y., BRONSON, R. T., GAO, Y. H., INADA, M., SATO, M., 
OKAMOTO, R., KITAMURA, Y., YOSHIKI, S. & KISHIMOTO, T. 1997. 
Targeted disruption of Cbfa1 results in a complete lack of bone 
formation owing to maturational arrest of osteoblasts. Cell, 89, 755-
64. 
KOZIEL, L., WUELLING, M., SCHNEIDER, S. & VORTKAMP, A. 2005. Gli3 acts 
as a repressor downstream of Ihh in regulating two distinct steps of 
chondrocyte differentiation. Development, 132, 5249-60. 
KUBOTA, Y. & ITO, K. 2000. Chemotactic migration of mesencephalic neural 
crest cells in the mouse. Dev Dyn, 217, 170-9. 
 185 
KUO, B. R. & ERICKSON, C. A. 2010. Regional differences in neural crest 
morphogenesis. Cell Adh Migr, 4, 567-85. 
LABONNE, C. & BRONNER-FRASER, M. 1998. Neural crest induction in 
Xenopus: evidence for a two-signal model. Development, 125, 2403-
14. 
LAM, D. J., TABANGIN, M. E., SHIKARY, T. A., URIBE-RIVERA, A., MEINZEN-
DERR, J. K., DE ALARCON, A., BILLMIRE, D. A. & GORDON, C. B. 2014. 
Outcomes of mandibular distraction osteogenesis in the treatment of 
severe micrognathia. JAMA Otolaryngol Head Neck Surg, 140, 338-45. 
LAPRISE, P., CHAILLER, P., HOUDE, M., BEAULIEU, J. F., BOUCHER, M. J. & 
RIVARD, N. 2002. Phosphatidylinositol 3-kinase controls human 
intestinal epithelial cell differentiation by promoting adherens 
junction assembly and p38 MAPK activation. J Biol Chem, 277, 8226-
34. 
LECLAIR, E. E., MUI, S. R., HUANG, A., TOPCZEWSKA, J. M. & TOPCZEWSKI, J. 
2009. Craniofacial skeletal defects of adult zebrafish Glypican 4 
(knypek) mutants. Dev Dyn, 238, 2550-63. 
LEE, B., THIRUNAVUKKARASU, K., ZHOU, L., PASTORE, L., BALDINI, A., 
HECHT, J., GEOFFROY, V., DUCY, P. & KARSENTY, G. 1997. Missense 
mutations abolishing DNA binding of the osteoblast-specific 
transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat 
Genet, 16, 307-10. 
LEE, J. J., EKKER, S. C., VON KESSLER, D. P., PORTER, J. A., SUN, B. I. & 
BEACHY, P. A. 1994. Autoproteolysis in hedgehog protein biogenesis. 
Science, 266, 1528-37. 
LEMONNIER, J., DELANNOY, P., HOTT, M., LOMRI, A., MODROWSKI, D. & 
MARIE, P. J. 2000. The Ser252Trp fibroblast growth factor receptor-2 
(FGFR-2) mutation induces PKC-independent downregulation of 
FGFR-2 associated with premature calvaria osteoblast differentiation. 
Exp Cell Res, 256, 158-67. 
LEUCHT, P., KIM, J. B. & HELMS, J. A. 2008. Beta-catenin-dependent Wnt 
signaling in mandibular bone regeneration. J Bone Joint Surg Am, 90 
Suppl 1, 3-8. 
LEUNG, V. Y., GAO, B., LEUNG, K. K., MELHADO, I. G., WYNN, S. L., AU, T. Y., 
DUNG, N. W., LAU, J. Y., MAK, A. C., CHAN, D. & CHEAH, K. S. 2011. 
SOX9 governs differentiation stage-specific gene expression in 
growth plate chondrocytes via direct concomitant transactivation 
and repression. PLoS Genet, 7, e1002356. 
LEVIN, L. S., PERRIN, J. C., OSE, L., DORST, J. P., MILLER, J. D. & MCKUSICK, V. 
A. 1977. A heritable syndrome of craniosynostosis, short thin hair, 
dental abnormalities, and short limbs: cranioectodermal dysplasia. J 
Pediatr, 90, 55-61. 
LEWANDOSKI, M., SUN, X. & MARTIN, G. R. 2000. Fgf8 signalling from the 
AER is essential for normal limb development. Nat Genet, 26, 460-3. 
LI, C., CHEN, L., IWATA, T., KITAGAWA, M., FU, X. Y. & DENG, C. X. 1999. A 
Lys644Glu substitution in fibroblast growth factor receptor 3 
(FGFR3) causes dwarfism in mice by activation of STATs and ink4 
cell cycle inhibitors. Hum Mol Genet, 8, 35-44. 
LIN, A. E., TRAUM, A. Z., SAHAI, I., KEPPLER-NOREUIL, K., KUKOLICH, M. K., 
ADAM, M. P., WESTRA, S. J. & ARTS, H. H. 2013. Sensenbrenner 
syndrome (Cranioectodermal dysplasia): clinical and molecular 
 186 
analyses of 39 patients including two new patients. Am J Med Genet A, 
161A, 2762-76. 
LINDER, M. D., URONEN, R. L., HOLTTA-VUORI, M., VAN DER SLUIJS, P., 
PERANEN, J. & IKONEN, E. 2007. Rab8-dependent recycling promotes 
endosomal cholesterol removal in normal and sphingolipidosis cells. 
Mol Biol Cell, 18, 47-56. 
LITINGTUNG, Y., DAHN, R. D., LI, Y., FALLON, J. F. & CHIANG, C. 2002. Shh 
and Gli3 are dispensable for limb skeleton formation but regulate 
digit number and identity. Nature, 418, 979-83. 
LIU, A., WANG, B. & NISWANDER, L. A. 2005a. Mouse intraflagellar transport 
proteins regulate both the activator and repressor functions of Gli 
transcription factors. Development, 132, 3103-11. 
LIU, K. J., ARRON, J. R., STANKUNAS, K., CRABTREE, G. R. & LONGAKER, M. T. 
2007. Chemical rescue of cleft palate and midline defects in 
conditional GSK-3beta mice. Nature, 446, 79-82. 
LIU, N., BARBOSA, A. C., CHAPMAN, S. L., BEZPROZVANNAYA, S., QI, X., 
RICHARDSON, J. A., YANAGISAWA, H. & OLSON, E. N. 2009. DNA 
binding-dependent and -independent functions of the Hand2 
transcription factor during mouse embryogenesis. Development, 136, 
933-42. 
LIU, W., SELEVER, J., MURALI, D., SUN, X., BRUGGER, S. M., MA, L., 
SCHWARTZ, R. J., MAXSON, R., FURUTA, Y. & MARTIN, J. F. 2005b. 
Threshold-specific requirements for Bmp4 in mandibular 
development. Dev Biol, 283, 282-93. 
LIU, Z., XU, J., COLVIN, J. S. & ORNITZ, D. M. 2002. Coordination of 
chondrogenesis and osteogenesis by fibroblast growth factor 18. 
Genes Dev, 16, 859-69. 
LOMRI, A., LEMONNIER, J., HOTT, M., DE PARSEVAL, N., LAJEUNIE, E., 
MUNNICH, A., RENIER, D. & MARIE, P. J. 1998. Increased calvaria cell 
differentiation and bone matrix formation induced by fibroblast 
growth factor receptor 2 mutations in Apert syndrome. J Clin Invest, 
101, 1310-7. 
MAENO, T., MORIISHI, T., YOSHIDA, C. A., KOMORI, H., KANATANI, N., IZUMI, 
S., TAKAOKA, K. & KOMORI, T. 2011. Early onset of Runx2 expression 
caused craniosynostosis, ectopic bone formation, and limb defects. 
Bone, 49, 673-82. 
MAHUZIER, A., GAUDE, H. M., GRAMPA, V., ANSELME, I., SILBERMANN, F., 
LEROUX-BERGER, M., DELACOUR, D., EZAN, J., MONTCOUQUIOL, M., 
SAUNIER, S., SCHNEIDER-MAUNOURY, S. & VESQUE, C. 2012. 
Dishevelled stabilization by the ciliopathy protein Rpgrip1l is 
essential for planar cell polarity. J Cell Biol, 198, 927-40. 
MAO, Y., MULVANEY, J., ZAKARIA, S., YU, T., MORGAN, K. M., ALLEN, S., 
BASSON, M. A., FRANCIS-WEST, P. & IRVINE, K. D. 2011. 
Characterization of a Dchs1 mutant mouse reveals requirements for 
Dchs1-Fat4 signaling during mammalian development. Development, 
138, 947-57. 
MARTELLI-JUNIOR, H., COLETTA, R. D., MIRANDA, R. T., BARROS, L. M., 
SWERTS, M. S. & BONAN, P. R. 2009. Orofacial features of Treacher 
Collins syndrome. Med Oral Patol Oral Cir Bucal, 14, E344-8. 
MASON, I. J., FULLER-PACE, F., SMITH, R. & DICKSON, C. 1994. FGF-7 
(keratinocyte growth factor) expression during mouse development 
 187 
suggests roles in myogenesis, forebrain regionalisation and 
epithelial-mesenchymal interactions. Mech Dev, 45, 15-30. 
MATISE, M. P., EPSTEIN, D. J., PARK, H. L., PLATT, K. A. & JOYNER, A. L. 1998. 
Gli2 is required for induction of floor plate and adjacent cells, but not 
most ventral neurons in the mouse central nervous system. 
Development, 125, 2759-70. 
MATSUSHITA, T., WILCOX, W. R., CHAN, Y. Y., KAWANAMI, A., BUKULMEZ, H., 
BALMES, G., KREJCI, P., MEKIKIAN, P. B., OTANI, K., YAMAURA, I., 
WARMAN, M. L., GIVOL, D. & MURAKAMI, S. 2009. FGFR3 promotes 
synchondrosis closure and fusion of ossification centers through the 
MAPK pathway. Hum Mol Genet, 18, 227-40. 
MAYOR, R. & THEVENEAU, E. 2014. The role of the non-canonical Wnt-
planar cell polarity pathway in neural crest migration. Biochem J, 457, 
19-26. 
MCGLINN, E., VAN BUEREN, K. L., FIORENZA, S., MO, R., POH, A. M., FORREST, 
A., SOARES, M. B., BONALDO MDE, F., GRIMMOND, S., HUI, C. C., 
WAINWRIGHT, B. & WICKING, C. 2005. Pax9 and Jagged1 act 
downstream of Gli3 in vertebrate limb development. Mech Dev, 122, 
1218-33. 
MCGONNELL, I. M., CLARKE, J. D. & TICKLE, C. 1998. Fate map of the 
developing chick face: analysis of expansion of facial primordia and 
establishment of the primary palate. Dev Dyn, 212, 102-18. 
MELNICK, M., WITCHER, D., BRINGAS, P., JR., CARLSSON, P. & JASKOLL, T. 
2005. Meckel's cartilage differentiation is dependent on hedgehog 
signaling. Cells Tissues Organs, 179, 146-57. 
MERCADER, N., LEONARDO, E., PIEDRA, M. E., MARTINEZ, A. C., ROS, M. A. & 
TORRES, M. 2000. Opposing RA and FGF signals control 
proximodistal vertebrate limb development through regulation of 
Meis genes. Development, 127, 3961-70. 
MIAO, D., LIU, H., PLUT, P., NIU, M., HUO, R., GOLTZMAN, D. & HENDERSON, J. 
E. 2004. Impaired endochondral bone development and osteopenia 
in Gli2-deficient mice. Exp Cell Res, 294, 210-22. 
MIKELS, A. J. & NUSSE, R. 2006. Purified Wnt5a protein activates or inhibits 
beta-catenin-TCF signaling depending on receptor context. PLoS Biol, 
4, e115. 
MINA, M., UPHOLT, W. B. & KOLLAR, E. J. 1994. Enhancement of avian 
mandibular chondrogenesis in vitro in the absence of epithelium. 
Arch Oral Biol, 39, 551-62. 
MO, R., FREER, A. M., ZINYK, D. L., CRACKOWER, M. A., MICHAUD, J., HENG, H. 
H., CHIK, K. W., SHI, X. M., TSUI, L. C., CHENG, S. H., JOYNER, A. L. & 
HUI, C. 1997. Specific and redundant functions of Gli2 and Gli3 zinc 
finger genes in skeletal patterning and development. Development, 
124, 113-23. 
MOHAMMADI, M., OLSEN, S. K. & IBRAHIMI, O. A. 2005. Structural basis for 
fibroblast growth factor receptor activation. Cytokine Growth Factor 
Rev, 16, 107-37. 
MONTCOUQUIOL, M., RACHEL, R. A., LANFORD, P. J., COPELAND, N. G., 
JENKINS, N. A. & KELLEY, M. W. 2003. Identification of Vangl2 and 
Scrb1 as planar polarity genes in mammals. Nature, 423, 173-7. 
MOORE, M. H., CANTRELL, S. B., TROTT, J. A. & DAVID, D. J. 1995a. Pfeiffer 
syndrome: a clinical review. Cleft Palate Craniofac J, 32, 62-70. 
 188 
MOORE, M. H., LODGE, M. L. & CLARK, B. E. 1995b. Spinal anomalies in 
Pfeiffer syndrome. Cleft Palate Craniofac J, 32, 251-4. 
MOORE-SCOTT, B. A. & MANLEY, N. R. 2005. Differential expression of Sonic 
hedgehog along the anterior-posterior axis regulates patterning of 
pharyngeal pouch endoderm and pharyngeal endoderm-derived 
organs. Dev Biol, 278, 323-35. 
MORI-AKIYAMA, Y., AKIYAMA, H., ROWITCH, D. H. & DE CROMBRUGGHE, B. 
2003. Sox9 is required for determination of the chondrogenic cell 
lineage in the cranial neural crest. Proc Natl Acad Sci U S A, 100, 
9360-5. 
MORRISON, S. J. & SCADDEN, D. T. 2014. The bone marrow niche for 
haematopoietic stem cells. Nature, 505, 327-34. 
MORRISS-KAY, G. M. 2001. Derivation of the mammalian skull vault. J Anat, 
199, 143-51. 
MUENKE, M. & SCHELL, U. 1995. Fibroblast-growth-factor receptor 
mutations in human skeletal disorders. Trends Genet, 11, 308-13. 
MUENKE, M., SCHELL, U., HEHR, A., ROBIN, N. H., LOSKEN, H. W., SCHINZEL, 
A., PULLEYN, L. J., RUTLAND, P., REARDON, W., MALCOLM, S. & ET AL. 
1994. A common mutation in the fibroblast growth factor receptor 1 
gene in Pfeiffer syndrome. Nat Genet, 8, 269-74. 
MUNDLOS, S., OTTO, F., MUNDLOS, C., MULLIKEN, J. B., AYLSWORTH, A. S., 
ALBRIGHT, S., LINDHOUT, D., COLE, W. G., HENN, W., KNOLL, J. H., 
OWEN, M. J., MERTELSMANN, R., ZABEL, B. U. & OLSEN, B. R. 1997. 
Mutations involving the transcription factor CBFA1 cause 
cleidocranial dysplasia. Cell, 89, 773-9. 
MURAKAMI, S., BALMES, G., MCKINNEY, S., ZHANG, Z., GIVOL, D. & DE 
CROMBRUGGHE, B. 2004. Constitutive activation of MEK1 in 
chondrocytes causes Stat1-independent achondroplasia-like 
dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes 
Dev, 18, 290-305. 
MURDOCH, B., DELCONTE, C. & GARCIA-CASTRO, M. I. 2012. Pax7 lineage 
contributions to the mammalian neural crest. PLoS One, 7, e41089. 
MURDOCH, J. N., DOUDNEY, K., PATERNOTTE, C., COPP, A. J. & STANIER, P. 
2001. Severe neural tube defects in the loop-tail mouse result from 
mutation of Lpp1, a novel gene involved in floor plate specification. 
Hum Mol Genet, 10, 2593-601. 
MURTAUGH, L. C., CHYUNG, J. H. & LASSAR, A. B. 1999. Sonic hedgehog 
promotes somitic chondrogenesis by altering the cellular response to 
BMP signaling. Genes Dev, 13, 225-37. 
MYAGERI, A., GRAMPUROHIT, V. & RAO, R. 2013. Meckel gruber syndrome: 
report of two cases with review of literature. J Family Med Prim Care, 
2, 106-8. 
MYLLYLA, R. M., HAAPASAARI, K. M., LEHENKARI, P. & TUUKKANEN, J. 2014. 
Bone morphogenetic proteins 4 and 2/7 induce osteogenic 
differentiation of mouse skin derived fibroblast and dermal papilla 
cells. Cell Tissue Res, 355, 463-70. 
NACHURY, M. V., LOKTEV, A. V., ZHANG, Q., WESTLAKE, C. J., PERANEN, J., 
MERDES, A., SLUSARSKI, D. C., SCHELLER, R. H., BAZAN, J. F., 
SHEFFIELD, V. C. & JACKSON, P. K. 2007. A core complex of BBS 
proteins cooperates with the GTPase Rab8 to promote ciliary 
membrane biogenesis. Cell, 129, 1201-13. 
 189 
NAKASHIMA, K., ZHOU, X., KUNKEL, G., ZHANG, Z., DENG, J. M., BEHRINGER, 
R. R. & DE CROMBRUGGHE, B. 2002. The novel zinc finger-containing 
transcription factor osterix is required for osteoblast differentiation 
and bone formation. Cell, 108, 17-29. 
NANNI, L., MING, J. E., BOCIAN, M., STEINHAUS, K., BIANCHI, D. W., DIE-
SMULDERS, C., GIANNOTTI, A., IMAIZUMI, K., JONES, K. L., CAMPO, M. 
D., MARTIN, R. A., MEINECKE, P., PIERPONT, M. E., ROBIN, N. H., 
YOUNG, I. D., ROESSLER, E. & MUENKE, M. 1999. The mutational 
spectrum of the sonic hedgehog gene in holoprosencephaly: SHH 
mutations cause a significant proportion of autosomal dominant 
holoprosencephaly. Hum Mol Genet, 8, 2479-88. 
NASKI, M. C., COLVIN, J. S., COFFIN, J. D. & ORNITZ, D. M. 1998. Repression of 
hedgehog signaling and BMP4 expression in growth plate cartilage by 
fibroblast growth factor receptor 3. Development, 125, 4977-88. 
NEILSON, K. M. & FRIESEL, R. 1996. Ligand-independent activation of 
fibroblast growth factor receptors by point mutations in the 
extracellular, transmembrane, and kinase domains. J Biol Chem, 271, 
25049-57. 
NEILSON, K. M. & FRIESEL, R. E. 1995. Constitutive activation of fibroblast 
growth factor receptor-2 by a point mutation associated with 
Crouzon syndrome. J Biol Chem, 270, 26037-40. 
NG, L. J., WHEATLEY, S., MUSCAT, G. E., CONWAY-CAMPBELL, J., BOWLES, J., 
WRIGHT, E., BELL, D. M., TAM, P. P., CHEAH, K. S. & KOOPMAN, P. 
1997. SOX9 binds DNA, activates transcription, and coexpresses with 
type II collagen during chondrogenesis in the mouse. Dev Biol, 183, 
108-21. 
NIEDERREITHER, K., VERMOT, J., SCHUHBAUR, B., CHAMBON, P. & DOLLE, P. 
2002. Embryonic retinoic acid synthesis is required for forelimb 
growth and anteroposterior patterning in the mouse. Development, 
129, 3563-74. 
NIGER, C., LUCIOTTI, M. A., BUO, A. M., HEBERT, C., MA, V. & STAINS, J. P. 
2013. The regulation of runt-related transcription factor 2 by 
fibroblast growth factor-2 and connexin43 requires the inositol 
polyphosphate/protein kinase Cdelta cascade. J Bone Miner Res, 28, 
1468-77. 
NISWANDER, L., TICKLE, C., VOGEL, A., BOOTH, I. & MARTIN, G. R. 1993. 
FGF-4 replaces the apical ectodermal ridge and directs outgrowth 
and patterning of the limb. Cell, 75, 579-87. 
NODEN, D. M. 1983. The role of the neural crest in patterning of avian 
cranial skeletal, connective, and muscle tissues. Dev Biol, 96, 144-65. 
NODEN, D. M. 1988. Interactions and fates of avian craniofacial mesenchyme. 
Development, 103 Suppl, 121-40. 
NODEN, D. M. 1992. Vertebrate craniofacial development: novel approaches 
and new dilemmas. Curr Opin Genet Dev, 2, 576-81. 
NONAKA, S., TANAKA, Y., OKADA, Y., TAKEDA, S., HARADA, A., KANAI, Y., 
KIDO, M. & HIROKAWA, N. 1998. Randomization of left-right 
asymmetry due to loss of nodal cilia generating leftward flow of 
extraembryonic fluid in mice lacking KIF3B motor protein. Cell, 95, 
829-37. 
ODGAARD, A. 1997. Three-dimensional methods for quantification of 
cancellous bone architecture. Bone, 20, 315-28. 
 190 
OHBA, S., KAWAGUCHI, H., KUGIMIYA, F., OGASAWARA, T., KAWAMURA, N., 
SAITO, T., IKEDA, T., FUJII, K., MIYAJIMA, T., KURAMOCHI, A., 
MIYASHITA, T., ODA, H., NAKAMURA, K., TAKATO, T. & CHUNG, U. I. 
2008. Patched1 haploinsufficiency increases adult bone mass and 
modulates Gli3 repressor activity. Dev Cell, 14, 689-99. 
OHBAYASHI, N., SHIBAYAMA, M., KUROTAKI, Y., IMANISHI, M., FUJIMORI, T., 
ITOH, N. & TAKADA, S. 2002. FGF18 is required for normal cell 
proliferation and differentiation during osteogenesis and 
chondrogenesis. Genes Dev, 16, 870-9. 
OHUCHI, H., NAKAGAWA, T., YAMAMOTO, A., ARAGA, A., OHATA, T., 
ISHIMARU, Y., YOSHIOKA, H., KUWANA, T., NOHNO, T., YAMASAKI, M., 
ITOH, N. & NOJI, S. 1997. The mesenchymal factor, FGF10, initiates 
and maintains the outgrowth of the chick limb bud through 
interaction with FGF8, an apical ectodermal factor. Development, 124, 
2235-44. 
OLSEN, B. R., REGINATO, A. M. & WANG, W. 2000. Bone development. Annu 
Rev Cell Dev Biol, 16, 191-220. 
OLSEN, S. K., LI, J. Y., BROMLEIGH, C., ELISEENKOVA, A. V., IBRAHIMI, O. A., 
LAO, Z., ZHANG, F., LINHARDT, R. J., JOYNER, A. L. & MOHAMMADI, M. 
2006. Structural basis by which alternative splicing modulates the 
organizer activity of FGF8 in the brain. Genes Dev, 20, 185-98. 
OMOTEYAMA, K. & TAKAGI, M. 2009. FGF8 regulates myogenesis and 
induces Runx2 expression and osteoblast differentiation in cultured 
cells. J Cell Biochem, 106, 546-52. 
OPPERMAN, L. A. 2000. Cranial sutures as intramembranous bone growth 
sites. Dev Dyn, 219, 472-85. 
ORHAN, D., BALCI, S., DEREN, O., UTINE, E. G., BASARAN, A. & KALE, G. 2008. 
Prenatally diagnosed lethal type Larsen-like syndrome associated 
with bifid tongue. Turk J Pediatr, 50, 395-9. 
ORNEK, D., AYDIN, G. B., KAHVECI, K., CICEK, F. & DIKMEN, B. 2012. 
Anesthetic management of a child with both Marfan syndrome and 
Turner syndrome. J Anesth, 26, 442-4. 
ORR-URTREGER, A., BEDFORD, M. T., BURAKOVA, T., ARMAN, E., ZIMMER, Y., 
YAYON, A., GIVOL, D. & LONAI, P. 1993. Developmental localization of 
the splicing alternatives of fibroblast growth factor receptor-2 
(FGFR2). Dev Biol, 158, 475-86. 
OSTROWSKI, L. E., BLACKBURN, K., RADDE, K. M., MOYER, M. B., SCHLATZER, 
D. M., MOSELEY, A. & BOUCHER, R. C. 2002. A proteomic analysis of 
human cilia: identification of novel components. Mol Cell Proteomics, 
1, 451-65. 
OSUMI-YAMASHITA, N., NINOMIYA, Y. & ETO, K. 1997. Mammalian 
craniofacial embryology in vitro. Int J Dev Biol, 41, 187-94. 
OZAKI, K., MIYAZAKI, S., TANIMURA, S. & KOHNO, M. 2005. Efficient 
suppression of FGF-2-induced ERK activation by the cooperative 
interaction among mammalian Sprouty isoforms. J Cell Sci, 118, 
5861-71. 
PACHECO, M., VALENCIA, M., CAPARROS-MARTIN, J. A., MULERO, F., 
GOODSHIP, J. A. & RUIZ-PEREZ, V. L. 2012. Evc works in chondrocytes 
and osteoblasts to regulate multiple aspects of growth plate 
development in the appendicular skeleton and cranial base. Bone, 50, 
28-41. 
 191 
PAN, Y. & WANG, B. 2007. A novel protein-processing domain in Gli2 and 
Gli3 differentially blocks complete protein degradation by the 
proteasome. J Biol Chem, 282, 10846-52. 
PANMAN, L., DRENTH, T., TEWELSCHER, P., ZUNIGA, A. & ZELLER, R. 2005. 
Genetic interaction of Gli3 and Alx4 during limb development. Int J 
Dev Biol, 49, 443-8. 
PARELKAR, S. V., KAPADNIS, S. P., SANGHVI, B. V., JOSHI, P. B., MUNDADA, D. 
& OAK, S. N. 2013. Meckel-Gruber syndrome: A rare and lethal 
anomaly with review of literature. J Pediatr Neurosci, 8, 154-7. 
PARK, H. L., BAI, C., PLATT, K. A., MATISE, M. P., BEEGHLY, A., HUI, C. C., 
NAKASHIMA, M. & JOYNER, A. L. 2000. Mouse Gli1 mutants are viable 
but have defects in SHH signaling in combination with a Gli2 
mutation. Development, 127, 1593-605. 
PARK, O. J., KIM, H. J., WOO, K. M., BAEK, J. H. & RYOO, H. M. 2010. FGF2-
activated ERK mitogen-activated protein kinase enhances Runx2 
acetylation and stabilization. J Biol Chem, 285, 3568-74. 
PARK, T. J., HAIGO, S. L. & WALLINGFORD, J. B. 2006. Ciliogenesis defects in 
embryos lacking inturned or fuzzy function are associated with 
failure of planar cell polarity and Hedgehog signaling. Nat Genet, 38, 
303-11. 
PARK, T. J., MITCHELL, B. J., ABITUA, P. B., KINTNER, C. & WALLINGFORD, J. 
B. 2008. Dishevelled controls apical docking and planar polarization 
of basal bodies in ciliated epithelial cells. Nat Genet, 40, 871-9. 
PARK, W. J., LIU, J., SHARP, E. J. & ADLER, P. N. 1996. The Drosophila tissue 
polarity gene inturned acts cell autonomously and encodes a novel 
protein. Development, 122, 961-9. 
PARK, W. J., MEYERS, G. A., LI, X., THEDA, C., DAY, D., ORLOW, S. J., JONES, M. 
C. & JABS, E. W. 1995. Novel FGFR2 mutations in Crouzon and 
Jackson-Weiss syndromes show allelic heterogeneity and phenotypic 
variability. Hum Mol Genet, 4, 1229-33. 
PATHI, S., PAGAN-WESTPHAL, S., BAKER, D. P., GARBER, E. A., RAYHORN, P., 
BUMCROT, D., TABIN, C. J., BLAKE PEPINSKY, R. & WILLIAMS, K. P. 
2001. Comparative biological responses to human Sonic, Indian, and 
Desert hedgehog. Mech Dev, 106, 107-17. 
PAZOUR, G. J., AGRIN, N., LESZYK, J. & WITMAN, G. B. 2005. Proteomic 
analysis of a eukaryotic cilium. J Cell Biol, 170, 103-13. 
PEDERSEN, L. B. & ROSENBAUM, J. L. 2008. Intraflagellar transport (IFT) 
role in ciliary assembly, resorption and signalling. Curr Top Dev Biol, 
85, 23-61. 
PEPINSKY, R. B., ZENG, C., WEN, D., RAYHORN, P., BAKER, D. P., WILLIAMS, K. 
P., BIXLER, S. A., AMBROSE, C. M., GARBER, E. A., MIATKOWSKI, K., 
TAYLOR, F. R., WANG, E. A. & GALDES, A. 1998. Identification of a 
palmitic acid-modified form of human Sonic hedgehog. J Biol Chem, 
273, 14037-45. 
PERSSON, M., STAMATAKI, D., TE WELSCHER, P., ANDERSSON, E., BOSE, J., 
RUTHER, U., ERICSON, J. & BRISCOE, J. 2002. Dorsal-ventral 
patterning of the spinal cord requires Gli3 transcriptional repressor 
activity. Genes Dev, 16, 2865-78. 
PETERS, D. J., SPRUIT, L., KLINGEL, R., PRINS, F., BAELDE, H. J., GIORDANO, P. 
C., BERNINI, L. F., DE HEER, E., BREUNING, M. H. & BRUIJN, J. A. 1996. 
 192 
Adult, fetal, and polycystic kidney expression of polycystin, the 
polycystic kidney disease-1 gene product. Lab Invest, 75, 221-30. 
PETERS, H., WILM, B., SAKAI, N., IMAI, K., MAAS, R. & BALLING, R. 1999. 
Pax1 and Pax9 synergistically regulate vertebral column 
development. Development, 126, 5399-408. 
PETERS, K., ORNITZ, D., WERNER, S. & WILLIAMS, L. 1993. Unique 
expression pattern of the FGF receptor 3 gene during mouse 
organogenesis. Dev Biol, 155, 423-30. 
PETIOT, A., FERRETTI, P., COPP, A. J. & CHAN, C. T. 2002. Induction of 
chondrogenesis in neural crest cells by mutant fibroblast growth 
factor receptors. Dev Dyn, 224, 210-21. 
PIGINO, G., GEIMER, S., LANZAVECCHIA, S., PACCAGNINI, E., CANTELE, F., 
DIENER, D. R., ROSENBAUM, J. L. & LUPETTI, P. 2009. Electron-
tomographic analysis of intraflagellar transport particle trains in situ. 
J Cell Biol, 187, 135-48. 
POLIAKOV, A., COTRINA, M. & WILKINSON, D. G. 2004. Diverse roles of eph 
receptors and ephrins in the regulation of cell migration and tissue 
assembly. Dev Cell, 7, 465-80. 
PORTER, J. A., EKKER, S. C., PARK, W. J., VON KESSLER, D. P., YOUNG, K. E., 
CHEN, C. H., MA, Y., WOODS, A. S., COTTER, R. J., KOONIN, E. V. & 
BEACHY, P. A. 1996. Hedgehog patterning activity: role of a lipophilic 
modification mediated by the carboxy-terminal autoprocessing 
domain. Cell, 86, 21-34. 
PRYOR, P. R., JACKSON, L., GRAY, S. R., EDELING, M. A., THOMPSON, A., 
SANDERSON, C. M., EVANS, P. R., OWEN, D. J. & LUZIO, J. P. 2008. 
Molecular basis for the sorting of the SNARE VAMP7 into endocytic 
clathrin-coated vesicles by the ArfGAP Hrb. Cell, 134, 817-27. 
PUMIGLIA, K. M. & DECKER, S. J. 1997. Cell cycle arrest mediated by the 
MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci U 
S A, 94, 448-52. 
RAMAESH, T. & BARD, J. B. 2003. The growth and morphogenesis of the 
early mouse mandible: a quantitative analysis. J Anat, 203, 213-22. 
RASH, B. G. & GROVE, E. A. 2007. Patterning the dorsal telencephalon: a role 
for sonic hedgehog? J Neurosci, 27, 11595-603. 
RICE, D. P., ABERG, T., CHAN, Y., TANG, Z., KETTUNEN, P. J., PAKARINEN, L., 
MAXSON, R. E. & THESLEFF, I. 2000. Integration of FGF and TWIST in 
calvarial bone and suture development. Development, 127, 1845-55. 
RICE, D. P., CONNOR, E. C., VELTMAAT, J. M., LANA-ELOLA, E., VEISTINEN, L., 
TANIMOTO, Y., BELLUSCI, S. & RICE, R. 2010. Gli3Xt-J/Xt-J mice 
exhibit lambdoid suture craniosynostosis which results from altered 
osteoprogenitor proliferation and differentiation. Hum Mol Genet, 19, 
3457-67. 
RICHMAN, J. M. & TICKLE, C. 1989. Epithelia are interchangeable between 
facial primordia of chick embryos and morphogenesis is controlled 
by the mesenchyme. Dev Biol, 136, 201-10. 
RIMOIN, D. L., HUGHES, G. N., KAUFMAN, R. L., ROSENTHAL, R. E., 
MCALISTER, W. H. & SILBERBERG, R. 1970. Endochondral 
ossification in achondroplastic dwarfism. N Engl J Med, 283, 728-35. 
ROACH, H. I., AIGNER, T. & KOURI, J. B. 2004. Chondroptosis: a variant of 
apoptotic cell death in chondrocytes? Apoptosis, 9, 265-77. 
 193 
ROBERTSON, S. C., MEYER, A. N., HART, K. C., GALVIN, B. D., WEBSTER, M. K. 
& DONOGHUE, D. J. 1998. Activating mutations in the extracellular 
domain of the fibroblast growth factor receptor 2 function by 
disruption of the disulfide bond in the third immunoglobulin-like 
domain. Proc Natl Acad Sci U S A, 95, 4567-72. 
ROSS, A. J., MAY-SIMERA, H., EICHERS, E. R., KAI, M., HILL, J., JAGGER, D. J., 
LEITCH, C. C., CHAPPLE, J. P., MUNRO, P. M., FISHER, S., TAN, P. L., 
PHILLIPS, H. M., LEROUX, M. R., HENDERSON, D. J., MURDOCH, J. N., 
COPP, A. J., ELIOT, M. M., LUPSKI, J. R., KEMP, D. T., DOLLFUS, H., 
TADA, M., KATSANIS, N., FORGE, A. & BEALES, P. L. 2005. Disruption 
of Bardet-Biedl syndrome ciliary proteins perturbs planar cell 
polarity in vertebrates. Nat Genet, 37, 1135-40. 
ROSSE, C. & GADDUM-ROSEE, P. 1997. Hollinshead's textbook of anatomy, 
Lippincott, Williams & Wilkins 
. 
ROSSI, V., BANFIELD, D. K., VACCA, M., DIETRICH, L. E., UNGERMANN, C., 
D'ESPOSITO, M., GALLI, T. & FILIPPINI, F. 2004. Longins and their 
longin domains: regulated SNAREs and multifunctional SNARE 
regulators. Trends Biochem Sci, 29, 682-8. 
ROUSSEAU, F., BONAVENTURE, J., LEGEAI-MALLET, L., PELET, A., ROZET, J. 
M., MAROTEAUX, P., LE MERRER, M. & MUNNICH, A. 1994. Mutations 
in the gene encoding fibroblast growth factor receptor-3 in 
achondroplasia. Nature, 371, 252-4. 
RUIZ I ALTABA, A. 1999. Gli proteins encode context-dependent positive and 
negative functions: implications for development and disease. 
Development, 126, 3205-16. 
RYNEARSON, R. D. 2000. Case report: orthodontic and dentofacial 
orthopedic considerations in Apert's syndrome. Angle Orthod, 70, 
247-52. 
SAKAKURA, Y., HOSOKAWA, Y., TSURUGA, E., IRIE, K. & YAJIMA, T. 2007. In 
situ localization of gelatinolytic activity during development and 
resorption of Meckel's cartilage in mice. Eur J Oral Sci, 115, 212-23. 
SAKAKURA, Y., TSURUGA, E., IRIE, K., HOSOKAWA, Y., NAKAMURA, H. & 
YAJIMA, T. 2005. Immunolocalization of receptor activator of nuclear 
factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in 
Meckel's cartilage compared with developing endochondral bones in 
mice. J Anat, 207, 325-37. 
SALA, F. G., DEL MORAL, P. M., TIOZZO, C., ALAM, D. A., WARBURTON, D., 
GRIKSCHEIT, T., VELTMAAT, J. M. & BELLUSCI, S. 2011. FGF10 
controls the patterning of the tracheal cartilage rings via Shh. 
Development, 138, 273-82. 
SASAI, N., KUTEJOVA, E. & BRISCOE, J. 2014. Integration of signals along 
orthogonal axes of the vertebrate neural tube controls progenitor 
competence and increases cell diversity. PLoS Biol, 12, e1001907. 
SATO, A., SCHOLL, A. M., KUHN, E. N., STADT, H. A., DECKER, J. R., PEGRAM, 
K., HUTSON, M. R. & KIRBY, M. L. 2011. FGF8 signaling is chemotactic 
for cardiac neural crest cells. Dev Biol, 354, 18-30. 
SAUNDERS, J. W., JR. 1948. The proximo-distal sequence of origin of the 
parts of the chick wing and the role of the ectoderm. J Exp Zool, 108, 
363-403. 
 194 
SCHELL, U., HEHR, A., FELDMAN, G. J., ROBIN, N. H., ZACKAI, E. H., DE DIE-
SMULDERS, C., VISKOCHIL, D. H., STEWART, J. M., WOLFF, G., OHASHI, 
H. & ET AL. 1995. Mutations in FGFR1 and FGFR2 cause familial and 
sporadic Pfeiffer syndrome. Hum Mol Genet, 4, 323-8. 
SCHEUER, L. & BLACK, S. 2004. The Juvenile Skeleton, New York, Elsevier 
Academic Pres. 
SCHLESSINGER, J., PLOTNIKOV, A. N., IBRAHIMI, O. A., ELISEENKOVA, A. V., 
YEH, B. K., YAYON, A., LINHARDT, R. J. & MOHAMMADI, M. 2000. 
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a 
dual role for heparin in FGFR binding and dimerization. Mol Cell, 6, 
743-50. 
SCHLESSINGER, K., HALL, A. & TOLWINSKI, N. 2009. Wnt signaling 
pathways meet Rho GTPases. Genes Dev, 23, 265-77. 
SEGEV, O., CHUMAKOV, I., NEVO, Z., GIVOL, D., MADAR-SHAPIRO, L., 
SHEININ, Y., WEINREB, M. & YAYON, A. 2000. Restrained 
chondrocyte proliferation and maturation with abnormal growth 
plate vascularization and ossification in human FGFR-3(G380R) 
transgenic mice. Hum Mol Genet, 9, 249-58. 
SELVAMURUGAN, N., PULUMATI, M. R., TYSON, D. R. & PARTRIDGE, N. C. 
2000. Parathyroid hormone regulation of the rat collagenase-3 
promoter by protein kinase A-dependent transactivation of core 
binding factor alpha1. J Biol Chem, 275, 5037-42. 
SENSENBRENNER, J. A., DORST, J. P. & OWENS, R. P. 1975. New syndrome of 
skeletal, dental and hair anomalies. Birth Defects Orig Artic Ser, 11, 
372-9. 
SEO, J. H., ZILBER, Y., BABAYEVA, S., LIU, J., KYRIAKOPOULOS, P., DE MARCO, 
P., MERELLO, E., CAPRA, V., GROS, P. & TORBAN, E. 2011. Mutations 
in the planar cell polarity gene, Fuzzy, are associated with neural 
tube defects in humans. Hum Mol Genet, 20, 4324-33. 
SHAWKY, R. M., ELSAYED, S. M., ABD-ELKHALEK, H. S. & GAD, S. 2013. Oral-
facial-digital syndrome type II: Transitional type between Mohr and 
Varadi. Egyptian Journal of Medical Human Genetics, 14, 311-315. 
SHEN, G. 2005. The role of type X collagen in facilitating and regulating 
endochondral ossification of articular cartilage. Orthod Craniofac Res, 
8, 11-7. 
SHIANG, R., THOMPSON, L. M., ZHU, Y.-Z., CHURCH, D. M., FIELDER, T. J., 
BOCIAN, M., WINOKUR, S. T. & WASMUTH, J. J. 1994. Mutations in the 
transmembrane domain of FGFR3 cause the most common genetic 
form of dwarfism, achondroplasia. Cell, 78, 335-342. 
SHIBATA, S., SUDA, N., YODA, S., FUKUOKA, H., OHYAMA, K., YAMASHITA, Y. 
& KOMORI, T. 2004. Runx2-deficient mice lack mandibular condylar 
cartilage and have deformed Meckel's cartilage. Anat Embryol (Berl), 
208, 273-80. 
SHIMADA, M., YAMAMOTO, M., WAKAYAMA, T., ISEKI, S. & AMANO, O. 2003. 
Different expression of 25-kDa heat-shock protein (Hsp25) in 
Meckel's cartilage compared with other cartilages in the mouse. Anat 
Embryol (Berl), 206, 163-73. 
SHIMO, T., KANYAMA, M., WU, C., SUGITO, H., BILLINGS, P. C., ABRAMS, W. R., 
ROSENBLOOM, J., IWAMOTO, M., PACIFICI, M. & KOYAMA, E. 2004. 
Expression and roles of connective tissue growth factor in Meckel's 
cartilage development. Dev Dyn, 231, 136-47. 
 195 
SHIMOYAMA, A., WADA, M., IKEDA, F., HATA, K., MATSUBARA, T., NIFUJI, A., 
NODA, M., AMANO, K., YAMAGUCHI, A., NISHIMURA, R. & YONEDA, T. 
2007. Ihh/Gli2 signaling promotes osteoblast differentiation by 
regulating Runx2 expression and function. Mol Biol Cell, 18, 2411-8. 
SILLIBOURNE, J. E., MILNE, D. M., TAKAHASHI, M., ONO, Y. & MEEK, D. W. 
2002. Centrosomal Anchoring of the Protein Kinase CK1δ Mediated 
by Attachment to the Large, Coiled-coil Scaffolding Protein CG-
NAP/AKAP450. Journal of Molecular Biology, 322, 785-797. 
SIMKIN, J. E., ZHANG, D., ROLLO, B. N. & NEWGREEN, D. F. 2013. Retinoic 
acid upregulates ret and induces chain migration and population 
expansion in vagal neural crest cells to colonise the embryonic gut. 
PLoS One, 8, e64077. 
SINGH, A., GOYAL, M., KUMAR, S., KRESS, W. & KAPOOR, S. 2014. Phenotypic 
Variability in Two Families of Muenke Syndrome with FGFR3 
Mutation. Indian J Pediatr. 
SINGH, P., GORAYA, J. S., SAGGAR, K. & AHLUWALIA, A. 2011. A report of 
Joubert syndrome in an infant, with literature review. J Pediatr 
Neurosci, 6, 44-7. 
SMITH, H. L. & HAND, A. M. 1958. Chondroectodermal dysplasia (Ellis-van 
Creveld syndrome); report of two cases. Pediatrics, 21, 298-307. 
SMITH, J. C., NORTHEY, J. G., GARG, J., PEARLMAN, R. E. & SIU, K. W. 2005. 
Robust method for proteome analysis by MS/MS using an entire 
translated genome: demonstration on the ciliome of Tetrahymena 
thermophila. J Proteome Res, 4, 909-19. 
SMITH, K. K. & SCHNEIDER, R. A. 1998. Have gene knockouts caused 
evolutionary reversals in the mammalian first arch? Bioessays, 20, 
245-55. 
SMOLICH, B. D., MCMAHON, J. A., MCMAHON, A. P. & PAPKOFF, J. 1993. Wnt 
family proteins are secreted and associated with the cell surface. Mol 
Biol Cell, 4, 1267-75. 
ST-JACQUES, B., HAMMERSCHMIDT, M. & MCMAHON, A. P. 1999. Indian 
hedgehog signaling regulates proliferation and differentiation of 
chondrocytes and is essential for bone formation. Genes Dev, 13, 
2072-86. 
STECCA, B., MAS, C., CLEMENT, V., ZBINDEN, M., CORREA, R., PIGUET, V., 
BEERMANN, F. & RUIZ, I. A. A. 2007. Melanomas require HEDGEHOG-
GLI signaling regulated by interactions between GLI1 and the RAS-
MEK/AKT pathways. Proc Natl Acad Sci U S A, 104, 5895-900. 
STORM, A. L., JOHNSON, J. M., LAMMER, E., GREEN, G. E. & CUNNIFF, C. 2005. 
Auriculo-condylar syndrome is associated with highly variable ear 
and mandibular defects in multiple kindreds. Am J Med Genet A, 138A, 
141-5. 
STORM, E. E., RUBENSTEIN, J. L. & MARTIN, G. R. 2003. Dosage of Fgf8 
determines whether cell survival is positively or negatively regulated 
in the developing forebrain. Proc Natl Acad Sci U S A, 100, 1757-62. 
STRICKER, S., FUNDELE, R., VORTKAMP, A. & MUNDLOS, S. 2002. Role of 
Runx genes in chondrocyte differentiation. Dev Biol, 245, 95-108. 
SU, N., SUN, Q., LI, C., LU, X., QI, H., CHEN, S., YANG, J., DU, X., ZHAO, L., HE, Q., 
JIN, M., SHEN, Y., CHEN, D. & CHEN, L. 2010a. Gain-of-function 
mutation in FGFR3 in mice leads to decreased bone mass by affecting 
 196 
both osteoblastogenesis and osteoclastogenesis. Hum Mol Genet, 19, 
1199-210. 
SU, N., XU, X., LI, C., HE, Q., ZHAO, L., LI, C., CHEN, S., LUO, F., YI, L., DU, X., 
HUANG, H., DENG, C. & CHEN, L. 2010b. Generation of Fgfr3 
conditional knockout mice. Int J Biol Sci, 6, 327-32. 
SU, X., DRISCOLL, K., YAO, G., RAED, A., WU, M., BEALES, P. L. & ZHOU, J. 2014. 
Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary 
trafficking of polycystic kidney disease 1 protein. Hum Mol Genet, 23, 
5441-51. 
SUGITO, H., SHIBUKAWA, Y., KINUMATSU, T., YASUDA, T., NAGAYAMA, M., 
YAMADA, S., MINUGH-PURVIS, N., PACIFICI, M. & KOYAMA, E. 2011. 
Ihh signaling regulates mandibular symphysis development and 
growth. J Dent Res, 90, 625-31. 
SUH, Y. J., BAE, H. S., CHOI, J. Y., LEE, J. H., KIM, M. J., KIM, S., RYOO, H. M. & 
BAEK, S. H. 2014. A novel FGFR2 mutation in tyrosine kinase II 
domain, L617F, in Crouzon syndrome. J Cell Biochem, 115, 102-10. 
SUMMERS, J., LUDWIG, J. & KANZE, D. 2014. Pierre robin sequence in a 
neonate with suckling difficulty and weight loss. J Am Osteopath Assoc, 
114, 727-31. 
SZABO-ROGERS, H. L., GEETHA-LOGANATHAN, P., NIMMAGADDA, S., FU, K. 
K. & RICHMAN, J. M. 2008. FGF signals from the nasal pit are 
necessary for normal facial morphogenesis. Dev Biol, 318, 289-302. 
TABLER, J. M., BARRELL, W. B., SZABO-ROGERS, H. L., HEALY, C., YEUNG, Y., 
PERDIGUERO, E. G., SCHULZ, C., YANNAKOUDAKIS, B. Z., MESBAHI, A., 
WLODARCZYK, B., GEISSMANN, F., FINNELL, R. H., WALLINGFORD, J. 
B. & LIU, K. J. 2013. Fuz Mutant Mice Reveal Shared Mechanisms 
between Ciliopathies and FGF-Related Syndromes. Dev Cell, 25, 623-
35. 
TALMAGE, R. V. 1970. Morphological and physiological considerations in a 
new concept of calcium transport in bone. Am J Anat, 129, 467-76. 
TAM, P. P. & TRAINOR, P. A. 1994. Specification and segmentation of the 
paraxial mesoderm. Anat Embryol (Berl), 189, 275-305. 
TANAKA, K., KITAGAWA, Y. & KADOWAKI, T. 2002. Drosophila segment 
polarity gene product porcupine stimulates the posttranslational N-
glycosylation of wingless in the endoplasmic reticulum. J Biol Chem, 
277, 12816-23. 
TANIMOTO, Y., VEISTINEN, L., ALAKURTTI, K., TAKATALO, M. & RICE, D. P. 
2012. Prevention of premature fusion of calvarial suture in GLI-
Kruppel family member 3 (Gli3)-deficient mice by removing one 
allele of Runt-related transcription factor 2 (Runx2). J Biol Chem, 287, 
21429-38. 
TAO, Q., YOKOTA, C., PUCK, H., KOFRON, M., BIRSOY, B., YAN, D., ASASHIMA, 
M., WYLIE, C. C., LIN, X. & HEASMAN, J. 2005. Maternal wnt11 
activates the canonical wnt signaling pathway required for axis 
formation in Xenopus embryos. Cell, 120, 857-71. 
TARTAGLIA, M., KALIDAS, K., SHAW, A., SONG, X., MUSAT, D. L., VAN DER 
BURGT, I., BRUNNER, H. G., BERTOLA, D. R., CROSBY, A., ION, A., 
KUCHERLAPATI, R. S., JEFFERY, S., PATTON, M. A. & GELB, B. D. 2002. 
PTPN11 mutations in Noonan syndrome: molecular spectrum, 
genotype-phenotype correlation, and phenotypic heterogeneity. Am J 
Hum Genet, 70, 1555-63. 
 197 
TAVELLA, S., BITICCHI, R., SCHITO, A., MININA, E., DI MARTINO, D., PAGANO, 
A., VORTKAMP, A., HORTON, W. A., CANCEDDA, R. & GAROFALO, S. 
2004. Targeted expression of SHH affects chondrocyte differentiation, 
growth plate organization, and Sox9 expression. J Bone Miner Res, 19, 
1678-88. 
TAVORMINA, P. L., SHIANG, R., THOMPSON, L. M., ZHU, Y. Z., WILKIN, D. J., 
LACHMAN, R. S., WILCOX, W. R., RIMOIN, D. L., COHN, D. H. & 
WASMUTH, J. J. 1995. Thanatophoric dysplasia (types I and II) caused 
by distinct mutations in fibroblast growth factor receptor 3. Nat 
Genet, 9, 321-8. 
TE WELSCHER, P., FERNANDEZ-TERAN, M., ROS, M. A. & ZELLER, R. 2002a. 
Mutual genetic antagonism involving GLI3 and dHAND prepatterns 
the vertebrate limb bud mesenchyme prior to SHH signaling. Genes 
Dev, 16, 421-6. 
TE WELSCHER, P., ZUNIGA, A., KUIJPER, S., DRENTH, T., GOEDEMANS, H. J., 
MEIJLINK, F. & ZELLER, R. 2002b. Progression of vertebrate limb 
development through SHH-mediated counteraction of GLI3. Science, 
298, 827-30. 
TIAN, G., ZHOU, Y., HAJKOVA, D., MIYAGI, M., DINCULESCU, A., HAUSWIRTH, 
W. W., PALCZEWSKI, K., GENG, R., ALAGRAMAM, K. N., ISOSOMPPI, J., 
SANKILA, E. M., FLANNERY, J. G. & IMANISHI, Y. 2009. Clarin-1, 
encoded by the Usher Syndrome III causative gene, forms a 
membranous microdomain: possible role of clarin-1 in organizing the 
actin cytoskeleton. J Biol Chem, 284, 18980-93. 
TISSIER-SETA, J. P., MUCCHIELLI, M. L., MARK, M., MATTEI, M. G., GORIDIS, C. 
& BRUNET, J. F. 1995. Barx1, a new mouse homeodomain 
transcription factor expressed in cranio-facial ectomesenchyme and 
the stomach. Mech Dev, 51, 3-15. 
TOBIN, J. L. & BEALES, P. L. 2007. Bardet-Biedl syndrome: beyond the cilium. 
Pediatr Nephrol, 22, 926-36. 
TOBIN, J. L., DI FRANCO, M., EICHERS, E., MAY-SIMERA, H., GARCIA, M., YAN, 
J., QUINLAN, R., JUSTICE, M. J., HENNEKAM, R. C., BRISCOE, J., TADA, 
M., MAYOR, R., BURNS, A. J., LUPSKI, J. R., HAMMOND, P. & BEALES, P. 
L. 2008. Inhibition of neural crest migration underlies craniofacial 
dysmorphology and Hirschsprung's disease in Bardet-Biedl 
syndrome. Proc Natl Acad Sci U S A, 105, 6714-9. 
TOLEDO, C., NAVARRO-BARROS, R., ALBA, L. & MUNOZ, E. 1999. Kyphomelic 
dysplasia: a report of a family with an autosomal dominant pattern. 
Ann Genet, 42, 170-3. 
TOMO, S., OGITA, M. & TOMO, I. 1997. Development of mandibular cartilages 
in the rat. Anat Rec, 249, 233-9. 
TRAINOR, P. A. 2005. Specification and patterning of neural crest cells 
during craniofacial development. Brain Behav Evol, 66, 266-80. 
TREVISAN, R. A. & SCAPINO, R. P. 1976. Secondary cartilages in growth and 
development of the symphysis menti in the hamster. Acta Anat 
(Basel), 94, 40-58. 
TRICHILIS, A. & WROBLEWSKI, J. 1997. Expression of p53 and hsp70 in 
relation to apoptosis during Meckel's cartilage development in the 
mouse. Anat Embryol (Berl), 196, 107-13. 
TRUMPP, A., DEPEW, M. J., RUBENSTEIN, J. L., BISHOP, J. M. & MARTIN, G. R. 
1999. Cre-mediated gene inactivation demonstrates that FGF8 is 
 198 
required for cell survival and patterning of the first branchial arch. 
Genes Dev, 13, 3136-48. 
TUCKER, A. & SHARPE, P. 2004. The cutting-edge of mammalian 
development; how the embryo makes teeth. Nat Rev Genet, 5, 499-
508. 
TUCKER, A. S., MATTHEWS, K. L. & SHARPE, P. T. 1998. Transformation of 
tooth type induced by inhibition of BMP signaling. Science, 282, 1136-
8. 
TUCKER, A. S., YAMADA, G., GRIGORIOU, M., PACHNIS, V. & SHARPE, P. T. 
1999. Fgf-8 determines rostral-caudal polarity in the first branchial 
arch. Development, 126, 51-61. 
TUKACHINSKY, H., LOPEZ, L. V. & SALIC, A. 2010. A mechanism for 
vertebrate Hedgehog signaling: recruitment to cilia and dissociation 
of SuFu-Gli protein complexes. J Cell Biol, 191, 415-28. 
TURKSEN, Z., OZAKPINAR, H. R. & TELLIOGLU, A. T. 2012. A case of 
syngnathia, cleft palate and hypospadias: an isolated case or 
syndromic syngnathism? J Craniomaxillofac Surg, 40, 8-10. 
TURNER, N. & GROSE, R. 2010. Fibroblast growth factor signalling: from 
development to cancer. Nat Rev Cancer, 10, 116-29. 
TUSON, M., HE, M. & ANDERSON, K. V. 2011. Protein kinase A acts at the 
basal body of the primary cilium to prevent Gli2 activation and 
ventralization of the mouse neural tube. Development, 138, 4921-30. 
UNDEN, A. B., HOLMBERG, E., LUNDH-ROZELL, B., STAHLE-BACKDAHL, M., 
ZAPHIROPOULOS, P. G., TOFTGARD, R. & VORECHOVSKY, I. 1996. 
Mutations in the human homologue of Drosophila patched (PTCH) in 
basal cell carcinomas and the Gorlin syndrome: different in vivo 
mechanisms of PTCH inactivation. Cancer Res, 56, 4562-5. 
VAN ALLEN, M. I., KALOUSEK, D. K., CHERNOFF, G. F., JURILOFF, D., HARRIS, 
M., MCGILLIVRAY, B. C., YONG, S. L., LANGLOIS, S., MACLEOD, P. M., 
CHITAYAT, D. & ET AL. 1993. Evidence for multi-site closure of the 
neural tube in humans. Am J Med Genet, 47, 723-43. 
VAN DER MERWE, A. E., WESTON, D. A., OOSTRA, R. J. & MAAT, G. J. 2013. A 
review of the embryological development and associated 
developmental abnormalities of the sternum in the light of a rare 
palaeopathological case of sternal clefting. Homo, 64, 129-41. 
VEISTINEN, L., TAKATALO, M., TANIMOTO, Y., KESPER, D. A., VORTKAMP, A. 
& RICE, D. P. 2012. Loss-of-Function of Gli3 in Mice Causes Abnormal 
Frontal Bone Morphology and Premature Synostosis of the 
Interfrontal Suture. Front Physiol, 3, 121. 
VELAND, I. R., AWAN, A., PEDERSEN, L. B., YODER, B. K. & CHRISTENSEN, S. 
T. 2009. Primary cilia and signaling pathways in mammalian 
development, health and disease. Nephron Physiol, 111, p39-53. 
VITELLI, F., LINDSAY, E. A. & BALDINI, A. 2002. Genetic dissection of the 
DiGeorge syndrome phenotype. Cold Spring Harb Symp Quant Biol, 67, 
327-32. 
VOGEL, A., RODRIGUEZ, C. & IZPISUA-BELMONTE, J. C. 1996. Involvement of 
FGF-8 in initiation, outgrowth and patterning of the vertebrate limb. 
Development, 122, 1737-50. 
VORTKAMP, A., GESSLER, M. & GRZESCHIK, K. H. 1991. GLI3 zinc-finger gene 
interrupted by translocations in Greig syndrome families. Nature, 
352, 539-40. 
 199 
VYAS, N., GOSWAMI, D., MANONMANI, A., SHARMA, P., RANGANATH, H. A., 
VIJAYRAGHAVAN, K., SHASHIDHARA, L. S., SOWDHAMINI, R. & 
MAYOR, S. 2008. Nanoscale organization of hedgehog is essential for 
long-range signaling. Cell, 133, 1214-27. 
WALLIN, J., WILTING, J., KOSEKI, H., FRITSCH, R., CHRIST, B. & BALLING, R. 
1994. The role of Pax-1 in axial skeleton development. Development, 
120, 1109-21. 
WALLINGFORD, J. B. 2006. Planar cell polarity, ciliogenesis and neural tube 
defects. Hum Mol Genet, 15 Spec No 2, R227-34. 
WALLINGFORD, J. B. & HARLAND, R. M. 2002. Neural tube closure requires 
Dishevelled-dependent convergent extension of the midline. 
Development, 129, 5815-25. 
WANG, B., FALLON, J. F. & BEACHY, P. A. 2000. Hedgehog-regulated 
processing of Gli3 produces an anterior/posterior repressor gradient 
in the developing vertebrate limb. Cell, 100, 423-34. 
WANG, E. A., ROSEN, V., D'ALESSANDRO, J. S., BAUDUY, M., CORDES, P., 
HARADA, T., ISRAEL, D. I., HEWICK, R. M., KERNS, K. M., LAPAN, P. & 
ET AL. 1990. Recombinant human bone morphogenetic protein 
induces bone formation. Proc Natl Acad Sci U S A, 87, 2220-4. 
WANG, J., MARK, S., ZHANG, X., QIAN, D., YOO, S. J., RADDE-GALLWITZ, K., 
ZHANG, Y., LIN, X., COLLAZO, A., WYNSHAW-BORIS, A. & CHEN, P. 
2005a. Regulation of polarized extension and planar cell polarity in 
the cochlea by the vertebrate PCP pathway. Nat Genet, 37, 980-5. 
WANG, Q., GREEN, R. P., ZHAO, G. & ORNITZ, D. M. 2001. Differential 
regulation of endochondral bone growth and joint development by 
FGFR1 and FGFR3 tyrosine kinase domains. Development, 128, 3867-
76. 
WANG, Y. & NATHANS, J. 2007. Tissue/planar cell polarity in vertebrates: 
new insights and new questions. Development, 134, 647-58. 
WANG, Y., SPATZ, M. K., KANNAN, K., HAYK, H., AVIVI, A., GORIVODSKY, M., 
PINES, M., YAYON, A., LONAI, P. & GIVOL, D. 1999. A mouse model for 
achondroplasia produced by targeting fibroblast growth factor 
receptor 3. Proc Natl Acad Sci U S A, 96, 4455-60. 
WANG, Y., XIAO, R., YANG, F., KARIM, B. O., IACOVELLI, A. J., CAI, J., LERNER, 
C. P., RICHTSMEIER, J. T., LESZL, J. M., HILL, C. A., YU, K., ORNITZ, D. M., 
ELISSEEFF, J., HUSO, D. L. & JABS, E. W. 2005b. Abnormalities in 
cartilage and bone development in the Apert syndrome 
FGFR2(+/S252W) mouse. Development, 132, 3537-48. 
WANG, Y., ZHOU, Z., WALSH, C. T. & MCMAHON, A. P. 2009. Selective 
translocation of intracellular Smoothened to the primary cilium in 
response to Hedgehog pathway modulation. Proc Natl Acad Sci U S A, 
106, 2623-8. 
WATERS, A. M. & BEALES, P. L. 2011. Ciliopathies: an expanding disease 
spectrum. Pediatr Nephrol, 26, 1039-56. 
WEATHERBEE, S. D., NISWANDER, L. A. & ANDERSON, K. V. 2009. A mouse 
model for Meckel syndrome reveals Mks1 is required for ciliogenesis 
and Hedgehog signaling. Hum Mol Genet, 18, 4565-75. 
WEBSTER, M. K. & DONOGHUE, D. J. 1996. Constitutive activation of 
fibroblast growth factor receptor 3 by the transmembrane domain 
point mutation found in achondroplasia. EMBO J, 15, 520-7. 
 200 
WEN, X., LAI, C. K., EVANGELISTA, M., HONGO, J. A., DE SAUVAGE, F. J. & 
SCALES, S. J. 2010. Kinetics of hedgehog-dependent full-length Gli3 
accumulation in primary cilia and subsequent degradation. Mol Cell 
Biol, 30, 1910-22. 
WIJGERDE, M., MCMAHON, J. A., RULE, M. & MCMAHON, A. P. 2002. A direct 
requirement for Hedgehog signaling for normal specification of all 
ventral progenitor domains in the presumptive mammalian spinal 
cord. Genes Dev, 16, 2849-64. 
WILKIE, A. O. 1997. Craniosynostosis: genes and mechanisms. Hum Mol 
Genet, 6, 1647-56. 
WILKIE, A. O. & MORRISS-KAY, G. M. 2001. Genetics of craniofacial 
development and malformation. Nat Rev Genet, 2, 458-68. 
WILKIE, A. O., PATEY, S. J., KAN, S. H., VAN DEN OUWELAND, A. M. & HAMEL, 
B. C. 2002. FGFs, their receptors, and human limb malformations: 
clinical and molecular correlations. Am J Med Genet, 112, 266-78. 
WILKIE, A. O., SLANEY, S. F., OLDRIDGE, M., POOLE, M. D., ASHWORTH, G. J., 
HOCKLEY, A. D., HAYWARD, R. D., DAVID, D. J., PULLEYN, L. J., 
RUTLAND, P. & ET AL. 1995. Apert syndrome results from localized 
mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet, 
9, 165-72. 
WILLERT, K., BROWN, J. D., DANENBERG, E., DUNCAN, A. W., WEISSMAN, I. 
L., REYA, T., YATES, J. R., 3RD & NUSSE, R. 2003. Wnt proteins are 
lipid-modified and can act as stem cell growth factors. Nature, 423, 
448-52. 
WISE, G. E., LUMPKIN, S. J., HUANG, H. & ZHANG, Q. 2000. Osteoprotegerin 
and osteoclast differentiation factor in tooth eruption. J Dent Res, 79, 
1937-42. 
XIAO, G., JIANG, D., GE, C., ZHAO, Z., LAI, Y., BOULES, H., PHIMPHILAI, M., 
YANG, X., KARSENTY, G. & FRANCESCHI, R. T. 2005. Cooperative 
interactions between activating transcription factor 4 and 
Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene 
expression. J Biol Chem, 280, 30689-96. 
XIONG, W., HE, F., MORIKAWA, Y., YU, X., ZHANG, Z., LAN, Y., JIANG, R., 
CSERJESI, P. & CHEN, Y. 2009. Hand2 is required in the epithelium for 
palatogenesis in mice. Dev Biol, 330, 131-41. 
XU, J., LAWSHE, A., MACARTHUR, C. A. & ORNITZ, D. M. 1999. Genomic 
structure, mapping, activity and expression of fibroblast growth 
factor 17. Mech Dev, 83, 165-78. 
XU, X., WEINSTEIN, M., LI, C., NASKI, M., COHEN, R. I., ORNITZ, D. M., LEDER, 
P. & DENG, C. 1998. Fibroblast growth factor receptor 2 (FGFR2)-
mediated reciprocal regulation loop between FGF8 and FGF10 is 
essential for limb induction. Development, 125, 753-65. 
YAMAGISHI, C., YAMAGISHI, H., MAEDA, J., TSUCHIHASHI, T., IVEY, K., HU, T. 
& SRIVASTAVA, D. 2006. Sonic hedgehog is essential for first 
pharyngeal arch development. Pediatr Res, 59, 349-54. 
YAMASHITA, S., ANDOH, M., UENO-KUDOH, H., SATO, T., MIYAKI, S. & 
ASAHARA, H. 2009. Sox9 directly promotes Bapx1 gene expression to 
repress Runx2 in chondrocytes. Exp Cell Res, 315, 2231-40. 
YAMAZAKI, K., SUDA, N. & KURODA, T. 1997. Immunohistochemical 
localization of parathyroid hormone-related protein in developing 
mouse Meckel's cartilage and mandible. Arch Oral Biol, 42, 787-94. 
 201 
YANAGISAWA, H., CLOUTHIER, D. E., RICHARDSON, J. A., CHARITE, J. & 
OLSON, E. N. 2003. Targeted deletion of a branchial arch-specific 
enhancer reveals a role of dHAND in craniofacial development. 
Development, 130, 1069-78. 
YANAGISAWA, H., YANAGISAWA, M., KAPUR, R. P., RICHARDSON, J. A., 
WILLIAMS, S. C., CLOUTHIER, D. E., DE WIT, D., EMOTO, N. & 
HAMMER, R. E. 1998. Dual genetic pathways of endothelin-mediated 
intercellular signaling revealed by targeted disruption of endothelin 
converting enzyme-1 gene. Development, 125, 825-36. 
YANG, R. T., ZHANG, C., LIU, Y., ZHOU, H. H. & LI, Z. B. 2012. Autophagy prior 
to chondrocyte cell death during the degeneration of Meckel's 
cartilage. Anat Rec (Hoboken), 295, 734-41. 
YANG, T., BASSUK, A. G. & FRITZSCH, B. 2013. Prickle1 stunts limb growth 
through alteration of cell polarity and gene expression. Dev Dyn, 242, 
1293-306. 
YANNAKOUDAKIS, B. Z. & LIU, K. J. 2013. Common skeletal features in rare 
diseases: New links between ciliopathies and FGF-related syndromes. 
Rare dis, 1:e27109 
YASHIRO, K., ZHAO, X., UEHARA, M., YAMASHITA, K., NISHIJIMA, M., 
NISHINO, J., SAIJOH, Y., SAKAI, Y. & HAMADA, H. 2004. Regulation of 
retinoic acid distribution is required for proximodistal patterning 
and outgrowth of the developing mouse limb. Dev Cell, 6, 411-22. 
YBOT-GONZALEZ, P., SAVERY, D., GERRELLI, D., SIGNORE, M., MITCHELL, C. 
E., FAUX, C. H., GREENE, N. D. & COPP, A. J. 2007. Convergent 
extension, planar-cell-polarity signalling and initiation of mouse 
neural tube closure. Development, 134, 789-99. 
YEH, B. K., IGARASHI, M., ELISEENKOVA, A. V., PLOTNIKOV, A. N., SHER, I., 
RON, D., AARONSON, S. A. & MOHAMMADI, M. 2003. Structural basis 
by which alternative splicing confers specificity in fibroblast growth 
factor receptors. Proc Natl Acad Sci U S A, 100, 2266-71. 
YODER, B. K. 2007. Role of primary cilia in the pathogenesis of polycystic 
kidney disease. J Am Soc Nephrol, 18, 1381-8. 
YONEI-TAMURA, S., ENDO, T., YAJIMA, H., OHUCHI, H., IDE, H. & TAMURA, K. 
1999. FGF7 and FGF10 directly induce the apical ectodermal ridge in 
chick embryos. Dev Biol, 211, 133-43. 
YOUNG, I. D. 1989. Cranioectodermal dysplasia (Sensenbrenner's syndrome). 
J Med Genet, 26, 393-6. 
ZENG, X., GOETZ, J. A., SUBER, L. M., SCOTT, W. J., JR., SCHREINER, C. M. & 
ROBBINS, D. J. 2001. A freely diffusible form of Sonic hedgehog 
mediates long-range signalling. Nature, 411, 716-20. 
ZHANG, X., IBRAHIMI, O. A., OLSEN, S. K., UMEMORI, H., MOHAMMADI, M. & 
ORNITZ, D. M. 2006. Receptor specificity of the fibroblast growth 
factor family. The complete mammalian FGF family. J Biol Chem, 281, 
15694-700. 
ZHANG, Z., WLODARCZYK, B. J., NIEDERREITHER, K., VENUGOPALAN, S., 
FLOREZ, S., FINNELL, R. H. & AMENDT, B. A. 2011. Fuz regulates 
craniofacial development through tissue specific responses to 
signaling factors. PLoS One, 6, e24608. 
ZHOU, G., GAROFALO, S., MUKHOPADHYAY, K., LEFEBVRE, V., SMITH, C. N., 
EBERSPAECHER, H. & DE CROMBRUGGHE, B. 1995. A 182 bp 
fragment of the mouse pro alpha 1(II) collagen gene is sufficient to 
 202 
direct chondrocyte expression in transgenic mice. J Cell Sci, 108 ( Pt 
12), 3677-84. 
ZHOU, G., ZHENG, Q., ENGIN, F., MUNIVEZ, E., CHEN, Y., SEBALD, E., KRAKOW, 
D. & LEE, B. 2006. Dominance of SOX9 function over RUNX2 during 
skeletogenesis. Proc Natl Acad Sci U S A, 103, 19004-9. 
ZHOU, Y. X., XU, X., CHEN, L., LI, C., BRODIE, S. G. & DENG, C. X. 2000. A 
Pro250Arg substitution in mouse Fgfr1 causes increased expression 
of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet, 9, 
2001-8. 
ZHU, J., GARRETT, R., JUNG, Y., ZHANG, Y., KIM, N., WANG, J., JOE, G. J., 
HEXNER, E., CHOI, Y., TAICHMAN, R. S. & EMERSON, S. G. 2007. 
Osteoblasts support B-lymphocyte commitment and differentiation 
from hematopoietic stem cells. Blood, 109, 3706-12. 
ZILBER, Y., BABAYEVA, S., SEO, J. H., LIU, J. J., MOOTIN, S. & TORBAN, E. 2013. 
The PCP effector Fuzzy controls cilial assembly and signaling by 
recruiting Rab8 and Dishevelled to the primary cilium. Mol Biol Cell, 
24, 555-65. 
ZUNIGA, A. & ZELLER, R. 1999. Gli3 (Xt) and formin (ld) participate in the 
positioning of the polarising region and control of posterior limb-bud 





Chapter 9 Appendix 
Developmental Cell
Article
FuzMutant Mice Reveal Shared Mechanisms
between Ciliopathies and FGF-Related Syndromes
Jacqueline M. Tabler,1,6 William B. Barrell,1 Heather L. Szabo-Rogers,1,5,7 Christopher Healy,1,5 Yvonne Yeung,1
Elisa Gomez Perdiguero,2 Christian Schulz,2 Basil Z. Yannakoudakis,1 Aida Mesbahi,1 Bogdan Wlodarczyk,3
Frederic Geissmann,2 Richard H. Finnell,3 John B. Wallingford,4 and Karen J. Liu1,*
1Department of Craniofacial Development and Stem Cell Biology, Dental Institute
2Centre for the Cellular and Molecular Biology of Inflammation
King’s College London, London SE1 9RT, UK
3Dell Pediatric Research Institute, Departments of Nutritional Sciences, Chemistry, and Biochemistry, The University of Texas at Austin,
Austin, TX 78723, USA
4Howard Hughes Medical Institute and Section of Molecular Cell and Developmental Biology and Institute for Cellular andMolecular Biology,
The University of Texas at Austin, Austin, TX 78712, USA
5These authors contributed equally to this work
6Present address: Section of Molecular Cell and Developmental Biology, University of Texas, Austin, TX 78712, USA





craniofacial dysmorphology as a common feature.
Among these is high arched palate, a condition that
affects speech andquality of life. Using the ciliopathic
Fuz mutant mouse, we find that high arched palate
does not, as commonly suggested, arise from mid-
face hypoplasia. Rather, increased neural crest ex-
pands the maxillary primordia. In Fuz mutants, this
phenotype stems from dysregulated Gli processing,
which in turn results in excessive craniofacial Fgf8
gene expression. Accordingly, genetic reduction of
Fgf8 ameliorates the maxillary phenotypes. Similar
phenotypes result from mutation of oral-facial-digital
syndrome 1 (Ofd1), suggesting that aberrant tran-
scription of Fgf8 is a common feature of ciliopathies.
High arched palate is also a prevalent feature of fibro-
blast growth factor (FGF) hyperactivation syndromes.
Thus, our findings elucidate the etiology for a com-
mon craniofacial anomaly and identify links between
two classes of human disease: FGF-hyperactivation
syndromes and ciliopathies.
INTRODUCTION
Craniofacial dysmorphology is a common component of the cili-
opathy disease spectrum, but while defective neural crest (NC)
cell migration has been implicated in Bardet-Biedl Syndrome
(BBS) (Tobin et al., 2008), little else is known about the underlying
developmental processes in ciliopathy-associated craniofacial
defects. Among the more consistent craniofacial phenotypes in
ciliopathies is the presence of a high arched palate (Beales
et al., 1999). In this condition, the palate is characterized by a
pronounced median groove, but the roof of the mouth remains
intact across the midline. This condition is often referred to as
a ‘‘pseudo-cleft.’’ Later in life, a high arched palate is also asso-
ciated with secondary dental anomalies, such as postnatal
gingival swelling and crowding of the molars. These defects
can impair speech and complicate intubation, a major concern
for craniofacial patients who frequently requiremultiple surgeries
during childhood. Thus, high arched palate has a significant
impact on patients’ quality of life.
The etiology of high arched palate remains obscure. One long-
held hypothesis proposes that the arch arises from a midface
hypoplasia causing insufficient maxillary growth and subsequent
compression of the upper dental arch (Hennekam et al., 2010;
Kreiborg and Cohen, 1992; Slaney et al., 1996). However, recent
morphometric analyses suggest that this may not be true (Martı´-
nez-Abadı´as et al., 2010). Although a chemically induced rat
model has existed for several decades, the embryological pro-
gression of the phenotype is unknown (Lorente et al., 1981). Sur-
prisingly, no genetic model of high arched palate has yet been
reported, so the underlying cellular and anatomical causes
remain unknown and developmental hypotheses are untested.
Clinical observations also complicate our picture of high
arched palate, as this defect is associated with a variety of seem-
ingly unrelated syndromes (Hayward et al., 2004; Hennekam
et al., 2010; Kreiborg and Cohen, 1992; Vadiati Saberi and Sha-
koorpour, 2011). For example, though rarely mentioned in the
literature, high arched palate is a central feature in many ciliopa-
thies, including BBS, oral-facial-digital syndromes (OFD types I
and IV), Joubert syndrome, and Sensenbrenner syndrome
(Beales et al., 1999; Hennekam et al., 2010; Moore et al., 2005;
Prattichizzo et al., 2008; Sensenbrenner et al., 1975; Somlo
et al., 1993). In fact, 88% of BBS patients present with high
arched palate, and many also display associated dental crowd-
ing and soft tissue swellings (Beales et al., 1999). High arched
palate is also consistently observed in an array of syndromes
characterized by dysregulation of fibroblast growth factor
(FGF) signaling or downstream components such as the Ras ki-
nase (Goodwin et al., 2012). Examples include Apert, Crouzon,
Muenke, and cardio-facio-cutaneous syndromes (Agochukwu
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et al., 2012; Berkowitz, 1971; Hennekam et al., 2010; Kreiborg
and Cohen, 1992; Letra et al., 2007; Rynearson, 2000; Vadiati
Saberi and Shakoorpour, 2011). This finding is curious, because
while FGF signals have been implicated in controlling cilium
length (Hong and Dawid, 2009; Neugebauer et al., 2009), there
has been no evidence to date suggesting a link between FGF
dysregulation syndromes and the ciliopathies.
To characterize ciliopathic craniofacial defects, we examined
mice with a mutation in the gene encoding Fuzzy (Fuz), which
has recently emerged as a key regulator of ciliogenesis (Gray
et al., 2009; Park et al., 2006). Initially described as a Drosophila
planar cell polarity effector gene (Collier and Gubb, 1997),
studies in both Xenopus and mice identified Fuz as a central
regulator of vertebrate ciliogenesis (Brooks and Wallingford,
2012; Gray et al., 2009; Park et al., 2006). Consistent with the
key role of cilia in Hedgehog (Hh) signaling, disruption of Fuz
affects Hedgehog-dependent patterning events in both frogs
and mice (Gray et al., 2009; Park et al., 2006), and in mice, loss
of Fuz has been shown directly to disrupt the processing of
Gli3 (Heydeck et al., 2009). Recently, live imaging analyses re-
vealed that Fuz is essential for normal trafficking of the retro-
grade intraflagellar transport (IFT) machinery in vertebrate cilia;
when Fuz is depleted, localization of IFT-A proteins, such as
IFT43, is disrupted (Brooks and Wallingford, 2012). As a conse-
quence, IFT trains become stalled, leading to shortened cilia and
impaired signal transduction. Finally, Fuz is of particular interest
because it is mutated in human patients with birth defects (Seo
et al., 2011) and because Fuz mutant mice display a variety of
craniofacial phenotypes (Zhang et al., 2011).
Here, we present the Fuz mutant mouse as a useful genetic
model for the study of high arched palate. Although current
Figure 1. Fuz Mutant Mice Are a Model for
High Arched Palate
(A and B) Ventral views of E17.5 palates. Mutants
exhibit a narrow palate (arrowheads) and dis-
rupted rugal organization compared to littermates.
(C and D) Sirius red/alcian blue staining of E17.5
coronal sections. Bilateral palatine bones are
formed in both control and mutant, abutting at the
midline (black). Mutant palatine bones (Pb) are
mediolaterally shortened with an increase in the
ventral extension. Note enlarged palatal mesen-
chyme (P). Molars (M) appear normal.
(C0 and D0) Schematics depicting skewed palatal
anatomy.
(E–J) Hemotoxylin and eosin staining of coronal
sections at indicated stages.
(E0–J0) Schematics of sections identifying palatal
mesenchyme (gray, P), molars (blue and purple,
M), and palatal bone condensations (red, Pb). In
(H) through (J0 ), mutant palatal condensations are
medially constrained and do not extend into the
oral cavity. Palatine bone can be observed in both
mutants and controls by E16.5.
See also Figure S1.
hypotheses suggest that high arched pal-
ate arises from constriction of the upper
jaw (Hennekam et al., 2010), our data
demonstrate that the primary cause of cil-
iopathic high arched palate is instead excessive NC producing an
enlarged first branchial arch (BA1) andmaxillary hyperplasia early
in embryogenesis. We have also discovered a surprising mecha-
nistic basis for this phenotype, as we observed a dramatic
increase in FGF signaling due to increased cranial Fgf8 gene
expression. Genetic reduction of Fgf8 rescues the maxillary
defects in Fuzmutant mice. Finally, we observed a similar maxil-
lary expansion and upregulation of Fgf8 expression in another cili-
opathymousemodel,OFD-1 (Ferranteet al., 2006). Thus,wehave
identified dysregulation of FGF function as the cause of facial de-
fects in ciliopathic mutant mice, demonstrating etiological com-
monalities between two broad categories of human congenital
anomalies: the ciliopathies and the FGF-related syndromes.
RESULTS
Fuz Mutant Mice Are a Model of High Arched Palate
Fuz mutant mice appear to have a cleft secondary palate (Fig-
ures 1A and 1B); however, frontal sections revealed that the
palatal shelves were, in fact, not clefted (Figures 1C–1D0).
Instead, in all mutants analyzed, the palatine bones displayed
the classic inverted-V shape typical of a high arched palate
(Figures 1D–1D0). Palatal narrowing and palatine bone defects
were observed throughout the anterior-posterior extent of the
secondary palate in mutants (Figure S1 available online). We
also observed expanded mesenchyme within the oral cavity
in Fuzmutant mice (Figure 1D, ‘‘P’’ in light blue area; Figure 1D0,
gray area). Thus, the maxillary phenotypes of Fuz mutant mice
bear a striking similarity to the high arched palate reported for
human ciliopathy patients (Beales et al., 1999; Hennekam et al.,
2010; Tagliani et al., 2010).
Developmental Cell
Fuz Mutation Links Ciliopathies and FGF Syndromes
624 Developmental Cell 25, 623–635, June 24, 2013 ª2013 Elsevier Inc.
The embryological events leading to high arched palate have
not been previously described, so we compared maxillary devel-
opment in a staged series of wild-type and Fuz/ littermates. In
controls, the palatal shelves developed bilaterally, growing and
extending ventrally into the oral cavity at E13.5 (Figures 1E
and 1E0). The palatal primordia were evident at the appropriate
stage in Fuz mutants but were displaced medially compared to
littermates and did not extend ventrally (Figures 1H and 1H0, out-
lined in gray). At E14.5, palatal condensations in controls
remained bilateral and were fully extended, flanking the tongue
(Figures 1F-1F0), with the palate fusing by E16.5 (Figures 1G
and 1G0). In mutants, however, the palatal condensations did
not extend and instead appeared as one contiguous domain
(Figures 1I–1J0). This medial shift of the palatal shelves was
also evident from Patched1 (Ptc1) expression, which spans
the midline (Figure S1A and S1B). Likewise, ossification of pala-
tine bones was apparent at E17.5 in controls, and in Fuzmutants
the palatine bones were displacedmedially (Figures 1D and 1D0).
Furthermore, analysis by microcomputed tomography (mCT)
revealed that the majority of midfacial bones are present and
ossifying. Though small and constrained, the mutant palatine
bones are roughly normal in shape (Figures S1M–S1M00). These
data raised the intriguing possibility that a recognizable palate
can form despite an initial failure of shelf outgrowth (Figures 1H
and 1H0).
Fuz Mutant Mice Displayed Enlarged Maxillary
Processes
When examined at earlier stages, we found that a largermaxillary
process was evident in Fuzmutants as early as E9.0 (Figures 2A
and 2B); by e9.5 the maxillary domain is substantially larger
(compare Figures 2C and 2E to Figures 2D and 2F). Cell numbers
were significantly increased in themaxilla, but there was no coin-
cident increase in mitotic cells or change in apoptosis (Figures
2G and 2H; data not shown). Overall, this developmental pro-
gression is strikingly divergent from that underlying traditional
cleft palates (Chai and Maxson, 2006), suggesting that the high
arched palate, though commonly referred to as a ‘‘pseudo-
cleft,’’ is unrelated to cleft palate and arises by a distinct devel-
opmental mechanism.
Disruption of Fuz Leads to Excessive NC
We next sought to better understand the developmental origin
of this defect. Because the maxillary process normally arises
from NC cells emanating from the posterior mesencephalon,
we lineage-traced the NC using a Wnt1-cre driver to follow
cell migration into BA1 (Figures 2A and 2B0 blue/lacZ; Figures
2I–2L green/green fluorescent protein [GFP]) (Danielian et al.,
1998; Muzumdar et al., 2007; Soriano, 1999). In Fuz mutants,
we observed an early expansion of cranial NC cells (Figures
2A and 2B). In Figure 2B, the rostral extent of this expansion
is marked by an asterisk. We also observed a general expansion
of midhindbrain streams (Figures 2A–2B0; note brackets in Fig-
ures 2A and 2B). Most strikingly, dorsal views of these embryos
revealed a substantial increase of labeled cells in BA1 and
the second branchial arch (BA2) (arrowheads, Figures 2A0
and 2B0). To confirm the increase in the NC, we isolated E9.25
cranial tissues from a reporter line expressing membrane GFP
(mT/mG) when crossed to the Wnt1-cre driver (schematic in
Figure 2O) (Danielian et al., 1998; Muzumdar et al., 2007). Using
flow cytometry, we analyzed Wnt1-cre induced GFP-positive
cells and found a significant increase in the proportion of NC
cells (summarized in Figure 2P; representative plot per geno-
type in Figure 2O). These experiments suggest that the
observed maxillary hyperplasia may stem from an excess of
NC cells.
Loss of Fuz Leads to Disorganized NC Migration
In addition to the significant increase in NC cell numbers, the
migration of the NC was disrupted in Fuz mutant mice. For
example, we frequently observed a large proportion of rostral
crest cells collecting ectopically in the optic cup regions (Fig-
ure 2B, arrowhead). To examine this at a cellular level, we utilized
membrane-bound GFP in Wnt1-cre; R26mT/mG embryos. Strik-
ingly, three-dimensional confocal imaging revealed that the
depth of the migratory streams was far greater in Fuz mutants
(79 ± 16 mmdeep inmutants versus 41 ± 20 mmdeep in wild-type
embryos; Figures 2K and 2L). This was surprising, as mesence-
phalic NC cells should remain adjacent to the epidermal ecto-
derm, avoiding the underlying mesenchyme (Noden, 1975).
Furthermore, we noted cells rostral to the trigeminal ganglion
in a region that should ordinarily be clear of NC cells (compare
Figure 2I0 to Figure 2J0).
We had previously shown that morpholino oligonucleotides
(MOs) were an effective means to block Fuz function in Xenopus
(Park et al., 2006). When we examined expression of Twist, a
migratory NC marker, following Fuz knockdown, we observed
aberrant migration of the anterior cranial crest (Figures 2M and
2N, arrowheads), consistent with the observed craniofacial
defects (Park et al., 2006). In many cases, we noted increased
and ectopic migration of the anterior NC into the eye field (Fig-
ure 2N, black arrowhead and inset). Together, these data sug-
gest that Fuz plays an evolutionarily conserved role in controlling
NC cell contributions to BA1.
Disruption of Cranial Hedgehog Signaling at Early
Stages in Fuz Mutant Mice
We next sought to understand the molecular basis of the maxil-
lary hyperplasia in Fuz mutant mice. Fuz controls ciliogenesis,
and cilia are central to proteolytic cleavage of Gli effector pro-
teins that transduce Hedgehog signals (Goetz and Anderson,
2010; Liu et al., 2005; Singla and Reiter, 2006). Indeed, loss of
Fuz leads to defective Hedgehog signaling in the spinal cord
and limb (Gray et al., 2009; Heydeck et al., 2009; Park et al.,
2006), and Heydeck et al. showed that, during patterning of
the limb, Fuz mutation leads to aberrant proteolytic processing
of Gli3 (Heydeck et al., 2009).
However, changes in palatal Hh signaling could not account
for the observed craniofacial phenotypes, as the Hh target
gene Ptc1 continues to be expressed in Fuz mutant palatal
primordia at E14.5 (Figures S1A–S1B0), and unlike the Fuzmuta-
tion, loss or gain of Hh activation in the palate leads to a true cleft
rather than an arched palate (Cobourne et al., 2009; Gritli-Linde
et al., 2007; Hu and Helms, 1999; Lan and Jiang, 2009; Mo et al.,
1997; Rice et al., 2004). Furthermore, Gli3 mutation also leads
to sporadic cleft palate due to obstruction by the tongue (Huang
et al., 2008). These data suggest that, if a Gli processing defect
is involved, it must occur prior to palate formation.
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Figure 2. Increase in NC in Maxillary Compartment
Wnt1-cre-driven LacZ (blue) or GFP (green) marks NC contributions.
(A and B) Lateral views of E9.25 embryos. BA1 and BA2NC streams are wider compared to controls (B compared to A, yellow bracket). Increased NC disrupts the
optic cup (OC) in Fuzmutants compared to controls (B compared to A, arrowhead). BA2NC stream is also increased in size and has failed tomigrate as far as BA2
control NC. Mx, maxillary compartment of BA1. OV, optic vesicle.
(A0 and B0) Dorsal views. Maxillary BA1 is enlarged compared to controls (B compared to A, top arrowhead). BA2 has failed to migrate sufficiently compared to
controls (bottom arrowhead).
(C and D) PH3 staining (green) and DAPI (blue) of E9.0, maxillary compartment. Mutant maxilla is enlarged (white dotted line).
(E and F) Coronal sections of E10.5Wnt1-cre; R26RmT/mG; Fuz+/+, orWnt1-cre; R26RmT/mG;Fuz/ maxillae.Wnt1-cre-driven membrane-GFP (green) marks NC
contributions. Epithelialmembrane-Tomato (red) highlightsall other tissuederivatives.Mutantmaxillae are larger compared to controls. Enlargedmaxillae comprise
NC-derived mesenchyme.
(G) Quantification of DAPI-positive cells from representative sections of E9.5 and 10.5 embryos. Note increase in cell number in mutant (red) maxilla compared to
wild-type (blue) (p < 0.004). Error bars indicate SD.
(H) Quantification of E9.5 maxillary PH3-positive cells compared to total cell number. A significant decrease in the percentage of PH3-positive cells is observed in
mutant maxillae (red) compared to controls (blue) (p < 0.01). Error bars indicate SD.
(I and J) Single confocal z-sections of Wnt1-cre; R26RmT/mG;Fuz+/+ or Wnt1-cre; R26RmT/mG;Fuz/ E9.5 embryos. Wnt1-cre-driven membrane-GFP (green)
marks NC contributions.
(I0–J0 ) Magnified maximum projections of (I) and (J), indicated by a white dotted box. In controls, chains of Wnt1-cre-driven membrane-GFP-positive NC are
observed (yellow arrowheads), with few isolated cells between brain and maxillary compartment (white arrowheads). Isolated NC cells are observed in mutant
embryos, indicated by a white arrowhead in (J0), and NC chains are disorganized.
(legend continued on next page)
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As it happens, Gli3 plays a crucial role in patterning the tissues
that give rise to NC destined for BA1 (Blaess et al., 2006). There-
fore, we assessed Hh signaling in the cranial regions of e9.0
embryos. We found a dramatic increase of full-length Gli3 in
our mutants and a concurrent decrease in the short repressor
form of Gli3 (Figure 3A). We also observed a reduction of Hh
target gene expression in cranial tissues (Figure 3B), which
may contribute to the observed NC defect.
Expanded FGF Expression in FuzMutants
We then considered molecular changes downstream of the early
Gli processing defects in Fuz/ mice. One possibility was that
(K and L) Z-projections of (I0 ) and (J0). The thickness of NC streams anterior to the prospective trigeminal ganglion is increased in mutants (WT = 41 ± 20 mm thick;
mutant = 79 ± 16 mm deep). The immediately underlying membrane-Tomato-positive mesenchymal cells are shown in red, at the bottom of the image. The
overlying epithelium is not included. Scale bar, 100 mm. This doubling in thickness is consistent with increased NC invasion into BA1.
(M and N) Twist in situ hybridization of stage 22 embryos injected unilaterally with FuzMO. In controls, Twist is expressed in three streams, where the anterior NC
stream surrounds the optic placode, indicated in (M) by open arrowhead and inset (bracket). Ectopic Twist expression is observed in the optic placode in Fuz
morphants, indicated in (N) by arrowhead and inset (bracket).
(O) Representative epifluorescence image of an E9Wnt1-cre; R26mT/mG embryo. Lineage-traced NC cells are labeled GFP (green), and nonrecombined cells are
Tomato positive (red). Dashed line illustrates where embryos were bisected caudal to BA1. Wnt1-cre; R26RmT/mG; Fuz+/+, or Wnt1-cre; R26RmT/mG;Fuz/
embryo heads were dissociated and GFP positive, Tomato, or double-labeled cells were analyzed by flow cytometry. Representative flow cytometry plots from
single E9 Wnt1-cre; R26mT/mG; Fuz+/+, or Wnt1-cre; R26RmT/mG;Fuz/ dissociated heads. mG, Wnt1-cre-driven membrane-GFP; mT, membrane-Tomato.
(P) The percentage of Wnt1-Cre-driven GFP-positive cells was significantly increased in mutants (79% ± 2%) compared to controls (68% ± 1%) (p = 0.0103).
Whiskers represent maximum/minimum data values with median and quartiles represented in the box.
Figure 3. Gli3 Processing and Hh and FGF
Signaling Are Altered in Fuz Mutants
(A) Western blot analysis of activator and
repressor forms of Gli3 (Gli3-L and Gli3-S,
respectively) in E9.0 embryos. Increased Gli3-L
and reduced Gli3-S was detected in Fuz/
embryos in (A), lanes 3–5, compared to controls
in (A), lanes 1 and 2. Alpha-tubulin was analyzed
as a loading control.
(B) qPCR of Hh target genes Patched 1 (Ptc1) and
Gli1 from E9.0 Fuz+/+ and Fuz/ heads. Relative
mRNA levels are normalized to b-actin. Ptc1 and
Gli1 are decreased in mutants (red) compared to
controls (blue). Whiskers represent maximum/
minimum data values with median and quartiles
represented in the box.
(C and D) Lateral views of Fgf8 expression in E9.0
embryos. Fgf8 is expressed in the midhindbrain
boundary (MHB), frontonasal prominence (FNP),
and the BA1 epithelium. In mutants, Fgf8 expres-
sion domains are expanded, indicated by bracket
and arrowheads.
(C0 and D0) Magnified view of BA1 in control and
mutant embryos. Dotted line indicates extent of
maxillary compartment. Note enlarged maxillary
prominence.
(E and F) Frontal view of Fgf8 expression in E10.5
embryos. Note mediolateral expansion of maxil-
lary Fgf8 expression in the mutant, indicated by
black arrowhead.
(G and H) Lateral views of Erm1mRNA expression
in E9.5 embryos. Erm1 is expressed in the MHB,
FNP, and BA1. In mutants, expression of Erm1 is
expanded ventrally from the MHB (yellow asterisk)
and in BA1 (yellow bracket).
(G0 and H0) Magnified view of BA1. Erm1 expres-
sion is increased in mutant maxillae (yellow
arrowheads).
(I and J) Lateral views of Pea3 expression in E9.5
embryos. Pea3 is expressed in theMHB, FNP, and
BA1. In mutants, expression of Pea3 is expanded
in BA1 (yellow bracket).
(I0 and J0) Magnified view of BA1 in control and
mutant embryos. Pea3 expression is increased in
mutant maxillae (yellow arrowhead).
See also Figure S2.
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loss of Fuz leads to upregulation ofWnt target genes (e.g., Zhang
et al., 2011); however, we found no changes in levels of activated
b-catenin at early stages (e9.0) in Fuz/ heads (data not shown).
Next, as mentioned, high arched palate is common in FGF
hyperactivation syndromes (Hajihosseini et al., 2001; Itoh and
Ornitz, 2011; Wilkie et al., 1995). While there is no link between
cilia and FGF signal transduction per se, loss of Gli3 can lead
to increased Fgf8 gene transcription, most obviously in the telen-
cephalon (Aoto et al., 2002; Blaess et al., 2006; Cordero et al.,
2004; Kuschel et al., 2003; Okada et al., 2008; Rash and Grove,
2007; Theil et al., 1999; Ueta et al., 2008). Indeed, a recent report
suggests that loss of cilia-dependent signaling can similarly
result in Fgf8 expansion during development of the corpus
callosum (Benadiba et al., 2012).
Therefore, we examined Fgf8 levels in Fuzmutants. Strikingly,
at E9.5, Fgf8 expression was significantly expanded in Fuz
mutants (Figures 3D and 3F), though there was minimal differ-
ence in mRNA levels prior to e9.0 (Figure S2). Fgf8 is normally
expressed in the midhindbrain boundary, the frontonasal
process, and at low levels within the lateral epithelium of the
maxillo-mandibular cleft (Figures 3C and 3C0). In Fuz mutants,
Fgf8 expression was expanded in all of these domains, with an
anterior expansion from the midhindbrain domain (Figure 3D,
bracket) and a mediolateral expansion within the mandibular
and maxillary prominences (Figures 3D and 3D0). This expansion
was maintained in mutant maxilla at E10.5 (Figure 3F). In addi-
tion, we found that Fuz knockdown in Xenopus also resulted in
broader Fgf8 gene expression, most strikingly in the domain
abutting the migratory NC and in the frontal midline (Figure S3).
Key transcriptional targets of FGF signaling, Erm1 and
Pea3 (Firnberg and Neubu¨ser, 2002; Raible and Brand, 2001;
Roehl and Nu¨sslein-Volhard, 2001), were strongly upregulated
in Fuz mutants (Figures 3I–3J0) including a clear rostral expan-
sion of both messenger RNAs (mRNAs) surrounding the
mesencephalon (Figures 3G–3J, asterisk). Furthermore, both
genes were robustly expressed throughout the expanded
maxillary primordia, in contrast to the wild-type littermates
(Figures 5H0 and 5J0, arrowhead). Together, these data iden-
tify a surprising role for Fuz in the regulation of Fgf8 gene
expression, and suggest that an aberrant increase in FGF
signaling underlies the craniofacial anomalies in Fuz mutant
mice.
Fgf8 Heterozygosity Rescues Maxillary Hyperplasia and
Palate Defects in Fuz Mutant Mice
Our analysis of Fuz mutants suggested that excessive FGF
signals drive the maxillary hyperplasia that underlies the
observed palate defects. To test this model directly, we asked
if decreasing the Fgf8 gene dose might ameliorate the craniofa-
cial defects in Fuz mutants. Using a null allele of Fgf8, in which
the coding region is replaced with the lacZ gene (Ilagan et al.,
2006), we halved the dose of Fgf8 in Fuz/ mice. We observed
substantial rescue of maxillary hyperplasia in Fuz/; Fgf8lacZ/+
compound mutants (compare Fuz mutants in Figures 4B
and 4B0 to rescued embryos in Figures 4C and 4C0). Heterozy-
gosity of Fgf8 also rescued the brain overgrowth and ocular
phenotypes observed in Fuz mutants (compare Figure 4E to
Figure 4F). Most strikingly, loss of one allele of Fgf8 restored
the e16.5 Fuz/ palate to a normal width (Figures 4H–4K; Fig-
ure S3), confirming that the early maxillary phenotype is due in
large part to an increase in FGF.
Because the Fgf8 and NC phenotypes we observed seemed
localized to the cranial structures, we hypothesized that pheno-
typic rescue after decreasing Fgf8 dose should be specific to the
head. Indeed, we found that Fgf8 heterozygosity had little effect
on digit development phenotypes in Fuzmutantmice (Figure S3).
Together, these data suggest that the proximate cause for
craniofacial defects in Fuz mutant mice is expanded Fgf8
expression, while the polydactyly is independent of Fgf8, result-
ing directly from aberrant cilia-mediated Gli3 regulation (Hey-
deck et al., 2009).
Conditional Disruption of Fuz in the NC Does Not Result
in High Arched Palate
Our data so far lead us to propose a model in which early dys-
regulation of cranial Gli processing in Fuz mutant mice leads to
excessive expression of Fgf8, which in turn causes an excess
of NC. We further propose that it is this early excess of NC,
rather than attendant crest migration defects, that results in
maxillary hyperplasia and high arched palate. To test this
model, we used the NC-specific Wnt1-cre driver to condition-
ally delete the Fuz gene. Notably, specific deletion of Fuz in
NC cells did not elicit early hyperplasia of the maxillary process
or high arched palate (Figure 5; data not shown). Instead, these
animals had a true cleft, indicating that, in the NC, Fuz is
required only much later for palatal shelf elevation or depres-
sion of the tongue. These data suggest that the early maxillary
phenotypes in Fuz mutant mice result from Fuz requirements in
the neural tissue prior to NC induction (see also the model,
Figure 7).
Maxillary Hyperplasia and FGF8 Upregulation in OFD-1
Mice
We next asked if Fgf8misregulation might be a general principle
in ciliopathies. We examined the mouse model of OFD syn-
drome, Ofd-1 (Ferrante et al., 2006). OFD patients frequently
present with high arched palate (Figure 6F) (Hennekam et al.,
2010; Prattichizzo et al., 2008; Tagliani et al., 2010), and OFD-1
is essential for ciliogenesis and centriole morphology (Ferrante
et al., 2006; Singla et al., 2010). Importantly, Ofd-1 mutant
animals were strikingly similar to the Fuz/ animals, with an
enormously enlarged maxillary process and a clear expansion
of cranial Fgf8 expression (Figures 6A–6D).
Broad Similarity between Fuz Mutant Mice and FGF
Hyperactivation Syndromes
Finally, the similarity of palatal phenotypes between OFD
patients and patients with FGF hyperactivation syndromes
such as Apert (Figures 6E–6G) suggest that ciliopathic cranial
phenotypes stem from excessive FGF signaling. If this were
the case, we hypothesized that Fuz/ mice might also display
craniosynostosis, another common feature of FGF hyperactiva-
tion syndromes. Therefore, we examined skull ossification
using Alizarin red staining and found complete synostosis of
the coronal sutures in Fuz mutant mice, akin to that seen in
Apert syndrome (Figures 6I–6I0, arrowhead). Mutants also
displayed other hallmarks of FGF syndromes, including fusion
of the cervical vertebra and upper airway anomalies (data not
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shown) (Anderson et al., 1997; Kreiborg et al., 1992; Moore et al.,
1995). Thus, our data suggest widespread commonalities
between ciliopathic craniofacial defects and FGF hyperactiva-
tion syndromes.
Figure 4. Fgf8Reduction RescuesMaxillary
Hyperplasia and Palatal Width in Compound
Mutants
(A–C) Lateral views of BA1. Maxillary size is
expanded in Fuz/ mutants in (B) compared to
Fgf8LacZ/+ in (A). Maxillary expansion is rescued in
Fuz/; Fgf8LacZ/+ embryos in (C). Fgf8 expression
is also rescued in compound mutants as b-gal
staining reveals similar BA1 epithelial expression
in compound mutants and Fgf8 heterozygotes.
(A0–C0) Maxillary size is schematized for each
genotype.
(D–F) Lateral view, E12.5. Maxillary size is
expanded in mutants in (E) compared to Fgf8LacZ/+
in (D). Maxillary expansion is rescued in Fuz/;
Fgf8LacZ/+ embryos in (F). Normal Fgf8 expression
(b-gal/blue) is also restored in compoundmutants.
Brain overgrowth and eye defects are rescued in
compound mutants (arrowheads).
(G–I) Trichrome staining of coronal sections of
E16.5 embryos. Palatal width and bone angle are
decreased in mutant embryos in (H) compared to
controls in (G). Palatal width in Fuz/; Fgf8LacZ/+ in
(I) appears normal compared to controls in (H).
Angle of palatine bone is partially rescued when
compared to controls, as shown in (I) compared to
(G) and (H).
(J) Schematic of palatal anatomy.
(K) Quantification of palatal width in E16.5
Fuz+/+; Fgf8LacZ/+(blue), Fuz/; Fgf8+/+ (green),
and Fuz/; Fgf8LacZ/+(red) embryos. Palatal width
is significantly decreased in Fuz/; Fgf8+/+
compared to controls, while Fgf8 heterozygosity
rescues palatal width in Fuz mutants (p < 0.0005,
one-way analysis of variance). Whiskers represent
maximum/minimum data values with median and
quartiles represented in the box.
See also Figure S3.
DISCUSSION
Recent evidence reveals significant roles
for cilia in human development and dis-
ease. First, mutations in genes known to
promote cilia biogenesis and IFT have
been implicated in a number of human
syndromes (Ferkol and Leigh, 2012). Sec-
ond, analysis of animal models suggests
that a variety of developmental disorders,
including craniofacial dysmorphology,
result from defects in ciliary function
(Huber and Cormier-Daire, 2012). Finally,
advances in clinical genomics have
improved annotation of disease alleles,
subsequently identifying numerous, un-
classified syndromes as ciliopathies
(Brugmann et al., 2010). The challenge
now is understanding how these seem-
ingly heterogeneous disorders arise (Novarino et al., 2011), and
our data suggest that commonalities in phenotype are likely to
reflect shared signaling events, which converge into shared phe-
notypes. The results reveal an association between ciliopathies
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and FGF syndromes, in turn providing insights into the diversity
of phenotypes seen in craniofacial anomalies.
We present the Fuz mutant as a genetic model of ciliopathic
high arched palate and provide experimental evidence of the
causes of this defect (Figure 7). Some aspects of skeletal devel-
opment in Fuz mutants have been previously described; how-
ever, those reports focus on mandibular outgrowth (Zhang
et al., 2011). We propose that the high arched palate arises
due to perturbation of facial development in the Fuz mutant
well before the stages examined previously and that the reported
effects on Hh and Wnt signaling are secondary to an earlier
developmental defect (Zhang et al., 2011).
Our data suggest that early expansion in Fgf gene expression
drives maxillary phenotypes in the Fuz mutant model (Figure 7),
but how does loss of a ciliopathy gene lead to an expansion of
FGF signaling? Inwild-type embryos,Gli3 repressor is expressed
in the midbrain, where it acts as a transcriptional repressor, and
indeed, Gli3R normally suppresses Fgf8 expression in neural
tissues, as loss of Gli3 leads to an increase in Fgf8 (Aoto et al.,
2002). Gli3 processing from Gli3-A (activator) to Gli3-R
(repressor) is thought to occur at the distal tip of the cilium (Fig-
ure 7A) (Endoh-Yamagami et al., 2009; Lai et al., 2011; Tukachin-
sky et al., 2010; Wen et al., 2010). This distal tip of
the ciliary axoneme is specifically lost in the absence of Fuz
(Brooks and Wallingford, 2012) and likely leads to attenuated
Gli3 processing (Figure 3). Subsequently, loss of Gli3R reduces
transcriptional inhibition, permitting expansion of hindbrain fates,
and Fgf8 expression.
Previous studies in chicken embryos have implicated brain-
specific Fgf8 in the control of NC numbers (Creuzet et al.,
2004). How does this occur? DiI labeling has shown that, in
mouse, anterior NC destined for BA1 arises from the posterior
mesencephalon and rhombomere 1 (Osumi-Yamashita et al.,
1994). Loss of Hh activity leads to dorsalization or expansion
of these structures (Fedtsova and Turner, 2001), concurrently
increasing Fgf8 expression and the NC domain. As a conse-
quence, increased numbers of NC cells migrate toward BA1,
overfilling it and forming enlarged maxillae (Figures 2 and 3).
Subsequently, Fgf8 is also upregulated in the BA1 epithelium,
as well as in the frontonasal prominence (Figure 3). Following
NC migration, the palatal condensation (Figure 7, red) arises
medially, adjacent to Fgf8 expression domains; in mutants, the
grossly enlarged maxillary region causes a medial shift in palatal
condensations (Figure 7).
These findings are significant for exposing an etiological link
between the ciliopathies and FGF hyperactivation disorders.
Furthermore, our data suggest that the long-held midface
hypoplasia model for high arched palate should be revisited
(Hayward et al., 2004; Hennekam et al., 2010). One source of
confusion may be the disparity between observations in human
patients versus phenotypes associated with mouse models. For
example, Snyder-Warwick and colleagues examine palatal
development in mice carrying a Crouzonmutation (FGFR2C342Y),
which causes increased FGF signaling associated with craniosy-
nostosis (Snyder-Warwick et al., 2010). In these mice, heterozy-
gotes, which should mirror the human genotype, have normal
palates. Furthermore, homozygotes have a true cleft, mimicking
a loss of FGFR2b (Hosokawa et al., 2009; Rice et al., 2004). This
clearly does not model the oral aspects of the human syndrome,
as it was noted nearly 40 years ago that true clefts in Crouzon
patients were likely to be misdiagnoses (Peterson and Pruzan-
sky, 1974).
Importantly, the relationship between ciliopathy and FGF
hyperactivation syndromes is not limited to the palate, as Fuz
mutant mice also display other manifestations of the FGFR-
associated syndromes, such as craniosynostoses, fusions of
the cervical vertebrae, and tracheal cartilaginous sleeve (Fig-
ure 6; data not shown). Finally, we note that this relationship is
not restricted to animal models, as high arched palate and
synostoses also co-occur in the human ciliopathy Sensenbren-
ner syndrome (Levin et al., 1977; Sensenbrenner et al., 1975).
Notably, the cilia defects in Sensenbrenner syndrome are
caused by mutations in proteins of the retrograde IFT particle,
including IFT43 (Arts et al., 2011), and we recently showed that
ciliogenesis defects following disruption of Fuz stem from a
failure of IFT43 trafficking (Brooks and Wallingford, 2012).
Thus, in summary, our studies of a high arched palate model
have revealed that excessive FGF transcription and increased
Figure 5. Maxillary Hyperplasia Is Not Due to Fuz Function in the NC
(A and B) Lateral views of E17.5 Wnt1-cre; Fuzfl/+ and Wnt1-cre; Fuzfl/
embryos. The control embryo in (A) is an albino and lacks pigment in the eye.
Arrowheads indicate rostral midline.
(A0 and B0) Frontal views of E17.5 Wnt1-cre; Fuzfl/+ and Wnt1-cre; Fuzfl/
embryos. A cleft lip is observed in conditional null embryos [(B0) compared to
(A0), indicated by arrowheads].
(A00 and B00) Hemotoxylin and eosin (H&E) staining of coronal sections of E17.5
Wnt1-cre; Fuzfl/+ and Wnt1-cre; Fuzfl/ embryos. Sections show the anterior
secondary palate (P), tongue (T), and molars (M). Palatal shelves are elevated
and fused across the midline in control embryos; however, a failure in shelf
elevation is observed in Wnt1-cre; Fuzfl/ embryos [(B00) compared to (A00),
indicated by P]. The tongue also appears smaller and irregularly shaped in
mutants [(B00) compared to (A00) indicated by T].
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NCmay be key factors in the poorly understood etiology of cilio-
pathic craniofacial defects. Furthermore, our report demon-
strates that the pathological events underlying this phenotype
are surprisingly different from those leading to a traditional cleft
palate, raising the possibility that clinical diagnoses and man-
agement of high arched palate should also be reconsidered in
this developmental and molecular context.
EXPERIMENTAL PROCEDURES
Mouse Lines
The followingmouse lines were used: Fuzmutants: Fuzgt(neo) (Gray et al., 2009);
conditional Fuz mutants: Fuzfl/fl, which were generated according to standard
methods and will be described elsewhere; conditional Ofd-1 mutants:
Ofd1tm2.1Bfra (Ferrante et al., 2006); Fgf8 mutants: Fgf8lacZ (Ilagan et al.,
2006); Wnt1-cre driver: Tg(Wnt1-cre)11Rth (Danielian et al., 1998); and
reporter lines: R26RmT/mG: GT(Rosa)26Sortm4(ACTB-tdTomato-EGFP)Luo (Muzum-
dar et al., 2007) and R26RlacZ:Gt(ROSA)26Sortm1Sor (Soriano, 1999). Genotyp-
ing was performed as described in the original publications cited earlier. In all
phenotypes depicted, at least four animals per genotype were examined. All
animal work was performed in accordance with UK Home Office Regulations.
Western Blotting
Tissues rostral to and including BA1 were dissected from E9.0 embryos. Pro-
tein preparations and western blotting were carried out according to estab-
lished protocols. Primary antibodies used were anti-Gli3 (clone H-280,
1:1,000, Santa Cruz Biotechnology no. sc-20688) and anti-alpha tubulin (clone
DM1a, 1:5,000, Sigma T6199). Chemiluminescent signal was visualized using
a BioRad ChemiDoc.
Real-Time PCR
Tissues rostral to and including BA1 were dissected from E9.0 embryos.
Reverse transcription and cDNA synthesis were carried out according to
standard protocols. Real-time PCR (RT-PCR) reactions were performed on a
Rotorgene Q 2-series using the following gene-specific primer pairs.
b-actin (F: CTAAGGCCAACCGTGAAAG, R: ACCAGAGGCATACAGG
GACA)
Gli1 (F: CAGGGAAGAGAGCAGACTGAC, R: CGCTGCTGCAAGAGACT)
Patched1 (F: AAGCCGACTACATGCCAGAG, R: AAGGGAACTGAGCGT
ACTCG)
Fgf8 (F: AGGTCTCTACATCTGCATGAAC, R: TGTTCTCCAGCACGAT
CTCT)
Erm (F: TGCCCACTTCATCGCCTGGAC, R: TAGCGGAGAGAGCGGC
TCAG)
Staining and Histology
All mRNA in situ hybridization, immunohistochemistry, b-gal activity, and his-
tological staining were performed according to standard protocols. Mouse
Figure 6. Ofd-1 Mutants Also Show Expanded Maxillary Compart-
ments and Cranial FGF8 Expression Domains
(A–D) Lateral views of E9.5 embryos showing cranial Fgf8 mRNA expression
domains. The 21 and 23 somite ofd-1 mutants have enlarged maxillae
compared to stage-matched control embryos, indicated by yellow brackets in
(B) and (D) compared to (A) and (C), respectively. Maxillary Fgf8 expression is
expanded in mutants compared to controls [brackets in (B) and (D) compared
to (A) and (C), as well as expression in the frontonasal process, indicated
by arrowheads].
(E–G) OFD-1 and Apert syndrome patients exhibit high arched palate. In (E), a
ventral view of a normal palate shows a hard palate with shallow, anterior
bilateral rugae and smooth posterior palate (after photo by Millicent Odunze:
http://plasticsurgery.about.com/od/Cleft-Lip-And-Palate/ss/
What-Is-A-Cleft-Palate_3.htm). In (F), a ventral view is shown of the palate from
OFD 1 (OFD-1) patient (after Tagliani et al., 2010; Figure 2F). (G) shows a
ventral view of palate from the Apert syndrome patient (after Rynearson, 2000).
Both (F) ciliopathic and (G) FGF-related high arched palates are narrow with a
deep medial cleft extending from the anterior hard palate. Rugal-like swellings
are more numerous and are extant with the medial cleft. Soft tissue swellings
and dental crowding are observed in both groups.
(H–I0) Loss of Fuz causes coronal craniosynostosis. E17.5 heads stained with
Alizarin red. (H) and (I) show dorsolateral views. (H0) and (I0) show dorsal views.
Alizarin red negative coronal suture (open arrowheads) separates frontal (F)
and parietal (P) bones in wild-type embryos. Coronal suture is absent in mutant
embryos (closed arrowheads).
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and Xenopus embryos were collected in cold PBS and fixed overnight in 4%
paraformaldehyde or MEMFA, respectively. mRNA in situ hybridization was
performed as previously described (Sive et al., 2000; Wilkinson et al., 1989).
The following mRNA probes were used: mouse Fgf8 (Mahmood et al., 1995),
mouse erm (Hippenmeyer et al., 2002), mouse Pea3 (Livet et al., 2002),
X. laevis Fgf8 (Monsoro-Burq et al., 2003), and X. laevis twist (Hopwood
et al., 1989). Primary antibodies used for immunohistochemistry: anti-rabbit
phospho-histone H3 (PH3) (BDH, 1:200) or anti-rabbit b-catenin (Sigma,
1:200). Sections were coverslipped with ProLong Gold antifade reagent with
DAPI (Invitrogen, P36931).
Confocal Microscopy and Image Analysis
To analyze NCmigration, whole-mount E9.0 embryos were cleared using 70%
glycerol/PBS andmounted on slides. Sagittal confocal z-stacks were obtained
using a Leica TCS SP5 DM16000. Image sequences were reconstructed using
Imaris image analysis software. Thickness of NC streams were determined by
measuring the depth of GFP positive NC cells at three points anterior to the
trigeminal ganglion, posterior to the maxillary compartment (outlined in
Figure 3).
mCT
Specimens were scanned using a GE Explore Locus SP mCT scanner. The
specimens were immersed in 20% (w/v) Pluronic F-127 (Sigma) at 4C and
warmed to room temperature for immobilization. Specimens were scanned
to produce 8 mm voxel size volumes, using an X-ray tube voltage of 80 kVp
and a tube current of 80 mA. An aluminum filter (0.05 mm) was used to adjust
the energy distribution of the X-ray source. The specimens were characterized
further by making three-dimensional isosurfaces, generated and measured
using Microview software (GE).
Flow Cytometry of Embryo Heads
Cell purification from embryonic tissues was performed as previously
described (Schulz et al., 2012). Heads from Wnt1-cre; R26mT/mG embryos,
as depicted in Figure 2E, were digested and passed through a 100 mm cell
strainer. Flow cytometry was performed using a BD Biosciences FACSAria II
cell sorter. Live cells were identified using side scatter and forward
scatter (FSC-A), followed by doublet exclusion using forward scatter
width against FSC-A. Populations were identified using endogenous exp-
ression of GFP and Tomato. All data were analyzed using FlowJo 9.53
(Celeza GmbH).
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Figure 7. Proposed Model for Palatal Defects in Fuz Mutants
(A and B) Schematics depict E8.5 embryos. In Hedgehog signaling, anterograde transport delivers Gli3L (Gli3-activator) to the distal CLAMP-positive ciliary tip
(red). Gli3-L is processed into Gli3-S (Gli3 repressor) which undergoes retrograde transport, repressing transcription of targets such as FGF8. Anterior NC (dark
green) arises from the posterior mesencephalon and anterior hindbrain (purple), and is normally limited by a balance of Hh and FGF signals. NC thenmigrates into
BA1, comprising maxillary and mandibular compartments (Mx and Md, respectively). When Fuz function is lost, ciliary transport and the distal compartment are
severely disrupted leading to disruption of Gli processing and an expansion in cranial NC numbers, specifically maxillary NC.
(C–F) In (C) and (D), schematics depict coronal sections of E9.5 embryos. In coronal sections, the maxilla forms as two bilateral prominences and Fgf8 is
expressed in lateral maxillary epithelia, indicated by purple in (C) through (F). In mutants, themaxillary compartment is enlarged and epithelial Fgf8 is expanded. In
(E) and (F), schematics depict coronal sections of E10.5 embryos. Palatal condensations (red) aremedial to FGF8 expression domains. In wild-type animals, these
flank midline mesenchyme but remain separated. In Fuz mutants, expansion of FGF8 causes a medial shift of the palatal condensations. Subsequently, the
normal bilateral palatal primordia join at the midline.
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Congenital skeletal anomalies are rare disorders, with a subset affecting 
both the cranial and appendicular 
skeleton. Two categories, craniosynostosis 
syndromes and chondrodysplasias, 
frequently result from aberrant regulation 
of the fibroblast growth factor (FGF) 
signaling pathway. Our recent work 
has implicated FGF signaling in a third 
category: ciliopathic skeletal dysplasias. 
In this work, we have used mouse 
mutants in two ciliopathy genes, Fuzzy 
(Fuz) and orofacial digital syndrome-1 
(Ofd-1), to demonstrate increase in Fgf8 
gene expression during critical stages of 
embryogenesis. While the mechanisms 
underlying FGF dysregulation differ 
in the different syndromes, our data 
raise the possibility that convergence on 
FGF signal transduction may underlie a 
wide range of skeletal anomalies. Here, 
we provide additional evidence of the 
skeletal phenotypes from the Fuz mouse 
model and highlight similarities between 
human ciliopathies and FGF-related 
syndromes.
Fibroblast growth factors are well-
studied signaling molecules that are critical 
for embryonic development.1,2 In humans, 
22 structurally related FGF ligands have 
been identified; most of these are secreted 
proteins that bind with varying affinities 
to tyrosine kinase receptors (FGFR1–4). 
The majority of FGF ligands can bind 
promiscuously to multiple different 
FGFRs; further complexity is generated 
by alternative splicing of FGFR1, 2 
and 3. Ligand binding induces receptor 
dimerization and cross-phosphorylation, 
which then initiates a broad range of 
intracellular signaling cascades such as 
PI3 kinase (PI3K), MAPK, phospholipase 
C (PLCγ) or JAK/STAT. Activation 
of the pathway elicits diverse cellular 
responses, including proliferation and 
differentiation of multiple cell types. In 
recent years, developmental studies, as 
well as identification of human alleles, 
has made it clear that precise temporal 
and spatial activation of FGF signaling is 
necessary for normal development.
The FGF signaling pathway is a key 
regulator of skeletal development. In 
humans, mutations in the FGF receptors 
(FGFRs) are a hallmark of two classes 
of skeletal anomalies: craniosynostoses 
and chondrodysplasias (reviewed 
by Ornitz et al.).1 Craniosynostosis 
syndromes are characterized by 
premature fusion of the cranial sutures 
and are frequently accompanied by 
malformations of the axial skeleton. 
In contrast, chondrodysplasias feature 
truncation of the appendicular skeleton, 
due to an increase in FGF signaling 
during endochondral ossification. Both 
craniosynostosis and chondrodysplasia 
syndromes are associated with autosomal 
dominant mutations of the FGF receptors, 
which result in increased activation 
of the signaling pathway.1 The array 
of phenotypes correlates with specific 
mutations in different receptors, but the 
net effect appears to be that sustained or 
increased FGF signaling tips the balance 
between critical steps in osteoblast 
differentiation.1,2
Ciliopathies are a heterogeneous group 
of disorders that arise from abnormal 
formation or function of the cilium.3 Cilia 
are finger-like organelles at the cell surface 
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comprised of a microtubule axoneme 
attached to a basal body. Depending on 
the microtubule arrangement, a cilium 
may be motile or immotile. Disorders of 
the motile cilia frequently involve fluid 
flow; for example, patients with primary 
ciliary dyskinesia have difficulty clearing 
mucus from their lungs due to defects in 
the multi-ciliated epithelium.4 Immotile or 
primary cilia stand alone and are required 
for function of many signaling pathways.5 
To date, ciliopathic skeletal phenotypes 
have mainly been attributed to changes 
in primary cilia-dependent transduction 
of Hedgehog signals.6 This has been 
best studied in the long bones; however, 
the phenotypic range of ciliopathies 
is extremely broad. As a consequence, 
it can be difficult to diagnose or treat 
ciliopathies, and the underlying etiology 
is often unclear.
Ciliopathies affecting the skeleton 
are rare syndromic anomalies. Some 
patients exhibit limb phenotypes such 
as syndactyly or polydactyly [in the 
case of Bardet-Biedl syndrome (MIM 
#209900)].7,8 Dysplasia of the ribs, and 
occasional shortened limbs, are also 
seen, as in Jeune asphyxiating thoracic 
dystrophy (MIM #208500).9 Frequently, 
ciliary defects also lead to changes in 
the craniofacial skeleton in humans 
and mice,10-12 with craniosynostosis 
observed in Sensenbrenner syndrome 
or cranioectodermal dysplasia (MIM 
#614378).13 The broad range of systems 
affected suggests varied molecular 
causes. Thus, grouping similar skeletal 
phenotypes across multiple disorders, and 
Figure 1. Skeletal preparations of wild-type and Fuz–/– embryos at e18.5. Alizarin red staining marks the bone. Alcian blue staining marks the cartilage. 
(A and B) dorsal views of the skull. (A) control. (B) mutant mice display synostosis of the coronal suture (yellow arrowhead) as well as an open anterior 
fontanelle (yellow asterix). (C and D) dorsal view of the axial skeleton. (C) control. (D) in mutant animals, the cervical vertebra (cv, bracket) are fused. 
Ossification of the centrum in thoracic vertebra is lost or aberrant (yellow arrow). (E and F) Frontal views of the sternum. (E) control. (F) in mutants, the 
sternum is shorter, hyperossified and cleft/bifid (black arrow). 
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comparison with animal models, may 
provide useful insight into the underlying 
molecular events.
The Fuzzy gene is associated with neural 
tube defects and has previously been shown 
to be a ciliopathy gene.14-17 In our current 
work, we examine the requirements for 
Fuz in development of the craniofacial 
structures.18 Craniofacial defects include 
craniosynostosis and facial anomalies 
(Fig. 1A and B).18 As documented in 
Tabler et al., Fuz mutant mice have a 
complete synostosis of the coronal suture, 
as well as an open anterior fontanelle, 
reminiscent of Apert syndrome synostoses 
(MIM #101200) (Fig. 1A-B).19 Our 
analysis of the Fuzzy mutant also showed 
broader defects of the skeleton. Consistent 
Table 1. Skeletal phenotypes observed in ciliopathies and FGF syndromes. included are selected human disorders and animal models. unfortunately, 
due to space constraints, we regret that we are unable to cite all relevant papers.
Affected structure
Skull/Face Palate Limb/Hand Vertebra Rib/Thorax Sternum Refs.
Ciliopathies
Human
meckel encephalocele c Pd ? - - 20
Bardet-Biedl Shape change HA Pd, Sd scoliosis - - 37
Joubert - c? - cervical fusion - - 28
OFd1 Shape change HA Pd - - - 20
Jeune - - Pd cervical stenosis irregular bulge 9, 38
Sensenbrenner SS HA Sl, Pd - Short ribs - 13, 39–41
ellis-Van creveld - - Sl, Pd - Short ribs - 42
Mouse Models
meckel: MKS1hlb614/MKS1krc - c - - - bifid, fused 35, 43
ellis-van creveld: EVC - - Sl Fusions Short ribs - 44, 45
Orofacial digital: OFD1 - c Sl, Pd - - bifid, fused 46, 47
Sensenbrenner: WDR35 - - - - Short ribs - 48
ciliopathy: Fuz cS HA Sl, Pd cervical fusion Short ribs Fused, bifid 14, 16–18
Craniosynostosis
Human
Apert cS HA Sd cervical fusion - - 19, 49
crouzon cS HA Sl, Sd cervical fusion - - 21, 50
Pfeiffer cS HA Sd cervical fusion - - 22, 23
Mouse Models
crouzon/Pfeiffer: Fgfr2cC342Y cS c - - - Fused 51, 52
Pfeiffer: tg(Fgfr1P252R) cS - Pd Homeotic transformation - Fusions 27
Apert: Fgfr2IIIc/Δ cS - - - - Fused 29, 53
Apert: Fgfr2S252W cS c - - - Fusions 30
Chondrodysplasia
Human
chondrodysplasia punctata 2 variable - Sl Scoliosis fusions calcified calcified 20
Hypochondroplasia variable - Sl stenosis - - 53
thanatophoric dysplasia - - Sl flattened Short ribs - 54
Achondroplasia Small base - Sl stenosis Small chest - 55
Mouse Models
Achondroplasia: Fgfr3G374R - - Sl cervical fusion - - 56
thanatophoric 
dysplasia: FGFr3369
- - Sl - Short ribs - 57
Abbreviations: SS, sagittal synostosis; cS, coronal synostosis; c, cleft palate; HA, high arched palate; Pd, polydactyly; Sd, syndactyly; Sl, short limbs
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with ciliopathic Hedgehog phenotypes, 
Fuz mutants have polydactyly and 
shortened long bones.17 Most interesting, 
we also found anomalous elements in the 
axial skeleton. The cervical vertebra (cv) 
were frequently fused (Fig. 1C and D, 
bracket), while ossification of the centrum 
in the thoracic vertebra is generally absent. 
Occasionally, small islands of ectopic 
ossification are seen (Fig. 1C and D, 
yellow arrow). As in ciliopathies such as 
Jeune Syndrome (MIM #208500), the 
ribs are shorter. Surprisingly, the sternum 
is hyperossified, shorter, and bifid 
(Fig. 1E and F, black arrow marks cleft). 
In earlier stages, cartilaginous joints are 
formed (data not shown); by embryonic 
day (E)18.5, the sternal joints have been 
obliterated (Fig. 1E and F).
This array of phenotypes suggested 
a similarity to several classes of 
FGFR-dependent skeletal anomalies, 
including craniosynostosis syndromes 
and chondrodysplasias.20  All of these 
syndromes arise from dysregulation of 
FGF receptors;1 however, the status of 
FGF signaling in ciliopathy mutants has 
not been well explored. Table 1 catalogs 
the skeletal malformations ciliopathies 
and FGF related syndromes. We found 
significant overlap across the range of 
disorders.
Many craniosynostosis patients 
have a progressive fusion of the cervical 
spine, with two thirds of Apert patients 
exhibiting complex fusions in the C5-C6 
segment.21 C2-C3 fusions are also quite 
common in these syndromes, with 
additional reports from Saethre-Chotzen 
(MIM #101400) and Pfeiffer syndromes 
(MIM#101600).22-24 To our knowledge, 
FGF-induced chondrodysplasias are 
not associated with spinal stenosis; 
however, cases have been reported in 
rhizomelic chondrodysplasia punctata 
patients.25 Interestingly, congenital 
scoliosis due to vertebral defects has also 
been linked to aberrant FGF signaling 
during development.26 In addition, in 
a mouse model of Pfeiffer syndrome, 
vertebral homeotic transformations have 
been noted.27 Thus, phenotypes seen in 
the different mouse models, combined 
with some reported anomalies of the 
cervical vertebra in Joubert Syndrome 
(MIM #213300), suggest that ciliopathy 
patients could be assessed for spinal 
aberrations.28
Sternal abnormalities, a common 
feature of ciliopathies and FGF syndromes, 
are another striking phenotype seen 
in Fuz mutants. Premature or ectopic 
fusion of the sternum is seen in a number 
of mouse models, including Apert/
Pfeiffer Syndrome and achondroplasia 
mice.27,29-31 The current data suggest that 
hyperactivation of FGF receptors leads to 
an impairment in sternal joint formation 
and subsequent hyperossification. In 
humans, premature ossification of 
the sternum is a hallmark of Noonan 
syndrome.32 The causative mutation in 
Noonan syndrome is PTPN11, which 
encodes SHP-2, a key regulator of the 
FGF-Ras-MAPK pathway.33 Finally, 
sternal anomalies are also observed in 
ciliopathic animal models.34,35
Taken together, our data suggest 
that the skeletal anomalies described 
may all converge on deregulation of 
the FGF signaling pathway. Indeed, we 
found that a subset of phenotypes in our 
ciliopathic mouse mutants, Fuz and OFD-
1, are attributable to increased Fgf8 gene 
expression and genetic reduction of FGF8 
rescued these phenotypes.18
Our approach of cataloguing 
human phenotypes, and comparison 
to animal models, led us to a surprising 
role for FGFs in ciliopathies. However, 
clearly, FGFs alone, or in combination 
with Hedgehog signaling, cannot be 
the sole molecular players in skeletal 
dysplasias. FGF signaling plays roles 
at multiple steps in both endochondral 
and intramembranous ossification.1 For 
example, during long bone formation, 
signaling via FGFR2 and FGFR3 
promotes chondrocyte condensation 
and differentiation respectively. Later 
in this process, FGFR3 is needed to 
limit the amounts of proliferative 
pre-hypertrophic chondrocytes. In 
intramembranous ossification, as seen in 
the calvaria, FGFs are involved in every 
step of osteoblast differentiation and 
subsequent ossification. FGFR1 and 2 are 
expressed at the osteogenic front, and are 
necessary for osteoblast differentiation. 
FGF2 is expressed in the sutures, and 
signals to the adjacent osteogenic cells. 
Thus, specific phenotypes observed in 
the human syndromes described can 
be attributed to inappropriate temporal 
or spatial activation of the pathway. 
For example, hyperactivation of 
FGFR3 severely reduces regions of pre-
hypertrophic chondrocyte proliferation 
resulting in short long bones. Conversely, 
FGFR1 and 2 dysregulation leads to 
premature osteoblast differentiation and 
craniosynostosis.
Dysregulation of Gli processing is 
also known to cause a variety of skeletal 
defects, notably in the long bones, vertebra 
and sternum. Gli2 mouse mutants have 
shortened long bones and absence or 
malformation of vertebral bodies, while 
Gli3 mutants have slightly shortened long 
bones accompanied by polydactyly, as 
well as fusions of the cervical vertebra and 
bifid, hyperossified sterna.36 Thus, there 
is substantial phenotypic overlap between 
Gli mutants and other animal models of 
skeletal syndromes. As described above, it 
is likely that correct timing and location 
of a suite of signals is critical for shaping 
the skeleton. Because pathological 
mutations can lead to changes at 
multiple levels during development, 
we propose that further comparison of 
human phenotypes and animal models 
can provide important insights into the 
genetic networks governing overlapping 
disease phenotypes.
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